data_2joa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2joa _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.711 0.291 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -141.76 123.14 14.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.257 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 5.4 pt -113.29 -13.72 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.347 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 72.14 57.53 5.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.772 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 12.4 tt -160.18 151.74 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.417 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 17.7 mtt180 -106.02 127.6 53.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.71 145.29 48.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.9 ptm -127.27 160.55 30.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 83.9 p -85.4 110.02 18.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.5 tp -58.06 89.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.018 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 5.7 t -75.72 166.47 23.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.77 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.1 t -49.53 -36.11 22.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.425 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -63.73 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.175 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -49.6 75.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.9 -39.69 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.313 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.04 -29.19 39.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.6 -34.81 79.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.19 -43.15 78.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.05 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -59.63 -34.35 72.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.64 -37.87 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -82.51 -70.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 96.46 8.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.04 60.43 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.8 14.23 1.92 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.23 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.31 150.96 40.08 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.09 179.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.87 28.42 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 14.9 m -101.38 173.84 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.441 HG22 HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -138.63 16.7 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.373 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.2 p -116.2 139.89 49.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.882 0.372 . . . . 0.0 110.801 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.12 167.06 11.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.35 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -101.56 142.9 32.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.128 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -104.14 130.38 51.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 17.4 mt -80.08 128.76 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.54 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 62.7 mt -96.24 -68.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.563 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 153.12 40.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 0.0 111.044 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.16 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.464 ' HB ' HG22 ' A' ' 421' ' ' THR . 1.5 mp -79.84 134.69 56.57 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.308 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.421 ' HD2' HG21 ' A' ' 418' ' ' ILE . 57.1 Cg_exo -53.97 -11.21 2.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.249 2.632 . . . . 0.0 114.678 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -130.95 76.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.464 HG22 ' HB ' ' A' ' 418' ' ' ILE . 0.2 OUTLIER -160.15 163.58 21.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.603 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.64 -25.17 78.13 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.408 2.072 . . . . 0.0 111.6 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -59.14 -54.67 44.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.169 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.08 -31.08 65.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.5 -30.51 59.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.265 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.98 -38.15 84.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.35 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.77 29.42 1.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.82 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.97 -164.28 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.686 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.25 163.71 22.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.854 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 41.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 0.0 110.977 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -151.88 28.54 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.57 -177.04 3.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 29.8 t -136.68 123.21 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.315 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.04 157.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.0 pp -148.79 -46.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.411 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 54.2 p -124.34 160.95 26.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.979 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.421 HG12 ' ND2' ' A' ' 438' ' ' ASN . 2.8 tt -156.58 119.57 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.249 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . 0.421 ' ND2' HG12 ' A' ' 437' ' ' ILE . 19.6 p30 43.54 46.94 6.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.718 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 74.27 47.18 18.2 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.713 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -142.95 161.49 37.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.679 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 61.9 m -111.62 110.5 20.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.961 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 5.3 t -95.04 152.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.9 m -130.12 -42.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.453 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 2.2 p -134.3 172.35 13.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 0.0 111.242 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -56.38 -42.97 78.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.408 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 25.1 p30 -55.31 -29.14 57.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.843 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.52 -35.68 45.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 32.4 t -69.75 -41.51 79.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.266 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 20.2 t -54.78 -62.62 1.54 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.529 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -48.28 -35.97 13.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.409 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.3 t -65.81 -46.05 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.068 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 6.5 mt -61.92 -31.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.03 -14.3 24.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.455 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -94.37 -44.99 7.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.317 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.13 128.52 53.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 53.9 m -70.2 -37.71 75.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.7 p -104.25 121.38 43.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.582 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 9.2 mt -107.38 129.27 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -127.92 83.07 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.642 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.68 136.62 32.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.07 126.51 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.164 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 11.6 t -121.15 129.3 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -89.73 120.96 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -124.3 128.52 49.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.03 -100.98 0.89 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.347 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -139.93 23.85 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -141.91 148.35 38.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.147 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -91.73 136.46 33.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.01 146.59 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.216 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -101.89 119.92 39.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 12.1 mm -107.17 133.6 51.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.54 126.55 55.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.936 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.98 130.35 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.03 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 33.8 mm -105.24 109.92 63.8 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.06 175.49 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -123.92 155.81 37.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.985 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 60.4 71.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 pt -84.82 134.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . 0.408 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 12.5 m95 -117.91 91.11 3.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.417 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 3.8 t90 -70.71 72.47 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.118 179.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.679 0.276 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.435 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 52.1 t80 -152.97 131.76 12.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 22.4 pt -116.85 -14.95 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.62 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.435 ' HA2' ' CZ ' ' A' ' 382' ' ' TYR . . . 67.01 61.95 4.83 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.882 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 10.3 tt -165.37 137.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 111.266 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.485 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -96.59 145.9 25.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.782 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.46 139.5 33.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.742 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.2 ptm -116.83 162.88 17.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.9 p -85.37 115.85 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.13 84.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.8 t -71.12 173.7 7.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.9 m -62.56 -19.1 63.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.305 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -46.43 12.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 -32.65 27.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.58 -51.02 62.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.386 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.19 -29.47 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -38.09 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.06 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 6.1 mt -62.45 -52.58 62.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.059 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -29.93 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -60.0 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -65.68 -42.4 91.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.058 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.411 ' HB3' ' CD2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -119.89 113.94 21.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -82.92 -27.44 30.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -25.64 59.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 402' ' ' HIS . 4.8 m-85 -55.46 161.27 3.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.53 173.2 10.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.59 2.193 . . . . 0.0 112.21 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -98.31 30.98 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 13.2 m -114.66 126.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.66 -30.16 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.51 173.78 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 104.65 173.94 24.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.443 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.28 140.14 43.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.15 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -90.54 128.06 36.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.668 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 8.0 mt -79.88 127.94 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 9.6 mm -85.4 -69.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -160.14 153.79 22.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.723 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.09 139.05 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.454 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 22.7 mm -79.75 146.57 64.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.507 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 15.8 Cg_exo -69.52 6.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.822 2.348 . . . . 0.0 113.877 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.06 62.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.146 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.454 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 0.1 OUTLIER -155.42 171.81 6.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.772 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 82.3 Cg_endo -79.19 -18.12 11.36 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.535 2.157 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -60.43 -58.87 6.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.049 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.37 -27.76 66.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.859 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.63 38.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.383 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.24 -39.19 32.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.435 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 133.24 16.97 1.16 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.154 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 3.0 mt -85.99 -170.65 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.074 0.437 . . . . 0.0 110.68 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.82 141.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 16.0 pm0 -62.22 178.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 62.88 23.5 14.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.805 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -125.42 -177.11 3.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.554 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -139.47 123.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 111.536 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.3 154.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.86 -49.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.683 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 52.3 p -114.14 155.43 26.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.207 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.1 tt -157.77 111.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.028 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 13.5 p30 45.43 41.65 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.578 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 78.7 35.1 32.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.769 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -134.62 125.57 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.766 0.317 . . . . 0.0 110.924 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 68.8 p -80.93 110.77 16.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 10.8 t -92.2 143.1 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.11 -32.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.48 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.99 177.59 9.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.239 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.45 98.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.037 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.425 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 24.5 p30 -53.87 -26.25 23.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.91 -50.69 10.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.688 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 41.3 t -56.75 -37.25 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.291 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 24.8 t -57.1 -65.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.399 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -51.67 -32.16 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.37 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.64 -49.91 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 9.1 mt -58.25 -29.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -97.14 -14.28 21.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.422 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -97.64 -54.64 3.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -86.48 126.3 34.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 73.5 m -69.03 -36.84 78.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.5 p -108.44 136.27 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 mt -120.14 140.74 50.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -141.9 91.78 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.586 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.74 159.34 14.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 23.7 t -129.93 122.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.875 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.91 147.45 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.206 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -114.61 139.36 49.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -132.23 126.51 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 59.93 -96.51 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -136.88 29.0 2.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 0.0 110.961 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.54 143.79 39.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.95 141.77 28.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.675 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.03 125.31 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.159 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.93 125.27 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.769 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.5 132.55 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.401 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 1.2 m -116.71 119.82 36.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.435 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.92 140.71 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 111.399 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 27.3 mm -124.09 111.99 28.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.717 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.05 144.23 95.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.315 2.01 . . . . 0.0 112.353 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.7 171.62 7.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.968 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.788 0.328 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -65.5 99.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pt -69.5 157.03 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . 0.425 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 13.3 m95 -118.78 91.89 3.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.404 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 5.4 t90 -72.98 79.64 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.18 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -154.37 159.16 41.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.843 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 383' ' ' ILE . 0.7 OUTLIER -135.38 -59.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.37 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 115.5 49.32 0.48 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.359 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 5.5 tp -138.93 132.58 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.031 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -89.8 129.82 36.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.561 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.36 157.57 45.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.106 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 412' ' ' ALA . 1.5 ptm -134.32 -179.59 5.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 4.2 p -94.67 15.82 17.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.369 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 12.5 tp 47.26 95.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.874 0.369 . . . . 0.0 111.481 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 2.6 t -71.67 156.26 39.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.23 -30.57 70.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.1 m -66.62 -56.67 9.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -29.84 65.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.59 -60.01 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.45 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -61.9 -36.38 81.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.1 -43.5 98.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -66.12 -30.54 71.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -59.89 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -68.53 -60.62 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.8 85.23 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 65.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.124 0.488 . . . . 0.0 110.854 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -167.54 28.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -89.63 167.34 17.71 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.773 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.64 -24.4 12.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.527 2.151 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.6 t0 68.36 51.79 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.51 90.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.025 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -46.54 -30.97 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.474 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.4 m -116.61 130.49 56.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 163.57 178.33 37.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 448' ' ' VAL . . . -98.08 123.41 42.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.83 129.99 44.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 21.5 mt -80.69 109.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.605 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.89 -58.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.294 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -160.1 147.78 16.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.814 0.34 . . . . 0.0 111.208 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 24.8 t -108.85 133.28 54.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.939 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -80.4 156.7 73.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.93 44.08 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.793 2.329 . . . . 0.0 112.58 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -173.31 35.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.562 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.411 ' OG1' ' HD2' ' A' ' 422' ' ' PRO . 4.0 t -129.46 154.39 80.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.023 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.411 ' HD2' ' OG1' ' A' ' 421' ' ' THR . 36.1 Cg_exo -61.19 -24.39 79.0 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.761 2.308 . . . . 0.0 112.325 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -53.72 -38.56 64.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.66 -29.66 59.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.39 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.953 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.89 -69.57 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.29 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 151.69 39.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.81 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mt -98.48 -165.12 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.902 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -178.97 170.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.04 28.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.22 12.97 3.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -119.12 173.37 6.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.631 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 28.4 t -138.25 117.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.365 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 3.6 mp -66.2 142.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 pp -136.43 -46.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.567 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 24.2 p -121.7 156.51 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.057 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.54 124.45 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.002 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 13.9 p30 44.71 30.89 0.57 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.576 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.22 27.26 23.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -118.13 170.19 9.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.746 0.307 . . . . 0.0 110.713 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 16.4 m -118.35 111.09 18.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 10.8 t -97.67 161.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 8.6 m -139.45 -48.31 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.475 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.05 167.82 14.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.414 . . . . 0.0 111.282 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.38 81.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -55.84 -26.34 46.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.88 -29.74 21.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.471 HG23 ' HB1' ' A' ' 412' ' ' ALA . 13.4 t -72.13 -44.67 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.314 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 3.7 t -50.84 -64.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.624 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -46.61 -36.5 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.474 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 41.1 t -63.33 -50.09 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.207 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.75 -37.2 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -90.34 -4.88 56.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.399 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -100.07 -51.35 3.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.63 142.36 28.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 5.3 t -81.28 -38.25 27.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.674 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.61 117.76 34.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.601 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . 0.4 ' CB ' ' CE ' ' A' ' 460' ' ' MET . 6.0 mt -101.97 126.75 48.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -132.22 92.78 3.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.634 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' MET . . . . . 0.4 ' CE ' ' CB ' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -96.74 151.69 19.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.35 121.95 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.017 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 9.0 t -107.43 161.42 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 138.7 54.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.0 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.65 121.27 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.743 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.79 -113.68 5.84 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.26 29.37 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.52 150.2 43.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.243 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -94.25 147.15 23.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.88 132.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.256 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.31 119.88 39.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.654 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 11.5 mm -112.54 132.67 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 25.1 m -122.62 119.86 32.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.1 133.74 63.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.3 mm -118.11 109.14 41.23 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.84 -172.71 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.462 2.108 . . . . 0.0 112.226 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -143.1 173.5 11.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.857 0.361 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 113.6 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pt -81.26 118.13 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -94.71 92.65 7.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -68.24 85.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.123 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.6 mttp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.801 0.334 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -131.0 126.98 37.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 11.0 pt -116.72 -4.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.425 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 50.07 67.27 1.91 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.857 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 4.8 tp -151.73 126.22 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 110.841 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.412 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 27.7 mtt85 -89.9 125.96 35.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.85 142.53 47.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 8.6 ptm -125.54 156.98 38.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 49.2 p -84.21 114.53 21.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 6.8 tp -63.93 81.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.4 t -62.12 158.69 16.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 m -57.42 -23.24 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -54.7 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.092 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.71 -45.16 91.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.169 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.18 -39.85 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.185 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -77.63 -29.87 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.79 -47.57 62.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.14 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.5 -44.06 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -65.86 -31.7 72.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.74 -43.31 94.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 ttm-85 -93.09 -20.34 20.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.311 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -135.57 78.79 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -69.14 -22.8 63.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.79 -26.64 10.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -65.06 160.39 56.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.835 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.27 -167.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.565 2.177 . . . . 0.0 112.243 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -116.7 31.33 6.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.015 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.7 m -91.9 132.27 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.5 -18.26 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.31 154.23 18.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 116.56 159.35 11.65 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -90.11 147.77 23.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.117 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -102.42 131.25 49.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 21.2 mt -80.01 122.92 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 17.9 mt -91.84 -61.24 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.831 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -157.88 149.29 21.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.403 . . . . 0.0 111.415 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 20.4 t -117.4 140.37 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.3 mp -86.79 135.37 35.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.729 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 7.9 Cg_exo -72.57 56.18 2.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.779 2.319 . . . . 0.0 112.496 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 178.25 40.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.162 0.506 . . . . 0.0 110.498 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.4 OUTLIER -142.78 173.83 4.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -75.77 -13.87 19.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.132 1.888 . . . . 0.0 111.856 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -66.15 -56.9 9.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.65 -31.78 70.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.456 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.94 -30.62 58.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.843 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -66.86 -34.06 86.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.255 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.95 26.83 2.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.843 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.47 -177.81 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -159.64 161.5 35.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.762 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -85.59 56.17 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.17 31.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.034 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -135.22 -174.34 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.815 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 38.6 t -142.21 123.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.312 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.7 mt -75.7 147.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.417 ' CD1' ' N ' ' A' ' 436' ' ' SER . 2.5 pp -138.69 -46.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.351 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' SER . . . . . 0.417 ' N ' ' CD1' ' A' ' 435' ' ' ILE . 90.9 p -116.93 156.32 27.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.726 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.403 HG12 ' ND2' ' A' ' 438' ' ' ASN . 4.5 tt -155.9 114.51 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.198 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . 0.403 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.7 p30 44.33 33.42 0.85 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.454 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.68 36.16 9.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.773 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.47 114.42 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 m -70.19 114.4 8.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.401 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 2.7 t -97.65 162.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.76 -45.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.9 p -130.95 173.73 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.16 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.84 94.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.045 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.416 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 1.3 p-10 -53.99 -26.64 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -86.85 -41.4 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.401 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 46.9 t -63.19 -30.63 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.131 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 4.9 t -63.59 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -51.27 -36.38 41.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.504 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.72 -47.73 91.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 0.0 111.111 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 5.5 mt -62.09 -37.5 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.15 -8.05 55.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.224 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -98.92 -46.82 5.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.819 0.343 . . . . 0.0 110.843 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.26 140.33 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 35.3 t -84.88 -34.31 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.739 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 2.1 p -109.17 100.21 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.758 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 8.3 mt -94.53 136.31 34.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -133.82 89.02 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.633 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.48 173.78 7.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 13.2 t -134.68 145.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 7.3 t -140.58 153.47 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.001 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -101.76 119.84 39.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.98 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . 0.414 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 9.3 mtp180 -127.81 139.64 52.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.7 -101.72 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.169 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -140.19 20.56 2.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.778 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -145.8 168.47 20.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.92 136.08 42.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.649 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 464' ' ' ARG . 2.8 mt -127.53 143.98 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.7 119.89 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.714 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 21.8 mm -103.21 130.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.77 129.12 49.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.013 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 18.4 t -140.36 119.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 21.2 mm -108.19 109.85 61.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.165 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.43 131.27 35.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.43 2.087 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.0 170.56 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.841 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.816 0.341 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -60.16 117.05 4.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pt -84.26 123.08 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . 0.416 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.6 m95 -108.57 95.37 5.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.412 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 6.8 t90 -76.85 62.56 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.808 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.064 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.739 0.305 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -152.02 124.42 8.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.024 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 24.5 pt -113.36 -4.2 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.463 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 53.6 65.82 3.17 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.734 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 0.0 OUTLIER -165.13 124.82 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.947 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -92.3 125.15 36.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.07 137.28 53.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 3.7 ptm -115.85 173.26 6.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.5 p -97.69 105.55 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.632 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.2 tp -54.37 98.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.7 t -87.01 165.09 16.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.839 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.8 m -58.92 -29.7 67.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.067 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 71.2 m -78.55 -19.05 53.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -51.26 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 111.072 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.84 83.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.313 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -66.72 -29.71 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.82 -41.06 62.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.993 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.97 -38.45 82.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -34.2 68.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.98 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -77.28 -29.27 53.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -53.25 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -116.31 115.74 26.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.003 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.79 55.62 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.841 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -146.97 19.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.103 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.83 158.28 35.35 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 -172.74 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.588 2.192 . . . . 0.0 112.211 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -109.29 32.03 5.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 11.7 m -102.3 129.6 53.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pt -102.57 -32.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.5 m -87.78 149.9 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.773 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 132.17 -157.8 22.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -132.96 127.62 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -90.33 128.03 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 15.3 mt -80.57 109.97 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.3 -58.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -158.31 152.14 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.401 . . . . 0.0 111.245 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 22.2 t -127.95 136.35 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.954 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.45 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 8.4 mm -79.86 146.23 63.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 11.9 Cg_exo -71.15 0.52 6.54 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.744 2.296 . . . . 0.0 113.319 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -127.35 61.75 1.38 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.8 OUTLIER -152.7 168.99 10.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.564 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 59.7 Cg_endo -74.31 -18.06 20.89 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.265 1.977 . . . . 0.0 111.48 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -61.8 -59.22 5.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.554 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.49 -27.08 64.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.563 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.44 -30.45 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.18 1.26 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 167.97 31.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.903 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.12 -168.15 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.805 0.336 . . . . 0.0 110.82 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.55 169.62 2.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.774 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.92 49.93 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -160.46 29.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -134.15 -177.34 4.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.58 117.89 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.19 149.58 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.409 ' CD1' ' N ' ' A' ' 436' ' ' SER . 2.3 pp -141.95 -47.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' SER . . . . . 0.409 ' N ' ' CD1' ' A' ' 435' ' ' ILE . 96.3 p -123.64 144.94 49.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 3.9 tt -143.52 119.62 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 18.9 p30 44.85 30.49 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.734 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.07 20.37 42.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.201 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -112.31 157.67 20.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.78 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.17 118.3 31.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.51 127.45 66.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.29 6.49 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.95 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.41 161.52 8.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.881 0.372 . . . . 0.0 111.152 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.2 -45.19 88.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.048 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.412 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 36.4 p-10 -56.58 -28.42 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.69 -33.8 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 18.0 t -74.45 -37.39 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.195 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 7.6 t -55.27 -57.55 11.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -54.94 -41.04 70.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.339 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 39.5 t -58.56 -47.34 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.148 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.4 mt -58.8 -36.05 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.68 -0.84 54.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.322 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -100.22 -47.8 4.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 110.916 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.2 152.81 31.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.75 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.9 t -94.27 -35.61 12.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.695 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 94.3 6.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.86 123.24 33.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -111.13 83.16 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.6 mtt -90.29 133.35 35.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 28.7 t -108.28 124.71 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.0 t -111.27 163.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.76 143.91 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.047 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -144.73 130.36 19.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.82 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.22 -99.54 0.21 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.436 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.26 30.89 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.754 0.312 . . . . 0.0 110.944 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.12 144.94 24.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.76 129.65 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 111.317 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.69 125.21 47.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.492 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.8 mp -132.66 143.61 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.44 . . . . 0.0 111.618 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.18 135.92 53.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.94 135.1 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.566 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.412 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.5 mp -119.83 109.26 37.97 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.586 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.12 155.96 5.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.425 2.084 . . . . 0.0 112.292 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.18 170.62 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.97 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.0 mtt-85 -61.62 89.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pp -80.78 133.43 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . 0.412 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.4 m0 -112.04 88.13 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -71.17 68.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.768 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.198 -179.816 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.8 mptt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.727 0.298 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.417 ' CE1' ' HA2' ' A' ' 384' ' ' GLY . 13.0 t80 -155.83 121.1 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.241 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 5.0 pt -111.35 -13.02 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.237 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 382' ' ' TYR . . . 70.42 52.77 15.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.729 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 10.9 tt -165.31 137.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -89.96 158.18 17.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.463 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.22 133.63 13.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -110.69 173.8 6.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.019 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.3 p -100.16 112.6 24.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.832 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.3 tp -63.52 88.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.127 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 2.3 t -85.57 167.37 15.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.32 -39.68 6.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.728 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -68.97 -58.36 4.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 111.229 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -52.5 64.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.323 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.25 -33.89 21.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.474 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -90.1 -29.51 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.043 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -65.32 -44.0 89.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 3.4 mt -58.69 -39.23 80.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.046 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -67.08 -30.2 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -68.83 -59.38 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -66.03 -38.54 88.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.798 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.03 98.23 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -81.91 59.72 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.036 0.446 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.39 23.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.939 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -93.87 146.37 31.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.17 179.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.269 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.42 38.23 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.814 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 34.9 m -109.44 117.39 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.51 -29.72 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.11 148.85 25.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.003 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 122.21 170.43 13.71 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.685 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.46 152.71 24.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.026 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.415 ' CE1' ' O ' ' A' ' 414' ' ' ILE . 27.2 t80 -92.19 133.79 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . 0.415 ' O ' ' CE1' ' A' ' 413' ' ' TYR . 38.2 mt -79.98 121.78 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.037 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.415 ' CG2' ' H ' ' A' ' 416' ' ' GLU . 2.0 mm -88.76 -152.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . 0.415 ' H ' ' CG2' ' A' ' 415' ' ' ILE . 17.0 pt-20 -79.35 145.15 33.58 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 0.0 111.074 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 14.2 t -110.9 159.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.028 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.419 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 20.6 mm -96.86 136.0 21.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.8 59.03 4.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.519 2.146 . . . . 0.0 112.579 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 174.93 44.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.586 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.457 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.2 OUTLIER -150.95 173.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -76.18 -16.28 17.77 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.309 2.006 . . . . 0.0 112.089 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.436 ' O ' ' HG ' ' A' ' 428' ' ' LEU . . . -60.63 -60.05 4.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -74.06 -23.25 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -82.04 -26.12 34.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.13 -70.06 1.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 171.55 30.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.997 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 0.2 OUTLIER -107.74 176.03 5.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.829 0.315 . . . . 0.0 110.643 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.99 157.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.28 77.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.95 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -72.24 179.32 3.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.978 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 22.7 t -139.8 131.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 3.2 mt -86.06 145.34 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 pp -140.57 -48.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 19.1 p -110.01 158.79 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.2 tt -158.48 116.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.281 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 19.5 p30 42.52 50.54 4.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.649 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 70.61 44.96 56.03 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.798 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -137.97 152.94 49.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 55.6 m -103.79 107.32 18.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.425 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 13.3 t -100.29 143.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.07 -4.21 5.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.93 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.8 p -169.97 168.27 8.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.249 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.84 87.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.409 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 18.3 p30 -53.31 -27.0 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -84.86 -33.77 22.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.758 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.425 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 45.8 t -72.95 -37.36 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.205 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 11.1 t -55.26 -59.14 5.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.71 -24.64 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.28 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 37.7 t -76.5 -50.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.165 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 7.8 mt -56.58 -27.58 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.21 -11.93 22.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.403 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.04 -51.04 3.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -95.03 134.91 37.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.55 -34.97 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.2 p -103.34 115.22 30.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 10.1 mt -106.93 133.54 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.227 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 90.15 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.518 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.28 149.05 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.308 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.38 125.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.837 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.25 -179.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.353 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -119.46 125.99 50.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -118.55 120.24 36.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.61 -94.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.277 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -140.05 27.12 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -144.56 168.46 20.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.92 140.09 42.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.9 mt -128.13 147.38 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 111.232 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.97 125.36 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.713 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.0 127.91 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.259 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 55.3 m -106.93 122.95 47.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 27.1 t -127.63 137.21 58.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.044 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -122.65 109.63 32.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.55 159.46 53.42 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.419 2.079 . . . . 0.0 112.35 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.54 -176.1 2.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.942 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.793 0.33 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 56.32 39.24 30.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -75.27 148.14 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . 0.409 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 9.7 m0 -109.7 111.15 22.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -80.7 75.87 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.149 -179.933 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.84 0.352 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -145.67 131.46 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.441 HG22 HD12 ' A' ' 383' ' ' ILE . 3.6 pt -127.71 12.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.725 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 42.95 63.14 2.08 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.375 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.419 ' CD1' ' CG2' ' A' ' 417' ' ' VAL . 7.2 tp -148.74 124.33 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.163 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 386' ' ' ARG . 11.6 mtt180 -89.64 121.27 31.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.86 147.46 50.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.056 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 5.5 ptm -127.51 173.9 9.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.934 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 31.9 p -89.16 99.98 12.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.53 88.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 7.7 t -75.79 169.53 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.809 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.7 p -54.65 -37.65 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.1 t -69.62 -56.14 8.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -39.11 92.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.66 80.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.141 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -27.74 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -45.74 83.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.04 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . 0.414 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 17.8 mt -67.14 -30.93 71.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -30.8 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -50.76 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.92 -68.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 87.55 7.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -78.71 61.64 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -151.19 21.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.945 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 398' ' ' LEU . 23.2 m-85 -91.57 159.33 38.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.99 174.83 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.659 2.239 . . . . 0.0 112.188 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.33 45.73 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.36 148.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.37 -40.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.298 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.44 133.0 41.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.887 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 146.06 -177.59 24.33 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.407 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -106.68 141.53 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -94.71 137.84 33.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 23.0 mt -87.04 116.41 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 37.0 mt -84.84 -62.93 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.464 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -154.57 153.57 31.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.158 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.419 ' CG2' ' CD1' ' A' ' 385' ' ' ILE . 21.7 t -121.36 141.83 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . . . . . . . . . 16.2 mm -81.52 142.55 50.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.773 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.83 -0.91 8.52 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.816 2.344 . . . . 0.0 113.686 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -130.55 59.58 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.25 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.452 ' OG1' ' HD2' ' A' ' 422' ' ' PRO . 0.7 OUTLIER -160.54 157.8 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.452 ' HD2' ' OG1' ' A' ' 421' ' ' THR . 31.9 Cg_exo -60.14 -20.68 62.67 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.09 75.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.012 0.434 . . . . 0.0 110.985 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -84.72 -30.95 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.695 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.15 -31.5 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -66.75 -35.5 89.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.271 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.77 27.48 2.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.861 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.63 -174.28 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.817 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.91 169.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.907 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.88 54.65 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.84 26.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.206 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -138.96 -174.53 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.837 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.36 119.41 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.369 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.55 116.92 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.6 pp -105.05 -42.18 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.692 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 51.6 p -126.53 159.52 33.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.962 0.411 . . . . 0.0 111.062 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.407 ' CG2' ' HB2' ' A' ' 440' ' ' GLN . 3.4 tt -156.54 113.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 24.0 p30 44.23 44.61 6.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.75 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.15 37.93 36.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.072 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.407 ' HB2' ' CG2' ' A' ' 437' ' ' ILE . 7.4 mm-40 -131.99 128.3 38.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t -76.34 110.19 10.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' A' ' 448' ' ' VAL . 58.0 t -90.61 156.07 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 12.2 m -145.95 -47.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.6 p -137.5 171.63 14.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.36 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.303 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.404 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 25.7 p30 -54.42 -26.1 28.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.34 -57.3 3.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.419 HG22 ' CG1' ' A' ' 442' ' ' VAL . 38.9 t -47.57 -40.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.569 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 6.9 t -55.55 -63.71 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.49 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -50.31 -26.87 5.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.545 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.56 -46.95 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.128 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 7.3 mt -57.8 -27.53 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.165 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -100.31 -8.76 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.552 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.07 -49.46 4.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.18 132.4 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -35.72 55.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.806 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 2.6 t -104.34 116.07 31.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 10.5 mt -102.69 129.98 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.016 0.436 . . . . 0.0 111.315 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -131.84 96.82 4.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.55 147.15 26.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.54 132.93 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.776 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.4 m -132.77 167.91 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 111.338 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 119.78 34.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.016 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -116.14 136.36 53.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.526 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.7 -101.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.218 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.37 28.6 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.799 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -143.59 147.66 34.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.148 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.06 140.04 30.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.4 mt -131.12 142.61 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.459 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.46 119.72 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 11.2 mm -105.47 136.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.654 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 21.3 m -124.18 119.56 29.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.369 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 22.4 t -129.32 141.12 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.336 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 27.9 mm -119.21 109.98 38.32 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.57 164.77 10.7 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.487 2.125 . . . . 0.0 112.404 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -113.89 -176.83 2.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.838 0.351 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -64.81 88.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.781 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -84.27 124.5 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m0 -109.92 120.4 42.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -82.56 58.37 4.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.037 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.838 0.351 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.417 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 19.2 t80 -144.49 122.3 11.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 10.1 pt -106.17 -5.55 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.48 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 382' ' ' TYR . . . 56.89 64.39 4.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.512 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.408 HD13 ' CG2' ' A' ' 414' ' ' ILE . 3.8 tp -161.36 134.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.011 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.421 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 20.4 mtt180 -91.34 133.0 35.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.669 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.78 150.33 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.406 ' CE ' ' CB ' ' B' ' 2' ' ' SER . 1.8 ptm -128.26 -177.59 4.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.793 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.8 p -99.48 9.74 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.53 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 7.8 tp 52.42 97.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.3 t -83.65 163.58 20.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -31.92 68.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -30.32 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -96.73 -42.27 8.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.11 58.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.24 66.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.6 -39.03 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 9.8 mt -64.17 -45.66 87.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.97 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -59.29 -29.97 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.34 -28.73 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -93.23 -29.69 15.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -100.67 -53.66 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.011 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 74.48 -59.26 0.56 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -47.13 -28.32 1.74 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.372 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -55.94 161.79 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -175.34 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.606 2.204 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.94 -11.98 19.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.351 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.6 m -52.39 167.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.425 HG22 HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -136.73 12.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.467 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.4 m -130.37 130.61 44.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.813 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 171.52 169.04 33.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.379 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -100.28 122.81 43.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 111.161 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -103.87 128.97 51.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . 0.408 ' CG2' HD13 ' A' ' 385' ' ' ILE . 4.3 mt -79.81 114.98 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.589 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 2.8 mp -78.48 -70.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.628 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -144.17 143.12 30.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' A' ' 385' ' ' ILE . 21.3 t -111.37 146.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.05 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.3 mp -98.35 128.96 31.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.78 61.53 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.698 2.266 . . . . 0.0 112.38 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.44 40.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.598 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.65 158.92 49.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.801 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.92 -23.2 33.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.327 2.018 . . . . 0.0 111.808 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -58.36 -60.06 4.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.207 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.78 -31.51 64.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.745 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.69 68.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.58 -30.98 70.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.383 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 24.91 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.777 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.33 -177.66 3.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.776 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.74 179.66 7.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.767 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.76 31.63 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -143.24 26.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -119.44 -177.75 3.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.588 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 38.8 t -142.07 129.58 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 0.0 111.403 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.1 mp -86.09 152.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.9 pp -140.63 -50.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.654 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 69.9 p -128.67 158.44 38.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.432 HG21 ' HB2' ' A' ' 440' ' ' GLN . 10.8 tt -150.3 118.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.337 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 19.8 p30 44.78 35.35 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.931 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.34 38.94 8.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.985 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.432 ' HB2' HG21 ' A' ' 437' ' ' ILE . 5.1 mt-30 -129.44 145.19 51.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.547 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.59 104.4 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.462 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.6 147.45 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.72 -45.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.37 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.67 169.86 16.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.422 . . . . 0.0 111.149 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.4 71.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.019 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.404 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 16.6 p30 -59.5 -30.59 68.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.62 -43.5 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.787 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.23 -37.04 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 3.5 t -59.42 -65.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.467 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -48.25 -27.6 2.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 47.4 t -71.32 -43.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.922 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 4.8 mt -61.98 -32.36 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.91 -17.26 25.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.328 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -93.47 -47.51 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.13 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.76 142.25 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.59 -32.18 14.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.677 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.3 t -109.03 99.95 9.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.5 mt -90.22 133.71 34.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -134.24 91.77 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.628 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.48 152.39 24.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 27.2 t -100.05 141.69 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.628 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.2 t -142.28 160.53 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.175 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -98.92 133.15 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.867 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -130.55 132.61 45.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.04 -95.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.157 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.06 21.36 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.701 0.286 . . . . 0.0 110.851 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -143.58 164.7 29.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.02 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.43 137.22 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.4 mt -131.8 160.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -99.68 119.69 38.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.16 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 13.1 mm -107.89 152.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 91.8 m -139.02 119.79 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.797 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.74 151.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 21.2 mm -121.35 109.9 34.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.17 152.23 77.29 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.358 2.039 . . . . 0.0 112.237 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.54 168.68 10.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.406 ' CB ' ' CE ' ' A' ' 388' ' ' MET . 1.1 p . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.822 0.344 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -59.68 108.45 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -79.22 127.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.22 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . 0.404 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m95 -107.29 91.08 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.421 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 1.5 t90 -73.57 68.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.198 -0.905 . . . . 0.0 111.123 179.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.653 0.264 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -155.85 120.47 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.254 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 12.0 pt -111.16 -22.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.436 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 80.64 66.92 1.59 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.801 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -165.29 129.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.389 . . . . 0.0 110.813 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -89.95 120.42 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.36 143.65 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.812 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.8 ptm -123.52 164.53 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 40.1 p -85.87 99.43 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 10.6 tp -55.76 108.59 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.52 170.33 10.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.766 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.8 m -58.17 -21.76 48.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.421 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.3 t -77.61 -47.28 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.98 -32.14 25.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.168 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.31 -36.35 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.205 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -90.01 -32.47 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.29 -33.49 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.25 -49.88 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -58.29 -43.1 87.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.47 -25.98 67.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -93.06 -62.13 1.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 1.0 OUTLIER -85.05 -59.46 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 79.72 -49.2 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.03 -27.04 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.717 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 29.6 m-85 -43.01 163.16 0.16 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.428 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.98 -20.83 14.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.625 2.217 . . . . 0.0 112.761 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 75.71 40.56 0.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 110.781 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.35 98.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pp -55.63 -29.27 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.38 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.84 141.48 39.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 145.47 176.97 19.87 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -104.28 155.62 18.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -107.66 138.46 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.74 109.96 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.403 ' CD1' ' CG2' ' B' ' 4' ' ' ILE . 5.3 mt -74.51 -66.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.214 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.85 167.85 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.887 0.375 . . . . 0.0 111.139 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 21.2 t -134.84 147.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.093 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.3 mp -79.72 134.5 57.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.308 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.436 ' HD2' HG21 ' A' ' 418' ' ' ILE . 50.5 Cg_exo -55.33 -12.47 5.73 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.031 2.487 . . . . 0.0 114.686 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -132.97 72.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.925 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.448 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 4.9 p -159.08 160.87 28.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.984 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.95 -20.17 51.58 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.329 2.02 . . . . 0.0 111.41 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -61.19 -60.15 4.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -76.33 -30.57 57.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.24 -7.4 59.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.558 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -90.15 -31.74 10.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.418 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 129.79 17.79 1.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.022 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.9 -175.87 3.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.75 146.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.97 -177.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.64 24.94 12.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -126.71 177.01 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 33.1 t -136.89 126.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.472 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 3.8 mt -81.11 154.58 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.9 pp -143.19 -47.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 94.6 p -120.94 154.99 35.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.344 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 2.7 tt -153.88 116.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 16.9 p30 45.43 32.03 0.99 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.545 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.37 8.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.693 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -133.53 138.1 45.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.29 107.9 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 63.2 t -90.75 146.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.32 -43.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.335 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.62 172.32 13.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.913 0.387 . . . . 0.0 111.17 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.33 -38.76 74.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -59.19 -29.74 67.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.65 -38.35 54.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.12 -37.99 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 9.5 t -56.67 -62.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.322 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -50.43 -29.18 9.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 59.9 t -70.78 -42.96 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.277 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 4.6 mt -63.23 -33.85 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.33 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 -13.06 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.622 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -99.94 -54.03 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.767 0.318 . . . . 0.0 110.774 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -89.46 132.82 34.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -36.23 42.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.677 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 2.5 t -105.47 125.51 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.684 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 6.7 mt -119.65 149.4 42.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -147.3 97.65 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.451 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 1.1 mtm -102.77 144.74 30.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 19.7 t -111.58 127.26 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.686 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.28 158.66 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.26 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -104.0 119.67 39.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.994 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . 0.425 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 0.2 OUTLIER -119.51 127.32 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.434 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.22 -99.13 0.85 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.177 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.22 24.82 2.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.767 0.318 . . . . 0.0 110.677 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.57 162.63 36.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.97 141.01 34.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 464' ' ' ARG . 4.0 mt -130.74 143.24 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.369 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -94.76 124.42 38.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.645 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -113.79 140.28 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 111.343 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 70.8 m -116.9 119.87 36.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.76 131.68 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.53 110.76 57.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 148.88 87.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.101 . . . . 0.0 112.336 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.88 -178.77 3.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.825 0.345 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -61.3 93.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 415' ' ' ILE . 46.4 pt -83.59 137.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.302 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -116.81 89.61 3.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.45 82.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.144 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mttp . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.817 0.342 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -118.44 126.29 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 9.7 pt -122.44 -1.1 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.333 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 46.92 62.94 3.47 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.082 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 6.8 tp -149.16 122.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.758 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -89.73 128.18 36.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' MET . . . . . 0.413 ' CA ' HD11 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -132.93 140.59 47.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.511 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.409 ' CE ' ' HA ' ' B' ' 2' ' ' SER . 7.7 ptm -119.31 158.84 25.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.028 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 21.3 p -83.11 106.27 14.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 7.3 tp -56.92 102.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.075 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.9 t -89.94 174.54 7.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 27.8 t -66.96 -33.02 74.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 60.6 p -68.88 -28.59 66.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -95.83 -48.6 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.988 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.92 -59.93 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.26 68.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.37 -38.28 89.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.29 -36.61 74.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.996 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -77.75 -31.69 52.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -28.99 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -54.98 3.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -73.46 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 402' ' ' HIS . 57.5 mtm180 82.73 -25.62 0.15 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.752 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -20.51 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.752 0.311 . . . . 0.0 110.957 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.45 153.95 74.57 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.973 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.7 -179.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.637 2.224 . . . . 0.0 112.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -111.74 30.77 6.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.13 150.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.33 17.12 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.455 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -140.29 142.85 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.16 156.49 7.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -91.45 152.08 20.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -107.37 131.66 54.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 18.3 mt -83.97 111.08 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.433 ' CD1' ' CG2' ' B' ' 4' ' ' ILE . 2.8 mp -75.35 -66.42 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.61 167.14 31.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 0.0 111.175 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.53 156.95 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.3 mp -96.32 133.43 24.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.4 ' HD2' HG21 ' A' ' 418' ' ' ILE . 54.5 Cg_endo -68.54 60.02 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.766 2.311 . . . . 0.0 112.82 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 168.88 44.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.972 0.415 . . . . 0.0 110.757 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.541 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 7.7 p -141.84 162.19 47.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 34.8 Cg_endo -66.72 -14.13 42.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.012 1.808 . . . . 0.0 111.17 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.4 ' CA ' HD13 ' A' ' 428' ' ' LEU . . . -68.73 -59.94 2.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.645 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.86 -32.71 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -82.4 -21.14 35.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.296 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -72.42 -29.93 65.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.304 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 121.1 17.65 4.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.026 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.4 HD13 ' CA ' ' A' ' 423' ' ' ALA . 2.5 mt -88.2 -167.08 1.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.91 0.355 . . . . 0.0 110.732 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.9 146.34 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -179.36 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 60.09 22.52 11.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -119.3 -175.87 3.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.412 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.48 117.28 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.543 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.0 mt -78.42 123.05 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.461 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 pp -110.07 -48.63 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.882 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 3.8 t -119.24 160.97 21.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 111.294 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.28 119.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.024 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 16.1 p30 44.43 42.41 5.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.511 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 77.5 41.92 19.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.635 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -135.69 162.6 32.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 108.55 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.418 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 2.5 t -94.59 148.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.247 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.58 -35.96 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.333 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.6 p -147.5 176.03 10.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.212 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.12 87.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.176 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -53.91 -24.22 15.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.268 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.33 -50.01 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.418 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 43.9 t -54.93 -40.7 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 42.2 t -53.13 -68.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.469 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -51.69 -35.06 41.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.641 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.09 -49.33 81.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.294 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.4 mt -57.68 -40.53 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.223 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.01 -5.21 59.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.325 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -100.18 -47.66 4.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -100.13 133.57 44.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.047 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -34.42 48.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.5 t -105.08 103.21 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 12.4 mt -96.08 153.36 17.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -154.43 96.76 1.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.645 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.26 135.51 45.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.263 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 25.8 t -102.09 120.41 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.0 t -105.54 160.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.92 124.41 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.702 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.53 -98.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.346 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -140.28 24.84 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 111.033 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -139.77 157.36 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.91 139.62 35.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.646 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.8 mt -128.21 128.01 68.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.08 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.66 125.13 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.769 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 28.9 mm -120.04 136.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.9 m -109.61 135.05 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 11.5 t -138.91 146.22 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.065 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 30.0 mm -134.03 110.34 11.89 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.57 132.91 51.05 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.398 2.065 . . . . 0.0 112.309 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -94.83 -174.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.409 ' HA ' ' CE ' ' A' ' 388' ' ' MET . 37.4 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.686 0.279 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 52.54 65.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.444 . . . . 0.0 110.656 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.433 ' CG2' ' CD1' ' A' ' 415' ' ' ILE . 1.4 pt -82.05 96.25 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.335 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -65.64 104.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.826 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -76.76 67.01 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.21 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.6 mptt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -118.08 119.55 35.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.363 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 16.4 pt -130.58 -8.97 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.478 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.506 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 50.67 68.1 1.61 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.747 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 8.1 tp -157.0 135.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -101.03 129.43 46.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.45 146.19 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.0 ptm -128.26 157.44 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.071 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.7 p -79.48 101.32 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 9.4 tp -51.79 97.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.4 t -84.8 158.54 20.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.785 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.3 m -57.51 -22.05 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.12 -28.28 54.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.308 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -100.33 -37.4 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.131 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.87 -50.95 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.367 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -28.33 67.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -34.25 73.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.065 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.17 -41.83 93.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.027 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -75.11 -30.81 60.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.77 -33.15 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.7 -33.34 20.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -145.59 120.63 10.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.97 -27.73 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -55.79 -27.2 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.115 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.46 147.35 59.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.72 174.43 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.568 2.179 . . . . 0.0 112.301 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -111.91 32.77 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.66 -179.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.459 HG22 HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -149.18 -40.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' SER . . . . . 0.433 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -89.6 154.47 19.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.79 170.43 13.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . 0.4 ' CB ' HG23 ' A' ' 448' ' ' VAL . . . -98.2 138.75 35.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 110.991 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -94.44 130.19 40.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 12.1 mt -80.23 114.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 430' ' ' GLU . 9.4 mt -82.13 -72.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.609 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.145 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.412 ' CG1' ' CB ' ' A' ' 423' ' ' ALA . 3.3 t -111.8 140.43 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.554 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 19.6 mm -79.69 144.99 61.6 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.37 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.422 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 23.3 Cg_exo -65.83 -3.91 9.02 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.881 2.387 . . . . 0.0 114.521 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -138.35 71.03 1.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.965 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.554 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 1.1 p -159.55 165.61 17.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.141 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.8 -23.78 77.42 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.622 2.215 . . . . 0.0 111.62 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.412 ' CB ' ' CG1' ' A' ' 417' ' ' VAL . . . -57.78 -60.05 4.29 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.996 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -74.63 -26.74 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.16 -26.16 55.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.363 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -79.29 -70.36 1.33 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.417 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 166.64 34.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 0.4 OUTLIER -104.47 -173.11 2.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.778 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.46 169.09 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 0.8 OUTLIER -87.58 52.48 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -158.89 28.37 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.625 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.36 -177.2 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 24.0 t -145.16 107.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.42 138.48 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.674 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 436' ' ' SER . 2.5 pp -133.57 -43.07 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.52 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' SER . . . . . 0.436 ' N ' ' CD1' ' A' ' 435' ' ' ILE . 41.5 p -114.72 155.5 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.5 tt -157.61 118.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 13.5 p30 45.52 33.85 1.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.494 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.8 28.74 34.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.724 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -124.01 143.4 50.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.864 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 9.3 t -92.09 110.69 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 25.7 t -93.89 159.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 22.4 m -130.36 -45.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.502 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.05 176.42 8.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.225 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.412 ' HB3' ' CG ' ' B' ' 5' ' ' TRP . . . -57.52 -40.45 78.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -56.42 -25.6 50.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.879 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.05 -30.74 20.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.4 HG23 ' CB ' ' A' ' 412' ' ' ALA . 23.5 t -70.58 -43.32 77.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 33.0 t -50.97 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.335 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -49.88 -41.61 45.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.36 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.88 -45.5 91.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.076 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 22.3 mt -58.86 -40.49 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.65 0.4 57.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.158 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -46.74 5.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -111.18 165.28 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.4 t -103.64 -32.17 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 p -106.37 102.45 11.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.741 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.5 129.46 39.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.947 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -123.91 88.09 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.705 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.5 mtt -92.2 129.68 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 27.1 t -107.47 126.29 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.22 159.37 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.175 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 119.95 40.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -120.62 133.18 55.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.486 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.18 -103.83 1.23 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.219 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -138.22 27.72 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.619 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.33 157.12 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.254 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.88 142.91 28.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.449 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.24 141.09 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.478 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.47 119.81 36.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.513 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.16 137.02 57.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 58.6 m -117.24 127.37 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.66 122.24 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.096 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 28.5 mm -103.02 109.86 62.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.01 151.42 82.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.078 . . . . 0.0 112.299 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -102.74 158.44 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.833 179.96 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.736 0.303 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.14 106.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 pt -76.19 149.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.531 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 445' ' ' ALA . 26.9 m95 -121.14 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.627 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -70.33 70.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.073 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.658 0.266 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -134.17 125.91 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.307 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 5.8 pt -117.67 -26.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 75.67 64.57 2.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.648 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.463 HD12 HG22 ' A' ' 385' ' ' ILE . 0.0 OUTLIER -165.31 123.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.1 OUTLIER -90.04 126.97 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.85 152.59 48.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -130.63 -179.4 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 111.481 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 7.5 p -98.46 94.7 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.169 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 413' ' ' TYR . 9.0 tp -47.63 121.55 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.571 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.11 165.81 13.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.797 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -27.27 63.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -66.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.166 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -40.24 74.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.217 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.293 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -83.91 -30.68 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.037 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.98 -31.19 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.023 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.26 -47.32 44.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -65.45 -37.84 88.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.047 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.83 -42.86 94.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -87.7 -17.51 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -150.08 87.04 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.715 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -25.72 67.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -23.62 11.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.284 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 402' ' ' HIS . 3.7 m-85 -53.18 163.69 0.87 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.09 178.22 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.306 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -105.63 35.84 2.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.34 92.87 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.49 -33.8 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.56 163.23 21.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 126.21 175.97 14.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.375 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -102.8 157.37 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 111.093 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.408 ' HB2' ' CD1' ' A' ' 390' ' ' LEU . 69.4 t80 -104.82 128.72 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 24.6 mt -80.7 109.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.552 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 2.7 mp -71.86 -70.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -151.43 166.82 29.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.299 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 35.0 t -132.84 155.39 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.043 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.3 mp -90.28 132.56 35.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.406 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.22 57.72 3.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.542 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 169.41 47.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.061 0.457 . . . . 0.0 110.383 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 4.2 p -149.86 164.46 20.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.974 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.64 -26.85 67.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.269 1.979 . . . . 0.0 111.101 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -54.91 -54.39 43.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.116 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.73 -29.99 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.67 -29.42 65.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.12 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -74.0 -30.2 61.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.481 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.88 23.67 2.97 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.767 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.67 -175.59 3.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.772 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.65 152.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -61.74 -175.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.702 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 24.6 m120 61.23 22.35 12.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -122.66 -176.5 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 34.9 t -143.69 127.54 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.623 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.65 152.76 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.441 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.2 -55.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 16.7 p -120.42 157.32 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.313 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.401 HG12 ' ND2' ' A' ' 438' ' ' ASN . 1.8 tt -151.04 119.94 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.344 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . 0.401 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.3 p30 43.4 44.08 4.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.693 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.62 49.24 8.16 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.793 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -144.88 158.97 43.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.702 0.287 . . . . 0.0 110.672 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 6.0 p -106.49 112.19 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 4.2 t -100.08 147.58 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 6.3 m -130.82 -42.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.4 p -127.93 168.11 15.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.01 0.434 . . . . 0.0 111.284 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.34 -41.14 79.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -57.24 -28.92 63.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.726 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.77 -36.47 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.414 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 28.4 t -69.55 -41.86 80.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 1.7 t -54.72 -63.17 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.601 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -46.96 -29.18 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.458 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 30.4 t -68.61 -48.58 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 3.6 mt -58.62 -33.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -91.13 -21.55 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.251 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -88.67 -59.91 2.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.02 127.14 35.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -39.06 75.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -104.67 116.26 31.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 9.0 mt -102.34 133.99 46.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.274 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -135.13 93.9 3.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.638 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.67 156.81 16.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.4 124.6 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.975 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.6 t -108.58 147.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -105.44 140.11 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.174 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . 0.427 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 17.6 mtp180 -144.52 133.84 23.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 57.88 -100.24 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.494 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -140.07 28.38 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 111.06 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.25 152.62 46.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.165 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -96.29 139.26 32.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.541 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 464' ' ' ARG . 2.4 mt -126.7 123.28 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.64 127.19 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 11.7 mm -124.46 135.16 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.976 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 44.9 m -116.51 121.13 40.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 34.9 t -127.34 119.92 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.87 111.96 64.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.08 173.95 7.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.07 . . . . 0.0 112.349 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -160.41 174.31 14.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.787 179.861 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.794 0.33 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -59.46 90.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 27.5 pt -75.69 129.2 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -108.95 99.35 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.079 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -74.46 66.39 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.092 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.76 0.314 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -160.41 119.84 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.422 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 5.1 pt -108.2 -3.68 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.332 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 60.56 50.82 63.42 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.649 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.422 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 11.7 tt -154.1 140.23 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.025 0.44 . . . . 0.0 111.07 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.59 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 2.9 mtt-85 -90.76 132.08 36.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.738 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.96 133.5 35.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.639 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 10.2 ptm -121.34 176.33 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.3 p -106.12 130.39 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 2.3 tp -74.65 96.86 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 4.4 t -87.45 177.52 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 82.7 p -63.93 -16.67 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -80.77 -42.29 22.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.787 0.327 . . . . 0.0 111.25 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -43.03 9.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.92 79.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.338 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -29.99 61.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.009 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -30.92 71.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . 0.41 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 84.1 mt -69.89 -33.35 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -74.46 -24.42 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.0 -37.73 33.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.071 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -82.69 -66.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.446 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -76.07 -52.42 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.08 -52.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.686 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.51 38.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 1.6 m-85 -91.01 167.72 15.39 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.671 0.272 . . . . 0.0 110.51 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.02 -21.48 21.63 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.533 2.155 . . . . 0.0 112.472 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.7 t0 73.3 46.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.2 97.54 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.023 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -56.72 -29.08 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.536 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 14.8 m -93.13 159.86 15.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.031 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 127.53 150.01 7.29 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.451 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.14 135.81 35.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -90.07 132.47 35.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 10.3 mt -86.18 116.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 3.3 mt -89.22 -144.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.253 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . 0.462 ' H ' ' CG2' ' A' ' 415' ' ' ILE . 9.2 pt-20 -79.67 155.27 28.11 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.088 -0.382 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.15 151.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.045 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.546 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 8.4 mm -87.4 145.63 38.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.621 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 16.5 Cg_exo -68.7 -3.48 11.31 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.988 2.459 . . . . 0.0 114.113 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.87 62.87 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.712 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.546 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 0.7 OUTLIER -154.45 158.02 32.27 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.009 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.4 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 34.3 Cg_exo -59.03 -20.25 52.65 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.554 2.17 . . . . 0.0 111.701 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -62.4 -60.12 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.77 -28.89 66.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.54 -27.63 45.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.27 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.02 65.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.353 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.1 23.85 2.87 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.774 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.43 -170.0 2.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.314 . . . . 0.0 110.693 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.48 153.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -65.88 171.34 4.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 64.51 27.33 13.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.027 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.88 -175.76 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.71 122.88 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.571 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.13 160.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.507 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.4 pp -146.37 -49.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 94.4 p -118.02 161.84 19.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.014 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 3.6 tt -155.62 119.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.5 p30 49.11 33.09 4.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.624 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.29 28.02 28.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.819 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -121.23 164.16 17.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 110.647 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 69.3 p -106.56 114.15 28.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.147 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.412 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 11.7 t -101.54 141.72 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.17 -25.8 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.494 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.16 175.7 13.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.273 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -56.51 -41.13 76.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -55.44 -28.66 55.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.765 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 -32.95 29.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.733 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.412 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 21.8 t -76.0 -41.92 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.211 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 15.0 t -52.61 -57.44 10.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.344 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -53.97 -42.22 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.63 -47.59 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.4 mt -57.9 -30.96 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.946 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -7.11 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.545 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -99.71 -48.66 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.701 0.286 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -102.04 166.52 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.2 -36.69 6.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 98.53 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.78 119.95 30.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.051 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.16 91.21 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.99 142.85 29.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.37 128.95 56.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.21 156.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 140.59 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.081 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -143.53 124.52 14.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 64.42 -98.51 0.28 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.226 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -140.05 27.28 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 0.0 110.766 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -145.23 162.78 36.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.7 139.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.1 mt -127.68 158.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.36 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.0 126.2 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.541 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 23.7 mm -115.37 137.12 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 m -116.17 140.6 49.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.689 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' A' ' 422' ' ' PRO . 20.1 t -150.03 135.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.448 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.4 mp -117.88 109.73 40.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.585 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.81 152.41 80.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.438 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -89.16 -179.53 5.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -79.82 -9.9 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.3 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.423 HG22 HD12 ' B' ' 4' ' ' ILE . 9.7 pt 41.08 91.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.862 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -79.95 91.09 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.887 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -69.38 71.75 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.243 -179.85 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.65 0.262 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -140.02 126.2 19.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.362 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.412 ' CD1' HG23 ' A' ' 385' ' ' ILE . 5.7 pt -119.27 -2.67 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.403 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.419 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 54.91 62.45 6.25 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.444 HD13 ' CG2' ' A' ' 417' ' ' VAL . 7.2 tp -153.75 129.86 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -90.7 132.42 35.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' MET . . . . . 0.429 ' CA ' HD11 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -141.06 138.83 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.856 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.2 ptm -120.93 165.79 14.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.298 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 82.8 p -93.44 109.25 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.513 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.5 tp -53.22 121.37 7.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.304 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.1 t -90.16 166.91 13.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -30.83 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 21.0 m -70.45 -29.52 66.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -91.12 -39.91 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.058 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.7 -50.4 73.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.246 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -32.93 74.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.66 -45.15 54.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.082 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.27 -31.45 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.069 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -67.37 -47.13 71.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.013 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -27.42 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.155 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -91.74 -62.41 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.401 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -64.66 -59.81 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.072 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 10.7 mtt85 79.65 -7.84 1.65 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.502 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.28 14.85 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.704 0.287 . . . . 0.0 111.162 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -105.53 128.8 25.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.07 -174.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.113 . . . . 0.0 112.346 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.53 23.47 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.459 ' O ' HG21 ' A' ' 409' ' ' ILE . 26.4 m -83.35 -23.31 8.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.059 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.558 ' O ' ' CG2' ' A' ' 409' ' ' ILE . 0.0 OUTLIER 37.0 75.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.468 0.652 . . . . 0.0 111.94 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 7.2 p -169.46 131.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.22 173.78 19.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.432 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.34 140.88 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 0.0 111.08 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -98.13 133.5 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 15.3 mt -82.6 116.2 26.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.429 HD11 ' CA ' ' A' ' 387' ' ' MET . 3.1 mt -77.96 -60.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.619 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.75 139.49 11.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.293 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.444 ' CG2' HD13 ' A' ' 385' ' ' ILE . 13.6 t -105.45 136.95 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.118 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.504 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 33.8 mm -82.84 138.46 43.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.238 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 42.7 Cg_endo -68.0 4.2 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 114.243 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -132.44 56.46 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.517 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.504 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 0.6 OUTLIER -155.63 164.91 19.66 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.421 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 32.1 Cg_exo -60.84 -20.94 68.74 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.651 2.234 . . . . 0.0 111.828 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.416 ' HA ' ' CD1' ' A' ' 428' ' ' LEU . . . -61.94 -59.15 5.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.21 -34.85 77.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.732 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -23.22 55.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -74.72 -34.35 53.66 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.414 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 25.4 2.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.85 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 423' ' ' ALA . 0.8 OUTLIER -93.39 -163.66 1.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 0.0 110.652 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.4 169.1 6.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.816 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.67 36.17 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.013 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.82 27.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -128.94 175.71 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.65 116.9 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.2 155.52 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.401 ' CD1' ' N ' ' A' ' 436' ' ' SER . 2.3 pp -148.78 -45.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.57 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' SER . . . . . 0.401 ' N ' ' CD1' ' A' ' 435' ' ' ILE . 15.6 p -124.07 154.78 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.973 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.405 HG12 ' ND2' ' A' ' 438' ' ' ASN . 3.5 tt -153.59 112.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.055 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . 0.405 ' ND2' HG12 ' A' ' 437' ' ' ILE . 22.9 p30 43.03 51.17 5.43 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.676 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 71.05 43.72 56.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.708 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -146.35 126.53 13.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 65.5 m -81.48 118.22 22.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 7.1 t -98.94 144.7 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.905 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 9.1 m -118.52 -36.82 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.653 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.0 p -144.68 179.59 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.86 94.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.072 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.408 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 23.8 p30 -54.82 -25.88 31.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.52 -52.06 7.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.986 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.409 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 46.8 t -55.77 -35.82 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.288 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 10.8 t -58.74 -61.68 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.374 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.4 -28.76 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.493 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.32 -47.49 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.009 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 15.4 mt -58.17 -28.54 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 -6.79 26.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.442 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -100.07 -47.22 5.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -105.06 144.59 31.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -29.03 21.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.761 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -109.73 97.38 6.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.535 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 6.8 mt -89.71 120.13 30.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.84 85.81 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.665 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.56 128.13 36.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 18.8 t -99.56 126.66 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 23.9 t -115.24 154.08 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.173 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.48 119.86 40.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 18.6 mtp180 -119.53 140.83 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 58.51 -97.34 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.34 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -140.25 24.96 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -142.56 158.02 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.174 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.23 137.68 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.585 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 464' ' ' ARG . 2.0 mt -126.91 141.86 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -92.31 139.55 30.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.772 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 12.6 mm -128.82 134.11 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.175 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.0 m -107.57 132.67 53.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 422' ' ' PRO . 23.3 t -144.31 124.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.223 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.418 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.5 mp -115.72 110.05 44.86 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.731 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.86 -178.13 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.207 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -136.77 -178.5 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.829 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.763 0.316 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 51.16 51.29 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 415' ' ' ILE . 1.2 pt -72.85 130.47 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.228 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . 0.408 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.4 m0 -111.64 101.22 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.936 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -75.75 68.63 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.134 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . 0.419 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 17.3 t80 -159.99 129.58 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 23.3 pt -116.11 -3.87 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.42 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' A' ' 382' ' ' TYR . . . 56.62 60.31 9.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.87 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.407 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 11.2 tt -165.08 144.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.976 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.435 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -100.36 157.99 16.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.05 137.53 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 1.3 ptp -115.5 173.79 6.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.115 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 89.2 p -99.34 99.78 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.285 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 7.1 tp -47.56 109.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 9.0 t -90.16 150.83 21.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 m -46.19 -36.54 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.593 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -47.15 84.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.35 -31.91 24.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.141 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -60.65 -36.23 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -88.89 -29.29 19.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -68.49 -25.51 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.178 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.01 -32.08 39.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.172 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -85.77 -29.72 23.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -37.59 48.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.994 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -53.77 6.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 104.24 11.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -83.12 60.79 5.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.737 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -142.75 13.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.144 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.78 150.72 48.96 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.39 166.76 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.634 2.222 . . . . 0.0 112.293 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.56 3.72 43.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 15.6 m -70.93 112.8 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 111.067 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pp -92.26 -29.57 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.155 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 142.16 41.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.2 177.2 14.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.0 151.87 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.421 ' CE1' ' O ' ' A' ' 414' ' ' ILE . 31.1 t80 -93.49 136.08 34.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . 0.421 ' O ' ' CE1' ' A' ' 413' ' ' TYR . 40.3 mt -81.09 119.92 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.106 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 1.5 mm -89.27 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.359 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.57 142.81 35.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.27 151.25 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.172 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.406 ' CG2' ' HD2' ' A' ' 419' ' ' PRO . 18.5 mm -84.14 136.77 40.5 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.406 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 61.7 Cg_endo -73.09 58.98 3.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.43 2.086 . . . . 0.0 112.662 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.25 40.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.872 0.367 . . . . 0.0 111.028 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.1 OUTLIER -138.92 172.24 6.87 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 77.9 Cg_endo -78.38 -9.43 16.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.487 2.125 . . . . 0.0 112.194 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -72.57 -58.9 3.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.031 0.444 . . . . 0.0 110.824 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -33.3 74.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -85.56 -27.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -64.37 -70.14 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.36 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.2 28.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.054 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.71 -175.94 2.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.753 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.97 155.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 63.64 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.95 36.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.807 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -146.24 -176.05 5.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.8 t -143.81 125.65 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.305 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.73 145.87 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.4 pp -137.87 -43.48 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.657 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 60.3 p -122.49 152.36 40.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.915 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.437 HD12 ' ND2' ' A' ' 438' ' ' ASN . 0.0 OUTLIER -148.0 119.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . 0.437 ' ND2' HD12 ' A' ' 437' ' ' ILE . 13.1 p30 48.04 28.08 1.38 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.05 25.77 28.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.459 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -116.73 166.17 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.8 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.6 117.49 34.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 92.9 t -105.23 147.18 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.95 -44.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.332 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.2 p -132.88 168.31 18.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 111.121 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.98 72.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.071 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -58.5 -29.95 66.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.91 -40.72 46.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 37.5 t -69.86 -35.71 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.096 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 27.2 t -57.59 -63.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -48.46 -32.49 7.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 55.1 t -70.84 -48.5 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.226 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.0 mt -61.65 -30.04 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.259 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -92.02 -19.02 22.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -98.67 -64.3 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.41 138.76 38.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 17.6 m -89.43 -34.21 16.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 31.5 p -99.13 108.0 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . 0.41 ' CB ' ' CE ' ' A' ' 460' ' ' MET . 2.5 mt -108.7 120.14 41.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 111.418 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -123.74 93.46 3.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.415 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' MET . . . . . 0.41 ' CE ' ' CB ' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -99.46 152.35 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.365 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 24.3 t -114.91 127.57 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.738 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.0 138.25 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.22 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -106.31 134.07 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.973 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.31 132.74 30.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.69 0.86 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.305 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -140.13 28.98 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -140.22 155.64 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.019 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.38 138.95 33.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.627 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.2 mt -126.73 139.25 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -103.56 133.8 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . 0.406 ' CD1' ' N ' ' A' ' 471' ' ' ILE . 3.2 mp -135.27 148.87 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 13.8 m -134.65 125.4 27.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.081 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.85 119.83 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 27.7 mm -105.24 109.47 63.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.314 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.0 143.62 39.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.282 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -100.47 -177.95 3.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 97.6 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.925 0.393 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.04 74.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.64 151.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.465 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -112.08 101.95 10.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -73.28 65.03 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.121 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.7 mttp . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.691 0.281 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -139.55 120.49 14.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.5 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 12.2 pt -124.57 -2.96 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.483 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 49.32 68.08 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.42 ' CD1' ' CG2' ' A' ' 417' ' ' VAL . 4.5 tp -153.52 118.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.822 0.344 . . . . 0.0 110.534 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 9.5 mtt85 -91.29 132.04 36.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.59 143.69 39.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.0 ptm -128.06 159.47 34.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.165 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.3 p -77.82 101.32 6.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 10.7 tp -55.38 100.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 11.6 t -87.53 156.25 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.6 t -51.59 -25.77 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -75.68 -29.13 58.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.253 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -99.84 -39.12 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -58.17 -40.06 80.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.211 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -83.05 -32.08 27.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.981 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.25 -34.55 75.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.85 -39.54 76.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -59.2 -22.52 61.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.75 -23.26 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -67.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.172 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -80.26 -49.08 12.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 5.0 ttm105 83.52 -39.53 0.08 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.958 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -68.23 -9.73 49.3 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -56.77 152.89 24.52 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.98 -172.14 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.78 2.32 . . . . 0.0 112.525 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.05 33.55 3.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.7 m -101.56 164.79 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.116 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . 0.433 HG12 ' N ' ' A' ' 410' ' ' SER . 0.2 OUTLIER -138.77 -39.53 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.459 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' SER . . . . . 0.433 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -79.25 167.58 20.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 111.33 170.56 19.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.511 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.2 140.45 29.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 0.0 111.091 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -95.57 126.3 40.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.005 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 18.6 mt -80.0 110.04 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' B' ' 4' ' ' ILE . 2.9 mp -75.24 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -157.84 156.12 30.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 111.221 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.42 ' CG2' ' CD1' ' A' ' 385' ' ' ILE . 14.0 t -128.4 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.5 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 7.3 mm -88.95 136.62 30.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.417 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 39.7 Cg_endo -67.38 -5.87 15.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.639 2.226 . . . . 0.0 113.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -112.48 46.83 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.114 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.523 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.8 OUTLIER -149.62 170.31 7.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . 0.523 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 64.1 Cg_endo -75.5 -11.42 20.6 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.215 1.943 . . . . 0.0 111.867 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -67.07 -59.27 3.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.091 0.472 . . . . 0.0 110.936 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -29.76 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.715 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.25 38.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.318 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -78.29 -22.18 68.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.74 16.08 5.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.731 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.49 -171.6 2.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 110.636 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -177.32 146.5 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -176.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 33.2 m120 56.1 24.91 8.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.051 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -120.48 -175.75 3.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.805 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.53 123.76 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.4 mp -83.79 146.59 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.588 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 436' ' ' SER . 2.5 pp -135.24 -43.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.554 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' SER . . . . . 0.428 ' N ' ' CD1' ' A' ' 435' ' ' ILE . 24.9 p -119.99 147.77 44.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.361 . . . . 0.0 111.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.2 tt -144.87 114.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.061 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 14.1 p30 44.49 43.92 6.69 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.601 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 79.39 27.4 55.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.758 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -131.46 126.32 34.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.916 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.19 125.54 29.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 3.0 t -108.94 150.75 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.19 -28.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.661 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 20.2 p -148.58 170.33 18.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.24 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.079 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -53.67 -26.99 25.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.32 -37.99 22.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.668 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.23 -33.28 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 26.8 t -60.13 -60.29 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.281 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.82 -29.52 41.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.478 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.2 -51.56 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 111.114 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 5.9 mt -57.94 -29.23 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.023 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.323 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -99.16 -58.02 2.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -82.43 132.17 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 59.5 m -74.22 -37.02 63.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.4 t -107.83 127.08 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.558 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 8.6 mt -119.73 119.74 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.328 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -119.15 99.67 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.426 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.99 144.41 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.82 139.25 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.452 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.29 160.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.199 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -97.47 119.69 36.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -109.34 119.77 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.383 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.49 -92.01 0.26 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.094 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -140.38 25.92 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.829 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.01 154.44 43.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.79 130.16 45.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.8 mt -129.02 151.49 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.311 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.6 119.86 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.444 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.68 137.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.372 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 50.2 m -111.13 126.28 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 20.7 t -139.13 141.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 21.5 mm -124.21 117.47 26.85 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.62 162.45 34.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.466 2.11 . . . . 0.0 112.279 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.56 -179.74 6.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.916 0.389 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -65.2 79.99 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 415' ' ' ILE . 2.2 pt -85.29 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.36 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.19 95.16 5.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.89 66.26 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.785 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.111 -179.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 475' ' ' PRO . 27.7 mttm . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.769 0.319 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -128.41 125.05 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.377 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 30.5 pt -136.84 -1.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.874 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.479 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 48.14 70.67 0.7 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.993 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.414 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 6.8 tp -165.22 121.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.577 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 1.5 mtt85 -90.78 139.2 30.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.722 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.13 146.39 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 1.4 ptp -120.62 -179.64 4.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.4 p -103.39 105.74 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.6 tp -57.0 99.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.054 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.5 t -80.74 162.65 24.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 53.4 p -57.91 -20.54 37.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 20.6 m -77.6 -33.41 53.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.096 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -49.49 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.164 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -52.01 -34.11 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.615 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.38 -26.79 23.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.164 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -39.11 73.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 10.7 mt -58.01 -32.2 67.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -80.92 -26.25 36.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.13 -26.07 20.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.13 -42.22 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . 0.432 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -93.62 -53.65 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 4.6 mtt180 84.55 -23.13 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.599 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 -23.8 32.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -58.39 147.4 68.37 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.62 166.98 22.19 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.571 2.181 . . . . 0.0 112.233 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.16 -23.31 64.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.176 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.97 91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.885 0.374 . . . . 0.0 111.309 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.9 -30.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -69.35 151.33 46.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 125.01 -177.51 16.86 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.758 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -110.68 170.55 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.413 ' CE1' ' O ' ' A' ' 414' ' ' ILE . 24.1 t80 -116.8 137.79 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . 0.413 ' O ' ' CE1' ' A' ' 413' ' ' TYR . 21.9 mt -86.04 117.29 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 12.4 mm -75.24 -68.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.125 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -159.92 150.23 18.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.732 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 20.4 t -113.72 151.4 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.438 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 17.9 mm -86.7 143.51 35.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.421 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 37.1 Cg_exo -61.9 -7.92 10.57 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.8 2.333 . . . . 0.0 113.594 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -135.08 71.51 1.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.701 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.479 HG22 ' HA3' ' A' ' 384' ' ' GLY . 24.5 p -149.7 156.3 38.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.351 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.63 -21.16 70.19 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.143 1.895 . . . . 0.0 110.351 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 428' ' ' LEU . . . -66.2 -60.05 3.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.496 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.95 -32.82 74.54 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.055 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.14 -25.68 59.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -75.12 -66.44 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.191 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 162.08 29.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.158 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 0.6 OUTLIER -99.24 -175.72 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.73 139.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.719 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.38 179.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.41 19.99 11.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.404 ' CB ' HD11 ' A' ' 414' ' ' ILE . 8.2 m-20 -120.28 -176.03 3.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.671 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 26.1 t -147.97 117.26 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 111.524 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.57 152.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.189 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.35 -51.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.764 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 84.2 p -113.02 144.27 42.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 111.091 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.403 HG12 ' CG1' ' A' ' 451' ' ' VAL . 1.1 tt -140.7 113.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.7 p30 43.9 45.67 6.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.533 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 73.72 52.46 8.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.703 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.9 157.96 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.654 0.264 . . . . 0.0 110.814 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.7 m -103.21 114.47 28.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.245 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.427 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 21.6 t -99.34 141.69 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.018 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.98 -37.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.503 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.14 172.43 12.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 111.264 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -56.37 -41.79 76.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.086 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -55.35 -29.52 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.712 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -80.01 -33.94 38.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.427 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 26.0 t -72.99 -38.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 12.1 t -55.63 -63.13 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.515 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -48.83 -28.41 3.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.375 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . 0.403 ' CG1' HG12 ' A' ' 437' ' ' ILE . 38.7 t -72.86 -49.6 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 5.2 mt -57.86 -26.44 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -100.13 -11.52 20.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.421 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -99.79 -47.72 4.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.719 0.295 . . . . 0.0 111.012 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -98.72 150.32 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 -33.85 11.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.661 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 5.2 t -106.15 96.21 6.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.576 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 12.3 mt -90.24 122.03 32.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -113.9 90.51 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.585 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.2 mtm -99.83 131.73 45.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.27 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.79 119.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.817 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 6.7 t -103.82 160.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -116.03 131.01 57.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -136.34 119.94 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.75 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.42 -109.92 3.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.494 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -126.59 27.14 6.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.659 0.266 . . . . 0.0 111.061 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.97 157.83 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -98.3 150.14 21.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.2 mp -129.37 136.63 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.885 0.374 . . . . 0.0 111.331 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.25 122.07 42.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.293 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . 0.418 ' N ' ' CD1' ' A' ' 471' ' ' ILE . 3.3 mp -125.4 126.73 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.926 0.394 . . . . 0.0 111.706 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.8 m -114.03 119.61 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.066 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.32 141.38 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 0.0 111.704 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.443 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.4 mp -114.95 114.17 43.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.405 ' HB2' ' HD3' ' A' ' 381' ' ' LYS . 15.1 Cg_endo -57.27 135.54 70.88 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.362 2.042 . . . . 0.0 112.362 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.32 151.85 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.791 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.826 0.346 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -72.97 113.65 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.47 145.57 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -113.54 99.83 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 386' ' ' ARG . 2.4 t90 -76.17 72.12 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.11 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 3.8 mptt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.671 0.272 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -131.87 119.95 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.31 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.405 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 24.8 pt -122.53 -12.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.611 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.499 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 54.85 69.66 1.19 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.057 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.439 HG22 HD12 ' A' ' 385' ' ' ILE . 11.3 tt -165.27 152.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.026 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.458 ' HG3' ' HB ' ' A' ' 415' ' ' ILE . 1.8 ptm180 -122.07 132.05 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.5 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.52 131.69 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.006 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.407 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 10.0 ptm -109.64 158.44 18.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.037 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.7 p -87.57 109.12 19.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.4 tp -56.07 114.64 2.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.3 t -86.46 159.09 19.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.4 t -56.05 -25.7 46.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.233 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.32 -39.14 54.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.093 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -87.44 -27.25 22.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -56.06 -42.14 76.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.288 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -85.98 -30.21 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.82 -32.42 73.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 6.2 mt -66.07 -55.55 15.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.2 -30.92 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -51.41 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -34.0 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.801 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -119.71 104.69 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -82.07 59.23 4.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -159.8 26.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.14 151.96 38.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.92 -176.16 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.14 20.25 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 13.2 m -89.62 160.5 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.927 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.33 -33.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.801 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.3 m -93.9 159.37 15.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.7 165.49 11.4 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -92.79 138.25 31.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -92.62 128.2 38.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.053 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 13.9 mt -79.71 116.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.458 ' HB ' ' HG3' ' A' ' 386' ' ' ARG . 4.8 mt -83.76 -68.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.639 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -159.58 144.71 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.994 0.426 . . . . 0.0 111.305 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.406 ' CG1' ' CB ' ' A' ' 423' ' ' ALA . 8.5 t -116.66 137.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.846 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.504 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 4.9 mm -79.66 138.86 54.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.675 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 27.0 Cg_exo -62.75 -10.39 19.67 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.909 2.406 . . . . 0.0 113.771 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.33 55.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.001 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.504 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 1.1 p -153.96 157.95 32.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.07 -25.17 79.06 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.432 2.088 . . . . 0.0 111.251 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 428' ' ' LEU . . . -58.72 -58.45 8.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.008 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.81 -30.24 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.667 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.74 -26.55 57.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.25 -30.15 63.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.204 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.82 23.16 3.12 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.819 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 423' ' ' ALA . 0.9 OUTLIER -91.73 -176.65 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.748 0.309 . . . . 0.0 110.768 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.17 159.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -176.98 1.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 59.41 27.57 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -125.23 -177.93 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.703 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -146.27 124.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.379 . . . . 0.0 111.495 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.34 154.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.715 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.69 -48.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.745 0.307 . . . . 0.0 111.717 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 77.1 p -113.8 152.93 29.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 440' ' ' GLN . 7.6 tt -150.83 112.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 18.0 p30 44.98 41.51 5.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.679 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 80.55 23.92 59.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.851 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . 0.408 ' HB2' ' CG2' ' A' ' 437' ' ' ILE . 6.8 mm100 -125.05 120.68 32.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.699 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 11.5 p -72.69 123.35 23.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.258 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 10.2 t -107.67 143.14 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.833 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.68 4.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.1 p -170.2 164.72 9.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.891 0.377 . . . . 0.0 111.222 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . 0.426 ' HB3' ' CG ' ' B' ' 5' ' ' TRP . . . -58.07 -45.18 87.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.06 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . 0.417 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 23.7 p30 -57.34 -29.15 63.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.78 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.12 -35.56 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 33.5 t -73.02 -39.46 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.376 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 23.0 t -57.02 -63.94 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.458 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -47.1 -32.2 4.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.423 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 45.6 t -68.85 -45.54 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.975 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 22.1 mt -59.65 -29.66 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -6.09 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.356 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.06 -46.96 5.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.28 155.35 20.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 8.5 t -97.8 -35.85 10.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.3 95.93 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 437' ' ' ILE . 4.8 mt -94.0 119.29 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.25 93.28 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.462 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.53 160.29 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 20.3 t -119.56 127.6 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.801 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.3 141.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -96.73 119.88 36.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.37 126.78 48.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.25 -99.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.373 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.92 29.32 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 110.837 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -141.74 147.99 38.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.089 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -90.11 136.26 33.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.38 136.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.34 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.14 119.9 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.534 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 18.1 mm -115.36 145.1 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.189 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 31.0 m -135.04 132.8 38.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.08 138.33 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.248 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.4 mp -112.66 109.99 52.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.4 119.1 6.13 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.332 2.022 . . . . 0.0 112.14 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -79.92 169.0 18.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.907 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.407 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.724 0.297 . . . . 0.0 110.728 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 54.05 52.17 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.45 155.34 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.42 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . 0.426 ' CG ' ' HB3' ' A' ' 445' ' ' ALA . 20.8 m95 -127.34 79.65 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.706 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -67.51 75.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.064 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 31.6 mttt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.668 0.27 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -147.01 128.41 14.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.344 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.402 HD11 ' CG2' ' A' ' 385' ' ' ILE . 7.1 pt -118.31 -10.62 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.41 ' HA3' HG23 ' A' ' 421' ' ' THR . . . 60.83 71.06 0.85 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.828 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 417' ' ' VAL . 7.3 tp -164.41 123.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.811 0.338 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -89.71 129.61 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.88 146.56 51.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.851 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.0 ptm -127.82 160.84 30.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.7 p -80.05 101.67 8.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.63 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.65 108.8 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.6 t -88.82 157.78 18.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.858 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.56 -25.55 60.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.59 -27.93 61.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.113 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -99.61 -40.1 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.36 67.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -89.97 -34.76 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.54 -37.07 74.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.81 -32.48 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -68.22 -41.67 80.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -56.34 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -33.73 76.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -130.96 105.98 8.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 55.94 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.051 0.453 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.45 -20.18 4.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.77 129.09 88.76 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.028 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.14 -167.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.271 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.88 64.8 4.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.79 81.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.38 -31.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.41 144.73 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 137.82 178.23 15.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -100.77 158.18 16.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 111.019 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -114.82 127.75 55.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.896 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 4.6 mt -80.71 118.82 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 430' ' ' GLU . 5.1 mt -83.65 -55.36 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.568 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -160.68 162.89 32.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.349 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.41 ' CG2' ' CD1' ' A' ' 385' ' ' ILE . 25.5 t -119.7 155.63 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.672 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.483 ' HB ' HG22 ' A' ' 421' ' ' THR . 1.7 mp -95.27 139.41 22.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 420' ' ' ASP . 21.3 Cg_endo -60.73 102.93 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.455 2.103 . . . . 0.0 112.205 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 419' ' ' PRO . 13.2 m-20 94.0 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.144 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.483 HG22 ' HB ' ' A' ' 418' ' ' ILE . 0.8 OUTLIER -150.65 158.09 35.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.175 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.19 -22.45 74.19 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.124 1.883 . . . . 0.0 110.726 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.447 ' CA ' ' HG ' ' A' ' 428' ' ' LEU . . . -64.74 -60.07 3.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.912 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.82 -39.86 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.974 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.28 70.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.276 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -78.61 -70.15 1.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 174.48 39.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.453 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.447 ' HG ' ' CA ' ' A' ' 423' ' ' ALA . 0.1 OUTLIER -87.61 175.45 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.921 0.391 . . . . 0.0 111.166 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -165.01 143.54 6.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.492 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 3.6 pt-20 -87.05 47.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 111.291 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -169.53 33.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.582 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -131.89 -179.52 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 30.6 t -134.65 121.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.419 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.9 mt -76.04 150.93 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.38 -50.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 17.4 p -112.04 159.21 18.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 111.213 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 2.5 tt -164.14 114.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.078 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 17.0 p30 46.11 34.22 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.666 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.45 32.86 24.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.69 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.09 134.3 49.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 110.64 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.29 104.6 14.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.282 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.9 t -88.06 136.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.64 -3.66 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -169.95 168.76 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.238 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.48 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.01 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -54.79 -27.53 42.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.81 -33.68 40.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.795 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.06 -40.35 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.264 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 4.5 t -56.07 -59.13 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.453 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.75 -25.6 11.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.568 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.01 -49.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.0 mt -59.43 -26.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -19.32 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.252 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -96.39 -60.88 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.81 0.338 . . . . 0.0 110.744 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -83.75 124.57 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 67.9 m -71.83 -37.26 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 9.0 p -101.65 123.58 45.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.76 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.5 mt -107.73 119.93 40.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -118.66 84.5 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.634 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.3 mtt -91.48 161.29 15.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.41 126.12 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.24 150.19 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -106.42 126.68 52.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -125.34 133.27 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.736 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.92 -104.94 1.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.236 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.49 25.93 3.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.834 0.35 . . . . 0.0 110.692 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -146.52 149.65 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.045 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.46 142.84 27.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.63 155.39 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.349 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 3.9 mmt -109.54 119.9 40.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.479 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.96 120.61 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.371 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 19.3 m -102.28 121.5 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.552 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.85 144.31 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.486 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.476 HD12 HG22 ' A' ' 474' ' ' ILE . 28.3 mm -127.77 109.9 20.47 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.855 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.72 149.65 81.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.394 2.063 . . . . 0.0 112.288 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.45 176.84 5.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.889 0.376 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -66.76 88.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 24.3 pt -74.35 141.24 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -119.58 94.09 4.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.38 77.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.156 -179.941 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 475' ' ' PRO . 24.6 mttm . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.736 0.303 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -160.04 128.42 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.175 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 12.7 pt -118.48 -5.74 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.271 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . 0.436 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 55.78 66.15 3.05 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.654 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 385' ' ' ILE . 0.0 OUTLIER -153.45 124.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.815 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' ARG . . . . . 0.413 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 25.3 mtt180 -90.2 123.88 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.069 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.21 145.03 51.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' MET . . . . . 0.402 ' HG3' ' HB3' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -122.23 179.09 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.6 p -104.75 104.83 14.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.665 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 6.2 tp -51.97 114.81 1.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.269 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.3 t -90.23 170.16 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 56.2 m -67.84 -14.5 63.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.527 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.3 t -87.94 -35.96 17.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 0.0 111.204 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.86 -30.92 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.95 98.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -76.53 -33.31 58.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -29.18 70.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.49 -49.34 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.041 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -58.59 -30.37 67.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.092 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.36 -37.57 80.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.95 -65.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.56 -58.4 8.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 75.8 -54.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.362 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -44.72 -29.7 0.81 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.01 138.91 71.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.78 -159.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.485 2.123 . . . . 0.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -101.57 27.31 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.2 m -71.74 140.3 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.98 -30.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 16.8 m -101.62 -178.2 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 112.61 167.21 17.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.598 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.6 151.6 25.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' TYR . . . . . 0.402 ' HB3' ' HG3' ' A' ' 388' ' ' MET . 52.8 t80 -101.46 128.72 47.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 16.1 mt -79.94 114.62 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.826 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.76 -66.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.27 158.57 41.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 111.585 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' VAL . . . . . 0.401 ' CG1' ' HB3' ' A' ' 423' ' ' ALA . 41.3 t -130.63 153.3 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.824 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' ILE . . . . . 0.515 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.1 mp -97.22 129.8 31.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.523 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.98 -12.91 16.69 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.009 2.473 . . . . 0.0 113.857 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -111.24 53.48 0.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' THR . . . . . 0.436 HG22 ' HA3' ' A' ' 384' ' ' GLY . 18.1 p -153.89 153.82 29.2 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.095 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.58 -24.46 45.02 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.099 1.866 . . . . 0.0 110.906 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 428' ' ' LEU . . . -58.81 -60.25 4.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.37 -30.96 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.726 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.0 -15.46 58.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -84.07 -31.85 24.89 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.349 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 125.59 16.97 2.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.153 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 3.9 mt -85.69 -171.21 3.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.133 0.467 . . . . 0.0 110.74 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.86 153.87 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.43 -178.91 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 28.59 16.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -132.63 170.02 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.751 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.26 127.06 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.324 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.1 mp -84.89 147.85 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.569 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.2 pp -137.99 -43.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.728 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 23.6 p -124.94 151.94 44.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.091 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.5 tt -148.81 115.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.982 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.7 p30 47.64 36.36 5.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.641 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.03 30.18 32.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.747 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -122.78 145.69 48.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.778 0.323 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.2 t -86.76 107.88 18.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.16 152.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 10.7 m -139.76 -46.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 2.3 p -132.64 166.48 22.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.999 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -56.21 -38.05 70.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.293 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -58.53 -29.67 66.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.63 -41.26 39.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 32.9 t -63.16 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 3.6 t -54.89 -66.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.547 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.7 t -75.62 -46.12 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.289 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 6.4 mt -58.76 -32.9 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 -4.15 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.628 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -100.38 -49.7 4.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.67 150.25 22.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 -35.88 14.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.807 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.21 96.83 6.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 10.6 mt -91.35 121.16 32.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -111.78 90.21 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 3.2 mtm -95.71 130.35 42.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.105 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 22.1 t -99.22 122.82 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.956 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.64 148.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.27 131.35 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -138.74 125.53 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 69.52 -101.4 0.83 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.464 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -140.12 25.39 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.655 0.264 . . . . 0.0 111.116 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -140.08 151.77 45.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.821 0.344 . . . . 0.0 111.2 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.08 139.24 31.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.62 129.18 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 111.362 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.8 120.11 33.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.51 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 8.6 mm -117.8 142.9 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.31 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 1.3 m -123.45 136.03 54.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 5.7 t -143.82 137.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.249 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.4 mp -113.66 109.8 50.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' PRO . . . . . 0.408 ' HB2' ' HB3' ' A' ' 381' ' ' LYS . 28.8 Cg_endo -63.07 134.14 44.55 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.059 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.89 -177.4 5.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.773 0.32 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.8 mtm-85 -58.09 89.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 5.0 pt -83.36 115.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -99.76 101.29 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.97 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' TRP . . . . . 0.413 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 8.8 t90 -82.59 63.32 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.787 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.059 -179.949 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.6 m -152.14 -66.36 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -129.61 101.09 5.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 1.2 mtp -156.09 164.46 38.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.9 tptm 61.35 93.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -71.64 -176.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.749 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -141.76 123.14 14.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.257 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 5.4 pt -113.29 -13.72 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.347 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 72.14 57.53 5.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.772 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 12.4 tt -160.18 151.74 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.14 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.417 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 17.7 mtt180 -106.02 127.6 53.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.71 145.29 48.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.9 ptm -127.27 160.55 30.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 83.9 p -85.4 110.02 18.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.5 tp -58.06 89.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.018 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 5.7 t -75.72 166.47 23.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.77 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.1 t -49.53 -36.11 22.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.425 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -63.73 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.175 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -49.6 75.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.9 -39.69 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.313 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.04 -29.19 39.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.6 -34.81 79.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.19 -43.15 78.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.05 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -59.63 -34.35 72.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.64 -37.87 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -82.51 -70.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 96.46 8.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.04 60.43 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.8 14.23 1.92 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.23 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.31 150.96 40.08 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.09 179.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.87 28.42 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 14.9 m -101.38 173.84 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.441 HG22 HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -138.63 16.7 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.373 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.2 p -116.2 139.89 49.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.882 0.372 . . . . 0.0 110.801 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.12 167.06 11.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.35 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -101.56 142.9 32.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.128 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -104.14 130.38 51.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 17.4 mt -80.08 128.76 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.54 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 62.7 mt -96.24 -68.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.563 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 153.12 40.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 0.0 111.044 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.16 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.464 ' HB ' HG22 ' A' ' 421' ' ' THR . 1.5 mp -79.84 134.69 56.57 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.308 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.421 ' HD2' HG21 ' A' ' 418' ' ' ILE . 57.1 Cg_exo -53.97 -11.21 2.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.249 2.632 . . . . 0.0 114.678 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -130.95 76.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.464 HG22 ' HB ' ' A' ' 418' ' ' ILE . 0.2 OUTLIER -160.15 163.58 21.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.603 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.64 -25.17 78.13 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.408 2.072 . . . . 0.0 111.6 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -59.14 -54.67 44.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.169 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.08 -31.08 65.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.5 -30.51 59.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.265 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.98 -38.15 84.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.35 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.77 29.42 1.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.82 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.97 -164.28 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.686 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.25 163.71 22.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.854 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 41.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 0.0 110.977 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -151.88 28.54 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.57 -177.04 3.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 29.8 t -136.68 123.21 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.315 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.04 157.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.0 pp -148.79 -46.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.411 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 54.2 p -124.34 160.95 26.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.979 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.421 HG12 ' ND2' ' A' ' 438' ' ' ASN . 2.8 tt -156.58 119.57 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.249 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . 0.421 ' ND2' HG12 ' A' ' 437' ' ' ILE . 19.6 p30 43.54 46.94 6.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.718 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 74.27 47.18 18.2 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.713 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -142.95 161.49 37.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.679 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 61.9 m -111.62 110.5 20.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.961 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 5.3 t -95.04 152.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.9 m -130.12 -42.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.453 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 2.2 p -134.3 172.35 13.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 0.0 111.242 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -56.38 -42.97 78.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.408 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 25.1 p30 -55.31 -29.14 57.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.843 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.52 -35.68 45.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 32.4 t -69.75 -41.51 79.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.266 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 20.2 t -54.78 -62.62 1.54 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.529 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -48.28 -35.97 13.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.409 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.3 t -65.81 -46.05 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.068 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 6.5 mt -61.92 -31.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.135 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.03 -14.3 24.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.455 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -94.37 -44.99 7.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.317 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.13 128.52 53.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 53.9 m -70.2 -37.71 75.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.7 p -104.25 121.38 43.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.582 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 9.2 mt -107.38 129.27 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -127.92 83.07 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.642 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.68 136.62 32.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 21.8 t -99.07 126.51 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.164 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 11.6 t -121.15 129.3 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -89.73 120.96 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -124.3 128.52 49.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.03 -100.98 0.89 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.347 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -139.93 23.85 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -141.91 148.35 38.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.147 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -91.73 136.46 33.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.01 146.59 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.216 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -101.89 119.92 39.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 12.1 mm -107.17 133.6 51.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.54 126.55 55.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.936 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.98 130.35 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.03 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 33.8 mm -105.24 109.92 63.8 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.06 175.49 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -123.92 155.81 37.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -94.21 135.2 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -160.06 137.31 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.995 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -139.68 115.18 8.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.25 1.087 0 C-N-CA 122.387 2.058 . . . . 0.0 112.315 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.64 -74.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 60.4 71.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 9.2 pt -84.82 134.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . 0.408 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 12.5 m95 -117.91 91.11 3.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.417 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 3.8 t90 -70.71 72.47 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.118 179.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 47.3 m -90.11 122.64 33.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.96 92.35 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.993 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 8.6 mtt -84.46 155.85 22.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.28 140.49 48.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -123.63 143.13 50.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.435 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 52.1 t80 -152.97 131.76 12.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 22.4 pt -116.85 -14.95 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.62 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.435 ' HA2' ' CZ ' ' A' ' 382' ' ' TYR . . . 67.01 61.95 4.83 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.882 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 10.3 tt -165.37 137.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 111.266 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.485 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -96.59 145.9 25.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.782 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.46 139.5 33.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.742 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.2 ptm -116.83 162.88 17.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.9 p -85.37 115.85 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.13 84.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.8 t -71.12 173.7 7.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.9 m -62.56 -19.1 63.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.305 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -46.43 12.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 -32.65 27.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.58 -51.02 62.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.386 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.19 -29.47 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -38.09 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.06 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 6.1 mt -62.45 -52.58 62.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.059 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -29.93 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -60.0 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -65.68 -42.4 91.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.058 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.411 ' HB3' ' CD2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -119.89 113.94 21.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -82.92 -27.44 30.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -25.64 59.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.411 ' CD2' ' HB3' ' A' ' 402' ' ' HIS . 4.8 m-85 -55.46 161.27 3.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.53 173.2 10.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.59 2.193 . . . . 0.0 112.21 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -98.31 30.98 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 13.2 m -114.66 126.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.66 -30.16 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.51 173.78 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 104.65 173.94 24.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.443 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.28 140.14 43.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.15 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -90.54 128.06 36.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.668 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 8.0 mt -79.88 127.94 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 9.6 mm -85.4 -69.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -160.14 153.79 22.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.723 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.09 139.05 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.454 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 22.7 mm -79.75 146.57 64.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.507 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.412 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 15.8 Cg_exo -69.52 6.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.822 2.348 . . . . 0.0 113.877 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.06 62.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.146 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.454 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 0.1 OUTLIER -155.42 171.81 6.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.772 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 82.3 Cg_endo -79.19 -18.12 11.36 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.535 2.157 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -60.43 -58.87 6.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.049 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -68.37 -27.76 66.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.859 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.63 38.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.383 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.24 -39.19 32.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.435 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 133.24 16.97 1.16 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.154 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 3.0 mt -85.99 -170.65 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.074 0.437 . . . . 0.0 110.68 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.82 141.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 16.0 pm0 -62.22 178.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 62.88 23.5 14.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.805 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -125.42 -177.11 3.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.554 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -139.47 123.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 111.536 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.3 154.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.86 -49.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.683 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 52.3 p -114.14 155.43 26.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.207 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.1 tt -157.77 111.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.028 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 13.5 p30 45.43 41.65 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.578 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 78.7 35.1 32.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.769 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -134.62 125.57 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.766 0.317 . . . . 0.0 110.924 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 68.8 p -80.93 110.77 16.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 10.8 t -92.2 143.1 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.11 -32.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.48 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.99 177.59 9.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.239 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.45 98.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.037 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.425 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 24.5 p30 -53.87 -26.25 23.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.91 -50.69 10.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.688 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 41.3 t -56.75 -37.25 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.291 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 24.8 t -57.1 -65.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.399 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -51.67 -32.16 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.37 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 41.5 t -66.64 -49.91 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 9.1 mt -58.25 -29.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -97.14 -14.28 21.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.422 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -97.64 -54.64 3.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -86.48 126.3 34.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.927 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 73.5 m -69.03 -36.84 78.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.5 p -108.44 136.27 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 mt -120.14 140.74 50.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.052 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -141.9 91.78 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.586 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.74 159.34 14.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 23.7 t -129.93 122.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.875 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.91 147.45 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.206 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -114.61 139.36 49.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -132.23 126.51 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.793 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 59.93 -96.51 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -136.88 29.0 2.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 0.0 110.961 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.54 143.79 39.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.95 141.77 28.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.675 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.03 125.31 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.159 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.93 125.27 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.769 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.5 132.55 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.401 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 1.2 m -116.71 119.82 36.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.435 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.92 140.71 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 111.399 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 27.3 mm -124.09 111.99 28.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.717 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -62.05 144.23 95.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.315 2.01 . . . . 0.0 112.353 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.7 171.62 7.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.968 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.14 135.65 33.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.94 134.76 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.4 109.93 50.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.515 2.144 . . . . 0.0 112.274 179.952 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.818 0.342 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.58 30.62 15.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -65.5 99.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pt -69.5 157.03 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . 0.425 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 13.3 m95 -118.78 91.89 3.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.404 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 5.4 t90 -72.98 79.64 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.18 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.464 -0.255 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.51 122.03 24.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -108.35 121.12 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 5.3 ttm -128.83 178.52 6.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.85 167.17 16.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.94 146.41 23.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -154.37 159.16 41.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.843 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 383' ' ' ILE . 0.7 OUTLIER -135.38 -59.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.37 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 115.5 49.32 0.48 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.359 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 5.5 tp -138.93 132.58 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.031 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -89.8 129.82 36.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.561 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.36 157.57 45.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.106 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' A' ' 412' ' ' ALA . 1.5 ptm -134.32 -179.59 5.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 4.2 p -94.67 15.82 17.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.369 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 12.5 tp 47.26 95.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.874 0.369 . . . . 0.0 111.481 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 2.6 t -71.67 156.26 39.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.23 -30.57 70.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.1 m -66.62 -56.67 9.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -29.84 65.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.59 -60.01 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.45 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -61.9 -36.38 81.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.1 -43.5 98.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -66.12 -30.54 71.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -59.89 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -68.53 -60.62 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.8 85.23 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 65.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.124 0.488 . . . . 0.0 110.854 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -167.54 28.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -89.63 167.34 17.71 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.773 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.64 -24.4 12.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.527 2.151 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.6 t0 68.36 51.79 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.51 90.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.025 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -46.54 -30.97 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.474 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.4 m -116.61 130.49 56.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 163.57 178.33 37.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 448' ' ' VAL . . . -98.08 123.41 42.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -97.83 129.99 44.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 21.5 mt -80.69 109.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.605 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 2.8 mp -72.89 -58.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.294 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -160.1 147.78 16.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.814 0.34 . . . . 0.0 111.208 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 24.8 t -108.85 133.28 54.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.939 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -80.4 156.7 73.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.93 44.08 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.793 2.329 . . . . 0.0 112.58 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -173.31 35.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.562 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.411 ' OG1' ' HD2' ' A' ' 422' ' ' PRO . 4.0 t -129.46 154.39 80.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.023 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.411 ' HD2' ' OG1' ' A' ' 421' ' ' THR . 36.1 Cg_exo -61.19 -24.39 79.0 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.761 2.308 . . . . 0.0 112.325 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -53.72 -38.56 64.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.66 -29.66 59.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.39 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.953 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -67.89 -69.57 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.29 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 151.69 39.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.81 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.1 mt -98.48 -165.12 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.902 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -178.97 170.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.04 28.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.22 12.97 3.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -119.12 173.37 6.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.631 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 28.4 t -138.25 117.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.365 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 3.6 mp -66.2 142.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 pp -136.43 -46.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.567 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 24.2 p -121.7 156.51 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.057 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -151.54 124.45 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.002 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 13.9 p30 44.71 30.89 0.57 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.576 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.22 27.26 23.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -118.13 170.19 9.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.746 0.307 . . . . 0.0 110.713 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 16.4 m -118.35 111.09 18.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 10.8 t -97.67 161.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 8.6 m -139.45 -48.31 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.475 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.05 167.82 14.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.414 . . . . 0.0 111.282 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.38 81.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -55.84 -26.34 46.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -86.88 -29.74 21.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.471 HG23 ' HB1' ' A' ' 412' ' ' ALA . 13.4 t -72.13 -44.67 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.314 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 3.7 t -50.84 -64.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.624 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -46.61 -36.5 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.474 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 41.1 t -63.33 -50.09 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.207 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.75 -37.2 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -90.34 -4.88 56.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.399 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -100.07 -51.35 3.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.63 142.36 28.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 5.3 t -81.28 -38.25 27.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.674 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.61 117.76 34.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.601 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . 0.4 ' CB ' ' CE ' ' A' ' 460' ' ' MET . 6.0 mt -101.97 126.75 48.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -132.22 92.78 3.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.634 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' MET . . . . . 0.4 ' CE ' ' CB ' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -96.74 151.69 19.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.35 121.95 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.017 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 9.0 t -107.43 161.42 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.83 138.7 54.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.0 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.65 121.27 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.743 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.79 -113.68 5.84 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.26 29.37 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.52 150.2 43.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.243 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -94.25 147.15 23.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.88 132.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.256 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.31 119.88 39.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.654 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 11.5 mm -112.54 132.67 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 25.1 m -122.62 119.86 32.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 24.5 t -130.1 133.74 63.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.3 mm -118.11 109.14 41.23 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.84 -172.71 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.462 2.108 . . . . 0.0 112.226 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -143.1 173.5 11.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -102.83 130.34 49.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 16.5 tt -148.37 155.62 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.019 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.65 121.17 28.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.413 2.076 . . . . 0.0 112.292 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.754 0.311 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m 64.26 36.33 9.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.99 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 113.6 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pt -81.26 118.13 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -94.71 92.65 7.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -68.24 85.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.123 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.44 125.53 54.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.21 -69.01 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.882 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.39 97.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.812 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -138.65 146.92 42.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -110.93 155.2 23.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.713 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -131.0 126.98 37.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 11.0 pt -116.72 -4.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.425 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 50.07 67.27 1.91 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.857 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 4.8 tp -151.73 126.22 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 110.841 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.412 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 27.7 mtt85 -89.9 125.96 35.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.85 142.53 47.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 8.6 ptm -125.54 156.98 38.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 49.2 p -84.21 114.53 21.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 6.8 tp -63.93 81.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.4 t -62.12 158.69 16.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 m -57.42 -23.24 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -54.7 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.092 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.71 -45.16 91.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.169 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.18 -39.85 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.185 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -77.63 -29.87 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.79 -47.57 62.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.14 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.5 -44.06 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -65.86 -31.7 72.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.74 -43.31 94.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 ttm-85 -93.09 -20.34 20.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.311 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -135.57 78.79 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -69.14 -22.8 63.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.79 -26.64 10.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -65.06 160.39 56.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.835 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.27 -167.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.565 2.177 . . . . 0.0 112.243 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -116.7 31.33 6.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.015 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.7 m -91.9 132.27 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.5 -18.26 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.31 154.23 18.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 116.56 159.35 11.65 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -90.11 147.77 23.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.117 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -102.42 131.25 49.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 21.2 mt -80.01 122.92 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 17.9 mt -91.84 -61.24 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.831 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -157.88 149.29 21.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.403 . . . . 0.0 111.415 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 20.4 t -117.4 140.37 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.454 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.3 mp -86.79 135.37 35.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.729 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 7.9 Cg_exo -72.57 56.18 2.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.779 2.319 . . . . 0.0 112.496 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 178.25 40.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.162 0.506 . . . . 0.0 110.498 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.4 OUTLIER -142.78 173.83 4.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -75.77 -13.87 19.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.132 1.888 . . . . 0.0 111.856 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -66.15 -56.9 9.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.65 -31.78 70.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.456 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.94 -30.62 58.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.843 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -66.86 -34.06 86.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.255 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.95 26.83 2.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.843 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.47 -177.81 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -159.64 161.5 35.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.762 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -85.59 56.17 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.17 31.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.034 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -135.22 -174.34 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.815 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 38.6 t -142.21 123.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.312 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.7 mt -75.7 147.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.417 ' CD1' ' N ' ' A' ' 436' ' ' SER . 2.5 pp -138.69 -46.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.351 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' SER . . . . . 0.417 ' N ' ' CD1' ' A' ' 435' ' ' ILE . 90.9 p -116.93 156.32 27.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.726 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.403 HG12 ' ND2' ' A' ' 438' ' ' ASN . 4.5 tt -155.9 114.51 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.198 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . 0.403 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.7 p30 44.33 33.42 0.85 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.454 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.68 36.16 9.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.773 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.47 114.42 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 m -70.19 114.4 8.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.401 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 2.7 t -97.65 162.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.76 -45.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.9 p -130.95 173.73 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.16 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.84 94.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.045 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.416 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 1.3 p-10 -53.99 -26.64 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -86.85 -41.4 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.401 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 46.9 t -63.19 -30.63 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.131 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 4.9 t -63.59 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -51.27 -36.38 41.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.504 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.72 -47.73 91.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 0.0 111.111 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 5.5 mt -62.09 -37.5 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.15 -8.05 55.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.224 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -98.92 -46.82 5.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.819 0.343 . . . . 0.0 110.843 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.26 140.33 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 35.3 t -84.88 -34.31 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.739 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 2.1 p -109.17 100.21 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.758 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 8.3 mt -94.53 136.31 34.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -133.82 89.02 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.633 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.48 173.78 7.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 13.2 t -134.68 145.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 7.3 t -140.58 153.47 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.001 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -101.76 119.84 39.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.98 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . 0.414 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 9.3 mtp180 -127.81 139.64 52.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.7 -101.72 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.169 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -140.19 20.56 2.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.778 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -145.8 168.47 20.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.92 136.08 42.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.649 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 464' ' ' ARG . 2.8 mt -127.53 143.98 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.7 119.89 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.714 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 21.8 mm -103.21 130.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.77 129.12 49.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.013 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 18.4 t -140.36 119.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 21.2 mm -108.19 109.85 61.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.165 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -51.43 131.27 35.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.43 2.087 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.0 170.56 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.97 129.83 54.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.841 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 19.6 tt -140.97 152.76 20.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.041 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -147.51 119.13 4.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.843 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.462 2.108 . . . . 0.0 112.307 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.808 0.337 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m 55.55 26.46 9.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.076 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -60.16 117.05 4.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pt -84.26 123.08 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . 0.416 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.6 m95 -108.57 95.37 5.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.412 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 6.8 t90 -76.85 62.56 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.808 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.064 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 46.8 t -129.11 -43.87 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.42 -76.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.63 112.41 24.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.02 147.86 48.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.13 152.01 22.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -152.02 124.42 8.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.024 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 24.5 pt -113.36 -4.2 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.463 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 53.6 65.82 3.17 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.734 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 0.0 OUTLIER -165.13 124.82 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.947 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -92.3 125.15 36.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.07 137.28 53.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 3.7 ptm -115.85 173.26 6.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.012 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.5 p -97.69 105.55 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.632 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.2 tp -54.37 98.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.7 t -87.01 165.09 16.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.839 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.8 m -58.92 -29.7 67.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.067 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 71.2 m -78.55 -19.05 53.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -51.26 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 111.072 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.84 83.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.313 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -66.72 -29.71 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.82 -41.06 62.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.993 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.97 -38.45 82.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -34.2 68.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.98 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -77.28 -29.27 53.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -53.25 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -116.31 115.74 26.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.003 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.79 55.62 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.841 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -146.97 19.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.103 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.83 158.28 35.35 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 -172.74 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.588 2.192 . . . . 0.0 112.211 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -109.29 32.03 5.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 11.7 m -102.3 129.6 53.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pt -102.57 -32.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.5 m -87.78 149.9 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.773 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 132.17 -157.8 22.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -132.96 127.62 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -90.33 128.03 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 15.3 mt -80.57 109.97 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.3 -58.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -158.31 152.14 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.401 . . . . 0.0 111.245 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 22.2 t -127.95 136.35 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.954 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.45 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 8.4 mm -79.86 146.23 63.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 11.9 Cg_exo -71.15 0.52 6.54 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.744 2.296 . . . . 0.0 113.319 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -127.35 61.75 1.38 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.8 OUTLIER -152.7 168.99 10.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.564 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 59.7 Cg_endo -74.31 -18.06 20.89 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.265 1.977 . . . . 0.0 111.48 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -61.8 -59.22 5.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.554 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.49 -27.08 64.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.563 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.44 -30.45 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.18 1.26 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 167.97 31.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.903 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.12 -168.15 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.805 0.336 . . . . 0.0 110.82 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.55 169.62 2.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.774 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.92 49.93 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -160.46 29.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -134.15 -177.34 4.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.58 117.89 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.19 149.58 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.409 ' CD1' ' N ' ' A' ' 436' ' ' SER . 2.3 pp -141.95 -47.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' SER . . . . . 0.409 ' N ' ' CD1' ' A' ' 435' ' ' ILE . 96.3 p -123.64 144.94 49.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 3.9 tt -143.52 119.62 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 18.9 p30 44.85 30.49 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.734 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.07 20.37 42.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.201 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -112.31 157.67 20.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.78 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.17 118.3 31.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.51 127.45 66.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.29 6.49 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.95 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -170.41 161.52 8.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.881 0.372 . . . . 0.0 111.152 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.2 -45.19 88.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.048 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.412 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 36.4 p-10 -56.58 -28.42 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.69 -33.8 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 18.0 t -74.45 -37.39 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.195 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 7.6 t -55.27 -57.55 11.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -54.94 -41.04 70.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.339 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 39.5 t -58.56 -47.34 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.148 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.4 mt -58.8 -36.05 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.68 -0.84 54.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.322 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -100.22 -47.8 4.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 110.916 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.2 152.81 31.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.75 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.9 t -94.27 -35.61 12.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.695 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 94.3 6.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 14.9 mt -89.86 123.24 33.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -111.13 83.16 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.6 mtt -90.29 133.35 35.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 28.7 t -108.28 124.71 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.0 t -111.27 163.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.76 143.91 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.047 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -144.73 130.36 19.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.82 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.22 -99.54 0.21 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.436 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.26 30.89 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.754 0.312 . . . . 0.0 110.944 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.12 144.94 24.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.76 129.65 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 111.317 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.69 125.21 47.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.492 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.8 mp -132.66 143.61 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.44 . . . . 0.0 111.618 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.18 135.92 53.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.94 135.1 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.566 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.412 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.5 mp -119.83 109.26 37.97 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.586 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.12 155.96 5.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.425 2.084 . . . . 0.0 112.292 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.18 170.62 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.56 144.76 25.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.97 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 13.0 tt -143.5 130.46 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.046 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -115.19 111.97 44.42 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.859 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo . . . . . 0 C--O 1.249 1.037 0 C-N-CA 122.361 2.041 . . . . 0.0 112.341 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.816 0.341 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -97.72 47.2 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.0 mtt-85 -61.62 89.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pp -80.78 133.43 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . 0.412 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.4 m0 -112.04 88.13 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -71.17 68.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.768 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.198 -179.816 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.3 m -131.64 31.81 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -101.89 28.6 5.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.47 119.67 23.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.53 122.51 7.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.999 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -84.68 172.82 11.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.597 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.417 ' CE1' ' HA2' ' A' ' 384' ' ' GLY . 13.0 t80 -155.83 121.1 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.241 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 5.0 pt -111.35 -13.02 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.237 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.417 ' HA2' ' CE1' ' A' ' 382' ' ' TYR . . . 70.42 52.77 15.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.729 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 10.9 tt -165.31 137.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -89.96 158.18 17.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.463 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.22 133.63 13.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -110.69 173.8 6.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.019 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.3 p -100.16 112.6 24.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.832 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.3 tp -63.52 88.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.127 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 2.3 t -85.57 167.37 15.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.32 -39.68 6.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.728 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -68.97 -58.36 4.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 111.229 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -52.5 64.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.323 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.25 -33.89 21.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.474 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -90.1 -29.51 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.043 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -65.32 -44.0 89.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 3.4 mt -58.69 -39.23 80.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.046 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -67.08 -30.2 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -68.83 -59.38 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -66.03 -38.54 88.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.798 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.03 98.23 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -81.91 59.72 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.036 0.446 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.39 23.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.939 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -93.87 146.37 31.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.17 179.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.269 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.42 38.23 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.814 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 34.9 m -109.44 117.39 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.51 -29.72 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.11 148.85 25.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.003 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 122.21 170.43 13.71 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.685 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.46 152.71 24.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.026 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.415 ' CE1' ' O ' ' A' ' 414' ' ' ILE . 27.2 t80 -92.19 133.79 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . 0.415 ' O ' ' CE1' ' A' ' 413' ' ' TYR . 38.2 mt -79.98 121.78 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.037 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.415 ' CG2' ' H ' ' A' ' 416' ' ' GLU . 2.0 mm -88.76 -152.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . 0.415 ' H ' ' CG2' ' A' ' 415' ' ' ILE . 17.0 pt-20 -79.35 145.15 33.58 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 0.0 111.074 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 14.2 t -110.9 159.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.028 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.419 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 20.6 mm -96.86 136.0 21.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.8 59.03 4.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.519 2.146 . . . . 0.0 112.579 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 174.93 44.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.586 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.457 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.2 OUTLIER -150.95 173.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -76.18 -16.28 17.77 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.309 2.006 . . . . 0.0 112.089 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.436 ' O ' ' HG ' ' A' ' 428' ' ' LEU . . . -60.63 -60.05 4.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -74.06 -23.25 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -82.04 -26.12 34.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.13 -70.06 1.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 171.55 30.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.997 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 0.2 OUTLIER -107.74 176.03 5.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.829 0.315 . . . . 0.0 110.643 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.99 157.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.28 77.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.95 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -72.24 179.32 3.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.978 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 22.7 t -139.8 131.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 3.2 mt -86.06 145.34 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 pp -140.57 -48.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 19.1 p -110.01 158.79 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.2 tt -158.48 116.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.281 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 19.5 p30 42.52 50.54 4.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.649 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 70.61 44.96 56.03 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.798 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -137.97 152.94 49.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 55.6 m -103.79 107.32 18.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.425 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 13.3 t -100.29 143.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.07 -4.21 5.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.93 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.8 p -169.97 168.27 8.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.249 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.15 -43.84 87.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.409 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 18.3 p30 -53.31 -27.0 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -84.86 -33.77 22.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.758 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.425 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 45.8 t -72.95 -37.36 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.205 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 11.1 t -55.26 -59.14 5.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.71 -24.64 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.28 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 37.7 t -76.5 -50.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.165 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 7.8 mt -56.58 -27.58 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.21 -11.93 22.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.403 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.04 -51.04 3.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -95.03 134.91 37.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.55 -34.97 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.2 p -103.34 115.22 30.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 10.1 mt -106.93 133.54 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.227 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 90.15 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.518 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.28 149.05 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.308 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 25.6 t -120.38 125.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.837 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 16.1 m -117.25 -179.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.353 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -119.46 125.99 50.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -118.55 120.24 36.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.61 -94.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.277 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -140.05 27.12 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -144.56 168.46 20.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.92 140.09 42.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.9 mt -128.13 147.38 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 111.232 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.97 125.36 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.713 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.0 127.91 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.259 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 55.3 m -106.93 122.95 47.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 27.1 t -127.63 137.21 58.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.044 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -122.65 109.63 32.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.55 159.46 53.42 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.419 2.079 . . . . 0.0 112.35 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.54 -176.1 2.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -116.73 131.93 56.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 18.7 tt -148.64 150.08 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.95 121.07 52.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.351 2.034 . . . . 0.0 112.29 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.848 0.356 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 26.4 m -72.37 -54.16 10.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.746 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 56.32 39.24 30.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -75.27 148.14 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . 0.409 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 9.7 m0 -109.7 111.15 22.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -80.7 75.87 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.149 -179.933 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 14.9 t -152.09 172.67 15.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.739 0.304 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -125.99 41.46 3.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.005 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -147.7 68.62 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.938 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -143.71 102.36 3.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.788 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.81 146.51 28.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -145.67 131.46 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.441 HG22 HD12 ' A' ' 383' ' ' ILE . 3.6 pt -127.71 12.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.725 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 42.95 63.14 2.08 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.375 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.419 ' CD1' ' CG2' ' A' ' 417' ' ' VAL . 7.2 tp -148.74 124.33 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.163 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 386' ' ' ARG . 11.6 mtt180 -89.64 121.27 31.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.86 147.46 50.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.056 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 5.5 ptm -127.51 173.9 9.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.934 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 31.9 p -89.16 99.98 12.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 10.2 tp -58.53 88.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 7.7 t -75.79 169.53 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.809 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.7 p -54.65 -37.65 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.1 t -69.62 -56.14 8.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -39.11 92.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.66 80.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.141 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -27.74 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -45.74 83.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.04 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.414 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 17.8 mt -67.14 -30.93 71.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -30.8 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -50.76 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.92 -68.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 87.55 7.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -78.71 61.64 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -151.19 21.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.945 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 398' ' ' LEU . 23.2 m-85 -91.57 159.33 38.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.99 174.83 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.659 2.239 . . . . 0.0 112.188 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.33 45.73 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.36 148.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.37 -40.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.298 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.44 133.0 41.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.887 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 146.06 -177.59 24.33 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.407 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -106.68 141.53 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -94.71 137.84 33.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 23.0 mt -87.04 116.41 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 37.0 mt -84.84 -62.93 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.464 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -154.57 153.57 31.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.158 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.419 ' CG2' ' CD1' ' A' ' 385' ' ' ILE . 21.7 t -121.36 141.83 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . . . . . . . . . 16.2 mm -81.52 142.55 50.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.773 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.83 -0.91 8.52 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.816 2.344 . . . . 0.0 113.686 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -130.55 59.58 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.25 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.452 ' OG1' ' HD2' ' A' ' 422' ' ' PRO . 0.7 OUTLIER -160.54 157.8 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.452 ' HD2' ' OG1' ' A' ' 421' ' ' THR . 31.9 Cg_exo -60.14 -20.68 62.67 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.09 75.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.012 0.434 . . . . 0.0 110.985 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -84.72 -30.95 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.695 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.15 -31.5 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -66.75 -35.5 89.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.271 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.77 27.48 2.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.861 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.63 -174.28 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.817 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.91 169.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.907 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.88 54.65 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.84 26.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.206 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -138.96 -174.53 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.837 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.36 119.41 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.369 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.55 116.92 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.6 pp -105.05 -42.18 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.692 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 51.6 p -126.53 159.52 33.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.962 0.411 . . . . 0.0 111.062 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.407 ' CG2' ' HB2' ' A' ' 440' ' ' GLN . 3.4 tt -156.54 113.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 24.0 p30 44.23 44.61 6.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.75 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.15 37.93 36.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.072 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.407 ' HB2' ' CG2' ' A' ' 437' ' ' ILE . 7.4 mm-40 -131.99 128.3 38.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t -76.34 110.19 10.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' A' ' 448' ' ' VAL . 58.0 t -90.61 156.07 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 12.2 m -145.95 -47.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.6 p -137.5 171.63 14.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.36 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.303 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.404 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 25.7 p30 -54.42 -26.1 28.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.34 -57.3 3.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.419 HG22 ' CG1' ' A' ' 442' ' ' VAL . 38.9 t -47.57 -40.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.569 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 6.9 t -55.55 -63.71 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.49 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -50.31 -26.87 5.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.545 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 60.5 t -77.56 -46.95 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.128 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 7.3 mt -57.8 -27.53 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.165 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -100.31 -8.76 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.552 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.07 -49.46 4.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.18 132.4 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -35.72 55.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.806 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 2.6 t -104.34 116.07 31.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 10.5 mt -102.69 129.98 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.016 0.436 . . . . 0.0 111.315 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -131.84 96.82 4.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.55 147.15 26.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.54 132.93 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.776 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.4 m -132.77 167.91 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 111.338 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 119.78 34.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.016 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -116.14 136.36 53.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.526 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.7 -101.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.218 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.37 28.6 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.799 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -143.59 147.66 34.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.148 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.06 140.04 30.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.4 mt -131.12 142.61 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.459 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.46 119.72 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 11.2 mm -105.47 136.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.654 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 21.3 m -124.18 119.56 29.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.369 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 22.4 t -129.32 141.12 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.336 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 27.9 mm -119.21 109.98 38.32 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.57 164.77 10.7 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.487 2.125 . . . . 0.0 112.404 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -113.89 -176.83 2.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -101.88 121.09 41.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 19.8 tt -116.24 144.91 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.02 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -126.66 109.55 22.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.429 2.086 . . . . 0.0 112.317 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.903 0.382 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.6 p 50.13 42.95 25.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.318 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -64.81 88.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.781 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 pp -84.27 124.5 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m0 -109.92 120.4 42.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -82.56 58.37 4.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.037 179.762 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' SER . . . . . 0.4 ' O ' ' CG ' ' A' ' 378' ' ' HIS . 0.3 OUTLIER 60.82 161.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 0.0 110.889 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 377' ' ' SER . 39.0 m80 -159.45 -43.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -95.68 45.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.867 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -72.71 125.05 26.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -67.17 134.77 52.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.417 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 19.2 t80 -144.49 122.3 11.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 10.1 pt -106.17 -5.55 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.48 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 382' ' ' TYR . . . 56.89 64.39 4.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.512 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.408 HD13 ' CG2' ' A' ' 414' ' ' ILE . 3.8 tp -161.36 134.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.011 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.421 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 20.4 mtt180 -91.34 133.0 35.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.669 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.78 150.33 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.406 ' CE ' ' CB ' ' B' ' 2' ' ' SER . 1.8 ptm -128.26 -177.59 4.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.793 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.8 p -99.48 9.74 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.53 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 7.8 tp 52.42 97.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.3 t -83.65 163.58 20.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -31.92 68.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -30.32 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -96.73 -42.27 8.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.91 -52.11 58.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.24 66.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.6 -39.03 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 9.8 mt -64.17 -45.66 87.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.97 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -59.29 -29.97 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.34 -28.73 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -93.23 -29.69 15.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -100.67 -53.66 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.011 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 74.48 -59.26 0.56 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -47.13 -28.32 1.74 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.372 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -55.94 161.79 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -175.34 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.606 2.204 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.94 -11.98 19.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.351 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.6 m -52.39 167.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.425 HG22 HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -136.73 12.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.467 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.4 m -130.37 130.61 44.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.813 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 171.52 169.04 33.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.379 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -100.28 122.81 43.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 111.161 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -103.87 128.97 51.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . 0.408 ' CG2' HD13 ' A' ' 385' ' ' ILE . 4.3 mt -79.81 114.98 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.589 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 2.8 mp -78.48 -70.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.628 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -144.17 143.12 30.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' A' ' 385' ' ' ILE . 21.3 t -111.37 146.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.05 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.444 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.3 mp -98.35 128.96 31.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.78 61.53 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.698 2.266 . . . . 0.0 112.38 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.44 40.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.598 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.65 158.92 49.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.801 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.92 -23.2 33.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.327 2.018 . . . . 0.0 111.808 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -58.36 -60.06 4.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.207 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.78 -31.51 64.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.745 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.69 68.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.58 -30.98 70.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.383 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 24.91 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.777 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.33 -177.66 3.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.776 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.74 179.66 7.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.767 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.76 31.63 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -143.24 26.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -119.44 -177.75 3.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.588 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 38.8 t -142.07 129.58 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 0.0 111.403 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.1 mp -86.09 152.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.9 pp -140.63 -50.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.654 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 69.9 p -128.67 158.44 38.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.432 HG21 ' HB2' ' A' ' 440' ' ' GLN . 10.8 tt -150.3 118.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.337 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 19.8 p30 44.78 35.35 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.931 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.34 38.94 8.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.985 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.432 ' HB2' HG21 ' A' ' 437' ' ' ILE . 5.1 mt-30 -129.44 145.19 51.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.547 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.59 104.4 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.462 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 59.5 t -86.6 147.45 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.72 -45.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.37 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.67 169.86 16.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.422 . . . . 0.0 111.149 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.4 71.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.019 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.404 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 16.6 p30 -59.5 -30.59 68.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.62 -43.5 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.787 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.23 -37.04 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 3.5 t -59.42 -65.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.467 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -48.25 -27.6 2.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 47.4 t -71.32 -43.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.922 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 4.8 mt -61.98 -32.36 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.91 -17.26 25.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.328 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -93.47 -47.51 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.13 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.76 142.25 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.59 -32.18 14.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.677 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.3 t -109.03 99.95 9.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.5 mt -90.22 133.71 34.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -134.24 91.77 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.628 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.48 152.39 24.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 27.2 t -100.05 141.69 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.628 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.2 t -142.28 160.53 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.175 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -98.92 133.15 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.867 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.8 ttp180 -130.55 132.61 45.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.04 -95.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.157 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.06 21.36 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.701 0.286 . . . . 0.0 110.851 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -143.58 164.7 29.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.02 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.43 137.22 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.4 mt -131.8 160.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -99.68 119.69 38.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.16 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 13.1 mm -107.89 152.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 91.8 m -139.02 119.79 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.797 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.3 t -122.74 151.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 21.2 mm -121.35 109.9 34.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.17 152.23 77.29 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.358 2.039 . . . . 0.0 112.237 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.54 168.68 10.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.75 141.69 29.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 18.4 tt -145.75 140.5 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -98.79 109.75 54.69 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.477 2.118 . . . . 0.0 112.41 179.945 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.907 0.384 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.406 ' CB ' ' CE ' ' A' ' 388' ' ' MET . 1.1 p -96.0 41.31 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.949 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -59.68 108.45 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 pt -79.22 127.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.22 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . 0.404 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m95 -107.29 91.08 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.421 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 1.5 t90 -73.57 68.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.198 -0.905 . . . . 0.0 111.123 179.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.83 26.11 6.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 0.0 111.008 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 16.3 m80 54.08 86.31 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.064 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.46 -35.28 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.996 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -151.66 161.67 42.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.072 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -113.23 -175.76 2.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.737 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -155.85 120.47 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.254 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 12.0 pt -111.16 -22.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.436 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 80.64 66.92 1.59 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.801 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -165.29 129.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.389 . . . . 0.0 110.813 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -89.95 120.42 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.36 143.65 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.812 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.8 ptm -123.52 164.53 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 40.1 p -85.87 99.43 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 10.6 tp -55.76 108.59 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.52 170.33 10.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.766 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.8 m -58.17 -21.76 48.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.421 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.3 t -77.61 -47.28 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.98 -32.14 25.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.168 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.31 -36.35 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.205 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -90.01 -32.47 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.29 -33.49 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.25 -49.88 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -58.29 -43.1 87.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.47 -25.98 67.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -93.06 -62.13 1.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 1.0 OUTLIER -85.05 -59.46 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 79.72 -49.2 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.03 -27.04 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.717 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 29.6 m-85 -43.01 163.16 0.16 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.428 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.98 -20.83 14.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.625 2.217 . . . . 0.0 112.761 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 75.71 40.56 0.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 110.781 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 2.8 m -101.35 98.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pp -55.63 -29.27 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.38 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.84 141.48 39.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 145.47 176.97 19.87 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -104.28 155.62 18.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -107.66 138.46 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.74 109.96 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.939 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.403 ' CD1' ' CG2' ' B' ' 4' ' ' ILE . 5.3 mt -74.51 -66.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.214 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.85 167.85 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.887 0.375 . . . . 0.0 111.139 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 21.2 t -134.84 147.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.093 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.458 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.3 mp -79.72 134.5 57.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.308 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.436 ' HD2' HG21 ' A' ' 418' ' ' ILE . 50.5 Cg_exo -55.33 -12.47 5.73 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.031 2.487 . . . . 0.0 114.686 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -132.97 72.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.925 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.448 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 4.9 p -159.08 160.87 28.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.984 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.95 -20.17 51.58 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.329 2.02 . . . . 0.0 111.41 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -61.19 -60.15 4.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -76.33 -30.57 57.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.24 -7.4 59.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.558 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -90.15 -31.74 10.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.418 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 129.79 17.79 1.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.022 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.9 -175.87 3.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.75 146.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.97 -177.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.64 24.94 12.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -126.71 177.01 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 33.1 t -136.89 126.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.472 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 3.8 mt -81.11 154.58 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.9 pp -143.19 -47.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 94.6 p -120.94 154.99 35.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.344 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 2.7 tt -153.88 116.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 16.9 p30 45.43 32.03 0.99 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.545 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.37 8.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.693 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -133.53 138.1 45.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.29 107.9 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 63.2 t -90.75 146.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.32 -43.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.335 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.62 172.32 13.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.913 0.387 . . . . 0.0 111.17 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.33 -38.76 74.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -59.19 -29.74 67.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.65 -38.35 54.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.12 -37.99 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 9.5 t -56.67 -62.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.322 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -50.43 -29.18 9.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 59.9 t -70.78 -42.96 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.277 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 4.6 mt -63.23 -33.85 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.33 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 -13.06 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.622 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -99.94 -54.03 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.767 0.318 . . . . 0.0 110.774 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -89.46 132.82 34.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -36.23 42.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.677 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 2.5 t -105.47 125.51 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.684 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 6.7 mt -119.65 149.4 42.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -147.3 97.65 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.451 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 1.1 mtm -102.77 144.74 30.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 19.7 t -111.58 127.26 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.686 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.28 158.66 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.26 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -104.0 119.67 39.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.994 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . 0.425 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 0.2 OUTLIER -119.51 127.32 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.434 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.22 -99.13 0.85 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.177 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.22 24.82 2.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.767 0.318 . . . . 0.0 110.677 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.57 162.63 36.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.97 141.01 34.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.425 ' CD1' ' HB2' ' A' ' 464' ' ' ARG . 4.0 mt -130.74 143.24 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.369 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -94.76 124.42 38.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.645 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -113.79 140.28 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 111.343 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 70.8 m -116.9 119.87 36.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.76 131.68 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.53 110.76 57.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 148.88 87.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.101 . . . . 0.0 112.336 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.88 -178.77 3.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -95.96 129.38 43.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 19.6 tt -130.78 158.27 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.95 114.32 4.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.382 2.055 . . . . 0.0 112.311 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 11.4 p 59.49 44.35 14.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.062 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -61.3 93.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.403 ' CG2' ' CD1' ' A' ' 415' ' ' ILE . 46.4 pt -83.59 137.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.302 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.9 m95 -116.81 89.61 3.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.45 82.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.144 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.71 110.27 10.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -95.38 120.17 35.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.786 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 53.5 mtt -140.93 124.56 16.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -69.85 -69.38 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.825 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -101.84 114.32 28.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -118.44 126.29 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 9.7 pt -122.44 -1.1 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.333 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 46.92 62.94 3.47 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.082 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . . . . . . . . . 6.8 tp -149.16 122.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.758 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -89.73 128.18 36.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' MET . . . . . 0.413 ' CA ' HD11 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -132.93 140.59 47.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.511 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.409 ' CE ' ' HA ' ' B' ' 2' ' ' SER . 7.7 ptm -119.31 158.84 25.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.028 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 21.3 p -83.11 106.27 14.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 7.3 tp -56.92 102.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.075 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.9 t -89.94 174.54 7.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 27.8 t -66.96 -33.02 74.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 60.6 p -68.88 -28.59 66.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -95.83 -48.6 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.988 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.92 -59.93 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.26 68.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.37 -38.28 89.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.29 -36.61 74.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.996 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -77.75 -31.69 52.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -28.99 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -54.98 3.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.408 ' O ' ' HB2' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -73.46 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 402' ' ' HIS . 57.5 mtm180 82.73 -25.62 0.15 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.752 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -20.51 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.752 0.311 . . . . 0.0 110.957 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.45 153.95 74.57 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.973 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.7 -179.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.637 2.224 . . . . 0.0 112.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -111.74 30.77 6.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.13 150.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.33 17.12 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.455 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -140.29 142.85 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.16 156.49 7.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -91.45 152.08 20.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -107.37 131.66 54.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 18.3 mt -83.97 111.08 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.433 ' CD1' ' CG2' ' B' ' 4' ' ' ILE . 2.8 mp -75.35 -66.42 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -155.61 167.14 31.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 0.0 111.175 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 12.5 t -127.53 156.95 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.431 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.3 mp -96.32 133.43 24.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.4 ' HD2' HG21 ' A' ' 418' ' ' ILE . 54.5 Cg_endo -68.54 60.02 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.766 2.311 . . . . 0.0 112.82 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 168.88 44.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.972 0.415 . . . . 0.0 110.757 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.541 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 7.7 p -141.84 162.19 47.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.541 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 34.8 Cg_endo -66.72 -14.13 42.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.012 1.808 . . . . 0.0 111.17 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.4 ' CA ' HD13 ' A' ' 428' ' ' LEU . . . -68.73 -59.94 2.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.645 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.86 -32.71 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -82.4 -21.14 35.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.296 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -72.42 -29.93 65.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.304 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 121.1 17.65 4.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.026 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.4 HD13 ' CA ' ' A' ' 423' ' ' ALA . 2.5 mt -88.2 -167.08 1.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.91 0.355 . . . . 0.0 110.732 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.9 146.34 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -179.36 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 60.09 22.52 11.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -119.3 -175.87 3.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.412 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.48 117.28 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.543 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.0 mt -78.42 123.05 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.461 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 pp -110.07 -48.63 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.882 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 3.8 t -119.24 160.97 21.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 111.294 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.28 119.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.024 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 16.1 p30 44.43 42.41 5.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.511 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 77.5 41.92 19.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.635 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -135.69 162.6 32.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 108.55 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.418 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 2.5 t -94.59 148.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.247 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.58 -35.96 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.333 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.6 p -147.5 176.03 10.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.212 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.12 87.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.176 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -53.91 -24.22 15.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.268 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.33 -50.01 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.418 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 43.9 t -54.93 -40.7 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 42.2 t -53.13 -68.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.469 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -51.69 -35.06 41.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.641 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 43.7 t -64.09 -49.33 81.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.294 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.4 mt -57.68 -40.53 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.223 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.01 -5.21 59.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.325 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -100.18 -47.66 4.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -100.13 133.57 44.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.047 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -34.42 48.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.5 t -105.08 103.21 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 12.4 mt -96.08 153.36 17.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -154.43 96.76 1.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.645 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.26 135.51 45.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.263 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 25.8 t -102.09 120.41 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.0 t -105.54 160.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.92 124.41 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 30.5 mtp85 -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.702 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.53 -98.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.346 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -140.28 24.84 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 111.033 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -139.77 157.36 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.91 139.62 35.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.646 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.8 mt -128.21 128.01 68.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.08 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.66 125.13 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.769 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 28.9 mm -120.04 136.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.9 m -109.61 135.05 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 11.5 t -138.91 146.22 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.065 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 30.0 mm -134.03 110.34 11.89 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.57 132.91 51.05 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.398 2.065 . . . . 0.0 112.309 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -94.83 -174.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.54 152.96 34.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 2.5 tt -150.45 133.59 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -143.65 123.63 7.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.248 1.007 0 C-N-CA 122.375 2.05 . . . . 0.0 112.335 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.687 0.279 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.409 ' HA ' ' CE ' ' A' ' 388' ' ' MET . 37.4 m 61.9 -81.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.943 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 52.54 65.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.444 . . . . 0.0 110.656 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.433 ' CG2' ' CD1' ' A' ' 415' ' ' ILE . 1.4 pt -82.05 96.25 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.335 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -65.64 104.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.826 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -76.76 67.01 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.21 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 4.8 t -109.1 -50.79 2.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.352 . . . . 0.0 110.816 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -92.93 53.95 2.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -121.06 106.38 11.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.137 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.5 -50.63 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.533 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -106.75 146.37 30.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -118.08 119.55 35.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.363 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 16.4 pt -130.58 -8.97 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.478 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.506 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 50.67 68.1 1.61 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.747 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.406 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 8.1 tp -157.0 135.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -101.03 129.43 46.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.45 146.19 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.0 ptm -128.26 157.44 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.071 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.7 p -79.48 101.32 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 9.4 tp -51.79 97.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.4 t -84.8 158.54 20.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.785 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.3 m -57.51 -22.05 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.12 -28.28 54.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.308 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -100.33 -37.4 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.131 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.87 -50.95 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.367 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -28.33 67.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -34.25 73.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.065 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 62.8 mt -60.17 -41.83 93.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.027 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -75.11 -30.81 60.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.77 -33.15 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.7 -33.34 20.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -145.59 120.63 10.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.97 -27.73 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -55.79 -27.2 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.115 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.46 147.35 59.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.72 174.43 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.568 2.179 . . . . 0.0 112.301 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -111.91 32.77 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.66 -179.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.459 HG22 HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -149.18 -40.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' SER . . . . . 0.433 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -89.6 154.47 19.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.79 170.43 13.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . 0.4 ' CB ' HG23 ' A' ' 448' ' ' VAL . . . -98.2 138.75 35.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 110.991 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -94.44 130.19 40.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 12.1 mt -80.23 114.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 430' ' ' GLU . 9.4 mt -82.13 -72.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.609 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.145 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.412 ' CG1' ' CB ' ' A' ' 423' ' ' ALA . 3.3 t -111.8 140.43 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.554 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 19.6 mm -79.69 144.99 61.6 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.37 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.422 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 23.3 Cg_exo -65.83 -3.91 9.02 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.881 2.387 . . . . 0.0 114.521 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -138.35 71.03 1.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.965 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.554 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 1.1 p -159.55 165.61 17.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.141 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.8 -23.78 77.42 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.622 2.215 . . . . 0.0 111.62 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.412 ' CB ' ' CG1' ' A' ' 417' ' ' VAL . . . -57.78 -60.05 4.29 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.996 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -74.63 -26.74 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.16 -26.16 55.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.363 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -79.29 -70.36 1.33 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.417 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 166.64 34.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 0.4 OUTLIER -104.47 -173.11 2.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.778 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.46 169.09 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 0.8 OUTLIER -87.58 52.48 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -158.89 28.37 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.625 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.36 -177.2 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 24.0 t -145.16 107.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.42 138.48 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.674 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 436' ' ' SER . 2.5 pp -133.57 -43.07 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.52 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' SER . . . . . 0.436 ' N ' ' CD1' ' A' ' 435' ' ' ILE . 41.5 p -114.72 155.5 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.5 tt -157.61 118.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 13.5 p30 45.52 33.85 1.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.494 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.8 28.74 34.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.724 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -124.01 143.4 50.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.864 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 9.3 t -92.09 110.69 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 25.7 t -93.89 159.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 22.4 m -130.36 -45.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.502 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.05 176.42 8.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.225 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.412 ' HB3' ' CG ' ' B' ' 5' ' ' TRP . . . -57.52 -40.45 78.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -56.42 -25.6 50.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.879 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.05 -30.74 20.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.4 HG23 ' CB ' ' A' ' 412' ' ' ALA . 23.5 t -70.58 -43.32 77.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 33.0 t -50.97 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.335 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -49.88 -41.61 45.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.36 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 39.6 t -58.88 -45.5 91.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.076 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 22.3 mt -58.86 -40.49 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.65 0.4 57.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.158 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -46.74 5.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -111.18 165.28 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.4 t -103.64 -32.17 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 p -106.37 102.45 11.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.741 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.5 129.46 39.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.947 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -123.91 88.09 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.705 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.5 mtt -92.2 129.68 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 27.1 t -107.47 126.29 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.22 159.37 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.175 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 119.95 40.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -120.62 133.18 55.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.486 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.18 -103.83 1.23 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.219 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -138.22 27.72 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.619 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.33 157.12 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.254 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.88 142.91 28.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.449 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.4 mt -129.24 141.09 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.478 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.47 119.81 36.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.513 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.16 137.02 57.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 58.6 m -117.24 127.37 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.66 122.24 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.096 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 28.5 mm -103.02 109.86 62.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.01 151.42 82.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.078 . . . . 0.0 112.299 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -102.74 158.44 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -96.46 132.01 42.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -153.24 141.31 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.13 113.63 26.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.803 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo . . . . . 0 C--O 1.248 1.012 0 C-N-CA 122.381 2.054 . . . . 0.0 112.349 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.741 0.305 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p 51.81 26.35 3.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.169 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.14 106.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 pt -76.19 149.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.531 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 445' ' ' ALA . 26.9 m95 -121.14 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.627 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -70.33 70.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.073 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.2 t -135.59 -48.95 0.7 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.804 0.335 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.67 -50.99 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 7.1 ttt -63.68 118.33 8.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -146.73 169.42 19.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.56 162.18 4.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.73 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.437 ' CG ' HG23 ' A' ' 478' ' ' ILE . 33.1 t80 -134.17 125.91 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.307 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 5.8 pt -117.67 -26.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 75.67 64.57 2.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.648 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.463 HD12 HG22 ' A' ' 385' ' ' ILE . 0.0 OUTLIER -165.31 123.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.402 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.1 OUTLIER -90.04 126.97 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.85 152.59 48.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -130.63 -179.4 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 111.481 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 7.5 p -98.46 94.7 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.169 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 413' ' ' TYR . 9.0 tp -47.63 121.55 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.571 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.11 165.81 13.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.797 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -27.27 63.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -66.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.166 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -40.24 74.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.217 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.293 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -83.91 -30.68 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.037 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.98 -31.19 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.023 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.26 -47.32 44.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -65.45 -37.84 88.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.047 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.83 -42.86 94.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -87.7 -17.51 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -150.08 87.04 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.715 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -25.72 67.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -23.62 11.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.284 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 402' ' ' HIS . 3.7 m-85 -53.18 163.69 0.87 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.09 178.22 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.306 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -105.63 35.84 2.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 20.1 m -120.34 92.87 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.49 -33.8 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.56 163.23 21.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 126.21 175.97 14.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.375 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -102.8 157.37 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 111.093 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.408 ' HB2' ' CD1' ' A' ' 390' ' ' LEU . 69.4 t80 -104.82 128.72 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 24.6 mt -80.7 109.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.552 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 2.7 mp -71.86 -70.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -151.43 166.82 29.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.299 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 35.0 t -132.84 155.39 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.043 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.432 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.3 mp -90.28 132.56 35.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.406 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.22 57.72 3.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.542 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 169.41 47.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.061 0.457 . . . . 0.0 110.383 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' THR . . . . . . . . . . . . . 4.2 p -149.86 164.46 20.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.974 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.64 -26.85 67.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.269 1.979 . . . . 0.0 111.101 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -54.91 -54.39 43.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.116 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.73 -29.99 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.67 -29.42 65.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.12 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -74.0 -30.2 61.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.481 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.88 23.67 2.97 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.767 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.2 mt -95.67 -175.59 3.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.772 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.65 152.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -61.74 -175.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.702 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 24.6 m120 61.23 22.35 12.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -122.66 -176.5 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 34.9 t -143.69 127.54 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.623 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.65 152.76 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.441 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.2 pp -141.2 -55.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 16.7 p -120.42 157.32 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.313 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.401 HG12 ' ND2' ' A' ' 438' ' ' ASN . 1.8 tt -151.04 119.94 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.344 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . 0.401 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.3 p30 43.4 44.08 4.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.693 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.62 49.24 8.16 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.793 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -144.88 158.97 43.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.702 0.287 . . . . 0.0 110.672 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 6.0 p -106.49 112.19 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 4.2 t -100.08 147.58 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 6.3 m -130.82 -42.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.4 p -127.93 168.11 15.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.01 0.434 . . . . 0.0 111.284 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.34 -41.14 79.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -57.24 -28.92 63.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.726 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -77.77 -36.47 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.414 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 28.4 t -69.55 -41.86 80.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 1.7 t -54.72 -63.17 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.601 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -46.96 -29.18 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.458 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 30.4 t -68.61 -48.58 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 3.6 mt -58.62 -33.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -91.13 -21.55 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.251 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -88.67 -59.91 2.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.02 127.14 35.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -39.06 75.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -104.67 116.26 31.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 9.0 mt -102.34 133.99 46.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.274 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -135.13 93.9 3.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.638 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.67 156.81 16.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 21.0 t -124.4 124.6 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.975 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 5.6 t -108.58 147.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -105.44 140.11 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.174 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . 0.427 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 17.6 mtp180 -144.52 133.84 23.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 57.88 -100.24 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.494 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -140.07 28.38 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 111.06 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.25 152.62 46.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.165 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -96.29 139.26 32.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.541 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 464' ' ' ARG . 2.4 mt -126.7 123.28 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.64 127.19 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 11.7 mm -124.46 135.16 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.976 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 44.9 m -116.51 121.13 40.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 34.9 t -127.34 119.92 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.87 111.96 64.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.08 173.95 7.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.07 . . . . 0.0 112.349 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -160.41 174.31 14.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.46 131.69 36.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.787 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . 0.437 HG23 ' CG ' ' A' ' 382' ' ' TYR . 14.0 tt -131.05 153.38 39.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -123.3 127.79 25.49 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.411 2.074 . . . . 0.0 112.288 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.803 0.335 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m 60.05 37.6 21.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -59.46 90.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 27.5 pt -75.69 129.2 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -108.95 99.35 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.079 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -74.46 66.39 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.092 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.2 p -176.07 165.5 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -75.73 120.37 21.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.0 -59.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -137.93 137.05 37.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -96.31 -177.97 4.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.688 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -160.41 119.84 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.422 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 5.1 pt -108.2 -3.68 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.332 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 60.56 50.82 63.42 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.649 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.422 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 11.7 tt -154.1 140.23 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.025 0.44 . . . . 0.0 111.07 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.59 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 2.9 mtt-85 -90.76 132.08 36.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.738 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -136.96 133.5 35.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.639 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 10.2 ptm -121.34 176.33 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.3 p -106.12 130.39 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 2.3 tp -74.65 96.86 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 4.4 t -87.45 177.52 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 82.7 p -63.93 -16.67 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -80.77 -42.29 22.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.787 0.327 . . . . 0.0 111.25 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -43.03 9.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.92 79.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.338 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -29.99 61.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.009 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -30.92 71.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . 0.41 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 84.1 mt -69.89 -33.35 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -74.46 -24.42 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.0 -37.73 33.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.071 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -82.69 -66.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.446 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -76.07 -52.42 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.08 -52.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.686 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.51 38.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 1.6 m-85 -91.01 167.72 15.39 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.671 0.272 . . . . 0.0 110.51 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.02 -21.48 21.63 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.533 2.155 . . . . 0.0 112.472 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.7 t0 73.3 46.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.2 97.54 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.023 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -56.72 -29.08 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.536 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 14.8 m -93.13 159.86 15.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.031 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 127.53 150.01 7.29 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.451 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.14 135.81 35.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -90.07 132.47 35.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 10.3 mt -86.18 116.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.59 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 3.3 mt -89.22 -144.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.253 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . 0.462 ' H ' ' CG2' ' A' ' 415' ' ' ILE . 9.2 pt-20 -79.67 155.27 28.11 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.088 -0.382 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.15 151.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.045 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.546 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 8.4 mm -87.4 145.63 38.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.621 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 16.5 Cg_exo -68.7 -3.48 11.31 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.988 2.459 . . . . 0.0 114.113 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.87 62.87 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.712 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.546 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 0.7 OUTLIER -154.45 158.02 32.27 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.009 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.4 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 34.3 Cg_exo -59.03 -20.25 52.65 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.554 2.17 . . . . 0.0 111.701 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -62.4 -60.12 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.77 -28.89 66.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.54 -27.63 45.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.27 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.02 65.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.353 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.1 23.85 2.87 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.774 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.43 -170.0 2.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.314 . . . . 0.0 110.693 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.48 153.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -65.88 171.34 4.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 64.51 27.33 13.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.027 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -118.88 -175.76 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.71 122.88 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.571 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.13 160.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.507 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.4 pp -146.37 -49.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 94.4 p -118.02 161.84 19.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.014 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 3.6 tt -155.62 119.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.5 p30 49.11 33.09 4.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.624 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.29 28.02 28.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.819 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -121.23 164.16 17.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 110.647 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 69.3 p -106.56 114.15 28.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.147 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.412 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 11.7 t -101.54 141.72 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.17 -25.8 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.494 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.16 175.7 13.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.273 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -56.51 -41.13 76.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -55.44 -28.66 55.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.765 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.18 -32.95 29.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.733 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.412 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 21.8 t -76.0 -41.92 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.211 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 15.0 t -52.61 -57.44 10.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.344 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -53.97 -42.22 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.63 -47.59 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.4 mt -57.9 -30.96 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.946 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -7.11 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.545 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -99.71 -48.66 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.701 0.286 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -102.04 166.52 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.2 -36.69 6.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 98.53 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 8.4 mt -89.78 119.95 30.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.051 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.16 91.21 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.99 142.85 29.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 23.7 t -103.37 128.95 56.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.21 156.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 140.59 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.081 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -143.53 124.52 14.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 64.42 -98.51 0.28 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.226 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -140.05 27.28 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 0.0 110.766 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -145.23 162.78 36.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.7 139.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.1 mt -127.68 158.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.36 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.0 126.2 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.541 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 23.7 mm -115.37 137.12 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.27 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 m -116.17 140.6 49.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.689 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . 0.4 ' CG1' ' HB2' ' A' ' 422' ' ' PRO . 20.1 t -150.03 135.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.448 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.4 mp -117.88 109.73 40.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.585 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.81 152.41 80.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.438 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -89.16 -179.53 5.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.85 138.09 44.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 14.0 tt -155.37 152.39 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.989 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -140.93 133.7 14.41 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.766 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.418 2.078 . . . . 0.0 112.319 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.775 0.322 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.6 m -73.22 65.09 0.81 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.869 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -79.82 -9.9 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.3 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.423 HG22 HD12 ' B' ' 4' ' ' ILE . 9.7 pt 41.08 91.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.862 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -79.95 91.09 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.887 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -69.38 71.75 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.243 -179.85 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.78 90.26 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 56.7 m170 60.53 37.62 19.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.96 103.71 7.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -176.89 136.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.59 161.59 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.679 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -140.02 126.2 19.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.362 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.412 ' CD1' HG23 ' A' ' 385' ' ' ILE . 5.7 pt -119.27 -2.67 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.403 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.419 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 54.91 62.45 6.25 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.444 HD13 ' CG2' ' A' ' 417' ' ' VAL . 7.2 tp -153.75 129.86 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -90.7 132.42 35.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' MET . . . . . 0.429 ' CA ' HD11 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -141.06 138.83 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.856 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.2 ptm -120.93 165.79 14.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.298 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 82.8 p -93.44 109.25 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.513 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.5 tp -53.22 121.37 7.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.304 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.1 t -90.16 166.91 13.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -30.83 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 21.0 m -70.45 -29.52 66.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -91.12 -39.91 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.058 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.7 -50.4 73.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.246 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -32.93 74.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.66 -45.15 54.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.082 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.27 -31.45 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.069 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -67.37 -47.13 71.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.013 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -27.42 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.155 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -91.74 -62.41 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.401 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -64.66 -59.81 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.072 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 10.7 mtt85 79.65 -7.84 1.65 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.502 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.28 14.85 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.704 0.287 . . . . 0.0 111.162 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -105.53 128.8 25.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.07 -174.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.113 . . . . 0.0 112.346 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.53 23.47 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.459 ' O ' HG21 ' A' ' 409' ' ' ILE . 26.4 m -83.35 -23.31 8.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.059 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.558 ' O ' ' CG2' ' A' ' 409' ' ' ILE . 0.0 OUTLIER 37.0 75.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.468 0.652 . . . . 0.0 111.94 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 7.2 p -169.46 131.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.22 173.78 19.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.432 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.34 140.88 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 0.0 111.08 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -98.13 133.5 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 15.3 mt -82.6 116.2 26.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.429 HD11 ' CA ' ' A' ' 387' ' ' MET . 3.1 mt -77.96 -60.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.619 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.75 139.49 11.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.293 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.444 ' CG2' HD13 ' A' ' 385' ' ' ILE . 13.6 t -105.45 136.95 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.118 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.504 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 33.8 mm -82.84 138.46 43.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.238 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.435 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 42.7 Cg_endo -68.0 4.2 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 114.243 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -132.44 56.46 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.517 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.504 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 0.6 OUTLIER -155.63 164.91 19.66 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.421 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 32.1 Cg_exo -60.84 -20.94 68.74 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.651 2.234 . . . . 0.0 111.828 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.416 ' HA ' ' CD1' ' A' ' 428' ' ' LEU . . . -61.94 -59.15 5.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.21 -34.85 77.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.732 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -23.22 55.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -74.72 -34.35 53.66 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.414 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 25.4 2.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.85 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 423' ' ' ALA . 0.8 OUTLIER -93.39 -163.66 1.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 0.0 110.652 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.4 169.1 6.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.816 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.67 36.17 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.013 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.82 27.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -128.94 175.71 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.65 116.9 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.2 155.52 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.401 ' CD1' ' N ' ' A' ' 436' ' ' SER . 2.3 pp -148.78 -45.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.57 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' SER . . . . . 0.401 ' N ' ' CD1' ' A' ' 435' ' ' ILE . 15.6 p -124.07 154.78 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.973 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.405 HG12 ' ND2' ' A' ' 438' ' ' ASN . 3.5 tt -153.59 112.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.055 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . 0.405 ' ND2' HG12 ' A' ' 437' ' ' ILE . 22.9 p30 43.03 51.17 5.43 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.676 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 71.05 43.72 56.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.708 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -146.35 126.53 13.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 65.5 m -81.48 118.22 22.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 7.1 t -98.94 144.7 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.905 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 9.1 m -118.52 -36.82 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.653 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.0 p -144.68 179.59 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.86 94.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.072 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.408 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 23.8 p30 -54.82 -25.88 31.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.52 -52.06 7.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.986 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.409 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 46.8 t -55.77 -35.82 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.288 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 10.8 t -58.74 -61.68 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.374 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.4 -28.76 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.493 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 59.5 t -73.32 -47.49 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.009 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 15.4 mt -58.17 -28.54 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 -6.79 26.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.442 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -100.07 -47.22 5.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -105.06 144.59 31.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -29.03 21.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.761 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -109.73 97.38 6.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.535 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 6.8 mt -89.71 120.13 30.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.84 85.81 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.665 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.56 128.13 36.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 18.8 t -99.56 126.66 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 23.9 t -115.24 154.08 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.173 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.48 119.86 40.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 18.6 mtp180 -119.53 140.83 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 58.51 -97.34 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.34 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -140.25 24.96 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -142.56 158.02 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.174 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.23 137.68 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.585 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 464' ' ' ARG . 2.0 mt -126.91 141.86 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -92.31 139.55 30.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.772 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 12.6 mm -128.82 134.11 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.175 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.0 m -107.57 132.67 53.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 422' ' ' PRO . 23.3 t -144.31 124.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.223 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.418 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.5 mp -115.72 110.05 44.86 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.731 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -60.86 -178.13 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.207 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -136.77 -178.5 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -110.35 125.8 53.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.829 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 17.0 tt -118.06 133.05 66.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.46 115.45 7.57 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.448 2.098 . . . . 0.0 112.293 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.815 0.34 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.72 -69.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 51.16 51.29 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 415' ' ' ILE . 1.2 pt -72.85 130.47 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.228 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . 0.408 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.4 m0 -111.64 101.22 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.936 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -75.75 68.63 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.134 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.3 m -135.28 116.91 14.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.777 0.323 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -110.23 116.37 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -146.75 130.62 17.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -143.89 165.6 27.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.52 146.41 27.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.856 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . 0.419 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 17.3 t80 -159.99 129.58 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 23.3 pt -116.11 -3.87 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.42 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' A' ' 382' ' ' TYR . . . 56.62 60.31 9.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.87 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.407 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 11.2 tt -165.08 144.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.976 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.435 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -100.36 157.99 16.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.05 137.53 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 1.3 ptp -115.5 173.79 6.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.115 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 89.2 p -99.34 99.78 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.285 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 7.1 tp -47.56 109.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 9.0 t -90.16 150.83 21.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 m -46.19 -36.54 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.593 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -47.15 84.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.35 -31.91 24.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.141 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -60.65 -36.23 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -88.89 -29.29 19.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -68.49 -25.51 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.178 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.01 -32.08 39.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.172 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -85.77 -29.72 23.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -37.59 48.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.994 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -53.77 6.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 104.24 11.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -83.12 60.79 5.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.737 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -142.75 13.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.144 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.78 150.72 48.96 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.39 166.76 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.634 2.222 . . . . 0.0 112.293 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.56 3.72 43.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 15.6 m -70.93 112.8 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 111.067 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pp -92.26 -29.57 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.155 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 142.16 41.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.2 177.2 14.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.0 151.87 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.421 ' CE1' ' O ' ' A' ' 414' ' ' ILE . 31.1 t80 -93.49 136.08 34.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . 0.421 ' O ' ' CE1' ' A' ' 413' ' ' TYR . 40.3 mt -81.09 119.92 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.106 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 1.5 mm -89.27 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.359 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -79.57 142.81 35.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.27 151.25 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.172 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.406 ' CG2' ' HD2' ' A' ' 419' ' ' PRO . 18.5 mm -84.14 136.77 40.5 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.406 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 61.7 Cg_endo -73.09 58.98 3.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.43 2.086 . . . . 0.0 112.662 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.25 40.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.872 0.367 . . . . 0.0 111.028 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.1 OUTLIER -138.92 172.24 6.87 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 77.9 Cg_endo -78.38 -9.43 16.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.487 2.125 . . . . 0.0 112.194 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -72.57 -58.9 3.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.031 0.444 . . . . 0.0 110.824 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -33.3 74.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -85.56 -27.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -64.37 -70.14 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.36 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.2 28.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.054 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.71 -175.94 2.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.753 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.97 155.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 63.64 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.95 36.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.807 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -146.24 -176.05 5.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.8 t -143.81 125.65 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.305 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.73 145.87 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.4 pp -137.87 -43.48 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.657 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 60.3 p -122.49 152.36 40.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.915 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.437 HD12 ' ND2' ' A' ' 438' ' ' ASN . 0.0 OUTLIER -148.0 119.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . 0.437 ' ND2' HD12 ' A' ' 437' ' ' ILE . 13.1 p30 48.04 28.08 1.38 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.05 25.77 28.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.459 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -116.73 166.17 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.8 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.6 117.49 34.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 92.9 t -105.23 147.18 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.95 -44.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.332 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.2 p -132.88 168.31 18.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 111.121 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.0 -37.98 72.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.071 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -58.5 -29.95 66.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.91 -40.72 46.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 37.5 t -69.86 -35.71 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.096 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 27.2 t -57.59 -63.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -48.46 -32.49 7.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 55.1 t -70.84 -48.5 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.226 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.0 mt -61.65 -30.04 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.259 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -92.02 -19.02 22.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -98.67 -64.3 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -78.41 138.76 38.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 17.6 m -89.43 -34.21 16.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 31.5 p -99.13 108.0 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . 0.41 ' CB ' ' CE ' ' A' ' 460' ' ' MET . 2.5 mt -108.7 120.14 41.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 111.418 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -123.74 93.46 3.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.415 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' MET . . . . . 0.41 ' CE ' ' CB ' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -99.46 152.35 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.365 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 24.3 t -114.91 127.57 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.738 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 17.7 t -114.0 138.25 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.22 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -106.31 134.07 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.973 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.31 132.74 30.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.69 0.86 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.305 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -140.13 28.98 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -140.22 155.64 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.019 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.38 138.95 33.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.627 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.2 mt -126.73 139.25 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -103.56 133.8 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . 0.406 ' CD1' ' N ' ' A' ' 471' ' ' ILE . 3.2 mp -135.27 148.87 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 13.8 m -134.65 125.4 27.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.081 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.85 119.83 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 27.7 mm -105.24 109.47 63.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.314 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.0 143.62 39.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.282 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -100.47 -177.95 3.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.42 142.95 34.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 18.5 tt -146.24 142.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -98.67 117.53 64.39 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.442 2.095 . . . . 0.0 112.246 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.815 0.341 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 97.6 p -102.33 47.17 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.04 74.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -52.64 151.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.465 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -112.08 101.95 10.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -73.28 65.03 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.121 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.78 38.89 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.866 0.365 . . . . 0.0 110.921 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -109.47 95.47 5.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.92 146.74 23.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -83.9 160.29 21.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -58.21 156.44 9.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.768 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -139.55 120.49 14.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.5 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 12.2 pt -124.57 -2.96 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.483 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 49.32 68.08 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.42 ' CD1' ' CG2' ' A' ' 417' ' ' VAL . 4.5 tp -153.52 118.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.822 0.344 . . . . 0.0 110.534 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 9.5 mtt85 -91.29 132.04 36.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.59 143.69 39.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 6.0 ptm -128.06 159.47 34.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.165 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.3 p -77.82 101.32 6.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 10.7 tp -55.38 100.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 11.6 t -87.53 156.25 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.6 t -51.59 -25.77 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -75.68 -29.13 58.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.253 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -99.84 -39.12 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -58.17 -40.06 80.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.211 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -83.05 -32.08 27.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.981 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.25 -34.55 75.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.85 -39.54 76.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -59.2 -22.52 61.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.75 -23.26 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -67.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.172 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -80.26 -49.08 12.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 5.0 ttm105 83.52 -39.53 0.08 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.958 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -68.23 -9.73 49.3 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -56.77 152.89 24.52 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.98 -172.14 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.78 2.32 . . . . 0.0 112.525 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.05 33.55 3.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.7 m -101.56 164.79 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.116 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . 0.433 HG12 ' N ' ' A' ' 410' ' ' SER . 0.2 OUTLIER -138.77 -39.53 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.459 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' SER . . . . . 0.433 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -79.25 167.58 20.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 111.33 170.56 19.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.511 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.2 140.45 29.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 0.0 111.091 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -95.57 126.3 40.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.005 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 18.6 mt -80.0 110.04 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' B' ' 4' ' ' ILE . 2.9 mp -75.24 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -157.84 156.12 30.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 111.221 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.42 ' CG2' ' CD1' ' A' ' 385' ' ' ILE . 14.0 t -128.4 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.5 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 7.3 mm -88.95 136.62 30.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.417 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 39.7 Cg_endo -67.38 -5.87 15.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.639 2.226 . . . . 0.0 113.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -112.48 46.83 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.114 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.523 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.8 OUTLIER -149.62 170.31 7.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . 0.523 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 64.1 Cg_endo -75.5 -11.42 20.6 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.215 1.943 . . . . 0.0 111.867 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -67.07 -59.27 3.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.091 0.472 . . . . 0.0 110.936 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -29.76 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.715 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.25 38.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.318 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -78.29 -22.18 68.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.74 16.08 5.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.731 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.49 -171.6 2.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 110.636 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -177.32 146.5 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -176.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 33.2 m120 56.1 24.91 8.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.051 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -120.48 -175.75 3.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.805 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.53 123.76 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.4 mp -83.79 146.59 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.588 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 436' ' ' SER . 2.5 pp -135.24 -43.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.554 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' SER . . . . . 0.428 ' N ' ' CD1' ' A' ' 435' ' ' ILE . 24.9 p -119.99 147.77 44.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.361 . . . . 0.0 111.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.2 tt -144.87 114.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.061 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 14.1 p30 44.49 43.92 6.69 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.601 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 79.39 27.4 55.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.758 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -131.46 126.32 34.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.916 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.19 125.54 29.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 3.0 t -108.94 150.75 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.19 -28.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.661 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 20.2 p -148.58 170.33 18.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.24 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.079 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -53.67 -26.99 25.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.32 -37.99 22.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.668 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.23 -33.28 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 26.8 t -60.13 -60.29 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.281 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.82 -29.52 41.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.478 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 42.0 t -69.2 -51.56 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 111.114 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 5.9 mt -57.94 -29.23 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.023 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.323 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -99.16 -58.02 2.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -82.43 132.17 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 59.5 m -74.22 -37.02 63.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.4 t -107.83 127.08 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.558 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 8.6 mt -119.73 119.74 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.328 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -119.15 99.67 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.426 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.99 144.41 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.82 139.25 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.452 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.29 160.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.199 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -97.47 119.69 36.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -109.34 119.77 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.383 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.49 -92.01 0.26 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.094 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -140.38 25.92 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.829 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.01 154.44 43.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.79 130.16 45.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.8 mt -129.02 151.49 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.311 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.6 119.86 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.444 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.68 137.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.372 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 50.2 m -111.13 126.28 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 20.7 t -139.13 141.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 21.5 mm -124.21 117.47 26.85 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.62 162.45 34.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.466 2.11 . . . . 0.0 112.279 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.56 -179.74 6.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -109.04 125.86 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.65 123.66 42.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.9 116.23 62.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.824 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.462 2.108 . . . . 0.0 112.341 179.89 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.81 0.338 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -89.85 54.27 2.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.018 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -65.2 79.99 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 415' ' ' ILE . 2.2 pt -85.29 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.36 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.19 95.16 5.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.89 66.26 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.785 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.111 -179.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 27.6 m -78.19 146.97 34.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 60.04 76.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 4.0 ptp -78.3 -172.14 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 55.2 tttt 64.22 90.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.971 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 475' ' ' PRO . 27.7 mttm -77.15 -176.64 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.698 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -128.41 125.05 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.377 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 30.5 pt -136.84 -1.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.874 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.479 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 48.14 70.67 0.7 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.993 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.414 ' CG2' ' CD1' ' A' ' 383' ' ' ILE . 6.8 tp -165.22 121.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.577 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 1.5 mtt85 -90.78 139.2 30.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.722 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.13 146.39 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 1.4 ptp -120.62 -179.64 4.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.4 p -103.39 105.74 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 4.6 tp -57.0 99.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.054 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.5 t -80.74 162.65 24.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 53.4 p -57.91 -20.54 37.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 20.6 m -77.6 -33.41 53.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.096 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -49.49 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.164 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -52.01 -34.11 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.615 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.38 -26.79 23.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.164 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -39.11 73.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 10.7 mt -58.01 -32.2 67.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -80.92 -26.25 36.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.13 -26.07 20.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.13 -42.22 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . 0.432 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -93.62 -53.65 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 4.6 mtt180 84.55 -23.13 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.599 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 -23.8 32.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -58.39 147.4 68.37 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.62 166.98 22.19 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.571 2.181 . . . . 0.0 112.233 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.16 -23.31 64.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.176 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.97 91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.885 0.374 . . . . 0.0 111.309 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.9 -30.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -69.35 151.33 46.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 125.01 -177.51 16.86 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.758 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -110.68 170.55 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.413 ' CE1' ' O ' ' A' ' 414' ' ' ILE . 24.1 t80 -116.8 137.79 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . 0.413 ' O ' ' CE1' ' A' ' 413' ' ' TYR . 21.9 mt -86.04 117.29 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 12.4 mm -75.24 -68.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.125 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -159.92 150.23 18.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.732 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 20.4 t -113.72 151.4 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.438 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 17.9 mm -86.7 143.51 35.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.421 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 37.1 Cg_exo -61.9 -7.92 10.57 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.8 2.333 . . . . 0.0 113.594 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -135.08 71.51 1.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.701 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.479 HG22 ' HA3' ' A' ' 384' ' ' GLY . 24.5 p -149.7 156.3 38.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.351 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.63 -21.16 70.19 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.143 1.895 . . . . 0.0 110.351 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 428' ' ' LEU . . . -66.2 -60.05 3.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.496 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.95 -32.82 74.54 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.055 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.14 -25.68 59.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -75.12 -66.44 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.191 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 162.08 29.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.158 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 0.6 OUTLIER -99.24 -175.72 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.73 139.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.719 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.38 179.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.41 19.99 11.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.404 ' CB ' HD11 ' A' ' 414' ' ' ILE . 8.2 m-20 -120.28 -176.03 3.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.671 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 26.1 t -147.97 117.26 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 111.524 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.57 152.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.189 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.35 -51.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.764 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 84.2 p -113.02 144.27 42.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 111.091 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.403 HG12 ' CG1' ' A' ' 451' ' ' VAL . 1.1 tt -140.7 113.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.7 p30 43.9 45.67 6.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.533 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 73.72 52.46 8.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.703 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.9 157.96 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.654 0.264 . . . . 0.0 110.814 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.7 m -103.21 114.47 28.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.245 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.427 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 21.6 t -99.34 141.69 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.018 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.98 -37.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.503 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.14 172.43 12.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 111.264 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -56.37 -41.79 76.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.086 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -55.35 -29.52 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.712 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -80.01 -33.94 38.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.427 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 26.0 t -72.99 -38.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 12.1 t -55.63 -63.13 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.515 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -48.83 -28.41 3.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.375 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . 0.403 ' CG1' HG12 ' A' ' 437' ' ' ILE . 38.7 t -72.86 -49.6 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 5.2 mt -57.86 -26.44 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -100.13 -11.52 20.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.421 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -99.79 -47.72 4.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.719 0.295 . . . . 0.0 111.012 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -98.72 150.32 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 -33.85 11.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.661 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 5.2 t -106.15 96.21 6.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.576 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 12.3 mt -90.24 122.03 32.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -113.9 90.51 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.585 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 5.2 mtm -99.83 131.73 45.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.27 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.79 119.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.817 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 6.7 t -103.82 160.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -116.03 131.01 57.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -136.34 119.94 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.75 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.42 -109.92 3.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.494 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -126.59 27.14 6.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.659 0.266 . . . . 0.0 111.061 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.97 157.83 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -98.3 150.14 21.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.2 mp -129.37 136.63 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.885 0.374 . . . . 0.0 111.331 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.25 122.07 42.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.293 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . 0.418 ' N ' ' CD1' ' A' ' 471' ' ' ILE . 3.3 mp -125.4 126.73 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.926 0.394 . . . . 0.0 111.706 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.8 m -114.03 119.61 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.066 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.5 t -132.32 141.38 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 0.0 111.704 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.443 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.4 mp -114.95 114.17 43.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.405 ' HB2' ' HD3' ' A' ' 381' ' ' LYS . 15.1 Cg_endo -57.27 135.54 70.88 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.362 2.042 . . . . 0.0 112.362 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.32 151.85 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -99.84 133.46 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 1.9 tt -134.13 115.61 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.111 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.42 125.85 62.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.39 2.06 . . . . 0.0 112.254 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.795 0.331 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m 59.83 44.38 13.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -72.97 113.65 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.47 145.57 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -113.54 99.83 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 386' ' ' ARG . 2.4 t90 -76.17 72.12 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.11 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.3 p -124.58 158.71 32.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.821 0.343 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.77 38.78 17.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -118.59 120.97 39.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -132.96 -66.83 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.786 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -67.16 137.97 56.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.534 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -131.87 119.95 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.31 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.405 ' CD1' ' CG2' ' A' ' 385' ' ' ILE . 24.8 pt -122.53 -12.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.611 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.499 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 54.85 69.66 1.19 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.057 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.439 HG22 HD12 ' A' ' 385' ' ' ILE . 11.3 tt -165.27 152.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.026 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.458 ' HG3' ' HB ' ' A' ' 415' ' ' ILE . 1.8 ptm180 -122.07 132.05 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.5 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.52 131.69 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.006 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.407 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 10.0 ptm -109.64 158.44 18.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.037 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.7 p -87.57 109.12 19.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 5.4 tp -56.07 114.64 2.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.3 t -86.46 159.09 19.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.4 t -56.05 -25.7 46.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.233 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.32 -39.14 54.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.093 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -87.44 -27.25 22.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -56.06 -42.14 76.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.288 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -85.98 -30.21 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.82 -32.42 73.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 6.2 mt -66.07 -55.55 15.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.2 -30.92 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -51.41 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -34.0 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.801 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -119.71 104.69 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -82.07 59.23 4.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -159.8 26.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.14 151.96 38.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.92 -176.16 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.14 20.25 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 13.2 m -89.62 160.5 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.927 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.33 -33.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.801 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.3 m -93.9 159.37 15.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.7 165.49 11.4 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -92.79 138.25 31.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -92.62 128.2 38.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.053 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 13.9 mt -79.71 116.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.458 ' HB ' ' HG3' ' A' ' 386' ' ' ARG . 4.8 mt -83.76 -68.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.639 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -159.58 144.71 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.994 0.426 . . . . 0.0 111.305 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.406 ' CG1' ' CB ' ' A' ' 423' ' ' ALA . 8.5 t -116.66 137.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.846 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.504 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 4.9 mm -79.66 138.86 54.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.675 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 27.0 Cg_exo -62.75 -10.39 19.67 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.909 2.406 . . . . 0.0 113.771 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.33 55.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.001 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.504 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 1.1 p -153.96 157.95 32.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.07 -25.17 79.06 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.432 2.088 . . . . 0.0 111.251 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 428' ' ' LEU . . . -58.72 -58.45 8.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.008 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.81 -30.24 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.667 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.74 -26.55 57.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.25 -30.15 63.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.204 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.82 23.16 3.12 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.819 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 423' ' ' ALA . 0.9 OUTLIER -91.73 -176.65 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.748 0.309 . . . . 0.0 110.768 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.17 159.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.65 -176.98 1.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 59.41 27.57 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -125.23 -177.93 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.703 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -146.27 124.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.379 . . . . 0.0 111.495 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.34 154.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.715 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.0 pp -141.69 -48.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.745 0.307 . . . . 0.0 111.717 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 77.1 p -113.8 152.93 29.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 440' ' ' GLN . 7.6 tt -150.83 112.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 18.0 p30 44.98 41.51 5.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.679 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 80.55 23.92 59.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.851 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . 0.408 ' HB2' ' CG2' ' A' ' 437' ' ' ILE . 6.8 mm100 -125.05 120.68 32.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.699 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 11.5 p -72.69 123.35 23.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.258 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 448' ' ' VAL . 10.2 t -107.67 143.14 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.833 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.68 4.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.1 p -170.2 164.72 9.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.891 0.377 . . . . 0.0 111.222 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . 0.426 ' HB3' ' CG ' ' B' ' 5' ' ' TRP . . . -58.07 -45.18 87.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.06 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . 0.417 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 23.7 p30 -57.34 -29.15 63.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.78 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.12 -35.56 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . 0.405 ' CG2' ' CG1' ' A' ' 442' ' ' VAL . 33.5 t -73.02 -39.46 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.376 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 23.0 t -57.02 -63.94 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.458 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -47.1 -32.2 4.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.423 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 45.6 t -68.85 -45.54 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.975 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 22.1 mt -59.65 -29.66 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -6.09 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.356 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.06 -46.96 5.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.28 155.35 20.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 8.5 t -97.8 -35.85 10.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.3 95.93 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 437' ' ' ILE . 4.8 mt -94.0 119.29 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.25 93.28 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.462 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.53 160.29 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 20.3 t -119.56 127.6 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.801 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.3 141.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -96.73 119.88 36.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.37 126.78 48.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.25 -99.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.373 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.92 29.32 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 110.837 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -141.74 147.99 38.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.089 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -90.11 136.26 33.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.38 136.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.34 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.14 119.9 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.534 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 18.1 mm -115.36 145.1 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.189 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 31.0 m -135.04 132.8 38.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.08 138.33 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.248 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.4 mp -112.66 109.99 52.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.4 119.1 6.13 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.332 2.022 . . . . 0.0 112.14 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -79.92 169.0 18.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -97.01 147.61 23.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 1.7 tt -154.02 140.41 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -118.73 123.04 29.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.768 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.488 2.125 . . . . 0.0 112.268 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.869 0.366 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.407 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 0.7 OUTLIER -60.05 -69.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.728 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 54.05 52.17 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.45 155.34 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.42 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . 0.426 ' CG ' ' HB3' ' A' ' 445' ' ' ALA . 20.8 m95 -127.34 79.65 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.706 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -67.51 75.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.064 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.01 79.15 1.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.901 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.28 149.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.53 36.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.08 98.59 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.082 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -127.52 169.11 14.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.649 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -147.01 128.41 14.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.344 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.402 HD11 ' CG2' ' A' ' 385' ' ' ILE . 7.1 pt -118.31 -10.62 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.41 ' HA3' HG23 ' A' ' 421' ' ' THR . . . 60.83 71.06 0.85 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.828 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 417' ' ' VAL . 7.3 tp -164.41 123.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.811 0.338 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -89.71 129.61 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.88 146.56 51.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.851 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.0 ptm -127.82 160.84 30.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.7 p -80.05 101.67 8.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.63 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.65 108.8 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.6 t -88.82 157.78 18.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.858 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.56 -25.55 60.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.59 -27.93 61.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.113 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -99.61 -40.1 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.36 67.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -89.97 -34.76 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.54 -37.07 74.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.81 -32.48 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -68.22 -41.67 80.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -56.34 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -33.73 76.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -130.96 105.98 8.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 55.94 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.051 0.453 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.45 -20.18 4.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.77 129.09 88.76 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.028 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.14 -167.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.271 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.88 64.8 4.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.79 81.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.38 -31.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.41 144.73 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 137.82 178.23 15.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -100.77 158.18 16.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 111.019 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -114.82 127.75 55.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.896 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 4.6 mt -80.71 118.82 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 430' ' ' GLU . 5.1 mt -83.65 -55.36 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.568 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -160.68 162.89 32.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.349 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.41 ' CG2' ' CD1' ' A' ' 385' ' ' ILE . 25.5 t -119.7 155.63 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.672 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.483 ' HB ' HG22 ' A' ' 421' ' ' THR . 1.7 mp -95.27 139.41 22.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 420' ' ' ASP . 21.3 Cg_endo -60.73 102.93 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.455 2.103 . . . . 0.0 112.205 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 419' ' ' PRO . 13.2 m-20 94.0 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.144 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.483 HG22 ' HB ' ' A' ' 418' ' ' ILE . 0.8 OUTLIER -150.65 158.09 35.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.175 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.19 -22.45 74.19 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.124 1.883 . . . . 0.0 110.726 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.447 ' CA ' ' HG ' ' A' ' 428' ' ' LEU . . . -64.74 -60.07 3.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.912 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.82 -39.86 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.974 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.28 70.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.276 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -78.61 -70.15 1.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 174.48 39.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.453 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.447 ' HG ' ' CA ' ' A' ' 423' ' ' ALA . 0.1 OUTLIER -87.61 175.45 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.921 0.391 . . . . 0.0 111.166 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -165.01 143.54 6.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.492 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 3.6 pt-20 -87.05 47.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 111.291 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -169.53 33.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.582 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -131.89 -179.52 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 30.6 t -134.65 121.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.419 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.9 mt -76.04 150.93 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.38 -50.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 17.4 p -112.04 159.21 18.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 111.213 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 2.5 tt -164.14 114.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.078 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 17.0 p30 46.11 34.22 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.666 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.45 32.86 24.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.69 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.09 134.3 49.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 110.64 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.29 104.6 14.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.282 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.9 t -88.06 136.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.64 -3.66 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -169.95 168.76 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.238 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.48 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.01 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -54.79 -27.53 42.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.81 -33.68 40.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.795 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.06 -40.35 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.264 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 4.5 t -56.07 -59.13 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.453 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.75 -25.6 11.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.568 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.01 -49.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 8.0 mt -59.43 -26.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -19.32 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.252 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -96.39 -60.88 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.81 0.338 . . . . 0.0 110.744 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -83.75 124.57 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 67.9 m -71.83 -37.26 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 9.0 p -101.65 123.58 45.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.76 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.5 mt -107.73 119.93 40.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -118.66 84.5 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.634 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.3 mtt -91.48 161.29 15.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 19.4 t -132.41 126.12 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.24 150.19 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -106.42 126.68 52.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -125.34 133.27 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.736 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.92 -104.94 1.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.236 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.49 25.93 3.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.834 0.35 . . . . 0.0 110.692 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -146.52 149.65 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.045 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.46 142.84 27.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.63 155.39 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.349 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 3.9 mmt -109.54 119.9 40.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.479 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.96 120.61 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.371 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 19.3 m -102.28 121.5 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.552 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 23.2 t -127.85 144.31 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.486 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.476 HD12 HG22 ' A' ' 474' ' ' ILE . 28.3 mm -127.77 109.9 20.47 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.855 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.72 149.65 81.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.394 2.063 . . . . 0.0 112.288 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.45 176.84 5.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -103.55 139.44 38.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 10.0 tt -149.14 143.54 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -122.03 117.95 29.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.25 1.104 0 C-N-CA 122.388 2.058 . . . . 0.0 112.339 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.837 0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m 60.65 45.33 10.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -66.76 88.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 24.3 pt -74.35 141.24 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -119.58 94.09 4.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.38 77.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.156 -179.941 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 24.2 p -171.31 106.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 59.48 29.44 19.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 64.0 mmm -130.75 68.82 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -140.78 177.29 8.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.762 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 475' ' ' PRO . 24.6 mttm -59.64 -178.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.788 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -160.04 128.42 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.175 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . . . . . . . . . 12.7 pt -118.48 -5.74 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.271 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . 0.436 ' HA3' HG22 ' A' ' 421' ' ' THR . . . 55.78 66.15 3.05 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.654 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 385' ' ' ILE . 0.0 OUTLIER -153.45 124.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.815 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' ARG . . . . . 0.413 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 25.3 mtt180 -90.2 123.88 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.069 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.21 145.03 51.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' MET . . . . . 0.402 ' HG3' ' HB3' ' A' ' 413' ' ' TYR . 0.7 OUTLIER -122.23 179.09 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.6 p -104.75 104.83 14.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.665 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' LEU . . . . . . . . . . . . . 6.2 tp -51.97 114.81 1.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.269 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.3 t -90.23 170.16 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 56.2 m -67.84 -14.5 63.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.527 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.3 t -87.94 -35.96 17.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 0.0 111.204 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.86 -30.92 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.95 98.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -76.53 -33.31 58.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -29.18 70.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.49 -49.34 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.041 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -58.59 -30.37 67.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.092 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.36 -37.57 80.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.95 -65.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.56 -58.4 8.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 75.8 -54.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.362 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -44.72 -29.7 0.81 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.01 138.91 71.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.78 -159.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.485 2.123 . . . . 0.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -101.57 27.31 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.2 m -71.74 140.3 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.98 -30.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 16.8 m -101.62 -178.2 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 112.61 167.21 17.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.598 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.6 151.6 25.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' TYR . . . . . 0.402 ' HB3' ' HG3' ' A' ' 388' ' ' MET . 52.8 t80 -101.46 128.72 47.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ILE . . . . . . . . . . . . . 16.1 mt -79.94 114.62 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.826 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' ILE . . . . . . . . . . . . . 4.1 mt -78.76 -66.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.27 158.57 41.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 111.585 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' VAL . . . . . 0.401 ' CG1' ' HB3' ' A' ' 423' ' ' ALA . 41.3 t -130.63 153.3 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.824 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' ILE . . . . . 0.515 ' CD1' ' N ' ' A' ' 418' ' ' ILE . 1.1 mp -97.22 129.8 31.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.523 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.98 -12.91 16.69 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.009 2.473 . . . . 0.0 113.857 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -111.24 53.48 0.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' THR . . . . . 0.436 HG22 ' HA3' ' A' ' 384' ' ' GLY . 18.1 p -153.89 153.82 29.2 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.095 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.58 -24.46 45.02 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.099 1.866 . . . . 0.0 110.906 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' ALA . . . . . 0.416 ' O ' ' HG ' ' A' ' 428' ' ' LEU . . . -58.81 -60.25 4.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.37 -30.96 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.726 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.0 -15.46 58.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -84.07 -31.85 24.89 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.349 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 125.59 16.97 2.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.153 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 3.9 mt -85.69 -171.21 3.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.133 0.467 . . . . 0.0 110.74 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.86 153.87 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.43 -178.91 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 28.59 16.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -132.63 170.02 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.751 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.26 127.06 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.324 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.1 mp -84.89 147.85 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.569 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.2 pp -137.99 -43.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.728 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' SER . . . . . . . . . . . . . 23.6 p -124.94 151.94 44.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.091 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' ILE . . . . . . . . . . . . . 1.5 tt -148.81 115.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.982 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.7 p30 47.64 36.36 5.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.641 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.03 30.18 32.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.747 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -122.78 145.69 48.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.778 0.323 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.2 t -86.76 107.88 18.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 62.0 t -93.16 152.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 10.7 m -139.76 -46.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 2.3 p -132.64 166.48 22.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.999 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -56.21 -38.05 70.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.293 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -58.53 -29.67 66.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.63 -41.26 39.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' VAL . . . . . . . . . . . . . 32.9 t -63.16 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 3.6 t -54.89 -66.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.547 -179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 40.7 t -75.62 -46.12 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.289 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' ILE . . . . . . . . . . . . . 6.4 mt -58.76 -32.9 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 -4.15 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.628 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -100.38 -49.7 4.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.67 150.25 22.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 -35.88 14.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.807 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.21 96.83 6.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 10.6 mt -91.35 121.16 32.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -111.78 90.21 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 3.2 mtm -95.71 130.35 42.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.105 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 22.1 t -99.22 122.82 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.956 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.64 148.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.953 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.27 131.35 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -138.74 125.53 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 69.52 -101.4 0.83 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.464 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -140.12 25.39 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.655 0.264 . . . . 0.0 111.116 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -140.08 151.77 45.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.821 0.344 . . . . 0.0 111.2 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.08 139.24 31.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.62 129.18 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 111.362 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.8 120.11 33.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.51 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 8.6 mm -117.8 142.9 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.31 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 1.3 m -123.45 136.03 54.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 5.7 t -143.82 137.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.249 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' A' ' 474' ' ' ILE . 1.4 mp -113.66 109.8 50.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' PRO . . . . . 0.408 ' HB2' ' HB3' ' A' ' 381' ' ' LYS . 28.8 Cg_endo -63.07 134.14 44.55 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.059 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.89 -177.4 5.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -124.38 122.34 37.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 15.8 tt -106.08 145.49 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -149.56 111.58 3.42 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo . . . . . 0 C--O 1.25 1.086 0 C-N-CA 122.446 2.097 . . . . 0.0 112.371 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 64.5 p -96.78 40.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.97 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.8 mtm-85 -58.09 89.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 5.0 pt -83.36 115.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -99.76 101.29 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.97 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' TRP . . . . . 0.413 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 8.8 t90 -82.59 63.32 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.787 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.059 -179.949 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.528 ' HB2' HG22 ' A' ' 452' ' ' ILE . 6.9 mmtt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.711 0.291 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -141.76 123.14 14.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.257 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.571 HD12 ' CG2' ' A' ' 385' ' ' ILE . 5.4 pt -113.29 -13.72 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.347 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.52 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 72.14 57.53 5.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.772 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.891 HD11 HG23 ' A' ' 414' ' ' ILE . 12.4 tt -160.18 151.74 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.14 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 17.7 mtt180 -106.02 127.6 53.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.476 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -134.71 145.29 48.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.9 ptm -127.27 160.55 30.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 83.9 p -85.4 110.02 18.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.5 tp -58.06 89.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.018 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 394' ' ' LYS . 5.7 t -75.72 166.47 23.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.77 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.1 t -49.53 -36.11 22.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.425 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -63.73 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.175 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.416 ' H ' HG23 ' A' ' 391' ' ' THR . 0.0 OUTLIER -57.28 -49.6 75.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.9 -39.69 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.313 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.04 -29.19 39.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.6 -34.81 79.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.19 -43.15 78.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.05 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -59.63 -34.35 72.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.64 -37.87 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -82.51 -70.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 96.46 8.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.04 60.43 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.8 14.23 1.92 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.23 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.31 150.96 40.08 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.685 ' HB2' HG22 ' A' ' 408' ' ' VAL . 53.6 Cg_exo -52.09 179.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.87 28.42 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' A' ' 406' ' ' PRO . 14.9 m -101.38 173.84 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.731 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -138.63 16.7 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.373 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.2 p -116.2 139.89 49.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.882 0.372 . . . . 0.0 110.801 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.12 167.06 11.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.35 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -101.56 142.9 32.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.128 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.756 ' HB2' HD13 ' A' ' 390' ' ' LEU . 45.0 t80 -104.14 130.38 51.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.891 HG23 HD11 ' A' ' 385' ' ' ILE . 17.4 mt -80.08 128.76 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.54 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.806 HD13 HG22 ' B' ' 4' ' ' ILE . 62.7 mt -96.24 -68.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.563 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 153.12 40.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 0.0 111.044 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.16 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.8 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.5 mp -79.84 134.69 56.57 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.308 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.97 -11.21 2.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.249 2.632 . . . . 0.0 114.678 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' ASP . . . . . 0.8 ' H ' HG22 ' A' ' 418' ' ' ILE . 14.7 m-20 -130.95 76.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.52 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.2 OUTLIER -160.15 163.58 21.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.603 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.64 -25.17 78.13 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.408 2.072 . . . . 0.0 111.6 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -59.14 -54.67 44.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.169 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.08 -31.08 65.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.5 -30.51 59.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.265 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.98 -38.15 84.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.35 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.77 29.42 1.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.82 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.87 HD23 HG21 ' A' ' 471' ' ' ILE . 0.4 OUTLIER -96.97 -164.28 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.686 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.25 163.71 22.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.854 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 41.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 0.0 110.977 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -151.88 28.54 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.59 ' HB2' HD12 ' A' ' 414' ' ' ILE . 1.0 OUTLIER -126.57 -177.04 3.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 29.8 t -136.68 123.21 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.315 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 435' ' ' ILE . 1.7 mp -77.04 157.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 436' ' ' SER . 2.0 pp -148.79 -46.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.411 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 435' ' ' ILE . 54.2 p -124.34 160.95 26.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.979 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.996 HG21 HG11 ' A' ' 451' ' ' VAL . 2.8 tt -156.58 119.57 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.249 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.471 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 0.7 OUTLIER 43.54 46.94 6.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.718 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 74.27 47.18 18.2 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.713 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.471 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 48.7 mt-30 -142.95 161.49 37.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.679 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 61.9 m -111.62 110.5 20.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.961 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.937 HG11 HG22 ' A' ' 448' ' ' VAL . 5.3 t -95.04 152.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 444' ' ' SER . 27.9 m -130.12 -42.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.453 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 443' ' ' VAL . 2.2 p -134.3 172.35 13.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 0.0 111.242 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.476 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.38 -42.97 78.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.416 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 25.1 p30 -55.31 -29.14 57.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.843 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.83 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.8 m-20 -78.52 -35.68 45.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.937 HG22 HG11 ' A' ' 442' ' ' VAL . 32.4 t -69.75 -41.51 79.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.266 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.666 ' HA ' HD12 ' A' ' 452' ' ' ILE . 20.2 t -54.78 -62.62 1.54 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.529 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -48.28 -35.97 13.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.409 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.996 HG11 HG21 ' A' ' 437' ' ' ILE . 40.3 t -65.81 -46.05 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.068 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.5 mt -61.92 -31.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.135 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.03 -14.3 24.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.455 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -94.37 -44.99 7.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.317 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.13 128.52 53.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 53.9 m -70.2 -37.71 75.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.7 p -104.25 121.38 43.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.582 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.772 ' HB3' HD11 ' A' ' 437' ' ' ILE . 9.2 mt -107.38 129.27 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.6 m-80 -127.92 83.07 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.642 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.499 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.1 OUTLIER -89.68 136.62 32.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.495 HG22 ' HG3' ' A' ' 470' ' ' MET . 21.8 t -99.07 126.51 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.164 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.412 HG11 ' OD2' ' A' ' 432' ' ' ASP . 11.6 t -121.15 129.3 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -89.73 120.96 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -124.3 128.52 49.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.03 -100.98 0.89 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.347 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -139.93 23.85 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -141.91 148.35 38.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.147 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -91.73 136.46 33.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.1 mt -126.01 146.59 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.216 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.495 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -101.89 119.92 39.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.87 HG21 HD23 ' A' ' 428' ' ' LEU . 12.1 mm -107.17 133.6 51.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.4 HG23 ' OD1' ' A' ' 459' ' ' ASN . 0.2 OUTLIER -114.54 126.55 55.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.936 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 428' ' ' LEU . 20.6 t -135.98 130.35 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.03 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 33.8 mm -105.24 109.92 63.8 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.457 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.9 Cg_endo -58.06 175.49 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -123.92 155.81 37.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.985 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 60.4 71.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.806 HG22 HD13 ' A' ' 415' ' ' ILE . 9.2 pt -84.82 134.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.416 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 12.5 m95 -117.91 91.11 3.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 3.8 t90 -70.71 72.47 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.44 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.2 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.679 0.276 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.449 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 52.1 t80 -152.97 131.76 12.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.668 HG13 HG22 ' A' ' 385' ' ' ILE . 22.4 pt -116.85 -14.95 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.62 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 67.01 61.95 4.83 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.882 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.941 HD11 HG23 ' A' ' 414' ' ' ILE . 10.3 tt -165.37 137.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 111.266 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.509 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -96.59 145.9 25.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.782 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.504 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -141.46 139.5 33.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.742 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.446 ' CG ' HD11 ' A' ' 415' ' ' ILE . 6.2 ptm -116.83 162.88 17.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.9 p -85.37 115.85 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 398' ' ' LEU . 6.6 tp -69.13 84.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.8 t -71.12 173.7 7.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.9 m -62.56 -19.1 63.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.305 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -46.43 12.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.464 ' H ' HG23 ' A' ' 391' ' ' THR . 0.0 OUTLIER -82.91 -32.65 27.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -65.58 -51.02 62.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.386 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.19 -29.47 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -38.09 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.06 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 390' ' ' LEU . 6.1 mt -62.45 -52.58 62.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -29.93 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -60.0 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -65.68 -42.4 91.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.058 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -119.89 113.94 21.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -82.92 -27.44 30.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -25.64 59.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 402' ' ' HIS . 4.8 m-85 -55.46 161.27 3.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.582 ' HB2' HG22 ' A' ' 408' ' ' VAL . 45.6 Cg_endo -68.53 173.2 10.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.59 2.193 . . . . 0.0 112.21 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -98.31 30.98 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 406' ' ' PRO . 13.2 m -114.66 126.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.66 -30.16 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.51 173.78 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 104.65 173.94 24.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.443 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.28 140.14 43.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.15 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.849 ' HB2' HD13 ' A' ' 390' ' ' LEU . 23.3 t80 -90.54 128.06 36.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.668 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.941 HG23 HD11 ' A' ' 385' ' ' ILE . 8.0 mt -79.88 127.94 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 9.6 mm -85.4 -69.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -160.14 153.79 22.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.723 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.491 HG22 HD12 ' A' ' 385' ' ' ILE . 12.5 t -118.09 139.05 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.466 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 22.7 mm -79.75 146.57 64.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.507 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 418' ' ' ILE . 15.8 Cg_exo -69.52 6.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.822 2.348 . . . . 0.0 113.877 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.06 62.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.146 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.547 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.1 OUTLIER -155.42 171.81 6.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.772 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.46 ' HB2' HG13 ' A' ' 473' ' ' VAL . 82.3 Cg_endo -79.19 -18.12 11.36 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.535 2.157 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.616 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -60.43 -58.87 6.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.049 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.423 ' N ' HG11 ' A' ' 417' ' ' VAL . 3.4 tp10 -68.37 -27.76 66.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.63 38.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.383 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -76.24 -39.19 32.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.435 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 133.24 16.97 1.16 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.154 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 471' ' ' ILE . 3.0 mt -85.99 -170.65 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.074 0.437 . . . . 0.0 110.68 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.82 141.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 16.0 pm0 -62.22 178.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 36.1 m120 62.88 23.5 14.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.805 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.733 ' HB2' HD12 ' A' ' 414' ' ' ILE . 17.1 m-20 -125.42 -177.11 3.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.554 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -139.47 123.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 111.536 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.3 154.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -141.86 -49.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.683 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.71 ' N ' HD12 ' A' ' 435' ' ' ILE . 52.3 p -114.14 155.43 26.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.207 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.1 tt -157.77 111.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.028 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.447 ' O ' ' ND2' ' A' ' 438' ' ' ASN . 1.6 p-10 45.43 41.65 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.578 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 78.7 35.1 32.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.769 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.55 ' HB2' HG23 ' A' ' 437' ' ' ILE . 17.4 mm-40 -134.62 125.57 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.766 0.317 . . . . 0.0 110.924 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 68.8 p -80.93 110.77 16.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.906 HG11 ' CG2' ' A' ' 448' ' ' VAL . 10.8 t -92.2 143.1 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.11 -32.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.48 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.99 177.59 9.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.239 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.504 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -61.14 -42.45 98.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.037 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.433 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 24.5 p30 -53.87 -26.25 23.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.874 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -79.91 -50.69 10.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.688 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.906 ' CG2' HG11 ' A' ' 442' ' ' VAL . 41.3 t -56.75 -37.25 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.291 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 24.8 t -57.1 -65.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.399 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -51.67 -32.16 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.37 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 447' ' ' ASP . 41.5 t -66.64 -49.91 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.67 HD11 HG12 ' A' ' 448' ' ' VAL . 9.1 mt -58.25 -29.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -97.14 -14.28 21.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.422 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -97.64 -54.64 3.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 451' ' ' VAL . 17.2 mm-40 -86.48 126.3 34.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.927 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 73.5 m -69.03 -36.84 78.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' THR . . . . . 0.579 ' C ' HD23 ' A' ' 458' ' ' LEU . 1.5 p -108.44 136.27 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.679 ' HB3' HD11 ' A' ' 437' ' ' ILE . 4.0 mt -120.14 140.74 50.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.052 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' ASN . . . . . 0.717 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.1 m-80 -141.9 91.78 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.586 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.449 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -96.74 159.34 14.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 23.7 t -129.93 122.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.875 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.745 ' O ' HD12 ' A' ' 469' ' ' ILE . 5.6 t -112.91 147.45 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.206 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -114.61 139.36 49.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.804 ' HG2' HD11 ' A' ' 469' ' ' ILE . 21.1 ptt180 -132.23 126.51 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.793 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 59.93 -96.51 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -136.88 29.0 2.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 0.0 110.961 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.54 143.79 39.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.95 141.77 28.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.675 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.804 HD11 ' HG2' ' A' ' 464' ' ' ARG . 0.8 OUTLIER -127.03 125.31 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.159 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.522 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.0 OUTLIER -95.93 125.27 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.769 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 428' ' ' LEU . 3.5 mp -125.5 132.55 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.401 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.717 HG23 ' OD1' ' A' ' 459' ' ' ASN . 1.2 m -116.71 119.82 36.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.435 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 428' ' ' LEU . 21.2 t -124.92 140.71 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 111.399 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.569 HD12 HG22 ' A' ' 457' ' ' THR . 27.3 mm -124.09 111.99 28.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.717 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.449 ' HB3' HG23 ' A' ' 383' ' ' ILE . 23.9 Cg_endo -62.05 144.23 95.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.315 2.01 . . . . 0.0 112.353 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.7 171.62 7.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.968 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.788 0.328 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -65.5 99.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.455 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.8 pt -69.5 157.03 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.433 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 13.3 m95 -118.78 91.89 3.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.426 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 5.4 t90 -72.98 79.64 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.18 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -154.37 159.16 41.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.843 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.849 HG22 ' HG2' ' A' ' 422' ' ' PRO . 0.7 OUTLIER -135.38 -59.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.37 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 115.5 49.32 0.48 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.359 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.886 HD13 HG22 ' A' ' 417' ' ' VAL . 5.5 tp -138.93 132.58 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.031 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -89.8 129.82 36.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.561 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.457 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -138.36 157.57 45.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.106 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 412' ' ' ALA . 1.5 ptm -134.32 -179.59 5.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 4.2 p -94.67 15.82 17.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.369 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.778 HD13 ' HB2' ' A' ' 413' ' ' TYR . 12.5 tp 47.26 95.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.874 0.369 . . . . 0.0 111.481 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.673 HG23 ' H ' ' A' ' 394' ' ' LYS . 2.6 t -71.67 156.26 39.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.23 -30.57 70.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.1 m -66.62 -56.67 9.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.673 ' H ' HG23 ' A' ' 391' ' ' THR . 0.1 OUTLIER -71.43 -29.84 65.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.619 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -57.59 -60.01 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.45 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -61.9 -36.38 81.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 395' ' ' ALA . 4.7 mt -61.1 -43.5 98.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -66.12 -30.54 71.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -59.89 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -68.53 -60.62 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.8 85.23 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 65.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.124 0.488 . . . . 0.0 110.854 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -167.54 28.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -89.63 167.34 17.71 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.773 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.64 -24.4 12.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.527 2.151 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.6 t0 68.36 51.79 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.51 90.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.025 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.545 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -46.54 -30.97 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.474 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.4 m -116.61 130.49 56.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 163.57 178.33 37.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 434' ' ' ILE . . . -98.08 123.41 42.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.778 ' HB2' HD13 ' A' ' 390' ' ' LEU . 62.5 t80 -97.83 129.99 44.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.767 HG23 HD11 ' A' ' 385' ' ' ILE . 21.5 mt -80.69 109.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.605 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.768 HD13 HG22 ' B' ' 4' ' ' ILE . 2.8 mp -72.89 -58.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.294 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.735 ' O ' HD12 ' A' ' 385' ' ' ILE . 17.1 pt-20 -160.1 147.78 16.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.814 0.34 . . . . 0.0 111.208 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.886 HG22 HD13 ' A' ' 385' ' ' ILE . 24.8 t -108.85 133.28 54.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.939 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.508 ' O ' HG22 ' A' ' 421' ' ' THR . 0.3 OUTLIER -80.4 156.7 73.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.93 44.08 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.793 2.329 . . . . 0.0 112.58 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -173.31 35.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.562 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 418' ' ' ILE . 4.0 t -129.46 154.39 80.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.023 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.849 ' HG2' HG22 ' A' ' 383' ' ' ILE . 36.1 Cg_exo -61.19 -24.39 79.0 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.761 2.308 . . . . 0.0 112.325 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.848 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -53.72 -38.56 64.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.66 -29.66 59.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.39 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.953 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.724 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -67.89 -69.57 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.29 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 151.69 39.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.81 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.874 HD23 HG21 ' A' ' 471' ' ' ILE . 1.1 mt -98.48 -165.12 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -178.97 170.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.04 28.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.22 12.97 3.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.494 ' HB2' HD12 ' A' ' 414' ' ' ILE . 15.9 m-20 -119.12 173.37 6.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.631 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 412' ' ' ALA . 28.4 t -138.25 117.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.365 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 412' ' ' ALA . 3.6 mp -66.2 142.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.668 HD12 ' HB3' ' A' ' 436' ' ' SER . 2.1 pp -136.43 -46.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.567 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.668 ' HB3' HD12 ' A' ' 435' ' ' ILE . 24.2 p -121.7 156.51 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.926 HG21 HG11 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -151.54 124.45 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.002 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 44.71 30.89 0.57 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.576 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.22 27.26 23.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -118.13 170.19 9.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.746 0.307 . . . . 0.0 110.713 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 16.4 m -118.35 111.09 18.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.97 HG11 HG22 ' A' ' 448' ' ' VAL . 10.8 t -97.67 161.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.478 ' N ' HG12 ' A' ' 442' ' ' VAL . 8.6 m -139.45 -48.31 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.475 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.7 OUTLIER -126.05 167.82 14.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.414 . . . . 0.0 111.282 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.457 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.75 -41.38 81.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -55.84 -26.34 46.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.817 ' O ' HG23 ' A' ' 451' ' ' VAL . 6.3 m-20 -86.88 -29.74 21.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.97 HG22 HG11 ' A' ' 442' ' ' VAL . 13.4 t -72.13 -44.67 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.314 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.526 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.7 t -50.84 -64.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.624 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -46.61 -36.5 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.474 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.926 HG11 HG21 ' A' ' 437' ' ' ILE . 41.1 t -63.33 -50.09 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.207 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.2 mt -58.75 -37.2 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -90.34 -4.88 56.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.399 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -100.07 -51.35 3.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.63 142.36 28.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 5.3 t -81.28 -38.25 27.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.674 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' THR . . . . . 0.526 HG22 HD12 ' A' ' 474' ' ' ILE . 1.0 OUTLIER -106.61 117.76 34.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.601 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.765 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.0 mt -101.97 126.75 48.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -132.22 92.78 3.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.634 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.489 ' HG3' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -96.74 151.69 19.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.35 121.95 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.017 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 463' ' ' ARG . 9.0 t -107.43 161.42 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' ARG . . . . . 0.47 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -124.83 138.7 54.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.0 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.759 ' HB2' HD11 ' A' ' 469' ' ' ILE . 0.3 OUTLIER -147.65 121.27 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.743 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.79 -113.68 5.84 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.26 29.37 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.52 150.2 43.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.243 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -94.25 147.15 23.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.759 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.0 OUTLIER -127.88 132.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.256 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.31 119.88 39.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.654 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.874 HG21 HD23 ' A' ' 428' ' ' LEU . 11.5 mm -112.54 132.67 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 25.1 m -122.62 119.86 32.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.724 HG22 ' HA3' ' A' ' 426' ' ' GLY . 24.5 t -130.1 133.74 63.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.526 HD12 HG22 ' A' ' 457' ' ' THR . 26.3 mm -118.11 109.14 41.23 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.608 ' HB3' HG23 ' A' ' 383' ' ' ILE . 39.5 Cg_endo -66.84 -172.71 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.462 2.108 . . . . 0.0 112.226 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -143.1 173.5 11.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.857 0.361 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 113.6 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.768 HG22 HD13 ' A' ' 415' ' ' ILE . 2.6 pt -81.26 118.13 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -94.71 92.65 7.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -68.24 85.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.123 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.6 mttp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.801 0.334 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -131.0 126.98 37.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 385' ' ' ILE . 11.0 pt -116.72 -4.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.425 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.478 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 50.07 67.27 1.91 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.857 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.958 HD13 HG22 ' A' ' 417' ' ' VAL . 4.8 tp -151.73 126.22 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 110.841 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.426 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 27.7 mtt85 -89.9 125.96 35.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.85 142.53 47.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.457 ' HB3' HD11 ' A' ' 415' ' ' ILE . 8.6 ptm -125.54 156.98 38.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 49.2 p -84.21 114.53 21.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' ' 395' ' ' ALA . 6.8 tp -63.93 81.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.4 t -62.12 158.69 16.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 m -57.42 -23.24 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -54.7 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.092 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.746 ' H ' HG23 ' A' ' 391' ' ' THR . 0.5 OUTLIER -63.71 -45.16 91.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.169 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.594 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -59.18 -39.85 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.185 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -77.63 -29.87 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.79 -47.57 62.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.14 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.5 -44.06 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -65.86 -31.7 72.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.74 -43.31 94.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 ttm-85 -93.09 -20.34 20.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.311 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -135.57 78.79 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -69.14 -22.8 63.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.79 -26.64 10.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -65.06 160.39 56.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.835 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.27 -167.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.565 2.177 . . . . 0.0 112.243 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -116.7 31.33 6.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.015 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.7 m -91.9 132.27 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.611 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -110.5 -18.26 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.31 154.23 18.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 116.56 159.35 11.65 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.616 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -90.11 147.77 23.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.117 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.547 ' HB2' HD13 ' A' ' 390' ' ' LEU . 74.6 t80 -102.42 131.25 49.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 432' ' ' ASP . 21.2 mt -80.01 122.92 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.889 ' CD1' HG22 ' B' ' 4' ' ' ILE . 17.9 mt -91.84 -61.24 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.831 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.769 ' O ' HD12 ' A' ' 385' ' ' ILE . 8.0 pt-20 -157.88 149.29 21.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.403 . . . . 0.0 111.415 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.958 HG22 HD13 ' A' ' 385' ' ' ILE . 20.4 t -117.4 140.37 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -86.79 135.37 35.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.729 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 7.9 Cg_exo -72.57 56.18 2.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.779 2.319 . . . . 0.0 112.496 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 178.25 40.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.162 0.506 . . . . 0.0 110.498 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.4 OUTLIER -142.78 173.83 4.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -75.77 -13.87 19.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.132 1.888 . . . . 0.0 111.856 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.499 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -66.15 -56.9 9.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.65 -31.78 70.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.456 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.94 -30.62 58.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.843 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -66.86 -34.06 86.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.255 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.95 26.83 2.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.843 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 471' ' ' ILE . 0.3 OUTLIER -96.47 -177.81 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -159.64 161.5 35.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.762 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -85.59 56.17 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.17 31.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.034 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 414' ' ' ILE . 14.9 m-20 -135.22 -174.34 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.815 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 412' ' ' ALA . 38.6 t -142.21 123.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.312 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.7 mt -75.7 147.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -138.69 -46.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.351 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.763 ' N ' HD12 ' A' ' 435' ' ' ILE . 90.9 p -116.93 156.32 27.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.726 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.932 HG21 HG11 ' A' ' 451' ' ' VAL . 4.5 tt -155.9 114.51 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.198 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.591 HD22 ' HG3' ' A' ' 440' ' ' GLN . 0.8 OUTLIER 44.33 33.42 0.85 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.454 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.68 36.16 9.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.773 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.591 ' HG3' HD22 ' A' ' 438' ' ' ASN . 0.0 OUTLIER -138.47 114.42 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 m -70.19 114.4 8.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.93 HG11 HG22 ' A' ' 448' ' ' VAL . 2.7 t -97.65 162.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 444' ' ' SER . 16.1 m -133.76 -45.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.433 ' N ' HG23 ' A' ' 443' ' ' VAL . 1.9 p -130.95 173.73 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.16 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.84 94.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.045 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.428 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 1.3 p-10 -53.99 -26.64 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.863 ' O ' HG23 ' A' ' 451' ' ' VAL . 12.5 m-20 -86.85 -41.4 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.93 HG22 HG11 ' A' ' 442' ' ' VAL . 46.9 t -63.19 -30.63 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.131 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.494 ' HA ' HD12 ' A' ' 452' ' ' ILE . 4.9 t -63.59 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -51.27 -36.38 41.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.504 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.932 HG11 HG21 ' A' ' 437' ' ' ILE . 40.9 t -60.72 -47.73 91.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 448' ' ' VAL . 5.5 mt -62.09 -37.5 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.15 -8.05 55.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.224 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -98.92 -46.82 5.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.819 0.343 . . . . 0.0 110.843 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.26 140.33 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 35.3 t -84.88 -34.31 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.739 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' THR . . . . . 0.474 HG22 HD12 ' A' ' 474' ' ' ILE . 2.1 p -109.17 100.21 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.758 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 452' ' ' ILE . 8.3 mt -94.53 136.31 34.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.7 m-80 -133.82 89.02 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.633 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.458 ' HE1' ' HB ' ' A' ' 473' ' ' VAL . 0.1 OUTLIER -92.48 173.78 7.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 470' ' ' MET . 13.2 t -134.68 145.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.883 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 432' ' ' ASP . 7.3 t -140.58 153.47 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.001 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -101.76 119.84 39.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.98 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.496 ' HB2' HD12 ' A' ' 469' ' ' ILE . 9.3 mtp180 -127.81 139.64 52.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.7 -101.72 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.169 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -140.19 20.56 2.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.778 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -145.8 168.47 20.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.92 136.08 42.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.649 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.8 mt -127.53 143.98 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.593 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -90.7 119.89 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.714 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 428' ' ' LEU . 21.8 mm -103.21 130.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.455 HG23 ' OD1' ' A' ' 459' ' ' ASN . 0.2 OUTLIER -102.77 129.12 49.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.013 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.458 ' HB ' ' HE1' ' A' ' 460' ' ' MET . 18.4 t -140.36 119.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.474 HD12 HG22 ' A' ' 457' ' ' THR . 21.2 mm -108.19 109.85 61.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.165 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.459 ' HG3' HG23 ' A' ' 452' ' ' ILE . 58.2 Cg_exo -51.43 131.27 35.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.43 2.087 . . . . 0.0 112.33 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.0 170.56 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.841 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.816 0.341 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -60.16 117.05 4.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.889 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.4 pt -84.26 123.08 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.6 m95 -108.57 95.37 5.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.426 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 6.8 t90 -76.85 62.56 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.808 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.064 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.739 0.305 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -152.02 124.42 8.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.024 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 385' ' ' ILE . 24.5 pt -113.36 -4.2 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.463 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.551 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 53.6 65.82 3.17 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.734 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.807 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.13 124.82 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.947 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 1.9 mtp180 -92.3 125.15 36.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.505 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -127.07 137.28 53.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.416 ' HB3' HD11 ' A' ' 415' ' ' ILE . 3.7 ptm -115.85 173.26 6.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.012 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.5 p -97.69 105.55 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.632 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.867 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.2 tp -54.37 98.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.7 t -87.01 165.09 16.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.839 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.8 m -58.92 -29.7 67.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.067 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 71.2 m -78.55 -19.05 53.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -51.26 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 111.072 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -57.35 -45.84 83.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.313 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -66.72 -29.71 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.82 -41.06 62.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.993 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 395' ' ' ALA . 7.1 mt -59.97 -38.45 82.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -34.2 68.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.98 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -77.28 -29.27 53.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -53.25 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -116.31 115.74 26.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.003 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.79 55.62 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.841 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -146.97 19.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.103 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.83 158.28 35.35 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 -172.74 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.588 2.192 . . . . 0.0 112.211 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -109.29 32.03 5.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 11.7 m -102.3 129.6 53.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pt -102.57 -32.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.5 m -87.78 149.9 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.773 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 132.17 -157.8 22.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -132.96 127.62 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.867 ' HB2' HD13 ' A' ' 390' ' ' LEU . 41.4 t80 -90.33 128.03 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.807 HG23 HD11 ' A' ' 385' ' ' ILE . 15.3 mt -80.57 109.97 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.515 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -71.3 -58.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 430' ' ' GLU . 6.4 pt-20 -158.31 152.14 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.401 . . . . 0.0 111.245 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.53 HG22 ' CG1' ' A' ' 385' ' ' ILE . 22.2 t -127.95 136.35 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.954 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.596 HG22 ' HD2' ' A' ' 419' ' ' PRO . 8.4 mm -79.86 146.23 63.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.596 ' HD2' HG22 ' A' ' 418' ' ' ILE . 11.9 Cg_exo -71.15 0.52 6.54 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.744 2.296 . . . . 0.0 113.319 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -127.35 61.75 1.38 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.8 OUTLIER -152.7 168.99 10.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.564 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.561 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 59.7 Cg_endo -74.31 -18.06 20.89 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.265 1.977 . . . . 0.0 111.48 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -61.8 -59.22 5.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.554 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.49 -27.08 64.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.563 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.44 -30.45 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.18 1.26 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 167.97 31.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.903 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.661 HD11 HG21 ' A' ' 473' ' ' VAL . 0.3 OUTLIER -108.12 -168.15 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.805 0.336 . . . . 0.0 110.82 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.55 169.62 2.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.774 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 416' ' ' GLU . 0.4 OUTLIER -89.92 49.93 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -160.46 29.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.472 ' HB2' HD12 ' A' ' 414' ' ' ILE . 29.8 m-20 -134.15 -177.34 4.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.58 117.89 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.19 149.58 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 436' ' ' SER . 2.3 pp -141.95 -47.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.78 ' N ' HD12 ' A' ' 435' ' ' ILE . 96.3 p -123.64 144.94 49.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.97 HG21 HG11 ' A' ' 451' ' ' VAL . 3.9 tt -143.52 119.62 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.555 HD22 ' HG3' ' A' ' 440' ' ' GLN . 0.7 OUTLIER 44.85 30.49 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.734 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.07 20.37 42.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.201 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.555 ' HG3' HD22 ' A' ' 438' ' ' ASN . 20.3 mt-30 -112.31 157.67 20.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.78 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.17 118.3 31.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.628 HG11 HG22 ' A' ' 448' ' ' VAL . 57.9 t -109.51 127.45 66.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.29 6.49 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.95 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.9 OUTLIER -170.41 161.52 8.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.881 0.372 . . . . 0.0 111.152 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.505 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -58.2 -45.19 88.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.048 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.42 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 36.4 p-10 -56.58 -28.42 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.819 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.5 OUTLIER -77.69 -33.8 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.628 HG22 HG11 ' A' ' 442' ' ' VAL . 18.0 t -74.45 -37.39 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.195 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.542 ' HA ' HD12 ' A' ' 452' ' ' ILE . 7.6 t -55.27 -57.55 11.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -54.94 -41.04 70.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.339 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.97 HG11 HG21 ' A' ' 437' ' ' ILE . 39.5 t -58.56 -47.34 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.148 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 449' ' ' SER . 8.4 mt -58.8 -36.05 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.68 -0.84 54.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.322 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -100.22 -47.8 4.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 110.916 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.2 152.81 31.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.75 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.9 t -94.27 -35.61 12.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.695 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 94.3 6.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.714 ' HB3' HD11 ' A' ' 437' ' ' ILE . 14.9 mt -89.86 123.24 33.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -111.13 83.16 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.434 ' HE3' ' HB2' ' A' ' 458' ' ' LEU . 2.6 mtt -90.29 133.35 35.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 469' ' ' ILE . 28.7 t -108.28 124.71 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.902 HG23 HD13 ' A' ' 471' ' ' ILE . 3.0 t -111.27 163.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.6 OUTLIER -124.76 143.91 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.047 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.765 ' HB2' HD11 ' A' ' 469' ' ' ILE . 16.0 mtp180 -144.73 130.36 19.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.82 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.22 -99.54 0.21 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.436 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.26 30.89 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.754 0.312 . . . . 0.0 110.944 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.12 144.94 24.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.765 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mp -128.76 129.65 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 111.317 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.69 125.21 47.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.492 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.902 HD13 HG23 ' A' ' 462' ' ' VAL . 3.8 mp -132.66 143.61 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.44 . . . . 0.0 111.618 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.18 135.92 53.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.768 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.5 t -135.94 135.1 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.566 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.768 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.5 mp -119.83 109.26 37.97 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.586 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.12 155.96 5.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.425 2.084 . . . . 0.0 112.292 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.18 170.62 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.97 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.0 mtt-85 -61.62 89.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.515 HG22 ' CD1' ' A' ' 415' ' ' ILE . 2.3 pp -80.78 133.43 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.42 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.4 m0 -112.04 88.13 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.42 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 7.3 t90 -71.17 68.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.422 HG23 ' HE3' ' A' ' 387' ' ' MET . 21.1 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.198 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.8 mptt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.727 0.298 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 384' ' ' GLY . 13.0 t80 -155.83 121.1 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.241 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.0 pt -111.35 -13.02 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.237 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.559 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 70.42 52.77 15.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.729 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.797 HD11 HG23 ' A' ' 414' ' ' ILE . 10.9 tt -165.31 137.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.419 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -89.96 158.18 17.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.463 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.426 ' HE3' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -153.22 133.63 13.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.448 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.8 OUTLIER -110.69 173.8 6.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.019 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.3 p -100.16 112.6 24.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.832 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 398' ' ' LEU . 4.3 tp -63.52 88.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.127 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 2.3 t -85.57 167.37 15.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.32 -39.68 6.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.728 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -68.97 -58.36 4.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 111.229 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -52.5 64.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.323 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.25 -33.89 21.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.474 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -90.1 -29.51 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.043 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -65.32 -44.0 89.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 390' ' ' LEU . 3.4 mt -58.69 -39.23 80.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.046 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -67.08 -30.2 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -68.83 -59.38 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -66.03 -38.54 88.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.798 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.03 98.23 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -81.91 59.72 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.036 0.446 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.39 23.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.939 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -93.87 146.37 31.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.4 ' HB2' HG22 ' A' ' 408' ' ' VAL . 51.0 Cg_exo -53.17 179.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.269 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.42 38.23 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.814 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 408' ' ' VAL . 34.9 m -109.44 117.39 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.51 -29.72 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 435' ' ' ILE . 0.2 OUTLIER -87.11 148.85 25.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.003 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 122.21 170.43 13.71 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.685 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -108.46 152.71 24.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.026 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.707 ' HB2' HD13 ' A' ' 390' ' ' LEU . 27.2 t80 -92.19 133.79 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 432' ' ' ASP . 38.2 mt -79.98 121.78 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.037 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 416' ' ' GLU . 2.0 mm -88.76 -152.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.623 ' H ' HG22 ' A' ' 415' ' ' ILE . 17.0 pt-20 -79.35 145.15 33.58 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 0.0 111.074 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.473 HG11 ' N ' ' A' ' 424' ' ' GLU . 14.2 t -110.9 159.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.467 ' N ' HG12 ' A' ' 417' ' ' VAL . 20.6 mm -96.86 136.0 21.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.8 59.03 4.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.519 2.146 . . . . 0.0 112.579 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 174.93 44.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.586 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.559 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.2 OUTLIER -150.95 173.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -76.18 -16.28 17.77 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.309 2.006 . . . . 0.0 112.089 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -60.63 -60.05 4.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.473 ' N ' HG11 ' A' ' 417' ' ' VAL . 6.0 tp10 -74.06 -23.25 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 422' ' ' PRO . . . -82.04 -26.12 34.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.13 -70.06 1.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 171.55 30.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.997 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.539 HD21 HG21 ' A' ' 473' ' ' VAL . 0.2 OUTLIER -107.74 176.03 5.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.829 0.315 . . . . 0.0 110.643 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.99 157.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.28 77.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.95 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.846 ' HB2' HD12 ' A' ' 414' ' ' ILE . 22.9 m-20 -72.24 179.32 3.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.978 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 412' ' ' ALA . 22.7 t -139.8 131.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.556 HG23 ' HB3' ' A' ' 460' ' ' MET . 3.2 mt -86.06 145.34 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.735 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -140.57 -48.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.735 ' N ' HD12 ' A' ' 435' ' ' ILE . 19.1 p -110.01 158.79 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.2 tt -158.48 116.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.281 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.527 HD22 ' HG3' ' A' ' 440' ' ' GLN . 0.5 OUTLIER 42.52 50.54 4.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.649 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 70.61 44.96 56.03 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.798 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.527 ' HG3' HD22 ' A' ' 438' ' ' ASN . 1.3 mm100 -137.97 152.94 49.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 55.6 m -103.79 107.32 18.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.941 HG11 ' CG2' ' A' ' 448' ' ' VAL . 13.3 t -100.29 143.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.07 -4.21 5.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.93 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.8 p -169.97 168.27 8.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.249 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.426 ' HB1' ' HE3' ' A' ' 387' ' ' MET . . . -58.15 -43.84 87.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.417 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 18.3 p30 -53.31 -27.0 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.803 ' O ' HG23 ' A' ' 451' ' ' VAL . 13.0 m-20 -84.86 -33.77 22.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.758 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.941 ' CG2' HG11 ' A' ' 442' ' ' VAL . 45.8 t -72.95 -37.36 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.205 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.406 ' HA ' HD12 ' A' ' 452' ' ' ILE . 11.1 t -55.26 -59.14 5.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.71 -24.64 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.28 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 447' ' ' ASP . 37.7 t -76.5 -50.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.165 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.499 HD11 HG12 ' A' ' 448' ' ' VAL . 7.8 mt -56.58 -27.58 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.21 -11.93 22.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.403 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.04 -51.04 3.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -95.03 134.91 37.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.55 -34.97 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.2 p -103.34 115.22 30.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.703 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.1 mt -106.93 133.54 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.227 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 90.15 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.518 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.556 ' HB3' HG23 ' A' ' 434' ' ' ILE . 0.0 OUTLIER -97.28 149.05 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.308 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 469' ' ' ILE . 25.6 t -120.38 125.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.837 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.783 HG22 HD13 ' A' ' 471' ' ' ILE . 16.1 m -117.25 -179.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.353 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -119.46 125.99 50.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.82 ' HB3' HD11 ' A' ' 469' ' ' ILE . 1.2 ttt85 -118.55 120.24 36.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.61 -94.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.277 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -140.05 27.12 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -144.56 168.46 20.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.92 140.09 42.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 464' ' ' ARG . 1.9 mt -128.13 147.38 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 111.232 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.577 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -94.97 125.36 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.713 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.783 HD13 HG22 ' A' ' 462' ' ' VAL . 4.8 mp -121.0 127.91 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.259 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 55.3 m -106.93 122.95 47.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.539 HG21 HD21 ' A' ' 428' ' ' LEU . 27.1 t -127.63 137.21 58.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.044 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -122.65 109.63 32.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.738 ' HB3' HG23 ' A' ' 383' ' ' ILE . 47.9 Cg_endo -68.55 159.46 53.42 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.419 2.079 . . . . 0.0 112.35 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.54 -176.1 2.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.942 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.412 ' HB3' HG23 ' B' ' 4' ' ' ILE . 26.4 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.793 0.33 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 56.32 39.24 30.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' B' ' 2' ' ' SER . 2.0 pp -75.27 148.14 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.417 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 9.7 m0 -109.7 111.15 22.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -80.7 75.87 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.563 ' O ' HG12 ' B' ' 7' ' ' VAL . 10.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.149 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.84 0.352 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -145.67 131.46 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.82 HG13 HG22 ' A' ' 385' ' ' ILE . 3.6 pt -127.71 12.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.725 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 42.95 63.14 2.08 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.375 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 1.006 HD13 HG22 ' A' ' 417' ' ' VAL . 7.2 tp -148.74 124.33 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.163 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 386' ' ' ARG . 11.6 mtt180 -89.64 121.27 31.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.79 ' CE ' HG23 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -128.86 147.46 50.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.056 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.44 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 5.5 ptm -127.51 173.9 9.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.934 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 31.9 p -89.16 99.98 12.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.925 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.2 tp -58.53 88.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.624 HG23 ' H ' ' A' ' 394' ' ' LYS . 7.7 t -75.79 169.53 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.809 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.7 p -54.65 -37.65 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.1 t -69.62 -56.14 8.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.624 ' H ' HG23 ' A' ' 391' ' ' THR . 0.1 OUTLIER -62.45 -39.11 92.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.66 80.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.141 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -27.74 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -45.74 83.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.04 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 17.8 mt -67.14 -30.93 71.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -30.8 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -50.76 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.92 -68.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 87.55 7.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -78.71 61.64 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -151.19 21.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.945 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 398' ' ' LEU . 23.2 m-85 -91.57 159.33 38.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.99 174.83 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.659 2.239 . . . . 0.0 112.188 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.33 45.73 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.36 148.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 410' ' ' SER . 2.7 pp -125.37 -40.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.298 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' SER . . . . . 0.623 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -75.44 133.0 41.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.887 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 146.06 -177.59 24.33 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.407 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.587 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -106.68 141.53 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.925 ' HB2' HD13 ' A' ' 390' ' ' LEU . 64.2 t80 -94.71 137.84 33.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.835 HG23 HD11 ' A' ' 385' ' ' ILE . 23.0 mt -87.04 116.41 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.681 ' CD1' HG22 ' B' ' 4' ' ' ILE . 37.0 mt -84.84 -62.93 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.464 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.855 ' O ' HD12 ' A' ' 385' ' ' ILE . 10.9 pt-20 -154.57 153.57 31.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.158 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 1.006 HG22 HD13 ' A' ' 385' ' ' ILE . 21.7 t -121.36 141.83 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.456 ' HB ' HG22 ' A' ' 421' ' ' THR . 16.2 mm -81.52 142.55 50.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.83 -0.91 8.52 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.816 2.344 . . . . 0.0 113.686 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -130.55 59.58 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.25 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.472 ' OG1' ' HD2' ' A' ' 422' ' ' PRO . 0.7 OUTLIER -160.54 157.8 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.472 ' HD2' ' OG1' ' A' ' 421' ' ' THR . 31.9 Cg_exo -60.14 -20.68 62.67 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -58.0 -38.09 75.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.012 0.434 . . . . 0.0 110.985 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -84.72 -30.95 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.695 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.15 -31.5 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.561 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -66.75 -35.5 89.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.271 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.77 27.48 2.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.861 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.501 HD23 HG21 ' A' ' 471' ' ' ILE . 1.3 mt -92.63 -174.28 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.817 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.577 ' O ' HG21 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -179.91 169.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.907 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.88 54.65 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.84 26.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.206 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.522 ' HB2' HD12 ' A' ' 414' ' ' ILE . 1.6 m-20 -138.96 -174.53 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.837 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 412' ' ' ALA . 21.8 t -143.36 119.41 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.369 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.55 116.92 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.732 HD12 ' HB3' ' A' ' 436' ' ' SER . 2.6 pp -105.05 -42.18 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.692 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.732 ' HB3' HD12 ' A' ' 435' ' ' ILE . 51.6 p -126.53 159.52 33.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.962 0.411 . . . . 0.0 111.062 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.747 ' CG2' HG11 ' A' ' 451' ' ' VAL . 3.4 tt -156.54 113.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 24.0 p30 44.23 44.61 6.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.75 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.15 37.93 36.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.072 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.475 ' HB2' HG23 ' A' ' 437' ' ' ILE . 7.4 mm-40 -131.99 128.3 38.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t -76.34 110.19 10.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 443' ' ' VAL . 58.0 t -90.61 156.07 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.462 ' N ' HG12 ' A' ' 442' ' ' VAL . 12.2 m -145.95 -47.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.451 ' N ' HG23 ' A' ' 443' ' ' VAL . 1.6 p -137.5 171.63 14.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.014 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.36 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.303 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.409 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 25.7 p30 -54.42 -26.1 28.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.34 -57.3 3.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.805 HG12 HD11 ' A' ' 452' ' ' ILE . 38.9 t -47.57 -40.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.569 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 452' ' ' ILE . 6.9 t -55.55 -63.71 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.49 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -50.31 -26.87 5.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.545 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.747 HG11 ' CG2' ' A' ' 437' ' ' ILE . 60.5 t -77.56 -46.95 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.805 HD11 HG12 ' A' ' 448' ' ' VAL . 7.3 mt -57.8 -27.53 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.165 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -100.31 -8.76 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.552 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.07 -49.46 4.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.18 132.4 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -35.72 55.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.806 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 2.6 t -104.34 116.07 31.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.634 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.5 mt -102.69 129.98 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.016 0.436 . . . . 0.0 111.315 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' ASN . . . . . 0.617 ' OD1' HG23 ' A' ' 472' ' ' THR . 20.5 m-80 -131.84 96.82 4.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.55 147.15 26.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.5 t -121.54 132.93 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.776 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.4 m -132.77 167.91 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 111.338 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 119.78 34.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.016 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 23.1 mtp180 -116.14 136.36 53.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.526 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.7 -101.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.218 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.37 28.6 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.799 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -143.59 147.66 34.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.148 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.06 140.04 30.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.562 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.4 mt -131.12 142.61 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.459 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.46 119.72 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.501 HG21 HD23 ' A' ' 428' ' ' LEU . 11.2 mm -105.47 136.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.654 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.617 HG23 ' OD1' ' A' ' 459' ' ' ASN . 21.3 m -124.18 119.56 29.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.369 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.561 HG22 ' HA3' ' A' ' 426' ' ' GLY . 22.4 t -129.32 141.12 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.336 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 27.9 mm -119.21 109.98 38.32 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.651 ' HB3' HG23 ' A' ' 383' ' ' ILE . 17.9 Cg_endo -59.57 164.77 10.7 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.487 2.125 . . . . 0.0 112.404 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -113.89 -176.83 2.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.44 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 3.6 p . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.838 0.351 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -64.81 88.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.781 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.681 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.7 pp -84.27 124.5 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.409 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m0 -109.92 120.4 42.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -82.56 58.37 4.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.79 HG23 ' CE ' ' A' ' 387' ' ' MET . 1.8 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.037 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.838 0.351 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.43 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 19.2 t80 -144.49 122.3 11.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.667 HG13 HG22 ' A' ' 385' ' ' ILE . 10.1 pt -106.17 -5.55 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.48 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.523 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 56.89 64.39 4.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.512 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.967 HD13 HG22 ' A' ' 417' ' ' VAL . 3.8 tp -161.36 134.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.011 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.519 ' H ' HD12 ' A' ' 385' ' ' ILE . 20.4 mtt180 -91.34 133.0 35.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.669 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.418 ' HA ' HD12 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -140.78 150.33 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.406 ' CE ' ' CB ' ' B' ' 2' ' ' SER . 1.8 ptm -128.26 -177.59 4.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.793 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.8 p -99.48 9.74 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.53 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.8 tp 52.42 97.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.3 t -83.65 163.58 20.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -31.92 68.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -30.32 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -96.73 -42.27 8.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -64.91 -52.11 58.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.24 66.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.6 -39.03 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 395' ' ' ALA . 9.8 mt -64.17 -45.66 87.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.97 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -59.29 -29.97 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.34 -28.73 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -93.23 -29.69 15.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -100.67 -53.66 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.011 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 74.48 -59.26 0.56 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -47.13 -28.32 1.74 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.372 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -55.94 161.79 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -175.34 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.606 2.204 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.94 -11.98 19.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.351 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.6 m -52.39 167.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.734 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -136.73 12.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.467 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.4 m -130.37 130.61 44.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.813 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 171.52 169.04 33.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.379 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 434' ' ' ILE . . . -100.28 122.81 43.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 111.161 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.762 ' HB2' HD13 ' A' ' 390' ' ' LEU . 54.5 t80 -103.87 128.97 51.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.781 HG23 HD11 ' A' ' 385' ' ' ILE . 4.3 mt -79.81 114.98 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.589 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.526 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -78.48 -70.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.628 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.665 ' O ' HD12 ' A' ' 385' ' ' ILE . 4.8 pt-20 -144.17 143.12 30.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.967 HG22 HD13 ' A' ' 385' ' ' ILE . 21.3 t -111.37 146.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.05 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -98.35 128.96 31.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.78 61.53 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.698 2.266 . . . . 0.0 112.38 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.44 40.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.598 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.523 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -145.65 158.92 49.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.801 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.92 -23.2 33.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.327 2.018 . . . . 0.0 111.808 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.439 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -58.36 -60.06 4.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.207 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.78 -31.51 64.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.745 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.69 68.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.58 -30.98 70.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.383 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 24.91 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.777 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.584 HD23 HG21 ' A' ' 471' ' ' ILE . 0.1 OUTLIER -102.33 -177.66 3.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.776 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.74 179.66 7.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.767 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.76 31.63 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -143.24 26.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.593 ' C ' HD12 ' A' ' 414' ' ' ILE . 62.3 m-20 -119.44 -177.75 3.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.588 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 412' ' ' ALA . 38.8 t -142.07 129.58 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 0.0 111.403 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 412' ' ' ALA . 2.1 mp -86.09 152.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.669 HD12 ' N ' ' A' ' 436' ' ' SER . 1.9 pp -140.63 -50.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.654 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.669 ' N ' HD12 ' A' ' 435' ' ' ILE . 69.9 p -128.67 158.44 38.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.842 HD13 HG11 ' A' ' 451' ' ' VAL . 10.8 tt -150.3 118.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.337 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 19.8 p30 44.78 35.35 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.931 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.34 38.94 8.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.985 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -129.44 145.19 51.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.547 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.59 104.4 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.462 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.563 HG11 HG22 ' A' ' 448' ' ' VAL . 59.5 t -86.6 147.45 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.459 HG22 ' OD2' ' A' ' 447' ' ' ASP . 17.0 m -133.72 -45.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.37 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.444 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -133.67 169.86 16.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.422 . . . . 0.0 111.149 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.4 71.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.019 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.41 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 16.6 p30 -59.5 -30.59 68.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.831 ' O ' HG23 ' A' ' 451' ' ' VAL . 3.7 m-20 -75.62 -43.5 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.787 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.563 HG22 HG11 ' A' ' 442' ' ' VAL . 45.9 t -63.23 -37.04 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.814 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.5 t -59.42 -65.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.467 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -48.25 -27.6 2.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.842 HG11 HD13 ' A' ' 437' ' ' ILE . 47.4 t -71.32 -43.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.814 HD12 ' HA ' ' A' ' 449' ' ' SER . 4.8 mt -61.98 -32.36 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.91 -17.26 25.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.328 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -93.47 -47.51 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.13 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.76 142.25 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 474' ' ' ILE . 0.4 OUTLIER -92.59 -32.18 14.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.677 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.3 t -109.03 99.95 9.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.707 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.5 mt -90.22 133.71 34.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -134.24 91.77 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.628 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.433 ' HE1' ' HB3' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -108.48 152.39 24.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 469' ' ' ILE . 27.2 t -100.05 141.69 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.628 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 432' ' ' ASP . 4.2 t -142.28 160.53 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.175 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' ARG . . . . . 0.432 ' N ' HG12 ' A' ' 462' ' ' VAL . 6.8 tmm_? -98.92 133.15 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.867 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.458 ' HB3' HD11 ' A' ' 469' ' ' ILE . 7.8 ttp180 -130.55 132.61 45.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.04 -95.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.157 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.06 21.36 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.701 0.286 . . . . 0.0 110.851 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -143.58 164.7 29.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.02 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.43 137.22 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.4 mt -131.8 160.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.535 ' SD ' HG22 ' A' ' 461' ' ' VAL . 0.9 OUTLIER -99.68 119.69 38.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.16 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.584 HG21 HD23 ' A' ' 428' ' ' LEU . 13.1 mm -107.89 152.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 458' ' ' LEU . 91.8 m -139.02 119.79 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.797 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 428' ' ' LEU . 21.3 t -122.74 151.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 456' ' ' SER . 21.2 mm -121.35 109.9 34.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.437 ' HB3' HG23 ' A' ' 383' ' ' ILE . 26.2 Cg_endo -62.17 152.23 77.29 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.358 2.039 . . . . 0.0 112.237 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.54 168.68 10.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.406 ' CB ' ' CE ' ' A' ' 388' ' ' MET . 1.1 p . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.822 0.344 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -59.68 108.45 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.526 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.6 pt -79.22 127.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.22 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.41 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m95 -107.29 91.08 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 1.5 t90 -73.57 68.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.516 HG12 ' OXT' ' B' ' 7' ' ' VAL . 20.5 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.198 -0.905 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 452' ' ' ILE . 6.5 mmtt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.653 0.264 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -155.85 120.47 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.254 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.588 HG13 HG22 ' A' ' 385' ' ' ILE . 12.0 pt -111.16 -22.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 80.64 66.92 1.59 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.801 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.629 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.29 129.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.389 . . . . 0.0 110.813 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -89.95 120.42 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.483 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -126.36 143.65 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.812 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.47 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.8 ptm -123.52 164.53 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 40.1 p -85.87 99.43 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.886 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.6 tp -55.76 108.59 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.52 170.33 10.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.766 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.8 m -58.17 -21.76 48.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.421 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.3 t -77.61 -47.28 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.98 -32.14 25.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.168 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.31 -36.35 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.205 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -90.01 -32.47 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.29 -33.49 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.25 -49.88 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -58.29 -43.1 87.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.47 -25.98 67.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -93.06 -62.13 1.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 1.0 OUTLIER -85.05 -59.46 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 79.72 -49.2 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.03 -27.04 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.717 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 29.6 m-85 -43.01 163.16 0.16 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.428 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.98 -20.83 14.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.625 2.217 . . . . 0.0 112.761 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 75.71 40.56 0.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 110.781 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.519 HG11 HG21 ' A' ' 435' ' ' ILE . 2.8 m -101.35 98.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pp -55.63 -29.27 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.38 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.84 141.48 39.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 145.47 176.97 19.87 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -104.28 155.62 18.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.886 ' HB2' HD13 ' A' ' 390' ' ' LEU . 46.5 t80 -107.66 138.46 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.954 HD12 ' HB2' ' A' ' 432' ' ' ASP . 27.6 mt -89.74 109.96 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.765 ' CD1' HG22 ' B' ' 4' ' ' ILE . 5.3 mt -74.51 -66.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.214 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.85 167.85 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.887 0.375 . . . . 0.0 111.139 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.498 HG22 HG12 ' A' ' 385' ' ' ILE . 21.2 t -134.84 147.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.3 mp -79.72 134.5 57.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.308 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 50.5 Cg_exo -55.33 -12.47 5.73 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.031 2.487 . . . . 0.0 114.686 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' ASP . . . . . 0.799 ' H ' HG22 ' A' ' 418' ' ' ILE . 41.0 m-20 -132.97 72.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.925 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 4.9 p -159.08 160.87 28.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.984 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.95 -20.17 51.58 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.329 2.02 . . . . 0.0 111.41 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.492 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -61.19 -60.15 4.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -76.33 -30.57 57.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.24 -7.4 59.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.558 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 471' ' ' ILE . . . -90.15 -31.74 10.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.418 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 129.79 17.79 1.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.022 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 423' ' ' ALA . 0.9 OUTLIER -96.9 -175.87 3.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.75 146.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.97 -177.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.64 24.94 12.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.954 ' HB2' HD12 ' A' ' 414' ' ' ILE . 8.9 m-20 -126.71 177.01 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 412' ' ' ALA . 33.1 t -136.89 126.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.472 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 435' ' ' ILE . 3.8 mt -81.11 154.58 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.577 HD12 ' N ' ' A' ' 436' ' ' SER . 1.9 pp -143.19 -47.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.577 ' N ' HD12 ' A' ' 435' ' ' ILE . 94.6 p -120.94 154.99 35.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.344 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.572 HD11 ' HB3' ' A' ' 458' ' ' LEU . 2.7 tt -153.88 116.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 16.9 p30 45.43 32.03 0.99 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.545 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.37 8.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.693 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -133.53 138.1 45.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.29 107.9 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 448' ' ' VAL . 63.2 t -90.75 146.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 444' ' ' SER . 26.2 m -129.32 -43.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.335 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.441 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -138.62 172.32 13.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.913 0.387 . . . . 0.0 111.17 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.483 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.33 -38.76 74.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.404 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 6.1 p30 -59.19 -29.74 67.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -76.65 -38.35 54.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 442' ' ' VAL . 38.9 t -70.12 -37.99 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.785 ' HA ' HD12 ' A' ' 452' ' ' ILE . 9.5 t -56.67 -62.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.322 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -50.43 -29.18 9.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.885 HG13 ' OE2' ' A' ' 455' ' ' GLU . 59.9 t -70.78 -42.96 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.277 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 449' ' ' SER . 4.6 mt -63.23 -33.85 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.33 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 -13.06 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.622 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -99.94 -54.03 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.767 0.318 . . . . 0.0 110.774 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' GLU . . . . . 0.885 ' OE2' HG13 ' A' ' 451' ' ' VAL . 1.8 mp0 -89.46 132.82 34.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -36.23 42.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.677 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' THR . . . . . 0.446 ' C ' HD23 ' A' ' 458' ' ' LEU . 2.5 t -105.47 125.51 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.684 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.572 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.7 mt -119.65 149.4 42.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -147.3 97.65 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.451 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 1.1 mtm -102.77 144.74 30.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 469' ' ' ILE . 19.7 t -111.58 127.26 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.686 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.912 HG23 HD13 ' A' ' 471' ' ' ILE . 2.3 t -121.28 158.66 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.26 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -104.0 119.67 39.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.994 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.572 ' HB2' HD12 ' A' ' 469' ' ' ILE . 0.2 OUTLIER -119.51 127.32 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.434 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.22 -99.13 0.85 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.177 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.22 24.82 2.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.767 0.318 . . . . 0.0 110.677 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.57 162.63 36.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.97 141.01 34.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.627 ' O ' HG13 ' A' ' 461' ' ' VAL . 4.0 mt -130.74 143.24 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.369 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.585 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -94.76 124.42 38.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.645 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.912 HD13 HG23 ' A' ' 462' ' ' VAL . 4.4 mp -113.79 140.28 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 111.343 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 70.8 m -116.9 119.87 36.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.76 131.68 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.53 110.76 57.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 148.88 87.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.101 . . . . 0.0 112.336 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.88 -178.77 3.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.406 ' HA ' ' CE ' ' A' ' 388' ' ' MET . 11.4 p . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.825 0.345 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -61.3 93.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.765 HG22 ' CD1' ' A' ' 415' ' ' ILE . 46.4 pt -83.59 137.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.302 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.404 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 12.9 m95 -116.81 89.61 3.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.45 82.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.144 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mttp . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.817 0.342 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -118.44 126.29 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 385' ' ' ILE . 9.7 pt -122.44 -1.1 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.333 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 46.92 62.94 3.47 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.082 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 1.076 HD13 HG22 ' A' ' 417' ' ' VAL . 6.8 tp -149.16 122.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -89.73 128.18 36.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.403 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -132.93 140.59 47.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.511 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.42 ' CE ' ' HA ' ' B' ' 2' ' ' SER . 7.7 ptm -119.31 158.84 25.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.028 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 21.3 p -83.11 106.27 14.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.3 tp -56.92 102.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.075 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.9 t -89.94 174.54 7.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 27.8 t -66.96 -33.02 74.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 60.6 p -68.88 -28.59 66.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -95.83 -48.6 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.988 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.92 -59.93 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.26 68.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.37 -38.28 89.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.29 -36.61 74.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.996 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -77.75 -31.69 52.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -28.99 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -54.98 3.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -73.46 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 57.5 mtm180 82.73 -25.62 0.15 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.752 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -20.51 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.752 0.311 . . . . 0.0 110.957 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.45 153.95 74.57 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.973 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.7 -179.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.637 2.224 . . . . 0.0 112.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -111.74 30.77 6.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.13 150.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.523 ' C ' HD12 ' A' ' 409' ' ' ILE . 2.7 pp -125.33 17.12 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.455 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -140.29 142.85 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.16 156.49 7.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -91.45 152.08 20.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.756 ' HB2' HD13 ' A' ' 390' ' ' LEU . 59.8 t80 -107.37 131.66 54.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.907 HD12 ' HB2' ' A' ' 432' ' ' ASP . 18.3 mt -83.97 111.08 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.853 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -75.35 -66.42 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.848 ' O ' HD12 ' A' ' 385' ' ' ILE . 3.5 pt-20 -155.61 167.14 31.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 0.0 111.175 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 1.076 HG22 HD13 ' A' ' 385' ' ' ILE . 12.5 t -127.53 156.95 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -96.32 133.43 24.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.54 60.02 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.766 2.311 . . . . 0.0 112.82 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 168.88 44.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.972 0.415 . . . . 0.0 110.757 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 384' ' ' GLY . 7.7 p -141.84 162.19 47.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 34.8 Cg_endo -66.72 -14.13 42.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.012 1.808 . . . . 0.0 111.17 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -68.73 -59.94 2.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.645 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.86 -32.71 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -82.4 -21.14 35.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.296 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -72.42 -29.93 65.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.304 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 121.1 17.65 4.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.026 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 471' ' ' ILE . 2.5 mt -88.2 -167.08 1.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.91 0.355 . . . . 0.0 110.732 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.9 146.34 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -179.36 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 60.09 22.52 11.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.907 ' HB2' HD12 ' A' ' 414' ' ' ILE . 9.5 m-20 -119.3 -175.87 3.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.412 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.48 117.28 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.543 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.444 HD11 HG12 ' A' ' 414' ' ' ILE . 4.0 mt -78.42 123.05 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.461 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -110.07 -48.63 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.882 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 435' ' ' ILE . 3.8 t -119.24 160.97 21.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 111.294 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.799 HG21 HG11 ' A' ' 451' ' ' VAL . 1.0 OUTLIER -154.28 119.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.024 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.468 ' O ' ' ND2' ' A' ' 438' ' ' ASN . 1.1 p-10 44.43 42.41 5.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.511 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 77.5 41.92 19.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.635 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -135.69 162.6 32.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 108.55 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.942 HG11 ' CG2' ' A' ' 448' ' ' VAL . 2.5 t -94.59 148.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.247 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.58 -35.96 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.333 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.6 p -147.5 176.03 10.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.212 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.403 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -59.06 -41.12 87.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.176 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.409 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 17.6 p30 -53.91 -24.22 15.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.268 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.9 OUTLIER -86.33 -50.01 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.942 ' CG2' HG11 ' A' ' 442' ' ' VAL . 43.9 t -54.93 -40.7 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.488 ' HA ' HG11 ' B' ' 7' ' ' VAL . 42.2 t -53.13 -68.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.469 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -51.69 -35.06 41.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.641 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 447' ' ' ASP . 43.7 t -64.09 -49.33 81.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.294 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.854 HD11 HG12 ' A' ' 448' ' ' VAL . 8.4 mt -57.68 -40.53 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.223 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.01 -5.21 59.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.325 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -100.18 -47.66 4.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' GLU . . . . . 0.438 ' O ' HD21 ' A' ' 458' ' ' LEU . 1.9 mm-40 -100.13 133.57 44.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.047 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -34.42 48.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 457' ' ' THR . . . . . 0.406 ' HA ' HD12 ' A' ' 474' ' ' ILE . 1.5 t -105.08 103.21 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.765 HD11 HG23 ' A' ' 452' ' ' ILE . 12.4 mt -96.08 153.36 17.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -154.43 96.76 1.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.645 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.519 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -104.26 135.51 45.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.263 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 25.8 t -102.09 120.41 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 463' ' ' ARG . 5.0 t -105.54 160.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' ARG . . . . . 0.44 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -120.92 124.41 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.589 ' HB2' HD11 ' A' ' 469' ' ' ILE . 30.5 mtp85 -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.702 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.53 -98.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.346 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -140.28 24.84 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 111.033 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -139.77 157.36 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.91 139.62 35.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.646 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.8 mt -128.21 128.01 68.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.08 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.66 125.13 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.769 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.736 HG21 HD23 ' A' ' 428' ' ' LEU . 28.9 mm -120.04 136.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.9 m -109.61 135.05 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.703 ' O ' HD13 ' A' ' 474' ' ' ILE . 11.5 t -138.91 146.22 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.065 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 473' ' ' VAL . 30.0 mm -134.03 110.34 11.89 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 474' ' ' ILE . 19.2 Cg_endo -58.57 132.91 51.05 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.398 2.065 . . . . 0.0 112.309 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -94.83 -174.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.42 ' HA ' ' CE ' ' A' ' 388' ' ' MET . 37.4 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.686 0.279 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 52.54 65.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.444 . . . . 0.0 110.656 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.853 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.4 pt -82.05 96.25 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.335 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.409 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.0 m0 -65.64 104.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.826 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -76.76 67.01 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 449' ' ' SER . 21.9 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.21 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.6 mptt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -118.08 119.55 35.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.363 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.595 HD12 ' CG2' ' A' ' 385' ' ' ILE . 16.4 pt -130.58 -8.97 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.478 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.645 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 50.67 68.1 1.61 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.747 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.921 ' CD1' HG22 ' A' ' 417' ' ' VAL . 8.1 tp -157.0 135.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -101.03 129.43 46.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.412 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -135.45 146.19 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.49 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.0 ptm -128.26 157.44 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.071 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.7 p -79.48 101.32 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.889 HD13 ' HB2' ' A' ' 413' ' ' TYR . 9.4 tp -51.79 97.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.4 t -84.8 158.54 20.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.785 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.3 m -57.51 -22.05 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.12 -28.28 54.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.308 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -100.33 -37.4 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.131 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.51 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -62.87 -50.95 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.367 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -28.33 67.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -34.25 73.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.065 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.576 HD22 ' CE2' ' A' ' 405' ' ' PHE . 62.8 mt -60.17 -41.83 93.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.027 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -75.11 -30.81 60.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.77 -33.15 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.7 -33.34 20.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -145.59 120.63 10.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.97 -27.73 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -55.79 -27.2 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.115 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.576 ' CE2' HD22 ' A' ' 398' ' ' LEU . 8.4 m-85 -57.46 147.35 59.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.72 174.43 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.568 2.179 . . . . 0.0 112.301 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -111.91 32.77 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.66 -179.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.658 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -149.18 -40.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 410' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -89.6 154.47 19.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.79 170.43 13.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.43 ' CB ' HG21 ' A' ' 448' ' ' VAL . . . -98.2 138.75 35.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 110.991 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.889 ' HB2' HD13 ' A' ' 390' ' ' LEU . 58.7 t80 -94.44 130.19 40.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.49 HG21 ' O ' ' A' ' 429' ' ' LYS . 12.1 mt -80.23 114.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.79 HD13 HG22 ' B' ' 4' ' ' ILE . 9.4 mt -82.13 -72.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.609 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.145 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.921 HG22 ' CD1' ' A' ' 385' ' ' ILE . 3.3 t -111.8 140.43 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.571 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 19.6 mm -79.69 144.99 61.6 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.37 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.48 ' HD2' HG22 ' A' ' 418' ' ' ILE . 23.3 Cg_exo -65.83 -3.91 9.02 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.881 2.387 . . . . 0.0 114.521 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 421' ' ' THR . 22.5 m-20 -138.35 71.03 1.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.965 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.645 HG21 ' HA3' ' A' ' 384' ' ' GLY . 1.1 p -159.55 165.61 17.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.141 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.413 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 31.9 Cg_exo -60.8 -23.78 77.42 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.622 2.215 . . . . 0.0 111.62 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.488 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -57.78 -60.05 4.29 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.996 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -74.63 -26.74 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 422' ' ' PRO . . . -76.16 -26.16 55.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.363 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -79.29 -70.36 1.33 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.417 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 166.64 34.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.449 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.4 OUTLIER -104.47 -173.11 2.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.778 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 429' ' ' LYS . . . . . 0.49 ' O ' HG21 ' A' ' 414' ' ' ILE . 0.4 OUTLIER 177.46 169.09 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 0.8 OUTLIER -87.58 52.48 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -158.89 28.37 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.625 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB2' HD12 ' A' ' 414' ' ' ILE . 5.3 m-20 -142.36 -177.2 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.403 HG11 HD22 ' A' ' 390' ' ' LEU . 24.0 t -145.16 107.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.42 138.48 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.674 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.869 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -133.57 -43.07 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.52 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.869 ' N ' HD12 ' A' ' 435' ' ' ILE . 41.5 p -114.72 155.5 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.952 HG21 HG11 ' A' ' 451' ' ' VAL . 1.5 tt -157.61 118.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.483 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 1.3 p-10 45.52 33.85 1.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.494 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.8 28.74 34.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.724 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.483 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 51.5 mt-30 -124.01 143.4 50.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.864 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 9.3 t -92.09 110.69 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.717 HG11 HG22 ' A' ' 448' ' ' VAL . 25.7 t -93.89 159.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.547 HG22 ' OD2' ' A' ' 447' ' ' ASP . 22.4 m -130.36 -45.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.502 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.454 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -141.05 176.42 8.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.225 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.412 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.52 -40.45 78.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -56.42 -25.6 50.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.879 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.848 ' O ' HG23 ' A' ' 451' ' ' VAL . 4.9 m-20 -87.05 -30.74 20.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.717 HG22 HG11 ' A' ' 442' ' ' VAL . 23.5 t -70.58 -43.32 77.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.504 ' HA ' HD12 ' A' ' 452' ' ' ILE . 33.0 t -50.97 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.335 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -49.88 -41.61 45.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.36 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.952 HG11 HG21 ' A' ' 437' ' ' ILE . 39.6 t -58.88 -45.5 91.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.076 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 449' ' ' SER . 22.3 mt -58.86 -40.49 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.65 0.4 57.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.158 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -46.74 5.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -111.18 165.28 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.4 t -103.64 -32.17 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 p -106.37 102.45 11.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.741 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.782 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.6 mt -93.5 129.46 39.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.947 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 459' ' ' ASN . . . . . 0.54 ' ND2' HG23 ' A' ' 472' ' ' THR . 2.4 m-80 -123.91 88.09 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.5 mtt -92.2 129.68 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 470' ' ' MET . 27.1 t -107.47 126.29 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.904 HG22 HD13 ' A' ' 471' ' ' ILE . 1.5 m -121.22 159.37 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.175 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 119.95 40.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 1.5 mtp180 -120.62 133.18 55.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.486 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.18 -103.83 1.23 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.219 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.22 27.72 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.619 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.33 157.12 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.254 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.88 142.91 28.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.449 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.683 ' O ' HG13 ' A' ' 461' ' ' VAL . 3.4 mt -129.24 141.09 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.478 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -97.47 119.81 36.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.513 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.904 HD13 HG22 ' A' ' 462' ' ' VAL . 4.4 mp -122.16 137.02 57.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.54 HG23 ' ND2' ' A' ' 459' ' ' ASN . 58.6 m -117.24 127.37 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 422' ' ' PRO . 21.8 t -123.66 122.24 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.096 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 28.5 mm -103.02 109.86 62.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.01 151.42 82.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.078 . . . . 0.0 112.299 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -102.74 158.44 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.833 179.96 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.736 0.303 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.14 106.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.79 HG22 HD13 ' A' ' 415' ' ' ILE . 3.3 pt -76.19 149.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.531 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -121.14 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.627 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -70.33 70.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.073 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 475' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.658 0.266 . . . . 0.0 110.73 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -134.17 125.91 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.307 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.639 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.8 pt -117.67 -26.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 75.67 64.57 2.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.648 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.984 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.31 123.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.527 ' N ' HD13 ' A' ' 385' ' ' ILE . 0.1 OUTLIER -90.04 126.97 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.476 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -128.85 152.59 48.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 179.589 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.443 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.5 OUTLIER -130.63 -179.4 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 111.481 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 7.5 p -98.46 94.7 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.169 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.916 HD13 ' HB2' ' A' ' 413' ' ' TYR . 9.0 tp -47.63 121.55 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.571 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.11 165.81 13.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.797 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -27.27 63.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -66.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.166 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -40.24 74.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.217 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.293 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -83.91 -30.68 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.037 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.98 -31.19 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.023 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.26 -47.32 44.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -65.45 -37.84 88.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.047 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.83 -42.86 94.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -87.7 -17.51 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.434 ' HB3' ' CD1' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -150.08 87.04 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.715 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -25.72 67.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -23.62 11.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.284 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 402' ' ' HIS . 3.7 m-85 -53.18 163.69 0.87 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.484 ' HB2' HG22 ' A' ' 408' ' ' VAL . 18.6 Cg_endo -59.09 178.22 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.306 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -105.63 35.84 2.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 408' ' ' VAL . 20.1 m -120.34 92.87 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.49 -33.8 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.56 163.23 21.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 126.21 175.97 14.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.375 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 388' ' ' MET . . . -102.8 157.37 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.916 ' HB2' HD13 ' A' ' 390' ' ' LEU . 69.4 t80 -104.82 128.72 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.984 HG23 HD11 ' A' ' 385' ' ' ILE . 24.6 mt -80.7 109.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.552 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.581 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.7 mp -71.86 -70.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -151.43 166.82 29.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.299 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.555 HG22 HG12 ' A' ' 385' ' ' ILE . 35.0 t -132.84 155.39 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.043 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -90.28 132.56 35.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.406 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.22 57.72 3.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.542 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 169.41 47.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.061 0.457 . . . . 0.0 110.383 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.409 HG21 ' HB ' ' A' ' 418' ' ' ILE . 4.2 p -149.86 164.46 20.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.974 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.64 -26.85 67.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.269 1.979 . . . . 0.0 111.101 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 428' ' ' LEU . . . -54.91 -54.39 43.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.116 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.73 -29.99 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.67 -29.42 65.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.12 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.44 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -74.0 -30.2 61.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.481 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.88 23.67 2.97 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.767 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.843 HD11 HG21 ' A' ' 473' ' ' VAL . 1.2 mt -95.67 -175.59 3.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.772 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.65 152.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -61.74 -175.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.702 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 24.6 m120 61.23 22.35 12.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.951 ' HB2' HD12 ' A' ' 414' ' ' ILE . 28.5 m-20 -122.66 -176.5 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 412' ' ' ALA . 34.9 t -143.69 127.54 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.623 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.65 152.76 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.441 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 408' ' ' VAL . 1.2 pp -141.2 -55.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.469 ' N ' HD12 ' A' ' 435' ' ' ILE . 16.7 p -120.42 157.32 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.313 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.887 HG21 HG11 ' A' ' 451' ' ' VAL . 1.8 tt -151.04 119.94 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.344 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.487 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 0.9 OUTLIER 43.4 44.08 4.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.693 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.62 49.24 8.16 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.793 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.487 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 3.8 mt-30 -144.88 158.97 43.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.702 0.287 . . . . 0.0 110.672 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 6.0 p -106.49 112.19 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 1.048 HG11 HG22 ' A' ' 448' ' ' VAL . 4.2 t -100.08 147.58 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 6.3 m -130.82 -42.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.4 p -127.93 168.11 15.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.01 0.434 . . . . 0.0 111.284 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.476 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.34 -41.14 79.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -57.24 -28.92 63.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.726 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.8 ' O ' HG23 ' A' ' 451' ' ' VAL . 7.4 m-20 -77.77 -36.47 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 1.048 HG22 HG11 ' A' ' 442' ' ' VAL . 28.4 t -69.55 -41.86 80.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.806 ' HA ' HD12 ' A' ' 452' ' ' ILE . 1.7 t -54.72 -63.17 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.601 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -46.96 -29.18 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.458 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.887 HG11 HG21 ' A' ' 437' ' ' ILE . 30.4 t -68.61 -48.58 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' A' ' 449' ' ' SER . 3.6 mt -58.62 -33.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -91.13 -21.55 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.251 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -88.67 -59.91 2.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.02 127.14 35.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -39.06 75.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -104.67 116.26 31.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.839 ' HB3' HD11 ' A' ' 437' ' ' ILE . 9.0 mt -102.34 133.99 46.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.274 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -135.13 93.9 3.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.638 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.589 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -97.67 156.81 16.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.562 HG22 ' HG3' ' A' ' 470' ' ' MET . 21.0 t -124.4 124.6 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.975 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.508 HG11 ' OD2' ' A' ' 432' ' ' ASP . 5.6 t -108.58 147.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -105.44 140.11 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.174 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.563 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.6 mtp180 -144.52 133.84 23.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 57.88 -100.24 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.494 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -140.07 28.38 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 111.06 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.25 152.62 46.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.165 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -96.29 139.26 32.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.541 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 464' ' ' ARG . 2.4 mt -126.7 123.28 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.562 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -90.64 127.19 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 470' ' ' MET . 11.7 mm -124.46 135.16 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.976 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 44.9 m -116.51 121.13 40.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.843 HG21 HD11 ' A' ' 428' ' ' LEU . 34.9 t -127.34 119.92 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.87 111.96 64.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.639 ' HB3' HG23 ' A' ' 383' ' ' ILE . 41.3 Cg_endo -67.08 173.95 7.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.07 . . . . 0.0 112.349 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -160.41 174.31 14.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.787 179.861 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.794 0.33 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -59.46 90.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.581 HG22 ' CD1' ' A' ' 415' ' ' ILE . 27.5 pt -75.69 129.2 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -108.95 99.35 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.079 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -74.46 66.39 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 452' ' ' ILE . 16.7 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.76 0.314 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -160.41 119.84 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.7 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.1 pt -108.2 -3.68 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.332 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.675 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 60.56 50.82 63.42 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.649 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.673 HG13 HG22 ' A' ' 417' ' ' VAL . 11.7 tt -154.1 140.23 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.025 0.44 . . . . 0.0 111.07 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.797 ' HB3' HD12 ' A' ' 415' ' ' ILE . 2.9 mtt-85 -90.76 132.08 36.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.738 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.586 ' HE3' ' HB1' ' A' ' 445' ' ' ALA . 0.1 OUTLIER -136.96 133.5 35.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.639 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 10.2 ptm -121.34 176.33 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.3 p -106.12 130.39 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 413' ' ' TYR . 2.3 tp -74.65 96.86 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 4.4 t -87.45 177.52 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 82.7 p -63.93 -16.67 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -80.77 -42.29 22.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.787 0.327 . . . . 0.0 111.25 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -43.03 9.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.92 79.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.338 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -29.99 61.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.009 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -30.92 71.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 84.1 mt -69.89 -33.35 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -74.46 -24.42 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.0 -37.73 33.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.071 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -82.69 -66.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.46 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -76.07 -52.42 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.08 -52.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.686 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.51 38.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 1.6 m-85 -91.01 167.72 15.39 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.671 0.272 . . . . 0.0 110.51 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.02 -21.48 21.63 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.533 2.155 . . . . 0.0 112.472 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.7 t0 73.3 46.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 408' ' ' VAL . 18.9 m -113.2 97.54 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.023 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -56.72 -29.08 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.536 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 14.8 m -93.13 159.86 15.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.031 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 127.53 150.01 7.29 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.451 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.14 135.81 35.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.638 ' HB2' HD13 ' A' ' 390' ' ' LEU . 86.5 t80 -90.07 132.47 35.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.789 HD12 ' CB ' ' A' ' 432' ' ' ASP . 10.3 mt -86.18 116.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 386' ' ' ARG . 3.3 mt -89.22 -144.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.253 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.672 ' H ' HG22 ' A' ' 415' ' ' ILE . 9.2 pt-20 -79.67 155.27 28.11 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.088 -0.382 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.673 HG22 HG13 ' A' ' 385' ' ' ILE . 21.2 t -127.15 151.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.045 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.59 HG22 ' HD2' ' A' ' 419' ' ' PRO . 8.4 mm -87.4 145.63 38.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.621 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.59 ' HD2' HG22 ' A' ' 418' ' ' ILE . 16.5 Cg_exo -68.7 -3.48 11.31 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.988 2.459 . . . . 0.0 114.113 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.87 62.87 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.712 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.675 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.7 OUTLIER -154.45 158.02 32.27 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.009 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.412 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 34.3 Cg_exo -59.03 -20.25 52.65 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.554 2.17 . . . . 0.0 111.701 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.444 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -62.4 -60.12 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.77 -28.89 66.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.54 -27.63 45.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.27 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.02 65.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.353 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.1 23.85 2.87 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.774 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.751 HD23 HG21 ' A' ' 471' ' ' ILE . 1.2 mt -93.43 -170.0 2.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.314 . . . . 0.0 110.693 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.48 153.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -65.88 171.34 4.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 64.51 27.33 13.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.027 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.789 ' CB ' HD12 ' A' ' 414' ' ' ILE . 3.8 m-20 -118.88 -175.76 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.71 122.88 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.571 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 435' ' ' ILE . 2.8 mt -86.13 160.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.507 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.471 ' N ' HG22 ' A' ' 434' ' ' ILE . 1.4 pp -146.37 -49.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 435' ' ' ILE . 94.4 p -118.02 161.84 19.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.014 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.858 HG21 HG11 ' A' ' 451' ' ' VAL . 3.6 tt -155.62 119.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.505 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 1.2 p-10 49.11 33.09 4.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.624 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.29 28.02 28.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.819 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.505 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 9.3 mt-30 -121.23 164.16 17.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 110.647 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 69.3 p -106.56 114.15 28.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.147 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.93 HG11 HG22 ' A' ' 448' ' ' VAL . 11.7 t -101.54 141.72 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.17 -25.8 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.494 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.16 175.7 13.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.273 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.586 ' HB1' ' HE3' ' A' ' 387' ' ' MET . . . -56.51 -41.13 76.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.405 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 1.3 p-10 -55.44 -28.66 55.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.765 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.818 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.8 OUTLIER -82.18 -32.95 29.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.733 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.93 HG22 HG11 ' A' ' 442' ' ' VAL . 21.8 t -76.0 -41.92 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.211 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.67 ' HA ' HD12 ' A' ' 452' ' ' ILE . 15.0 t -52.61 -57.44 10.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.344 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -53.97 -42.22 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.858 HG11 HG21 ' A' ' 437' ' ' ILE . 47.0 t -59.63 -47.59 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 449' ' ' SER . 8.4 mt -57.9 -30.96 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.946 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -7.11 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.545 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -99.71 -48.66 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.701 0.286 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -102.04 166.52 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.2 -36.69 6.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 98.53 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.771 ' HB3' HD11 ' A' ' 437' ' ' ILE . 8.4 mt -89.78 119.95 30.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.051 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.16 91.21 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.99 142.85 29.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 469' ' ' ILE . 23.7 t -103.37 128.95 56.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.21 156.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 140.59 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.081 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.703 ' HB3' HD11 ' A' ' 469' ' ' ILE . 3.7 ttt-85 -143.53 124.52 14.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 64.42 -98.51 0.28 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.226 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -140.05 27.28 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 0.0 110.766 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -145.23 162.78 36.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.7 139.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 464' ' ' ARG . 2.1 mt -127.68 158.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.36 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.464 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -106.0 126.2 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.541 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.751 HG21 HD23 ' A' ' 428' ' ' LEU . 23.7 mm -115.37 137.12 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.27 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 m -116.17 140.6 49.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.689 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.761 ' C ' HD12 ' A' ' 474' ' ' ILE . 20.1 t -150.03 135.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.761 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -117.88 109.73 40.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.585 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.7 ' HB3' HG23 ' A' ' 383' ' ' ILE . 30.2 Cg_endo -63.81 152.41 80.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.438 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -89.16 -179.53 5.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -79.82 -9.9 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.3 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.603 HG22 ' CD1' ' A' ' 415' ' ' ILE . 9.7 pt 41.08 91.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.862 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.405 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 10.7 m95 -79.95 91.09 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.887 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -69.38 71.75 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.402 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.4 t . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.243 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.65 0.262 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -140.02 126.2 19.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.362 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.766 HG13 HG22 ' A' ' 385' ' ' ILE . 5.7 pt -119.27 -2.67 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.403 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.597 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 54.91 62.45 6.25 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.814 ' CD1' HG22 ' A' ' 417' ' ' VAL . 7.2 tp -153.75 129.86 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -90.7 132.42 35.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.436 ' CA ' HD12 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -141.06 138.83 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.856 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.456 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 6.2 ptm -120.93 165.79 14.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.298 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 82.8 p -93.44 109.25 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.513 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.5 tp -53.22 121.37 7.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.304 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.1 t -90.16 166.91 13.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -30.83 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 21.0 m -70.45 -29.52 66.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -91.12 -39.91 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.058 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.471 ' HB1' HG12 ' A' ' 409' ' ' ILE . . . -59.7 -50.4 73.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.246 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -32.93 74.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.66 -45.15 54.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.082 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.27 -31.45 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.069 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -67.37 -47.13 71.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.013 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -27.42 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.155 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -91.74 -62.41 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.401 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -64.66 -59.81 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.072 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 10.7 mtt85 79.65 -7.84 1.65 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.502 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.28 14.85 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.704 0.287 . . . . 0.0 111.162 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 406' ' ' PRO . 30.2 m-85 -105.53 128.8 25.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 405' ' ' PHE . 32.3 Cg_exo -58.07 -174.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.113 . . . . 0.0 112.346 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.53 23.47 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 406' ' ' PRO . 26.4 m -83.35 -23.31 8.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.059 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.8 HG23 ' O ' ' A' ' 409' ' ' ILE . 0.0 OUTLIER 37.0 75.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.468 0.652 . . . . 0.0 111.94 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 7.2 p -169.46 131.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.22 173.78 19.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.432 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.34 140.88 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 0.0 111.08 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.638 ' HB2' HD13 ' A' ' 390' ' ' LEU . 43.2 t80 -98.13 133.5 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 432' ' ' ASP . 15.3 mt -82.6 116.2 26.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.436 HD12 ' CA ' ' A' ' 387' ' ' MET . 3.1 mt -77.96 -60.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.619 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 385' ' ' ILE . 0.4 OUTLIER -159.75 139.49 11.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.293 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.814 HG22 ' CD1' ' A' ' 385' ' ' ILE . 13.6 t -105.45 136.95 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.118 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.517 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 33.8 mm -82.84 138.46 43.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.238 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 418' ' ' ILE . 42.7 Cg_endo -68.0 4.2 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 114.243 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -132.44 56.46 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.517 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.597 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.6 OUTLIER -155.63 164.91 19.66 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.458 ' HB2' HG13 ' A' ' 473' ' ' VAL . 32.1 Cg_exo -60.84 -20.94 68.74 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.651 2.234 . . . . 0.0 111.828 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.464 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -61.94 -59.15 5.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.21 -34.85 77.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.732 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -23.22 55.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -74.72 -34.35 53.66 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.414 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 25.4 2.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.85 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.833 HD23 HG21 ' A' ' 471' ' ' ILE . 0.8 OUTLIER -93.39 -163.66 1.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 0.0 110.652 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.4 169.1 6.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.816 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.67 36.17 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.013 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.82 27.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.551 ' HB2' HD12 ' A' ' 414' ' ' ILE . 10.3 m-20 -128.94 175.71 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.004 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.65 116.9 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 434' ' ' ILE . 3.8 mp -67.2 155.52 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 436' ' ' SER . 2.3 pp -148.78 -45.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.57 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.811 ' N ' HD12 ' A' ' 435' ' ' ILE . 15.6 p -124.07 154.78 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.973 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 458' ' ' LEU . 3.5 tt -153.59 112.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.055 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.468 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 0.5 OUTLIER 43.03 51.17 5.43 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.676 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 71.05 43.72 56.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.708 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.468 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 40.6 mt-30 -146.35 126.53 13.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.79 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 65.5 m -81.48 118.22 22.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.925 HG11 ' CG2' ' A' ' 448' ' ' VAL . 7.1 t -98.94 144.7 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.905 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 9.1 m -118.52 -36.82 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.653 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.0 p -144.68 179.59 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.86 94.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.072 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.413 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 23.8 p30 -54.82 -25.88 31.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.52 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.5 m-20 -81.52 -52.06 7.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.986 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.925 ' CG2' HG11 ' A' ' 442' ' ' VAL . 46.8 t -55.77 -35.82 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.288 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 452' ' ' ILE . 10.8 t -58.74 -61.68 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.374 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.4 -28.76 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.493 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 437' ' ' ILE . 59.5 t -73.32 -47.49 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.009 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 383' ' ' ILE . 15.4 mt -58.17 -28.54 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 -6.79 26.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.442 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -100.07 -47.22 5.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -105.06 144.59 31.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -29.03 21.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.761 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -109.73 97.38 6.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.535 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.8 mt -89.71 120.13 30.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.84 85.81 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.665 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.56 128.13 36.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.79 HG22 ' HG3' ' A' ' 470' ' ' MET . 18.8 t -99.56 126.66 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 463' ' ' ARG . 23.9 t -115.24 154.08 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' ARG . . . . . 0.405 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -110.48 119.86 40.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.432 ' HB2' HD11 ' A' ' 469' ' ' ILE . 18.6 mtp180 -119.53 140.83 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 58.51 -97.34 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.34 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -140.25 24.96 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -142.56 158.02 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.174 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.23 137.68 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.585 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 464' ' ' ARG . 2.0 mt -126.91 141.86 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.79 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -92.31 139.55 30.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.772 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.833 HG21 HD23 ' A' ' 428' ' ' LEU . 12.6 mm -128.82 134.11 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.175 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.0 m -107.57 132.67 53.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 474' ' ' ILE . 23.3 t -144.31 124.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.223 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.5 mp -115.72 110.05 44.86 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.731 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.723 ' HB3' HG23 ' A' ' 383' ' ' ILE . 20.4 Cg_endo -60.86 -178.13 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.207 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -136.77 -178.5 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.829 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.456 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.763 0.316 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 51.16 51.29 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.85 130.47 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.228 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.413 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.4 m0 -111.64 101.22 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.936 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -75.75 68.63 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.134 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' TYR . . . . . 0.433 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 17.3 t80 -159.99 129.58 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.757 HG13 HG22 ' A' ' 385' ' ' ILE . 23.3 pt -116.11 -3.87 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.42 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.574 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 56.62 60.31 9.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.87 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.757 HG22 HG13 ' A' ' 383' ' ' ILE . 11.2 tt -165.08 144.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.976 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.459 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -100.36 157.99 16.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.523 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -154.05 137.53 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.561 ' HG2' HD11 ' A' ' 415' ' ' ILE . 1.3 ptp -115.5 173.79 6.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.115 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 89.2 p -99.34 99.78 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.285 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.853 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.1 tp -47.56 109.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 9.0 t -90.16 150.83 21.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 m -46.19 -36.54 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.593 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -47.15 84.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.35 -31.91 24.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.141 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -60.65 -36.23 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -88.89 -29.29 19.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -68.49 -25.51 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.178 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.01 -32.08 39.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.172 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -85.77 -29.72 23.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -37.59 48.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.994 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -53.77 6.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 104.24 11.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -83.12 60.79 5.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.737 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -142.75 13.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.144 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.78 150.72 48.96 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.78 ' HB2' HG22 ' A' ' 408' ' ' VAL . 50.0 Cg_exo -53.39 166.76 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.634 2.222 . . . . 0.0 112.293 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.56 3.72 43.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.78 HG22 ' HB2' ' A' ' 406' ' ' PRO . 15.6 m -70.93 112.8 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 111.067 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pp -92.26 -29.57 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.155 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 142.16 41.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.2 177.2 14.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.0 151.87 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.853 ' HB2' HD13 ' A' ' 390' ' ' LEU . 31.1 t80 -93.49 136.08 34.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 432' ' ' ASP . 40.3 mt -81.09 119.92 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.106 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.616 HD13 ' HD1' ' A' ' 413' ' ' TYR . 1.5 mm -89.27 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.359 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 415' ' ' ILE . 1.9 pt-20 -79.57 142.81 35.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 385' ' ' ILE . 21.2 t -111.27 151.25 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.172 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 421' ' ' THR . 18.5 mm -84.14 136.77 40.5 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 61.7 Cg_endo -73.09 58.98 3.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.43 2.086 . . . . 0.0 112.662 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.25 40.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.872 0.367 . . . . 0.0 111.028 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.574 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.1 OUTLIER -138.92 172.24 6.87 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 77.9 Cg_endo -78.38 -9.43 16.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.487 2.125 . . . . 0.0 112.194 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.824 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -72.57 -58.9 3.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.031 0.444 . . . . 0.0 110.824 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -33.3 74.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -85.56 -27.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -64.37 -70.14 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.36 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.2 28.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.054 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.824 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.3 OUTLIER -105.71 -175.94 2.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.753 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.97 155.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 63.64 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.95 36.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.807 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.866 ' HB2' HD12 ' A' ' 414' ' ' ILE . 4.9 m-20 -146.24 -176.05 5.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.8 t -143.81 125.65 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.305 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.73 145.87 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.705 HD12 ' N ' ' A' ' 436' ' ' SER . 2.4 pp -137.87 -43.48 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.657 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.705 ' N ' HD12 ' A' ' 435' ' ' ILE . 60.3 p -122.49 152.36 40.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.915 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.641 HD12 HG11 ' A' ' 451' ' ' VAL . 0.0 OUTLIER -148.0 119.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.538 ' N ' HD13 ' A' ' 437' ' ' ILE . 13.1 p30 48.04 28.08 1.38 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.05 25.77 28.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.459 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -116.73 166.17 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.8 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.6 117.49 34.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.565 HG11 HG22 ' A' ' 448' ' ' VAL . 92.9 t -105.23 147.18 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.95 -44.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.332 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.2 p -132.88 168.31 18.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 111.121 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.523 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.0 -37.98 72.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.071 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -58.5 -29.95 66.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.0 m-20 -76.91 -40.72 46.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.781 HG12 HD11 ' A' ' 452' ' ' ILE . 37.5 t -69.86 -35.71 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.096 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.445 ' HA ' HG11 ' B' ' 7' ' ' VAL . 27.2 t -57.59 -63.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -48.46 -32.49 7.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.892 HG13 ' OE2' ' A' ' 455' ' ' GLU . 55.1 t -70.84 -48.5 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.226 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.781 HD11 HG12 ' A' ' 448' ' ' VAL . 8.0 mt -61.65 -30.04 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.259 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -92.02 -19.02 22.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -98.67 -64.3 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' GLU . . . . . 0.892 ' OE2' HG13 ' A' ' 451' ' ' VAL . 1.8 mp0 -78.41 138.76 38.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 474' ' ' ILE . 17.6 m -89.43 -34.21 16.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' THR . . . . . 0.623 ' HA ' HD12 ' A' ' 474' ' ' ILE . 31.5 p -99.13 108.0 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.484 ' HB3' HD11 ' A' ' 437' ' ' ILE . 2.5 mt -108.7 120.14 41.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 111.418 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -123.74 93.46 3.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.415 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.442 ' HE2' ' HB3' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -99.46 152.35 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.365 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 469' ' ' ILE . 24.3 t -114.91 127.57 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.738 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.853 HG23 HD13 ' A' ' 471' ' ' ILE . 17.7 t -114.0 138.25 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.22 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -106.31 134.07 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.973 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.594 ' HE ' HD13 ' A' ' 469' ' ' ILE . 0.2 OUTLIER -139.31 132.74 30.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.69 0.86 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.305 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -140.13 28.98 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -140.22 155.64 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.019 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.38 138.95 33.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.627 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.594 HD13 ' HE ' ' A' ' 464' ' ' ARG . 3.2 mt -126.73 139.25 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.602 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.3 OUTLIER -103.56 133.8 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.853 HD13 HG23 ' A' ' 462' ' ' VAL . 3.2 mp -135.27 148.87 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 13.8 m -134.65 125.4 27.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.081 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 422' ' ' PRO . 21.1 t -127.85 119.83 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 457' ' ' THR . 27.7 mm -105.24 109.47 63.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.314 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.449 ' HG3' HG23 ' A' ' 452' ' ' ILE . 54.3 Cg_exo -52.0 143.62 39.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.282 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -100.47 -177.95 3.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.495 ' HA ' ' HE2' ' A' ' 388' ' ' MET . 97.6 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.925 0.393 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.04 74.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.502 HD13 ' N ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER -52.64 151.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.465 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -112.08 101.95 10.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -73.28 65.03 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 449' ' ' SER . 17.8 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.121 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.7 mttp . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.691 0.281 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -139.55 120.49 14.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.5 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.774 HG13 HG22 ' A' ' 385' ' ' ILE . 12.2 pt -124.57 -2.96 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.716 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 49.32 68.08 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 1.067 HD13 HG22 ' A' ' 417' ' ' VAL . 4.5 tp -153.52 118.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.822 0.344 . . . . 0.0 110.534 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.404 ' HD2' ' CG ' ' A' ' 416' ' ' GLU . 9.5 mtt85 -91.29 132.04 36.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.482 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -138.59 143.69 39.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.427 ' HE1' ' HA ' ' B' ' 2' ' ' SER . 6.0 ptm -128.06 159.47 34.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.165 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.3 p -77.82 101.32 6.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.7 tp -55.38 100.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 11.6 t -87.53 156.25 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.6 t -51.59 -25.77 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -75.68 -29.13 58.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.253 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -99.84 -39.12 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.558 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -58.17 -40.06 80.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.211 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -83.05 -32.08 27.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.981 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.25 -34.55 75.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.85 -39.54 76.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -59.2 -22.52 61.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.75 -23.26 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -67.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.172 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -80.26 -49.08 12.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 5.0 ttm105 83.52 -39.53 0.08 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.958 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -68.23 -9.73 49.3 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -56.77 152.89 24.52 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.474 ' HG2' HG22 ' A' ' 408' ' ' VAL . 25.6 Cg_endo -61.98 -172.14 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.78 2.32 . . . . 0.0 112.525 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.05 33.55 3.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 406' ' ' PRO . 3.7 m -101.56 164.79 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.116 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.697 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -138.77 -39.53 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.459 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 410' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -79.25 167.58 20.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 111.33 170.56 19.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.511 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.2 140.45 29.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 0.0 111.091 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.835 ' HB2' HD13 ' A' ' 390' ' ' LEU . 45.7 t80 -95.57 126.3 40.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.005 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 432' ' ' ASP . 18.6 mt -80.0 110.04 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.805 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.9 mp -75.24 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.404 ' CG ' ' HD2' ' A' ' 386' ' ' ARG . 11.8 pt-20 -157.84 156.12 30.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 111.221 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 1.067 HG22 HD13 ' A' ' 385' ' ' ILE . 14.0 t -128.4 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.531 ' HB ' HG23 ' A' ' 421' ' ' THR . 7.3 mm -88.95 136.62 30.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 39.7 Cg_endo -67.38 -5.87 15.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.639 2.226 . . . . 0.0 113.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -112.48 46.83 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.114 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.716 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -149.62 170.31 7.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 422' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 64.1 Cg_endo -75.5 -11.42 20.6 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.215 1.943 . . . . 0.0 111.867 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.511 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -67.07 -59.27 3.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.091 0.472 . . . . 0.0 110.936 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -29.76 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.715 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.25 38.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.318 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -78.29 -22.18 68.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.74 16.08 5.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.731 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.511 HD12 ' CA ' ' A' ' 423' ' ' ALA . 0.8 OUTLIER -95.49 -171.6 2.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 110.636 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -177.32 146.5 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -176.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 33.2 m120 56.1 24.91 8.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.051 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.923 ' HB2' HD12 ' A' ' 414' ' ' ILE . 6.2 m-20 -120.48 -175.75 3.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.805 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.53 123.76 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.463 HD11 HG12 ' A' ' 414' ' ' ILE . 1.4 mp -83.79 146.59 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.588 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -135.24 -43.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.554 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.828 ' N ' HD12 ' A' ' 435' ' ' ILE . 24.9 p -119.99 147.77 44.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.361 . . . . 0.0 111.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.2 tt -144.87 114.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.061 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.5 HD22 ' HG3' ' A' ' 440' ' ' GLN . 1.4 p-10 44.49 43.92 6.69 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.601 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 79.39 27.4 55.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.758 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.5 ' HG3' HD22 ' A' ' 438' ' ' ASN . 6.6 mm100 -131.46 126.32 34.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.916 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.19 125.54 29.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.928 HG11 ' CG2' ' A' ' 448' ' ' VAL . 3.0 t -108.94 150.75 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.19 -28.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.661 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 20.2 p -148.58 170.33 18.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.482 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -59.98 -42.24 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.079 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.431 ' ND2' ' OD1' ' A' ' 447' ' ' ASP . 0.5 OUTLIER -53.67 -26.99 25.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.862 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.2 m-20 -83.32 -37.99 22.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.668 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.928 ' CG2' HG11 ' A' ' 442' ' ' VAL . 41.4 t -68.23 -33.28 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 26.8 t -60.13 -60.29 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.281 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.82 -29.52 41.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.478 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 447' ' ' ASP . 42.0 t -69.2 -51.56 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 111.114 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 448' ' ' VAL . 5.9 mt -57.94 -29.23 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.023 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.323 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -99.16 -58.02 2.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -82.43 132.17 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 59.5 m -74.22 -37.02 63.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' THR . . . . . 0.457 ' C ' HD23 ' A' ' 458' ' ' LEU . 6.4 t -107.83 127.08 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.558 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.709 ' HB3' HD11 ' A' ' 437' ' ' ILE . 8.6 mt -119.73 119.74 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.328 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' ASN . . . . . 0.467 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.4 m-80 -119.15 99.67 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.426 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.99 144.41 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.9 t -102.82 139.25 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.452 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 463' ' ' ARG . 3.3 t -139.29 160.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.199 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 462' ' ' VAL . 1.3 tmm_? -97.47 119.69 36.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.625 ' HB2' HD12 ' A' ' 469' ' ' ILE . 7.7 ttt180 -109.34 119.77 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.383 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.49 -92.01 0.26 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.094 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -140.38 25.92 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.829 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.01 154.44 43.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.79 130.16 45.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.631 ' O ' HG13 ' A' ' 461' ' ' VAL . 1.8 mt -129.02 151.49 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.311 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.527 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -93.6 119.86 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.444 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.68 137.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.372 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.467 HG23 ' OD1' ' A' ' 459' ' ' ASN . 50.2 m -111.13 126.28 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.545 HG22 ' HA3' ' A' ' 426' ' ' GLY . 20.7 t -139.13 141.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 21.5 mm -124.21 117.47 26.85 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.62 162.45 34.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.466 2.11 . . . . 0.0 112.279 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.56 -179.74 6.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.427 ' HA ' ' HE1' ' A' ' 388' ' ' MET . 19.5 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.916 0.389 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -65.2 79.99 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.805 HG22 ' CD1' ' A' ' 415' ' ' ILE . 2.2 pt -85.29 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.36 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.19 95.16 5.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.89 66.26 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.785 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.524 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.8 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 475' ' ' PRO . 27.7 mttm . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.769 0.319 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -128.41 125.05 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.377 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 385' ' ' ILE . 30.5 pt -136.84 -1.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.874 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 48.14 70.67 0.7 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.993 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.984 HD13 HG22 ' A' ' 417' ' ' VAL . 6.8 tp -165.22 121.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.612 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 1.5 mtt85 -90.78 139.2 30.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.722 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.507 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -140.13 146.39 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.441 ' C ' ' HB2' ' A' ' 445' ' ' ALA . 1.4 ptp -120.62 -179.64 4.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.4 p -103.39 105.74 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 413' ' ' TYR . 4.6 tp -57.0 99.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.054 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.5 t -80.74 162.65 24.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 53.4 p -57.91 -20.54 37.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 20.6 m -77.6 -33.41 53.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.096 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -49.49 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.164 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.467 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -52.01 -34.11 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.615 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.38 -26.79 23.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.164 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -39.11 73.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 10.7 mt -58.01 -32.2 67.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -80.92 -26.25 36.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.13 -26.07 20.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.13 -42.22 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' HIS . . . . . 0.432 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -93.62 -53.65 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 4.6 mtt180 84.55 -23.13 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.599 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 -23.8 32.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -58.39 147.4 68.37 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.58 ' HB2' HG22 ' A' ' 408' ' ' VAL . 41.8 Cg_endo -67.62 166.98 22.19 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.571 2.181 . . . . 0.0 112.233 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.16 -23.31 64.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.176 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 406' ' ' PRO . 15.5 m -54.97 91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.885 0.374 . . . . 0.0 111.309 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.9 -30.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -69.35 151.33 46.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 125.01 -177.51 16.86 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.758 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.682 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -110.68 170.55 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.808 ' HB2' HD13 ' A' ' 390' ' ' LEU . 24.1 t80 -116.8 137.79 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.883 HD12 ' HB2' ' A' ' 432' ' ' ASP . 21.9 mt -86.04 117.29 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.612 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 12.4 mm -75.24 -68.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.125 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.714 ' O ' HD12 ' A' ' 385' ' ' ILE . 9.5 pt-20 -159.92 150.23 18.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.732 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.984 HG22 HD13 ' A' ' 385' ' ' ILE . 20.4 t -113.72 151.4 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.604 ' HB ' HG23 ' A' ' 421' ' ' THR . 17.9 mm -86.7 143.51 35.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 37.1 Cg_exo -61.9 -7.92 10.57 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.8 2.333 . . . . 0.0 113.594 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -135.08 71.51 1.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.701 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.696 HG21 ' HA3' ' A' ' 384' ' ' GLY . 24.5 p -149.7 156.3 38.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.351 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.63 -21.16 70.19 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.143 1.895 . . . . 0.0 110.351 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.899 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -66.2 -60.05 3.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.496 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.95 -32.82 74.54 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.055 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.14 -25.68 59.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -75.12 -66.44 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.191 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 162.08 29.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.158 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.899 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.6 OUTLIER -99.24 -175.72 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.73 139.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.719 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.38 179.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.41 19.99 11.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.883 ' HB2' HD12 ' A' ' 414' ' ' ILE . 8.2 m-20 -120.28 -176.03 3.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.671 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 412' ' ' ALA . 26.1 t -147.97 117.26 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 111.524 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.466 HG23 ' HB3' ' A' ' 460' ' ' MET . 1.6 mp -76.57 152.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.189 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.685 HD12 ' N ' ' A' ' 436' ' ' SER . 1.7 pp -139.35 -51.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.764 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.685 ' N ' HD12 ' A' ' 435' ' ' ILE . 84.2 p -113.02 144.27 42.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 111.091 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.724 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.1 tt -140.7 113.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 438' ' ' ASN . 2.2 p-10 43.9 45.67 6.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.533 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 73.72 52.46 8.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.703 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.9 157.96 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.654 0.264 . . . . 0.0 110.814 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.7 m -103.21 114.47 28.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.245 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.961 HG11 HG22 ' A' ' 448' ' ' VAL . 21.6 t -99.34 141.69 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.018 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.98 -37.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.503 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.14 172.43 12.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 111.264 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.507 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.37 -41.79 76.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.086 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -55.35 -29.52 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.712 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 451' ' ' VAL . 3.0 m-20 -80.01 -33.94 38.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.961 HG22 HG11 ' A' ' 442' ' ' VAL . 26.0 t -72.99 -38.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.632 ' HA ' HD12 ' A' ' 452' ' ' ILE . 12.1 t -55.63 -63.13 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.515 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -48.83 -28.41 3.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.375 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 447' ' ' ASP . 38.7 t -72.86 -49.6 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 449' ' ' SER . 5.2 mt -57.86 -26.44 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -100.13 -11.52 20.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.421 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -99.79 -47.72 4.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.719 0.295 . . . . 0.0 111.012 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -98.72 150.32 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 -33.85 11.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.661 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 457' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 457' ' ' THR . 5.2 t -106.15 96.21 6.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.576 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.724 ' HB3' HD11 ' A' ' 437' ' ' ILE . 12.3 mt -90.24 122.03 32.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -113.9 90.51 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.585 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.501 ' CG ' HD12 ' A' ' 437' ' ' ILE . 5.2 mtm -99.83 131.73 45.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.27 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.4 t -99.79 119.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.817 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.731 HG23 HD13 ' A' ' 471' ' ' ILE . 6.7 t -103.82 160.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' ARG . . . . . 0.452 ' N ' HG12 ' A' ' 462' ' ' VAL . 5.5 tmm_? -116.03 131.01 57.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.834 ' HB2' HD11 ' A' ' 469' ' ' ILE . 9.9 mtp180 -136.34 119.94 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.75 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.42 -109.92 3.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.494 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.59 27.14 6.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.659 0.266 . . . . 0.0 111.061 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.97 157.83 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -98.3 150.14 21.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.834 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mp -129.37 136.63 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.885 0.374 . . . . 0.0 111.331 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.5 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.1 OUTLIER -100.25 122.07 42.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.293 179.575 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.731 HD13 HG23 ' A' ' 462' ' ' VAL . 3.3 mp -125.4 126.73 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.926 0.394 . . . . 0.0 111.706 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.8 m -114.03 119.61 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.066 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.709 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.5 t -132.32 141.38 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 0.0 111.704 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.709 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -114.95 114.17 43.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 383' ' ' ILE . 15.1 Cg_endo -57.27 135.54 70.88 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.362 2.042 . . . . 0.0 112.362 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.32 151.85 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.791 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.826 0.346 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -72.97 113.65 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.47 145.57 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -113.54 99.83 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 386' ' ' ARG . 2.4 t90 -76.17 72.12 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.11 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 3.8 mptt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.671 0.272 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -131.87 119.95 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.31 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.633 HD12 ' CG2' ' A' ' 385' ' ' ILE . 24.8 pt -122.53 -12.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.611 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.727 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 54.85 69.66 1.19 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.057 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.633 ' CG2' HD12 ' A' ' 383' ' ' ILE . 11.3 tt -165.27 152.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.026 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.496 ' HG3' ' HB ' ' A' ' 415' ' ' ILE . 1.8 ptm180 -122.07 132.05 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.5 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.508 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -128.52 131.69 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.006 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.486 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 10.0 ptm -109.64 158.44 18.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.037 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.7 p -87.57 109.12 19.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 398' ' ' LEU . 5.4 tp -56.07 114.64 2.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.3 t -86.46 159.09 19.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.4 t -56.05 -25.7 46.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.233 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.32 -39.14 54.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.093 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.502 ' H ' HG23 ' A' ' 391' ' ' THR . 25.3 mmtt -87.44 -27.25 22.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -56.06 -42.14 76.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.288 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -85.98 -30.21 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.82 -32.42 73.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 390' ' ' LEU . 6.2 mt -66.07 -55.55 15.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.2 -30.92 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -51.41 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -34.0 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.801 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -119.71 104.69 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -82.07 59.23 4.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -159.8 26.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.14 151.96 38.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.607 ' HG2' HG22 ' A' ' 408' ' ' VAL . 37.2 Cg_endo -65.92 -176.16 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.14 20.25 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.607 HG22 ' HG2' ' A' ' 406' ' ' PRO . 13.2 m -89.62 160.5 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.927 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.33 -33.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.801 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.3 m -93.9 159.37 15.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.7 165.49 11.4 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -92.79 138.25 31.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.857 ' HB2' HD13 ' A' ' 390' ' ' LEU . 43.5 t80 -92.62 128.2 38.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.053 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.912 HD12 ' HB2' ' A' ' 432' ' ' ASP . 13.9 mt -79.71 116.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.52 ' CD1' HG22 ' B' ' 4' ' ' ILE . 4.8 mt -83.76 -68.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.639 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 430' ' ' GLU . 10.5 pt-20 -159.58 144.71 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.994 0.426 . . . . 0.0 111.305 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.614 HG22 HD12 ' A' ' 385' ' ' ILE . 8.5 t -116.66 137.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.846 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.52 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 4.9 mm -79.66 138.86 54.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.675 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 27.0 Cg_exo -62.75 -10.39 19.67 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.909 2.406 . . . . 0.0 113.771 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.33 55.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.001 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.727 HG21 ' HA3' ' A' ' 384' ' ' GLY . 1.1 p -153.96 157.95 32.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.07 -25.17 79.06 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.432 2.088 . . . . 0.0 111.251 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.551 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -58.72 -58.45 8.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.008 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.81 -30.24 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.667 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.74 -26.55 57.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -73.25 -30.15 63.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.204 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.82 23.16 3.12 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.819 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 471' ' ' ILE . 0.9 OUTLIER -91.73 -176.65 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.748 0.309 . . . . 0.0 110.768 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.17 159.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 416' ' ' GLU . 0.0 OUTLIER -71.65 -176.98 1.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 59.41 27.57 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.912 ' HB2' HD12 ' A' ' 414' ' ' ILE . 7.1 m-20 -125.23 -177.93 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.703 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -146.27 124.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.379 . . . . 0.0 111.495 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 435' ' ' ILE . 3.4 mt -89.34 154.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.715 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.739 HD12 ' N ' ' A' ' 436' ' ' SER . 2.0 pp -141.69 -48.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.745 0.307 . . . . 0.0 111.717 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.739 ' N ' HD12 ' A' ' 435' ' ' ILE . 77.1 p -113.8 152.93 29.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.653 HG21 HG11 ' A' ' 451' ' ' VAL . 7.6 tt -150.83 112.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.65 HD22 ' HG3' ' A' ' 440' ' ' GLN . 0.8 OUTLIER 44.98 41.51 5.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.679 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 80.55 23.92 59.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.851 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.65 ' HG3' HD22 ' A' ' 438' ' ' ASN . 6.8 mm100 -125.05 120.68 32.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.699 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 11.5 p -72.69 123.35 23.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.258 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.955 HG11 HG22 ' A' ' 448' ' ' VAL . 10.2 t -107.67 143.14 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.833 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.68 4.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.1 p -170.2 164.72 9.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.891 0.377 . . . . 0.0 111.222 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.508 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -58.07 -45.18 87.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.06 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.425 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 23.7 p30 -57.34 -29.15 63.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.78 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.824 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.6 m-20 -75.12 -35.56 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.955 HG22 HG11 ' A' ' 442' ' ' VAL . 33.5 t -73.02 -39.46 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.376 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 452' ' ' ILE . 23.0 t -57.02 -63.94 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.458 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -47.1 -32.2 4.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.423 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 447' ' ' ASP . 45.6 t -68.85 -45.54 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.975 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 449' ' ' SER . 22.1 mt -59.65 -29.66 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -6.09 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.356 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.06 -46.96 5.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.28 155.35 20.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 8.5 t -97.8 -35.85 10.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.3 95.93 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.6 ' HB3' HD11 ' A' ' 437' ' ' ILE . 4.8 mt -94.0 119.29 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.25 93.28 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.462 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.53 160.29 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.671 HG22 ' HG3' ' A' ' 470' ' ' MET . 20.3 t -119.56 127.6 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.801 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.3 141.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -96.73 119.88 36.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.37 126.78 48.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.25 -99.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.373 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.92 29.32 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 110.837 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -141.74 147.99 38.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.089 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -90.11 136.26 33.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.38 136.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.34 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -97.14 119.9 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.534 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 428' ' ' LEU . 18.1 mm -115.36 145.1 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.189 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 31.0 m -135.04 132.8 38.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.652 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.8 t -141.08 138.33 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.248 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.652 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -112.66 109.99 52.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.432 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.0 Cg_endo -59.4 119.1 6.13 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.332 2.022 . . . . 0.0 112.14 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -79.92 169.0 18.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.907 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.486 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.724 0.297 . . . . 0.0 110.728 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 54.05 52.17 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.3 pp -75.45 155.34 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.42 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.425 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 20.8 m95 -127.34 79.65 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.706 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -67.51 75.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.56 ' O ' HG12 ' B' ' 7' ' ' VAL . 22.0 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.064 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 31.6 mttt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.668 0.27 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -147.01 128.41 14.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.344 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 385' ' ' ILE . 7.1 pt -118.31 -10.62 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.731 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 60.83 71.06 0.85 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.828 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.966 HD13 HG22 ' A' ' 417' ' ' VAL . 7.3 tp -164.41 123.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.811 0.338 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -89.71 129.61 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' B' ' 5' ' ' TRP . 0.0 OUTLIER -132.88 146.56 51.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.851 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.416 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.0 ptm -127.82 160.84 30.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.7 p -80.05 101.67 8.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.63 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.922 HD13 ' HB2' ' A' ' 413' ' ' TYR . 8.2 tp -54.65 108.8 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.6 t -88.82 157.78 18.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.858 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.56 -25.55 60.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.59 -27.93 61.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.113 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -99.61 -40.1 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.36 67.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -89.97 -34.76 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.54 -37.07 74.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.81 -32.48 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -68.22 -41.67 80.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -56.34 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -33.73 76.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -130.96 105.98 8.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 55.94 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.051 0.453 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.45 -20.18 4.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.77 129.09 88.76 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.028 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.525 ' HG2' HG22 ' A' ' 408' ' ' VAL . 33.1 Cg_endo -64.14 -167.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.271 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.88 64.8 4.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 406' ' ' PRO . 14.1 m -137.79 81.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 410' ' ' SER . 2.7 pp -59.38 -31.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' SER . . . . . 0.48 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.8 OUTLIER -93.41 144.73 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 137.82 178.23 15.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.494 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -100.77 158.18 16.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 111.019 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.922 ' HB2' HD13 ' A' ' 390' ' ' LEU . 13.0 t80 -114.82 127.75 55.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.896 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.861 ' CG2' HD11 ' A' ' 385' ' ' ILE . 4.6 mt -80.71 118.82 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.75 HD13 HG22 ' B' ' 4' ' ' ILE . 5.1 mt -83.65 -55.36 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.568 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 385' ' ' ILE . 4.3 pt-20 -160.68 162.89 32.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.349 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.966 HG22 HD13 ' A' ' 385' ' ' ILE . 25.5 t -119.7 155.63 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.672 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' A' ' 419' ' ' PRO . 1.7 mp -95.27 139.41 22.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 420' ' ' ASP . 21.3 Cg_endo -60.73 102.93 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.455 2.103 . . . . 0.0 112.205 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 419' ' ' PRO . 13.2 m-20 94.0 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.144 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.731 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -150.65 158.09 35.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.175 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.19 -22.45 74.19 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.124 1.883 . . . . 0.0 110.726 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.466 ' CA ' ' HG ' ' A' ' 428' ' ' LEU . . . -64.74 -60.07 3.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.912 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' GLU . . . . . 0.74 ' HB2' HG11 ' A' ' 417' ' ' VAL . 1.9 tm-20 -72.82 -39.86 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.974 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.28 70.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.276 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -78.61 -70.15 1.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 174.48 39.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.453 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.492 HD21 HG21 ' A' ' 473' ' ' VAL . 0.1 OUTLIER -87.61 175.45 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.921 0.391 . . . . 0.0 111.166 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -165.01 143.54 6.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.492 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 3.6 pt-20 -87.05 47.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 111.291 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -169.53 33.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.582 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -131.89 -179.52 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 412' ' ' ALA . 30.6 t -134.65 121.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.419 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.9 mt -76.04 150.93 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.6 HD12 ' HB3' ' A' ' 436' ' ' SER . 1.5 pp -141.38 -50.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.6 ' HB3' HD12 ' A' ' 435' ' ' ILE . 17.4 p -112.04 159.21 18.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 111.213 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.595 HD11 ' HB3' ' A' ' 458' ' ' LEU . 2.5 tt -164.14 114.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.078 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.4 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.0 p30 46.11 34.22 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.666 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.45 32.86 24.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.69 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.572 ' HB2' HG23 ' A' ' 437' ' ' ILE . 0.2 OUTLIER -128.09 134.3 49.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 110.64 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.29 104.6 14.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.282 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.874 HG11 HG22 ' A' ' 448' ' ' VAL . 32.9 t -88.06 136.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.64 -3.66 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.7 OUTLIER -169.95 168.76 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.238 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.48 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.01 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -54.79 -27.53 42.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.9 m-20 -79.81 -33.68 40.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.795 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.874 HG22 HG11 ' A' ' 442' ' ' VAL . 25.0 t -72.06 -40.35 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.264 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 4.5 t -56.07 -59.13 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.453 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.75 -25.6 11.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.568 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.857 HG13 ' OE2' ' A' ' 455' ' ' GLU . 47.1 t -76.01 -49.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.502 HD11 HG12 ' A' ' 448' ' ' VAL . 8.0 mt -59.43 -26.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -19.32 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.252 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -96.39 -60.88 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.81 0.338 . . . . 0.0 110.744 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' GLU . . . . . 0.857 ' OE2' HG13 ' A' ' 451' ' ' VAL . 2.0 mp0 -83.75 124.57 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 67.9 m -71.83 -37.26 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 9.0 p -101.65 123.58 45.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.76 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.595 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.5 mt -107.73 119.93 40.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -118.66 84.5 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.634 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.3 mtt -91.48 161.29 15.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 469' ' ' ILE . 19.4 t -132.41 126.12 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.785 HG23 HD13 ' A' ' 471' ' ' ILE . 10.0 t -125.24 150.19 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -106.42 126.68 52.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.514 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.4 mtp-105 -125.34 133.27 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.736 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.92 -104.94 1.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.236 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.49 25.93 3.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.834 0.35 . . . . 0.0 110.692 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -146.52 149.65 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.045 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.46 142.84 27.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.587 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.6 mt -128.63 155.39 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.349 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 3.9 mmt -109.54 119.9 40.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.479 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ILE . . . . . 0.785 HD13 HG23 ' A' ' 462' ' ' VAL . 3.7 mp -108.96 120.61 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 19.3 m -102.28 121.5 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.552 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.492 HG21 HD21 ' A' ' 428' ' ' LEU . 23.2 t -127.85 144.31 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.486 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 28.3 mm -127.77 109.9 20.47 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.855 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.56 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.1 Cg_endo -59.72 149.65 81.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.394 2.063 . . . . 0.0 112.288 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.45 176.84 5.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.889 0.376 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -66.76 88.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.75 HG22 HD13 ' A' ' 415' ' ' ILE . 24.3 pt -74.35 141.24 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.41 ' HB3' ' HE2' ' A' ' 387' ' ' MET . 9.2 m95 -119.58 94.09 4.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.38 77.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.418 HG12 ' OXT' ' B' ' 7' ' ' VAL . 11.7 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.156 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 475' ' ' PRO . 24.6 mttm . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.736 0.303 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -160.04 128.42 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.175 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.591 HG23 ' HB3' ' A' ' 475' ' ' PRO . 12.7 pt -118.48 -5.74 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.271 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' GLY . . . . . 0.445 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 55.78 66.15 3.05 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.654 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' ILE . . . . . 0.896 HG12 HG22 ' A' ' 417' ' ' VAL . 0.0 OUTLIER -153.45 124.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.815 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 386' ' ' ARG . . . . . 0.617 ' N ' HD13 ' A' ' 385' ' ' ILE . 25.3 mtt180 -90.2 123.88 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.069 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' MET . . . . . 0.475 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -131.21 145.03 51.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 388' ' ' MET . . . . . 0.541 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.7 OUTLIER -122.23 179.09 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.6 p -104.75 104.83 14.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.665 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 413' ' ' TYR . 6.2 tp -51.97 114.81 1.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.269 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.3 t -90.23 170.16 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 56.2 m -67.84 -14.5 63.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.527 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.3 t -87.94 -35.96 17.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 0.0 111.204 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.464 ' H ' HG23 ' A' ' 391' ' ' THR . 0.6 OUTLIER -84.86 -30.92 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.95 98.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -76.53 -33.31 58.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -29.18 70.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.49 -49.34 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.041 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -58.59 -30.37 67.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.092 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.36 -37.57 80.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.95 -65.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.56 -58.4 8.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 75.8 -54.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.362 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -44.72 -29.7 0.81 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.01 138.91 71.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.78 -159.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.485 2.123 . . . . 0.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -101.57 27.31 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.2 m -71.74 140.3 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.98 -30.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 16.8 m -101.62 -178.2 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 112.61 167.21 17.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.598 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 388' ' ' MET . . . -108.6 151.6 25.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' TYR . . . . . 0.776 ' HB2' HD13 ' A' ' 390' ' ' LEU . 52.8 t80 -101.46 128.72 47.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ILE . . . . . 0.937 HD12 ' HB2' ' A' ' 432' ' ' ASP . 16.1 mt -79.94 114.62 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.826 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' ILE . . . . . 0.833 ' CD1' HG22 ' B' ' 4' ' ' ILE . 4.1 mt -78.76 -66.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.27 158.57 41.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 111.585 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' VAL . . . . . 0.896 HG22 HG12 ' A' ' 385' ' ' ILE . 41.3 t -130.63 153.3 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.824 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' ILE . . . . . 0.829 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.1 mp -97.22 129.8 31.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.523 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.98 -12.91 16.69 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.009 2.473 . . . . 0.0 113.857 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' ASP . . . . . 0.829 ' H ' HG22 ' A' ' 418' ' ' ILE . 4.0 m-20 -111.24 53.48 0.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' THR . . . . . 0.445 HG21 ' HA3' ' A' ' 384' ' ' GLY . 18.1 p -153.89 153.82 29.2 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.095 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.58 -24.46 45.02 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.099 1.866 . . . . 0.0 110.906 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 428' ' ' LEU . . . -58.81 -60.25 4.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.37 -30.96 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.726 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.0 -15.46 58.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -84.07 -31.85 24.89 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.349 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 125.59 16.97 2.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.153 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 3.9 mt -85.69 -171.21 3.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.133 0.467 . . . . 0.0 110.74 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.86 153.87 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.43 -178.91 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 28.59 16.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.937 ' HB2' HD12 ' A' ' 414' ' ' ILE . 54.3 m-20 -132.63 170.02 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.751 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.26 127.06 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.324 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 414' ' ' ILE . 2.1 mp -84.89 147.85 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.569 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 436' ' ' SER . 2.2 pp -137.99 -43.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.728 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' SER . . . . . 0.821 ' N ' HD12 ' A' ' 435' ' ' ILE . 23.6 p -124.94 151.94 44.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.091 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 437' ' ' ILE . . . . . 0.729 HD12 ' CG ' ' A' ' 460' ' ' MET . 1.5 tt -148.81 115.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.982 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' ASN . . . . . 0.495 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 1.3 p-10 47.64 36.36 5.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.641 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.03 30.18 32.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.747 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' GLN . . . . . 0.495 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 6.1 mt-30 -122.78 145.69 48.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.778 0.323 . . . . 0.0 110.736 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.2 t -86.76 107.88 18.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.605 HG11 HG22 ' A' ' 448' ' ' VAL . 62.0 t -93.16 152.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 444' ' ' SER . 10.7 m -139.76 -46.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 443' ' ' VAL . 2.3 p -132.64 166.48 22.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.999 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' ALA . . . . . 0.475 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.21 -38.05 70.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.293 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' ASN . . . . . 0.4 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 1.2 p-10 -58.53 -29.67 66.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -77.63 -41.26 39.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 448' ' ' VAL . . . . . 0.686 HG12 HD11 ' A' ' 452' ' ' ILE . 32.9 t -63.16 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 449' ' ' SER . . . . . 0.704 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.6 t -54.89 -66.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.547 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 447' ' ' ASP . 40.7 t -75.62 -46.12 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.289 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 452' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.4 mt -58.76 -32.9 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 -4.15 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.628 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -100.38 -49.7 4.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.67 150.25 22.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 -35.88 14.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.807 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.21 96.83 6.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.6 mt -91.35 121.16 32.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' ASN . . . . . 0.523 ' CG ' HG23 ' A' ' 472' ' ' THR . 5.9 m-80 -111.78 90.21 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' MET . . . . . 0.729 ' CG ' HD12 ' A' ' 437' ' ' ILE . 3.2 mtm -95.71 130.35 42.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.105 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 461' ' ' VAL . . . . . 0.599 HG22 ' HG3' ' A' ' 470' ' ' MET . 22.1 t -99.22 122.82 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.956 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 432' ' ' ASP . 3.9 t -111.64 148.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.953 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.27 131.35 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 464' ' ' ARG . . . . . 0.613 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.9 mtp180 -138.74 125.53 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 69.52 -101.4 0.83 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.464 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -140.12 25.39 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.655 0.264 . . . . 0.0 111.116 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -140.08 151.77 45.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.821 0.344 . . . . 0.0 111.2 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.08 139.24 31.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mt -125.62 129.18 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 111.362 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 470' ' ' MET . . . . . 0.599 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -93.8 120.11 33.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.51 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 8.6 mm -117.8 142.9 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.31 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.523 HG23 ' CG ' ' A' ' 459' ' ' ASN . 1.3 m -123.45 136.03 54.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 473' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 474' ' ' ILE . 5.7 t -143.82 137.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.249 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 474' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -113.66 109.8 50.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 475' ' ' PRO . . . . . 0.591 ' HB3' HG23 ' A' ' 383' ' ' ILE . 28.8 Cg_endo -63.07 134.14 44.55 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.059 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.89 -177.4 5.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.773 0.32 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.8 mtm-85 -58.09 89.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ILE . . . . . 0.833 HG22 ' CD1' ' A' ' 415' ' ' ILE . 5.0 pt -83.36 115.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' TRP . . . . . 0.4 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.5 m0 -99.76 101.29 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 8.8 t90 -82.59 63.32 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.787 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.463 ' O ' HG12 ' B' ' 7' ' ' VAL . 25.5 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.059 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.6 m -152.14 -66.36 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -129.61 101.09 5.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 1.2 mtp -156.09 164.46 38.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.9 tptm 61.35 93.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.528 ' HB2' HG22 ' A' ' 452' ' ' ILE . 6.9 mmtt -71.64 -176.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.749 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.422 ' HB2' HG22 ' A' ' 478' ' ' ILE . 11.3 t80 -141.76 123.14 14.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.257 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.571 HD12 ' CG2' ' A' ' 385' ' ' ILE . 5.4 pt -113.29 -13.72 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.347 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.52 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 72.14 57.53 5.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.772 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.891 HD11 HG23 ' A' ' 414' ' ' ILE . 12.4 tt -160.18 151.74 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.14 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 17.7 mtt180 -106.02 127.6 53.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.476 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -134.71 145.29 48.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.9 ptm -127.27 160.55 30.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 83.9 p -85.4 110.02 18.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.5 tp -58.06 89.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.018 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 394' ' ' LYS . 5.7 t -75.72 166.47 23.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.77 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.1 t -49.53 -36.11 22.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.425 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -63.73 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.175 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.416 ' H ' HG23 ' A' ' 391' ' ' THR . 0.0 OUTLIER -57.28 -49.6 75.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.9 -39.69 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.313 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.04 -29.19 39.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.6 -34.81 79.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.19 -43.15 78.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.05 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -59.63 -34.35 72.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.64 -37.87 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -82.51 -70.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 96.46 8.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.04 60.43 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.8 14.23 1.92 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.23 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.31 150.96 40.08 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.685 ' HB2' HG22 ' A' ' 408' ' ' VAL . 53.6 Cg_exo -52.09 179.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.87 28.42 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' A' ' 406' ' ' PRO . 14.9 m -101.38 173.84 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.731 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -138.63 16.7 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.373 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.2 p -116.2 139.89 49.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.882 0.372 . . . . 0.0 110.801 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.12 167.06 11.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.35 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -101.56 142.9 32.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.128 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.756 ' HB2' HD13 ' A' ' 390' ' ' LEU . 45.0 t80 -104.14 130.38 51.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.891 HG23 HD11 ' A' ' 385' ' ' ILE . 17.4 mt -80.08 128.76 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.54 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.806 HD13 HG22 ' B' ' 4' ' ' ILE . 62.7 mt -96.24 -68.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.563 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 153.12 40.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 0.0 111.044 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.16 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.8 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.5 mp -79.84 134.69 56.57 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.308 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.97 -11.21 2.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.249 2.632 . . . . 0.0 114.678 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' ASP . . . . . 0.8 ' H ' HG22 ' A' ' 418' ' ' ILE . 14.7 m-20 -130.95 76.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.52 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.2 OUTLIER -160.15 163.58 21.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.603 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.64 -25.17 78.13 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.408 2.072 . . . . 0.0 111.6 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -59.14 -54.67 44.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.169 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.08 -31.08 65.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.5 -30.51 59.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.265 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.98 -38.15 84.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.35 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.77 29.42 1.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.82 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.87 HD23 HG21 ' A' ' 471' ' ' ILE . 0.4 OUTLIER -96.97 -164.28 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.686 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.25 163.71 22.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.854 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 41.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 0.0 110.977 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -151.88 28.54 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.59 ' HB2' HD12 ' A' ' 414' ' ' ILE . 1.0 OUTLIER -126.57 -177.04 3.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 29.8 t -136.68 123.21 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.315 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 435' ' ' ILE . 1.7 mp -77.04 157.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 436' ' ' SER . 2.0 pp -148.79 -46.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.411 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 435' ' ' ILE . 54.2 p -124.34 160.95 26.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.979 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.996 HG21 HG11 ' A' ' 451' ' ' VAL . 2.8 tt -156.58 119.57 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.249 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.471 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 0.7 OUTLIER 43.54 46.94 6.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.718 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 74.27 47.18 18.2 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.713 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.471 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 48.7 mt-30 -142.95 161.49 37.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.679 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 61.9 m -111.62 110.5 20.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.961 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.937 HG11 HG22 ' A' ' 448' ' ' VAL . 5.3 t -95.04 152.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 444' ' ' SER . 27.9 m -130.12 -42.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.453 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 443' ' ' VAL . 2.2 p -134.3 172.35 13.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 0.0 111.242 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.476 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.38 -42.97 78.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.416 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 25.1 p30 -55.31 -29.14 57.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.843 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.83 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.8 m-20 -78.52 -35.68 45.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.937 HG22 HG11 ' A' ' 442' ' ' VAL . 32.4 t -69.75 -41.51 79.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.266 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.666 ' HA ' HD12 ' A' ' 452' ' ' ILE . 20.2 t -54.78 -62.62 1.54 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.529 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -48.28 -35.97 13.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.409 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.996 HG11 HG21 ' A' ' 437' ' ' ILE . 40.3 t -65.81 -46.05 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.068 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.5 mt -61.92 -31.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.135 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.03 -14.3 24.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.455 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -94.37 -44.99 7.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.317 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.13 128.52 53.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 53.9 m -70.2 -37.71 75.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.7 p -104.25 121.38 43.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.582 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.772 ' HB3' HD11 ' A' ' 437' ' ' ILE . 9.2 mt -107.38 129.27 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.6 m-80 -127.92 83.07 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.642 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.499 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.1 OUTLIER -89.68 136.62 32.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.495 HG22 ' HG3' ' A' ' 470' ' ' MET . 21.8 t -99.07 126.51 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.164 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.412 HG11 ' OD2' ' A' ' 432' ' ' ASP . 11.6 t -121.15 129.3 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -89.73 120.96 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -124.3 128.52 49.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.03 -100.98 0.89 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.347 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -139.93 23.85 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -141.91 148.35 38.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.147 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -91.73 136.46 33.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.1 mt -126.01 146.59 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.216 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.495 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -101.89 119.92 39.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.87 HG21 HD23 ' A' ' 428' ' ' LEU . 12.1 mm -107.17 133.6 51.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.4 HG23 ' OD1' ' A' ' 459' ' ' ASN . 0.2 OUTLIER -114.54 126.55 55.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.936 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 428' ' ' LEU . 20.6 t -135.98 130.35 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.03 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 33.8 mm -105.24 109.92 63.8 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.457 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.9 Cg_endo -58.06 175.49 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -123.92 155.81 37.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -94.21 135.2 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ILE . . . . . 0.422 HG22 ' HB2' ' A' ' 382' ' ' TYR . 0.8 OUTLIER -160.06 137.31 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.995 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -139.68 115.18 8.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.25 1.087 0 C-N-CA 122.387 2.058 . . . . 0.0 112.315 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.64 -74.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 60.4 71.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.806 HG22 HD13 ' A' ' 415' ' ' ILE . 9.2 pt -84.82 134.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.416 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 12.5 m95 -117.91 91.11 3.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 3.8 t90 -70.71 72.47 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.44 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.2 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 47.3 m -90.11 122.64 33.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.96 92.35 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.993 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 8.6 mtt -84.46 155.85 22.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.28 140.49 48.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -123.63 143.13 50.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.449 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 52.1 t80 -152.97 131.76 12.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.668 HG13 HG22 ' A' ' 385' ' ' ILE . 22.4 pt -116.85 -14.95 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.62 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 67.01 61.95 4.83 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.882 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.941 HD11 HG23 ' A' ' 414' ' ' ILE . 10.3 tt -165.37 137.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 111.266 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.509 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -96.59 145.9 25.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.782 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.504 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -141.46 139.5 33.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.742 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.446 ' CG ' HD11 ' A' ' 415' ' ' ILE . 6.2 ptm -116.83 162.88 17.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.9 p -85.37 115.85 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 398' ' ' LEU . 6.6 tp -69.13 84.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.8 t -71.12 173.7 7.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.9 m -62.56 -19.1 63.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.305 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -46.43 12.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.464 ' H ' HG23 ' A' ' 391' ' ' THR . 0.0 OUTLIER -82.91 -32.65 27.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -65.58 -51.02 62.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.386 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.19 -29.47 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -38.09 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.06 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 390' ' ' LEU . 6.1 mt -62.45 -52.58 62.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -29.93 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -60.0 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -65.68 -42.4 91.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.058 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -119.89 113.94 21.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -82.92 -27.44 30.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -25.64 59.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 402' ' ' HIS . 4.8 m-85 -55.46 161.27 3.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.582 ' HB2' HG22 ' A' ' 408' ' ' VAL . 45.6 Cg_endo -68.53 173.2 10.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.59 2.193 . . . . 0.0 112.21 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -98.31 30.98 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 406' ' ' PRO . 13.2 m -114.66 126.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.66 -30.16 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.51 173.78 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 104.65 173.94 24.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.443 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.28 140.14 43.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.15 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.849 ' HB2' HD13 ' A' ' 390' ' ' LEU . 23.3 t80 -90.54 128.06 36.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.668 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.941 HG23 HD11 ' A' ' 385' ' ' ILE . 8.0 mt -79.88 127.94 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 9.6 mm -85.4 -69.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -160.14 153.79 22.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.723 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.491 HG22 HD12 ' A' ' 385' ' ' ILE . 12.5 t -118.09 139.05 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.466 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 22.7 mm -79.75 146.57 64.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.507 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 418' ' ' ILE . 15.8 Cg_exo -69.52 6.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.822 2.348 . . . . 0.0 113.877 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.06 62.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.146 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.547 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.1 OUTLIER -155.42 171.81 6.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.772 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.46 ' HB2' HG13 ' A' ' 473' ' ' VAL . 82.3 Cg_endo -79.19 -18.12 11.36 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.535 2.157 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.616 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -60.43 -58.87 6.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.049 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.423 ' N ' HG11 ' A' ' 417' ' ' VAL . 3.4 tp10 -68.37 -27.76 66.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.63 38.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.383 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -76.24 -39.19 32.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.435 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 133.24 16.97 1.16 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.154 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 471' ' ' ILE . 3.0 mt -85.99 -170.65 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.074 0.437 . . . . 0.0 110.68 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.82 141.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 16.0 pm0 -62.22 178.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 36.1 m120 62.88 23.5 14.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.805 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.733 ' HB2' HD12 ' A' ' 414' ' ' ILE . 17.1 m-20 -125.42 -177.11 3.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.554 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -139.47 123.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 111.536 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.3 154.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -141.86 -49.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.683 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.71 ' N ' HD12 ' A' ' 435' ' ' ILE . 52.3 p -114.14 155.43 26.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.207 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.1 tt -157.77 111.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.028 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.447 ' O ' ' ND2' ' A' ' 438' ' ' ASN . 1.6 p-10 45.43 41.65 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.578 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 78.7 35.1 32.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.769 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.55 ' HB2' HG23 ' A' ' 437' ' ' ILE . 17.4 mm-40 -134.62 125.57 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.766 0.317 . . . . 0.0 110.924 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 68.8 p -80.93 110.77 16.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.906 HG11 ' CG2' ' A' ' 448' ' ' VAL . 10.8 t -92.2 143.1 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.11 -32.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.48 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.99 177.59 9.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.239 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.504 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -61.14 -42.45 98.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.037 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.433 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 24.5 p30 -53.87 -26.25 23.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.874 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -79.91 -50.69 10.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.688 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.906 ' CG2' HG11 ' A' ' 442' ' ' VAL . 41.3 t -56.75 -37.25 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.291 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 24.8 t -57.1 -65.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.399 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -51.67 -32.16 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.37 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 447' ' ' ASP . 41.5 t -66.64 -49.91 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.67 HD11 HG12 ' A' ' 448' ' ' VAL . 9.1 mt -58.25 -29.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -97.14 -14.28 21.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.422 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -97.64 -54.64 3.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 451' ' ' VAL . 17.2 mm-40 -86.48 126.3 34.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.927 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 73.5 m -69.03 -36.84 78.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' THR . . . . . 0.579 ' C ' HD23 ' A' ' 458' ' ' LEU . 1.5 p -108.44 136.27 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.679 ' HB3' HD11 ' A' ' 437' ' ' ILE . 4.0 mt -120.14 140.74 50.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.052 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' ASN . . . . . 0.717 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.1 m-80 -141.9 91.78 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.586 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.449 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -96.74 159.34 14.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 23.7 t -129.93 122.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.875 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.745 ' O ' HD12 ' A' ' 469' ' ' ILE . 5.6 t -112.91 147.45 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.206 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -114.61 139.36 49.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.804 ' HG2' HD11 ' A' ' 469' ' ' ILE . 21.1 ptt180 -132.23 126.51 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.793 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 59.93 -96.51 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -136.88 29.0 2.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 0.0 110.961 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.54 143.79 39.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.95 141.77 28.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.675 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.804 HD11 ' HG2' ' A' ' 464' ' ' ARG . 0.8 OUTLIER -127.03 125.31 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.159 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.522 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.0 OUTLIER -95.93 125.27 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.769 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 428' ' ' LEU . 3.5 mp -125.5 132.55 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.401 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.717 HG23 ' OD1' ' A' ' 459' ' ' ASN . 1.2 m -116.71 119.82 36.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.435 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 428' ' ' LEU . 21.2 t -124.92 140.71 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 111.399 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.569 HD12 HG22 ' A' ' 457' ' ' THR . 27.3 mm -124.09 111.99 28.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.717 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.449 ' HB3' HG23 ' A' ' 383' ' ' ILE . 23.9 Cg_endo -62.05 144.23 95.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.315 2.01 . . . . 0.0 112.353 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.7 171.62 7.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.968 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.14 135.65 33.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.94 134.76 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.4 109.93 50.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.515 2.144 . . . . 0.0 112.274 179.952 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.818 0.342 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.58 30.62 15.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -65.5 99.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.455 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.8 pt -69.5 157.03 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.433 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 13.3 m95 -118.78 91.89 3.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.426 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 5.4 t90 -72.98 79.64 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.18 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.464 -0.255 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.51 122.03 24.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -108.35 121.12 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 5.3 ttm -128.83 178.52 6.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.85 167.17 16.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.94 146.41 23.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -154.37 159.16 41.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.843 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.849 HG22 ' HG2' ' A' ' 422' ' ' PRO . 0.7 OUTLIER -135.38 -59.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.37 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 115.5 49.32 0.48 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.359 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.886 HD13 HG22 ' A' ' 417' ' ' VAL . 5.5 tp -138.93 132.58 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.031 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -89.8 129.82 36.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.561 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.457 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -138.36 157.57 45.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.106 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 412' ' ' ALA . 1.5 ptm -134.32 -179.59 5.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 4.2 p -94.67 15.82 17.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.369 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.778 HD13 ' HB2' ' A' ' 413' ' ' TYR . 12.5 tp 47.26 95.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.874 0.369 . . . . 0.0 111.481 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.673 HG23 ' H ' ' A' ' 394' ' ' LYS . 2.6 t -71.67 156.26 39.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.23 -30.57 70.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.1 m -66.62 -56.67 9.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.673 ' H ' HG23 ' A' ' 391' ' ' THR . 0.1 OUTLIER -71.43 -29.84 65.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.619 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -57.59 -60.01 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.45 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -61.9 -36.38 81.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 395' ' ' ALA . 4.7 mt -61.1 -43.5 98.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -66.12 -30.54 71.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -59.89 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -68.53 -60.62 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.8 85.23 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 65.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.124 0.488 . . . . 0.0 110.854 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -167.54 28.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -89.63 167.34 17.71 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.773 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.64 -24.4 12.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.527 2.151 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.6 t0 68.36 51.79 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.51 90.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.025 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.545 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -46.54 -30.97 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.474 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.4 m -116.61 130.49 56.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 163.57 178.33 37.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 434' ' ' ILE . . . -98.08 123.41 42.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.778 ' HB2' HD13 ' A' ' 390' ' ' LEU . 62.5 t80 -97.83 129.99 44.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.767 HG23 HD11 ' A' ' 385' ' ' ILE . 21.5 mt -80.69 109.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.605 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.768 HD13 HG22 ' B' ' 4' ' ' ILE . 2.8 mp -72.89 -58.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.294 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.735 ' O ' HD12 ' A' ' 385' ' ' ILE . 17.1 pt-20 -160.1 147.78 16.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.814 0.34 . . . . 0.0 111.208 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.886 HG22 HD13 ' A' ' 385' ' ' ILE . 24.8 t -108.85 133.28 54.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.939 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.508 ' O ' HG22 ' A' ' 421' ' ' THR . 0.3 OUTLIER -80.4 156.7 73.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.93 44.08 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.793 2.329 . . . . 0.0 112.58 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -173.31 35.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.562 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 418' ' ' ILE . 4.0 t -129.46 154.39 80.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.023 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.849 ' HG2' HG22 ' A' ' 383' ' ' ILE . 36.1 Cg_exo -61.19 -24.39 79.0 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.761 2.308 . . . . 0.0 112.325 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.848 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -53.72 -38.56 64.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.66 -29.66 59.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.39 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.953 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.724 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -67.89 -69.57 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.29 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 151.69 39.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.81 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.874 HD23 HG21 ' A' ' 471' ' ' ILE . 1.1 mt -98.48 -165.12 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -178.97 170.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.04 28.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.22 12.97 3.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.494 ' HB2' HD12 ' A' ' 414' ' ' ILE . 15.9 m-20 -119.12 173.37 6.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.631 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 412' ' ' ALA . 28.4 t -138.25 117.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.365 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 412' ' ' ALA . 3.6 mp -66.2 142.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.668 HD12 ' HB3' ' A' ' 436' ' ' SER . 2.1 pp -136.43 -46.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.567 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.668 ' HB3' HD12 ' A' ' 435' ' ' ILE . 24.2 p -121.7 156.51 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.926 HG21 HG11 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -151.54 124.45 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.002 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 44.71 30.89 0.57 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.576 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.22 27.26 23.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -118.13 170.19 9.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.746 0.307 . . . . 0.0 110.713 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 16.4 m -118.35 111.09 18.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.97 HG11 HG22 ' A' ' 448' ' ' VAL . 10.8 t -97.67 161.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.478 ' N ' HG12 ' A' ' 442' ' ' VAL . 8.6 m -139.45 -48.31 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.475 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.7 OUTLIER -126.05 167.82 14.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.414 . . . . 0.0 111.282 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.457 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.75 -41.38 81.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -55.84 -26.34 46.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.817 ' O ' HG23 ' A' ' 451' ' ' VAL . 6.3 m-20 -86.88 -29.74 21.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.97 HG22 HG11 ' A' ' 442' ' ' VAL . 13.4 t -72.13 -44.67 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.314 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.526 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.7 t -50.84 -64.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.624 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -46.61 -36.5 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.474 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.926 HG11 HG21 ' A' ' 437' ' ' ILE . 41.1 t -63.33 -50.09 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.207 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.2 mt -58.75 -37.2 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -90.34 -4.88 56.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.399 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -100.07 -51.35 3.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.63 142.36 28.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 5.3 t -81.28 -38.25 27.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.674 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' THR . . . . . 0.526 HG22 HD12 ' A' ' 474' ' ' ILE . 1.0 OUTLIER -106.61 117.76 34.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.601 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.765 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.0 mt -101.97 126.75 48.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -132.22 92.78 3.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.634 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.489 ' HG3' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -96.74 151.69 19.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.35 121.95 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.017 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 463' ' ' ARG . 9.0 t -107.43 161.42 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' ARG . . . . . 0.47 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -124.83 138.7 54.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.0 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.759 ' HB2' HD11 ' A' ' 469' ' ' ILE . 0.3 OUTLIER -147.65 121.27 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.743 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.79 -113.68 5.84 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.26 29.37 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.52 150.2 43.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.243 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -94.25 147.15 23.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.759 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.0 OUTLIER -127.88 132.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.256 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.31 119.88 39.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.654 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.874 HG21 HD23 ' A' ' 428' ' ' LEU . 11.5 mm -112.54 132.67 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 25.1 m -122.62 119.86 32.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.724 HG22 ' HA3' ' A' ' 426' ' ' GLY . 24.5 t -130.1 133.74 63.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.526 HD12 HG22 ' A' ' 457' ' ' THR . 26.3 mm -118.11 109.14 41.23 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.608 ' HB3' HG23 ' A' ' 383' ' ' ILE . 39.5 Cg_endo -66.84 -172.71 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.462 2.108 . . . . 0.0 112.226 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -143.1 173.5 11.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -102.83 130.34 49.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 16.5 tt -148.37 155.62 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.019 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.65 121.17 28.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.413 2.076 . . . . 0.0 112.292 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.754 0.311 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m 64.26 36.33 9.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.99 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 113.6 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.768 HG22 HD13 ' A' ' 415' ' ' ILE . 2.6 pt -81.26 118.13 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -94.71 92.65 7.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -68.24 85.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.123 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.44 125.53 54.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.21 -69.01 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.882 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.39 97.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.812 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -138.65 146.92 42.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -110.93 155.2 23.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.713 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.444 ' HB3' HG22 ' A' ' 478' ' ' ILE . 76.1 t80 -131.0 126.98 37.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 385' ' ' ILE . 11.0 pt -116.72 -4.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.425 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.478 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 50.07 67.27 1.91 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.857 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.958 HD13 HG22 ' A' ' 417' ' ' VAL . 4.8 tp -151.73 126.22 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 110.841 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.426 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 27.7 mtt85 -89.9 125.96 35.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.85 142.53 47.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.457 ' HB3' HD11 ' A' ' 415' ' ' ILE . 8.6 ptm -125.54 156.98 38.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 49.2 p -84.21 114.53 21.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' ' 395' ' ' ALA . 6.8 tp -63.93 81.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.4 t -62.12 158.69 16.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 m -57.42 -23.24 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -54.7 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.092 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.746 ' H ' HG23 ' A' ' 391' ' ' THR . 0.5 OUTLIER -63.71 -45.16 91.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.169 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.594 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -59.18 -39.85 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.185 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -77.63 -29.87 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.79 -47.57 62.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.14 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.5 -44.06 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -65.86 -31.7 72.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.74 -43.31 94.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 ttm-85 -93.09 -20.34 20.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.311 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -135.57 78.79 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -69.14 -22.8 63.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.79 -26.64 10.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -65.06 160.39 56.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.835 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.27 -167.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.565 2.177 . . . . 0.0 112.243 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -116.7 31.33 6.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.015 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.7 m -91.9 132.27 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.611 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -110.5 -18.26 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.31 154.23 18.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 116.56 159.35 11.65 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.616 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -90.11 147.77 23.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.117 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.547 ' HB2' HD13 ' A' ' 390' ' ' LEU . 74.6 t80 -102.42 131.25 49.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 432' ' ' ASP . 21.2 mt -80.01 122.92 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.889 ' CD1' HG22 ' B' ' 4' ' ' ILE . 17.9 mt -91.84 -61.24 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.831 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.769 ' O ' HD12 ' A' ' 385' ' ' ILE . 8.0 pt-20 -157.88 149.29 21.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.403 . . . . 0.0 111.415 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.958 HG22 HD13 ' A' ' 385' ' ' ILE . 20.4 t -117.4 140.37 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -86.79 135.37 35.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.729 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 7.9 Cg_exo -72.57 56.18 2.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.779 2.319 . . . . 0.0 112.496 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 178.25 40.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.162 0.506 . . . . 0.0 110.498 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.4 OUTLIER -142.78 173.83 4.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -75.77 -13.87 19.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.132 1.888 . . . . 0.0 111.856 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.499 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -66.15 -56.9 9.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.65 -31.78 70.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.456 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.94 -30.62 58.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.843 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -66.86 -34.06 86.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.255 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.95 26.83 2.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.843 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 471' ' ' ILE . 0.3 OUTLIER -96.47 -177.81 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -159.64 161.5 35.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.762 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -85.59 56.17 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.17 31.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.034 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 414' ' ' ILE . 14.9 m-20 -135.22 -174.34 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.815 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 412' ' ' ALA . 38.6 t -142.21 123.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.312 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.7 mt -75.7 147.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -138.69 -46.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.351 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.763 ' N ' HD12 ' A' ' 435' ' ' ILE . 90.9 p -116.93 156.32 27.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.726 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.932 HG21 HG11 ' A' ' 451' ' ' VAL . 4.5 tt -155.9 114.51 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.198 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.591 HD22 ' HG3' ' A' ' 440' ' ' GLN . 0.8 OUTLIER 44.33 33.42 0.85 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.454 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.68 36.16 9.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.773 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.591 ' HG3' HD22 ' A' ' 438' ' ' ASN . 0.0 OUTLIER -138.47 114.42 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 m -70.19 114.4 8.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.93 HG11 HG22 ' A' ' 448' ' ' VAL . 2.7 t -97.65 162.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 444' ' ' SER . 16.1 m -133.76 -45.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.433 ' N ' HG23 ' A' ' 443' ' ' VAL . 1.9 p -130.95 173.73 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.16 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.84 94.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.045 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.428 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 1.3 p-10 -53.99 -26.64 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.863 ' O ' HG23 ' A' ' 451' ' ' VAL . 12.5 m-20 -86.85 -41.4 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.93 HG22 HG11 ' A' ' 442' ' ' VAL . 46.9 t -63.19 -30.63 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.131 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.494 ' HA ' HD12 ' A' ' 452' ' ' ILE . 4.9 t -63.59 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -51.27 -36.38 41.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.504 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.932 HG11 HG21 ' A' ' 437' ' ' ILE . 40.9 t -60.72 -47.73 91.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 448' ' ' VAL . 5.5 mt -62.09 -37.5 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.15 -8.05 55.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.224 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -98.92 -46.82 5.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.819 0.343 . . . . 0.0 110.843 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.26 140.33 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 35.3 t -84.88 -34.31 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.739 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' THR . . . . . 0.474 HG22 HD12 ' A' ' 474' ' ' ILE . 2.1 p -109.17 100.21 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.758 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 452' ' ' ILE . 8.3 mt -94.53 136.31 34.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.7 m-80 -133.82 89.02 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.633 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.458 ' HE1' ' HB ' ' A' ' 473' ' ' VAL . 0.1 OUTLIER -92.48 173.78 7.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 470' ' ' MET . 13.2 t -134.68 145.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.883 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 432' ' ' ASP . 7.3 t -140.58 153.47 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.001 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -101.76 119.84 39.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.98 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.496 ' HB2' HD12 ' A' ' 469' ' ' ILE . 9.3 mtp180 -127.81 139.64 52.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.7 -101.72 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.169 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -140.19 20.56 2.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.778 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -145.8 168.47 20.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.92 136.08 42.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.649 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.8 mt -127.53 143.98 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.593 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -90.7 119.89 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.714 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 428' ' ' LEU . 21.8 mm -103.21 130.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.455 HG23 ' OD1' ' A' ' 459' ' ' ASN . 0.2 OUTLIER -102.77 129.12 49.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.013 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.458 ' HB ' ' HE1' ' A' ' 460' ' ' MET . 18.4 t -140.36 119.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.474 HD12 HG22 ' A' ' 457' ' ' THR . 21.2 mm -108.19 109.85 61.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.165 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.459 ' HG3' HG23 ' A' ' 452' ' ' ILE . 58.2 Cg_exo -51.43 131.27 35.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.43 2.087 . . . . 0.0 112.33 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.0 170.56 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.97 129.83 54.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.841 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' ILE . . . . . 0.444 HG22 ' HB3' ' A' ' 382' ' ' TYR . 19.6 tt -140.97 152.76 20.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -147.51 119.13 4.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.843 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.462 2.108 . . . . 0.0 112.307 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.808 0.337 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m 55.55 26.46 9.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.076 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -60.16 117.05 4.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.889 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.4 pt -84.26 123.08 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.6 m95 -108.57 95.37 5.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.426 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 6.8 t90 -76.85 62.56 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.808 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.064 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 46.8 t -129.11 -43.87 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.42 -76.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.63 112.41 24.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.02 147.86 48.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.13 152.01 22.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -152.02 124.42 8.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.024 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 385' ' ' ILE . 24.5 pt -113.36 -4.2 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.463 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.551 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 53.6 65.82 3.17 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.734 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.807 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.13 124.82 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.947 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 1.9 mtp180 -92.3 125.15 36.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.505 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -127.07 137.28 53.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.416 ' HB3' HD11 ' A' ' 415' ' ' ILE . 3.7 ptm -115.85 173.26 6.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.012 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.5 p -97.69 105.55 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.632 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.867 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.2 tp -54.37 98.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.7 t -87.01 165.09 16.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.839 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.8 m -58.92 -29.7 67.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.067 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 71.2 m -78.55 -19.05 53.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -51.26 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 111.072 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -57.35 -45.84 83.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.313 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -66.72 -29.71 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.82 -41.06 62.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.993 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 395' ' ' ALA . 7.1 mt -59.97 -38.45 82.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -34.2 68.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.98 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -77.28 -29.27 53.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -53.25 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -116.31 115.74 26.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.003 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.79 55.62 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.841 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -146.97 19.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.103 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.83 158.28 35.35 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 -172.74 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.588 2.192 . . . . 0.0 112.211 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -109.29 32.03 5.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 11.7 m -102.3 129.6 53.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pt -102.57 -32.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.5 m -87.78 149.9 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.773 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 132.17 -157.8 22.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -132.96 127.62 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.867 ' HB2' HD13 ' A' ' 390' ' ' LEU . 41.4 t80 -90.33 128.03 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.807 HG23 HD11 ' A' ' 385' ' ' ILE . 15.3 mt -80.57 109.97 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.515 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -71.3 -58.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 430' ' ' GLU . 6.4 pt-20 -158.31 152.14 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.401 . . . . 0.0 111.245 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.53 HG22 ' CG1' ' A' ' 385' ' ' ILE . 22.2 t -127.95 136.35 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.954 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.596 HG22 ' HD2' ' A' ' 419' ' ' PRO . 8.4 mm -79.86 146.23 63.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.596 ' HD2' HG22 ' A' ' 418' ' ' ILE . 11.9 Cg_exo -71.15 0.52 6.54 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.744 2.296 . . . . 0.0 113.319 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -127.35 61.75 1.38 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.8 OUTLIER -152.7 168.99 10.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.564 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.561 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 59.7 Cg_endo -74.31 -18.06 20.89 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.265 1.977 . . . . 0.0 111.48 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -61.8 -59.22 5.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.554 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.49 -27.08 64.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.563 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.44 -30.45 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.18 1.26 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 167.97 31.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.903 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.661 HD11 HG21 ' A' ' 473' ' ' VAL . 0.3 OUTLIER -108.12 -168.15 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.805 0.336 . . . . 0.0 110.82 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.55 169.62 2.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.774 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 416' ' ' GLU . 0.4 OUTLIER -89.92 49.93 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -160.46 29.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.472 ' HB2' HD12 ' A' ' 414' ' ' ILE . 29.8 m-20 -134.15 -177.34 4.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.58 117.89 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.19 149.58 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 436' ' ' SER . 2.3 pp -141.95 -47.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.78 ' N ' HD12 ' A' ' 435' ' ' ILE . 96.3 p -123.64 144.94 49.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.97 HG21 HG11 ' A' ' 451' ' ' VAL . 3.9 tt -143.52 119.62 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.555 HD22 ' HG3' ' A' ' 440' ' ' GLN . 0.7 OUTLIER 44.85 30.49 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.734 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.07 20.37 42.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.201 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.555 ' HG3' HD22 ' A' ' 438' ' ' ASN . 20.3 mt-30 -112.31 157.67 20.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.78 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.17 118.3 31.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.628 HG11 HG22 ' A' ' 448' ' ' VAL . 57.9 t -109.51 127.45 66.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.29 6.49 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.95 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.9 OUTLIER -170.41 161.52 8.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.881 0.372 . . . . 0.0 111.152 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.505 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -58.2 -45.19 88.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.048 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.42 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 36.4 p-10 -56.58 -28.42 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.819 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.5 OUTLIER -77.69 -33.8 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.628 HG22 HG11 ' A' ' 442' ' ' VAL . 18.0 t -74.45 -37.39 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.195 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.542 ' HA ' HD12 ' A' ' 452' ' ' ILE . 7.6 t -55.27 -57.55 11.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -54.94 -41.04 70.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.339 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.97 HG11 HG21 ' A' ' 437' ' ' ILE . 39.5 t -58.56 -47.34 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.148 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 449' ' ' SER . 8.4 mt -58.8 -36.05 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.68 -0.84 54.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.322 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -100.22 -47.8 4.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 110.916 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.2 152.81 31.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.75 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.9 t -94.27 -35.61 12.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.695 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 94.3 6.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.714 ' HB3' HD11 ' A' ' 437' ' ' ILE . 14.9 mt -89.86 123.24 33.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -111.13 83.16 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.434 ' HE3' ' HB2' ' A' ' 458' ' ' LEU . 2.6 mtt -90.29 133.35 35.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 469' ' ' ILE . 28.7 t -108.28 124.71 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.902 HG23 HD13 ' A' ' 471' ' ' ILE . 3.0 t -111.27 163.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.6 OUTLIER -124.76 143.91 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.047 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.765 ' HB2' HD11 ' A' ' 469' ' ' ILE . 16.0 mtp180 -144.73 130.36 19.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.82 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.22 -99.54 0.21 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.436 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.26 30.89 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.754 0.312 . . . . 0.0 110.944 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.12 144.94 24.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.765 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mp -128.76 129.65 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 111.317 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.69 125.21 47.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.492 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.902 HD13 HG23 ' A' ' 462' ' ' VAL . 3.8 mp -132.66 143.61 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.44 . . . . 0.0 111.618 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.18 135.92 53.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.768 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.5 t -135.94 135.1 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.566 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.768 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.5 mp -119.83 109.26 37.97 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.586 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.12 155.96 5.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.425 2.084 . . . . 0.0 112.292 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.18 170.62 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.56 144.76 25.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.97 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 13.0 tt -143.5 130.46 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.046 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -115.19 111.97 44.42 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.859 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo . . . . . 0 C--O 1.249 1.037 0 C-N-CA 122.361 2.041 . . . . 0.0 112.341 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.816 0.341 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -97.72 47.2 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.0 mtt-85 -61.62 89.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.515 HG22 ' CD1' ' A' ' 415' ' ' ILE . 2.3 pp -80.78 133.43 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.42 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.4 m0 -112.04 88.13 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.42 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 7.3 t90 -71.17 68.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.422 HG23 ' HE3' ' A' ' 387' ' ' MET . 21.1 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.198 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.3 m -131.64 31.81 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -101.89 28.6 5.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.47 119.67 23.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.53 122.51 7.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.999 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -84.68 172.82 11.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.597 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 384' ' ' GLY . 13.0 t80 -155.83 121.1 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.241 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.0 pt -111.35 -13.02 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.237 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.559 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 70.42 52.77 15.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.729 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.797 HD11 HG23 ' A' ' 414' ' ' ILE . 10.9 tt -165.31 137.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.419 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -89.96 158.18 17.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.463 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.426 ' HE3' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -153.22 133.63 13.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.448 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.8 OUTLIER -110.69 173.8 6.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.019 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.3 p -100.16 112.6 24.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.832 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 398' ' ' LEU . 4.3 tp -63.52 88.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.127 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 2.3 t -85.57 167.37 15.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.32 -39.68 6.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.728 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -68.97 -58.36 4.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 111.229 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -52.5 64.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.323 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.25 -33.89 21.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.474 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -90.1 -29.51 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.043 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -65.32 -44.0 89.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 390' ' ' LEU . 3.4 mt -58.69 -39.23 80.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.046 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -67.08 -30.2 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -68.83 -59.38 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -66.03 -38.54 88.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.798 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.03 98.23 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -81.91 59.72 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.036 0.446 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.39 23.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.939 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -93.87 146.37 31.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.4 ' HB2' HG22 ' A' ' 408' ' ' VAL . 51.0 Cg_exo -53.17 179.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.269 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.42 38.23 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.814 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 408' ' ' VAL . 34.9 m -109.44 117.39 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.51 -29.72 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 435' ' ' ILE . 0.2 OUTLIER -87.11 148.85 25.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.003 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 122.21 170.43 13.71 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.685 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -108.46 152.71 24.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.026 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.707 ' HB2' HD13 ' A' ' 390' ' ' LEU . 27.2 t80 -92.19 133.79 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 432' ' ' ASP . 38.2 mt -79.98 121.78 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.037 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 416' ' ' GLU . 2.0 mm -88.76 -152.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.623 ' H ' HG22 ' A' ' 415' ' ' ILE . 17.0 pt-20 -79.35 145.15 33.58 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 0.0 111.074 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.473 HG11 ' N ' ' A' ' 424' ' ' GLU . 14.2 t -110.9 159.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.467 ' N ' HG12 ' A' ' 417' ' ' VAL . 20.6 mm -96.86 136.0 21.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.8 59.03 4.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.519 2.146 . . . . 0.0 112.579 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 174.93 44.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.586 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.559 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.2 OUTLIER -150.95 173.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -76.18 -16.28 17.77 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.309 2.006 . . . . 0.0 112.089 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -60.63 -60.05 4.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.473 ' N ' HG11 ' A' ' 417' ' ' VAL . 6.0 tp10 -74.06 -23.25 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 422' ' ' PRO . . . -82.04 -26.12 34.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.13 -70.06 1.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 171.55 30.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.997 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.539 HD21 HG21 ' A' ' 473' ' ' VAL . 0.2 OUTLIER -107.74 176.03 5.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.829 0.315 . . . . 0.0 110.643 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.99 157.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.28 77.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.95 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.846 ' HB2' HD12 ' A' ' 414' ' ' ILE . 22.9 m-20 -72.24 179.32 3.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.978 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 412' ' ' ALA . 22.7 t -139.8 131.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.556 HG23 ' HB3' ' A' ' 460' ' ' MET . 3.2 mt -86.06 145.34 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.735 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -140.57 -48.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.735 ' N ' HD12 ' A' ' 435' ' ' ILE . 19.1 p -110.01 158.79 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.2 tt -158.48 116.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.281 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.527 HD22 ' HG3' ' A' ' 440' ' ' GLN . 0.5 OUTLIER 42.52 50.54 4.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.649 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 70.61 44.96 56.03 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.798 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.527 ' HG3' HD22 ' A' ' 438' ' ' ASN . 1.3 mm100 -137.97 152.94 49.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 55.6 m -103.79 107.32 18.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.941 HG11 ' CG2' ' A' ' 448' ' ' VAL . 13.3 t -100.29 143.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.07 -4.21 5.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.93 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.8 p -169.97 168.27 8.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.249 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.426 ' HB1' ' HE3' ' A' ' 387' ' ' MET . . . -58.15 -43.84 87.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.417 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 18.3 p30 -53.31 -27.0 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.803 ' O ' HG23 ' A' ' 451' ' ' VAL . 13.0 m-20 -84.86 -33.77 22.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.758 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.941 ' CG2' HG11 ' A' ' 442' ' ' VAL . 45.8 t -72.95 -37.36 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.205 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.406 ' HA ' HD12 ' A' ' 452' ' ' ILE . 11.1 t -55.26 -59.14 5.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.71 -24.64 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.28 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 447' ' ' ASP . 37.7 t -76.5 -50.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.165 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.499 HD11 HG12 ' A' ' 448' ' ' VAL . 7.8 mt -56.58 -27.58 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.21 -11.93 22.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.403 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.04 -51.04 3.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -95.03 134.91 37.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.55 -34.97 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.2 p -103.34 115.22 30.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.703 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.1 mt -106.93 133.54 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.227 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 90.15 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.518 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.556 ' HB3' HG23 ' A' ' 434' ' ' ILE . 0.0 OUTLIER -97.28 149.05 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.308 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 469' ' ' ILE . 25.6 t -120.38 125.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.837 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.783 HG22 HD13 ' A' ' 471' ' ' ILE . 16.1 m -117.25 -179.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.353 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -119.46 125.99 50.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.82 ' HB3' HD11 ' A' ' 469' ' ' ILE . 1.2 ttt85 -118.55 120.24 36.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.61 -94.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.277 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -140.05 27.12 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -144.56 168.46 20.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.92 140.09 42.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 464' ' ' ARG . 1.9 mt -128.13 147.38 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 111.232 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.577 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -94.97 125.36 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.713 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.783 HD13 HG22 ' A' ' 462' ' ' VAL . 4.8 mp -121.0 127.91 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.259 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 55.3 m -106.93 122.95 47.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.539 HG21 HD21 ' A' ' 428' ' ' LEU . 27.1 t -127.63 137.21 58.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.044 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -122.65 109.63 32.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.738 ' HB3' HG23 ' A' ' 383' ' ' ILE . 47.9 Cg_endo -68.55 159.46 53.42 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.419 2.079 . . . . 0.0 112.35 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.54 -176.1 2.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -116.73 131.93 56.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 18.7 tt -148.64 150.08 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.95 121.07 52.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.351 2.034 . . . . 0.0 112.29 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.848 0.356 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.412 ' HB3' HG23 ' B' ' 4' ' ' ILE . 26.4 m -72.37 -54.16 10.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.746 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 56.32 39.24 30.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' B' ' 2' ' ' SER . 2.0 pp -75.27 148.14 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.417 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 9.7 m0 -109.7 111.15 22.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -80.7 75.87 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.563 ' O ' HG12 ' B' ' 7' ' ' VAL . 10.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.149 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 14.9 t -152.09 172.67 15.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.739 0.304 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -125.99 41.46 3.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.005 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -147.7 68.62 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.938 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -143.71 102.36 3.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.788 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.81 146.51 28.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.5 ' HB2' HG21 ' A' ' 478' ' ' ILE . 73.2 t80 -145.67 131.46 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.82 HG13 HG22 ' A' ' 385' ' ' ILE . 3.6 pt -127.71 12.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.725 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 42.95 63.14 2.08 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.375 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 1.006 HD13 HG22 ' A' ' 417' ' ' VAL . 7.2 tp -148.74 124.33 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.163 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 386' ' ' ARG . 11.6 mtt180 -89.64 121.27 31.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.79 ' CE ' HG23 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -128.86 147.46 50.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.056 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.44 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 5.5 ptm -127.51 173.9 9.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.934 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 31.9 p -89.16 99.98 12.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.925 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.2 tp -58.53 88.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.624 HG23 ' H ' ' A' ' 394' ' ' LYS . 7.7 t -75.79 169.53 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.809 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.7 p -54.65 -37.65 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.1 t -69.62 -56.14 8.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.624 ' H ' HG23 ' A' ' 391' ' ' THR . 0.1 OUTLIER -62.45 -39.11 92.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.66 80.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.141 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -27.74 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -45.74 83.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.04 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 17.8 mt -67.14 -30.93 71.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -30.8 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -50.76 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.92 -68.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 87.55 7.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -78.71 61.64 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -151.19 21.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.945 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 398' ' ' LEU . 23.2 m-85 -91.57 159.33 38.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.99 174.83 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.659 2.239 . . . . 0.0 112.188 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.33 45.73 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.36 148.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 410' ' ' SER . 2.7 pp -125.37 -40.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.298 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' SER . . . . . 0.623 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -75.44 133.0 41.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.887 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 146.06 -177.59 24.33 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.407 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.587 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -106.68 141.53 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.925 ' HB2' HD13 ' A' ' 390' ' ' LEU . 64.2 t80 -94.71 137.84 33.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.835 HG23 HD11 ' A' ' 385' ' ' ILE . 23.0 mt -87.04 116.41 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.681 ' CD1' HG22 ' B' ' 4' ' ' ILE . 37.0 mt -84.84 -62.93 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.464 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.855 ' O ' HD12 ' A' ' 385' ' ' ILE . 10.9 pt-20 -154.57 153.57 31.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.158 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 1.006 HG22 HD13 ' A' ' 385' ' ' ILE . 21.7 t -121.36 141.83 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.456 ' HB ' HG22 ' A' ' 421' ' ' THR . 16.2 mm -81.52 142.55 50.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.83 -0.91 8.52 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.816 2.344 . . . . 0.0 113.686 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -130.55 59.58 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.25 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.472 ' OG1' ' HD2' ' A' ' 422' ' ' PRO . 0.7 OUTLIER -160.54 157.8 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.472 ' HD2' ' OG1' ' A' ' 421' ' ' THR . 31.9 Cg_exo -60.14 -20.68 62.67 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -58.0 -38.09 75.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.012 0.434 . . . . 0.0 110.985 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -84.72 -30.95 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.695 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.15 -31.5 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.561 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -66.75 -35.5 89.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.271 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.77 27.48 2.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.861 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.501 HD23 HG21 ' A' ' 471' ' ' ILE . 1.3 mt -92.63 -174.28 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.817 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.577 ' O ' HG21 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -179.91 169.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.907 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.88 54.65 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.84 26.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.206 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.522 ' HB2' HD12 ' A' ' 414' ' ' ILE . 1.6 m-20 -138.96 -174.53 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.837 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 412' ' ' ALA . 21.8 t -143.36 119.41 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.369 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.55 116.92 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.732 HD12 ' HB3' ' A' ' 436' ' ' SER . 2.6 pp -105.05 -42.18 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.692 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.732 ' HB3' HD12 ' A' ' 435' ' ' ILE . 51.6 p -126.53 159.52 33.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.962 0.411 . . . . 0.0 111.062 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.747 ' CG2' HG11 ' A' ' 451' ' ' VAL . 3.4 tt -156.54 113.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 24.0 p30 44.23 44.61 6.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.75 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.15 37.93 36.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.072 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.475 ' HB2' HG23 ' A' ' 437' ' ' ILE . 7.4 mm-40 -131.99 128.3 38.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t -76.34 110.19 10.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 443' ' ' VAL . 58.0 t -90.61 156.07 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.462 ' N ' HG12 ' A' ' 442' ' ' VAL . 12.2 m -145.95 -47.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.451 ' N ' HG23 ' A' ' 443' ' ' VAL . 1.6 p -137.5 171.63 14.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.014 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.36 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.303 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.409 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 25.7 p30 -54.42 -26.1 28.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.34 -57.3 3.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.805 HG12 HD11 ' A' ' 452' ' ' ILE . 38.9 t -47.57 -40.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.569 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 452' ' ' ILE . 6.9 t -55.55 -63.71 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.49 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -50.31 -26.87 5.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.545 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.747 HG11 ' CG2' ' A' ' 437' ' ' ILE . 60.5 t -77.56 -46.95 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.805 HD11 HG12 ' A' ' 448' ' ' VAL . 7.3 mt -57.8 -27.53 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.165 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -100.31 -8.76 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.552 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.07 -49.46 4.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.18 132.4 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -35.72 55.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.806 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 2.6 t -104.34 116.07 31.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.634 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.5 mt -102.69 129.98 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.016 0.436 . . . . 0.0 111.315 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' ASN . . . . . 0.617 ' OD1' HG23 ' A' ' 472' ' ' THR . 20.5 m-80 -131.84 96.82 4.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.55 147.15 26.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.5 t -121.54 132.93 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.776 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.4 m -132.77 167.91 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 111.338 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 119.78 34.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.016 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 23.1 mtp180 -116.14 136.36 53.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.526 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.7 -101.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.218 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.37 28.6 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.799 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -143.59 147.66 34.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.148 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.06 140.04 30.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.562 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.4 mt -131.12 142.61 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.459 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.46 119.72 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.501 HG21 HD23 ' A' ' 428' ' ' LEU . 11.2 mm -105.47 136.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.654 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.617 HG23 ' OD1' ' A' ' 459' ' ' ASN . 21.3 m -124.18 119.56 29.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.369 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.561 HG22 ' HA3' ' A' ' 426' ' ' GLY . 22.4 t -129.32 141.12 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.336 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 27.9 mm -119.21 109.98 38.32 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.651 ' HB3' HG23 ' A' ' 383' ' ' ILE . 17.9 Cg_endo -59.57 164.77 10.7 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.487 2.125 . . . . 0.0 112.404 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -113.89 -176.83 2.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -101.88 121.09 41.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 382' ' ' TYR . 19.8 tt -116.24 144.91 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.02 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -126.66 109.55 22.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.429 2.086 . . . . 0.0 112.317 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.903 0.382 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.44 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 3.6 p 50.13 42.95 25.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.318 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -64.81 88.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.781 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.681 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.7 pp -84.27 124.5 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.409 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m0 -109.92 120.4 42.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -82.56 58.37 4.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.79 HG23 ' CE ' ' A' ' 387' ' ' MET . 1.8 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.037 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 377' ' ' SER . . . . . 0.4 ' O ' ' CG ' ' A' ' 378' ' ' HIS . 0.3 OUTLIER 60.82 161.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 0.0 110.889 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 378' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 377' ' ' SER . 39.0 m80 -159.45 -43.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -95.68 45.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.867 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -72.71 125.05 26.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -67.17 134.77 52.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.43 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 19.2 t80 -144.49 122.3 11.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.667 HG13 HG22 ' A' ' 385' ' ' ILE . 10.1 pt -106.17 -5.55 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.48 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.523 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 56.89 64.39 4.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.512 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.967 HD13 HG22 ' A' ' 417' ' ' VAL . 3.8 tp -161.36 134.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.011 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.519 ' H ' HD12 ' A' ' 385' ' ' ILE . 20.4 mtt180 -91.34 133.0 35.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.669 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.418 ' HA ' HD12 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -140.78 150.33 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.406 ' CE ' ' CB ' ' B' ' 2' ' ' SER . 1.8 ptm -128.26 -177.59 4.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.793 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.8 p -99.48 9.74 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.53 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.8 tp 52.42 97.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.3 t -83.65 163.58 20.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -31.92 68.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -30.32 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -96.73 -42.27 8.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -64.91 -52.11 58.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.24 66.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.6 -39.03 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 395' ' ' ALA . 9.8 mt -64.17 -45.66 87.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.97 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -59.29 -29.97 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.34 -28.73 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -93.23 -29.69 15.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -100.67 -53.66 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.011 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 74.48 -59.26 0.56 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -47.13 -28.32 1.74 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.372 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -55.94 161.79 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -175.34 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.606 2.204 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.94 -11.98 19.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.351 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.6 m -52.39 167.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.734 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -136.73 12.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.467 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.4 m -130.37 130.61 44.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.813 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 171.52 169.04 33.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.379 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 434' ' ' ILE . . . -100.28 122.81 43.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 111.161 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.762 ' HB2' HD13 ' A' ' 390' ' ' LEU . 54.5 t80 -103.87 128.97 51.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.781 HG23 HD11 ' A' ' 385' ' ' ILE . 4.3 mt -79.81 114.98 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.589 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.526 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -78.48 -70.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.628 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.665 ' O ' HD12 ' A' ' 385' ' ' ILE . 4.8 pt-20 -144.17 143.12 30.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.967 HG22 HD13 ' A' ' 385' ' ' ILE . 21.3 t -111.37 146.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.05 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -98.35 128.96 31.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.78 61.53 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.698 2.266 . . . . 0.0 112.38 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.44 40.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.598 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.523 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -145.65 158.92 49.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.801 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.92 -23.2 33.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.327 2.018 . . . . 0.0 111.808 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.439 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -58.36 -60.06 4.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.207 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.78 -31.51 64.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.745 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.69 68.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.58 -30.98 70.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.383 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 24.91 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.777 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.584 HD23 HG21 ' A' ' 471' ' ' ILE . 0.1 OUTLIER -102.33 -177.66 3.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.776 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.74 179.66 7.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.767 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.76 31.63 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -143.24 26.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.593 ' C ' HD12 ' A' ' 414' ' ' ILE . 62.3 m-20 -119.44 -177.75 3.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.588 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 412' ' ' ALA . 38.8 t -142.07 129.58 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 0.0 111.403 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 412' ' ' ALA . 2.1 mp -86.09 152.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.669 HD12 ' N ' ' A' ' 436' ' ' SER . 1.9 pp -140.63 -50.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.654 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.669 ' N ' HD12 ' A' ' 435' ' ' ILE . 69.9 p -128.67 158.44 38.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.842 HD13 HG11 ' A' ' 451' ' ' VAL . 10.8 tt -150.3 118.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.337 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 19.8 p30 44.78 35.35 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.931 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.34 38.94 8.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.985 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -129.44 145.19 51.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.547 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.59 104.4 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.462 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.563 HG11 HG22 ' A' ' 448' ' ' VAL . 59.5 t -86.6 147.45 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.459 HG22 ' OD2' ' A' ' 447' ' ' ASP . 17.0 m -133.72 -45.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.37 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.444 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -133.67 169.86 16.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.422 . . . . 0.0 111.149 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.4 71.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.019 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.41 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 16.6 p30 -59.5 -30.59 68.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.831 ' O ' HG23 ' A' ' 451' ' ' VAL . 3.7 m-20 -75.62 -43.5 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.787 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.563 HG22 HG11 ' A' ' 442' ' ' VAL . 45.9 t -63.23 -37.04 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.814 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.5 t -59.42 -65.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.467 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -48.25 -27.6 2.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.842 HG11 HD13 ' A' ' 437' ' ' ILE . 47.4 t -71.32 -43.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.814 HD12 ' HA ' ' A' ' 449' ' ' SER . 4.8 mt -61.98 -32.36 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.91 -17.26 25.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.328 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -93.47 -47.51 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.13 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.76 142.25 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 474' ' ' ILE . 0.4 OUTLIER -92.59 -32.18 14.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.677 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.3 t -109.03 99.95 9.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.707 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.5 mt -90.22 133.71 34.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -134.24 91.77 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.628 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.433 ' HE1' ' HB3' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -108.48 152.39 24.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 469' ' ' ILE . 27.2 t -100.05 141.69 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.628 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 432' ' ' ASP . 4.2 t -142.28 160.53 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.175 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' ARG . . . . . 0.432 ' N ' HG12 ' A' ' 462' ' ' VAL . 6.8 tmm_? -98.92 133.15 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.867 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.458 ' HB3' HD11 ' A' ' 469' ' ' ILE . 7.8 ttp180 -130.55 132.61 45.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.04 -95.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.157 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.06 21.36 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.701 0.286 . . . . 0.0 110.851 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -143.58 164.7 29.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.02 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.43 137.22 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.4 mt -131.8 160.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.535 ' SD ' HG22 ' A' ' 461' ' ' VAL . 0.9 OUTLIER -99.68 119.69 38.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.16 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.584 HG21 HD23 ' A' ' 428' ' ' LEU . 13.1 mm -107.89 152.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 458' ' ' LEU . 91.8 m -139.02 119.79 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.797 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 428' ' ' LEU . 21.3 t -122.74 151.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 456' ' ' SER . 21.2 mm -121.35 109.9 34.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.437 ' HB3' HG23 ' A' ' 383' ' ' ILE . 26.2 Cg_endo -62.17 152.23 77.29 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.358 2.039 . . . . 0.0 112.237 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.54 168.68 10.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.75 141.69 29.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 18.4 tt -145.75 140.5 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -98.79 109.75 54.69 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.477 2.118 . . . . 0.0 112.41 179.945 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.907 0.384 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.406 ' CB ' ' CE ' ' A' ' 388' ' ' MET . 1.1 p -96.0 41.31 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.949 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -59.68 108.45 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.526 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.6 pt -79.22 127.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.22 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.41 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m95 -107.29 91.08 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 1.5 t90 -73.57 68.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.516 HG12 ' OXT' ' B' ' 7' ' ' VAL . 20.5 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.198 -0.905 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.83 26.11 6.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 0.0 111.008 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 16.3 m80 54.08 86.31 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.064 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.46 -35.28 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.996 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -151.66 161.67 42.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.072 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 452' ' ' ILE . 6.5 mmtt -113.23 -175.76 2.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.737 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.693 ' HB2' HG21 ' A' ' 478' ' ' ILE . 80.6 t80 -155.85 120.47 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.254 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.588 HG13 HG22 ' A' ' 385' ' ' ILE . 12.0 pt -111.16 -22.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 80.64 66.92 1.59 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.801 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.629 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.29 129.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.389 . . . . 0.0 110.813 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -89.95 120.42 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.483 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -126.36 143.65 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.812 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.47 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.8 ptm -123.52 164.53 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 40.1 p -85.87 99.43 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.886 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.6 tp -55.76 108.59 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.52 170.33 10.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.766 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.8 m -58.17 -21.76 48.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.421 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.3 t -77.61 -47.28 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.98 -32.14 25.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.168 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.31 -36.35 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.205 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -90.01 -32.47 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.29 -33.49 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.25 -49.88 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -58.29 -43.1 87.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.47 -25.98 67.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -93.06 -62.13 1.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 1.0 OUTLIER -85.05 -59.46 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 79.72 -49.2 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.03 -27.04 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.717 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 29.6 m-85 -43.01 163.16 0.16 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.428 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.98 -20.83 14.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.625 2.217 . . . . 0.0 112.761 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 75.71 40.56 0.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 110.781 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.519 HG11 HG21 ' A' ' 435' ' ' ILE . 2.8 m -101.35 98.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pp -55.63 -29.27 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.38 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.84 141.48 39.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 145.47 176.97 19.87 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -104.28 155.62 18.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.886 ' HB2' HD13 ' A' ' 390' ' ' LEU . 46.5 t80 -107.66 138.46 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.954 HD12 ' HB2' ' A' ' 432' ' ' ASP . 27.6 mt -89.74 109.96 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.765 ' CD1' HG22 ' B' ' 4' ' ' ILE . 5.3 mt -74.51 -66.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.214 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.85 167.85 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.887 0.375 . . . . 0.0 111.139 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.498 HG22 HG12 ' A' ' 385' ' ' ILE . 21.2 t -134.84 147.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.3 mp -79.72 134.5 57.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.308 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 50.5 Cg_exo -55.33 -12.47 5.73 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.031 2.487 . . . . 0.0 114.686 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' ASP . . . . . 0.799 ' H ' HG22 ' A' ' 418' ' ' ILE . 41.0 m-20 -132.97 72.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.925 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 4.9 p -159.08 160.87 28.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.984 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.95 -20.17 51.58 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.329 2.02 . . . . 0.0 111.41 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.492 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -61.19 -60.15 4.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -76.33 -30.57 57.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.24 -7.4 59.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.558 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 471' ' ' ILE . . . -90.15 -31.74 10.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.418 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 129.79 17.79 1.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.022 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 423' ' ' ALA . 0.9 OUTLIER -96.9 -175.87 3.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.75 146.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.97 -177.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.64 24.94 12.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.954 ' HB2' HD12 ' A' ' 414' ' ' ILE . 8.9 m-20 -126.71 177.01 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 412' ' ' ALA . 33.1 t -136.89 126.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.472 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 435' ' ' ILE . 3.8 mt -81.11 154.58 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.577 HD12 ' N ' ' A' ' 436' ' ' SER . 1.9 pp -143.19 -47.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.577 ' N ' HD12 ' A' ' 435' ' ' ILE . 94.6 p -120.94 154.99 35.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.344 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.572 HD11 ' HB3' ' A' ' 458' ' ' LEU . 2.7 tt -153.88 116.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 16.9 p30 45.43 32.03 0.99 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.545 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.37 8.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.693 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -133.53 138.1 45.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.29 107.9 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 448' ' ' VAL . 63.2 t -90.75 146.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 444' ' ' SER . 26.2 m -129.32 -43.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.335 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.441 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -138.62 172.32 13.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.913 0.387 . . . . 0.0 111.17 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.483 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.33 -38.76 74.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.404 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 6.1 p30 -59.19 -29.74 67.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -76.65 -38.35 54.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 442' ' ' VAL . 38.9 t -70.12 -37.99 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.785 ' HA ' HD12 ' A' ' 452' ' ' ILE . 9.5 t -56.67 -62.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.322 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -50.43 -29.18 9.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.885 HG13 ' OE2' ' A' ' 455' ' ' GLU . 59.9 t -70.78 -42.96 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.277 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 449' ' ' SER . 4.6 mt -63.23 -33.85 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.33 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 -13.06 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.622 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -99.94 -54.03 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.767 0.318 . . . . 0.0 110.774 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' GLU . . . . . 0.885 ' OE2' HG13 ' A' ' 451' ' ' VAL . 1.8 mp0 -89.46 132.82 34.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -36.23 42.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.677 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' THR . . . . . 0.446 ' C ' HD23 ' A' ' 458' ' ' LEU . 2.5 t -105.47 125.51 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.684 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.572 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.7 mt -119.65 149.4 42.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -147.3 97.65 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.451 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 1.1 mtm -102.77 144.74 30.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 469' ' ' ILE . 19.7 t -111.58 127.26 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.686 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.912 HG23 HD13 ' A' ' 471' ' ' ILE . 2.3 t -121.28 158.66 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.26 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -104.0 119.67 39.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.994 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.572 ' HB2' HD12 ' A' ' 469' ' ' ILE . 0.2 OUTLIER -119.51 127.32 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.434 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.22 -99.13 0.85 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.177 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.22 24.82 2.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.767 0.318 . . . . 0.0 110.677 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.57 162.63 36.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.97 141.01 34.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.627 ' O ' HG13 ' A' ' 461' ' ' VAL . 4.0 mt -130.74 143.24 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.369 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.585 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -94.76 124.42 38.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.645 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.912 HD13 HG23 ' A' ' 462' ' ' VAL . 4.4 mp -113.79 140.28 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 111.343 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 70.8 m -116.9 119.87 36.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.76 131.68 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.53 110.76 57.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 148.88 87.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.101 . . . . 0.0 112.336 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.88 -178.77 3.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -95.96 129.38 43.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' ILE . . . . . 0.693 HG21 ' HB2' ' A' ' 382' ' ' TYR . 19.6 tt -130.78 158.27 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.95 114.32 4.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.382 2.055 . . . . 0.0 112.311 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.406 ' HA ' ' CE ' ' A' ' 388' ' ' MET . 11.4 p 59.49 44.35 14.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.062 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -61.3 93.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.765 HG22 ' CD1' ' A' ' 415' ' ' ILE . 46.4 pt -83.59 137.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.302 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.404 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 12.9 m95 -116.81 89.61 3.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.45 82.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.144 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.71 110.27 10.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -95.38 120.17 35.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.786 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 53.5 mtt -140.93 124.56 16.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -69.85 -69.38 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.825 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -101.84 114.32 28.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -118.44 126.29 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 385' ' ' ILE . 9.7 pt -122.44 -1.1 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.333 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 46.92 62.94 3.47 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.082 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 1.076 HD13 HG22 ' A' ' 417' ' ' VAL . 6.8 tp -149.16 122.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -89.73 128.18 36.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.403 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -132.93 140.59 47.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.511 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.42 ' CE ' ' HA ' ' B' ' 2' ' ' SER . 7.7 ptm -119.31 158.84 25.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.028 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 21.3 p -83.11 106.27 14.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.3 tp -56.92 102.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.075 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.9 t -89.94 174.54 7.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 27.8 t -66.96 -33.02 74.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 60.6 p -68.88 -28.59 66.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -95.83 -48.6 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.988 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.92 -59.93 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.26 68.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.37 -38.28 89.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.29 -36.61 74.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.996 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -77.75 -31.69 52.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -28.99 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -54.98 3.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -73.46 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 57.5 mtm180 82.73 -25.62 0.15 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.752 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -20.51 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.752 0.311 . . . . 0.0 110.957 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.45 153.95 74.57 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.973 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.7 -179.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.637 2.224 . . . . 0.0 112.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -111.74 30.77 6.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.13 150.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.523 ' C ' HD12 ' A' ' 409' ' ' ILE . 2.7 pp -125.33 17.12 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.455 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -140.29 142.85 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.16 156.49 7.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -91.45 152.08 20.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.756 ' HB2' HD13 ' A' ' 390' ' ' LEU . 59.8 t80 -107.37 131.66 54.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.907 HD12 ' HB2' ' A' ' 432' ' ' ASP . 18.3 mt -83.97 111.08 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.853 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -75.35 -66.42 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.848 ' O ' HD12 ' A' ' 385' ' ' ILE . 3.5 pt-20 -155.61 167.14 31.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 0.0 111.175 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 1.076 HG22 HD13 ' A' ' 385' ' ' ILE . 12.5 t -127.53 156.95 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -96.32 133.43 24.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.54 60.02 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.766 2.311 . . . . 0.0 112.82 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 168.88 44.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.972 0.415 . . . . 0.0 110.757 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 384' ' ' GLY . 7.7 p -141.84 162.19 47.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 34.8 Cg_endo -66.72 -14.13 42.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.012 1.808 . . . . 0.0 111.17 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -68.73 -59.94 2.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.645 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.86 -32.71 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -82.4 -21.14 35.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.296 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -72.42 -29.93 65.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.304 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 121.1 17.65 4.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.026 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 471' ' ' ILE . 2.5 mt -88.2 -167.08 1.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.91 0.355 . . . . 0.0 110.732 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.9 146.34 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -179.36 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 60.09 22.52 11.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.907 ' HB2' HD12 ' A' ' 414' ' ' ILE . 9.5 m-20 -119.3 -175.87 3.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.412 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.48 117.28 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.543 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.444 HD11 HG12 ' A' ' 414' ' ' ILE . 4.0 mt -78.42 123.05 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.461 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -110.07 -48.63 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.882 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 435' ' ' ILE . 3.8 t -119.24 160.97 21.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 111.294 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.799 HG21 HG11 ' A' ' 451' ' ' VAL . 1.0 OUTLIER -154.28 119.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.024 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.468 ' O ' ' ND2' ' A' ' 438' ' ' ASN . 1.1 p-10 44.43 42.41 5.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.511 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 77.5 41.92 19.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.635 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -135.69 162.6 32.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 108.55 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.942 HG11 ' CG2' ' A' ' 448' ' ' VAL . 2.5 t -94.59 148.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.247 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.58 -35.96 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.333 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.6 p -147.5 176.03 10.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.212 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.403 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -59.06 -41.12 87.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.176 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.409 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 17.6 p30 -53.91 -24.22 15.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.268 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.9 OUTLIER -86.33 -50.01 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.942 ' CG2' HG11 ' A' ' 442' ' ' VAL . 43.9 t -54.93 -40.7 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.488 ' HA ' HG11 ' B' ' 7' ' ' VAL . 42.2 t -53.13 -68.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.469 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -51.69 -35.06 41.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.641 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 447' ' ' ASP . 43.7 t -64.09 -49.33 81.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.294 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.854 HD11 HG12 ' A' ' 448' ' ' VAL . 8.4 mt -57.68 -40.53 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.223 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.01 -5.21 59.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.325 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -100.18 -47.66 4.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' GLU . . . . . 0.438 ' O ' HD21 ' A' ' 458' ' ' LEU . 1.9 mm-40 -100.13 133.57 44.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.047 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -34.42 48.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' THR . . . . . 0.406 ' HA ' HD12 ' A' ' 474' ' ' ILE . 1.5 t -105.08 103.21 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.765 HD11 HG23 ' A' ' 452' ' ' ILE . 12.4 mt -96.08 153.36 17.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -154.43 96.76 1.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.645 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.519 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -104.26 135.51 45.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.263 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 25.8 t -102.09 120.41 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 463' ' ' ARG . 5.0 t -105.54 160.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' ARG . . . . . 0.44 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -120.92 124.41 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.589 ' HB2' HD11 ' A' ' 469' ' ' ILE . 30.5 mtp85 -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.702 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.53 -98.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.346 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -140.28 24.84 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 111.033 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -139.77 157.36 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.91 139.62 35.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.646 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.8 mt -128.21 128.01 68.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.08 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.66 125.13 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.769 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.736 HG21 HD23 ' A' ' 428' ' ' LEU . 28.9 mm -120.04 136.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.9 m -109.61 135.05 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.703 ' O ' HD13 ' A' ' 474' ' ' ILE . 11.5 t -138.91 146.22 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.065 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 473' ' ' VAL . 30.0 mm -134.03 110.34 11.89 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 474' ' ' ILE . 19.2 Cg_endo -58.57 132.91 51.05 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.398 2.065 . . . . 0.0 112.309 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -94.83 -174.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.54 152.96 34.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 2.5 tt -150.45 133.59 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -143.65 123.63 7.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.248 1.007 0 C-N-CA 122.375 2.05 . . . . 0.0 112.335 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.687 0.279 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.42 ' HA ' ' CE ' ' A' ' 388' ' ' MET . 37.4 m 61.9 -81.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.943 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 52.54 65.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.444 . . . . 0.0 110.656 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.853 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.4 pt -82.05 96.25 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.335 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.409 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.0 m0 -65.64 104.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.826 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -76.76 67.01 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 449' ' ' SER . 21.9 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.21 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 4.8 t -109.1 -50.79 2.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.352 . . . . 0.0 110.816 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -92.93 53.95 2.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -121.06 106.38 11.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.137 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.5 -50.63 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.533 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -106.75 146.37 30.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.403 ' HB2' ' CG2' ' A' ' 478' ' ' ILE . 30.1 t80 -118.08 119.55 35.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.363 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.595 HD12 ' CG2' ' A' ' 385' ' ' ILE . 16.4 pt -130.58 -8.97 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.478 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.645 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 50.67 68.1 1.61 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.747 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.921 ' CD1' HG22 ' A' ' 417' ' ' VAL . 8.1 tp -157.0 135.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -101.03 129.43 46.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.412 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -135.45 146.19 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.49 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.0 ptm -128.26 157.44 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.071 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.7 p -79.48 101.32 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.889 HD13 ' HB2' ' A' ' 413' ' ' TYR . 9.4 tp -51.79 97.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.4 t -84.8 158.54 20.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.785 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.3 m -57.51 -22.05 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.12 -28.28 54.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.308 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -100.33 -37.4 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.131 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.51 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -62.87 -50.95 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.367 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -28.33 67.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -34.25 73.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.065 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.576 HD22 ' CE2' ' A' ' 405' ' ' PHE . 62.8 mt -60.17 -41.83 93.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.027 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -75.11 -30.81 60.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.77 -33.15 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.7 -33.34 20.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -145.59 120.63 10.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.97 -27.73 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -55.79 -27.2 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.115 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.576 ' CE2' HD22 ' A' ' 398' ' ' LEU . 8.4 m-85 -57.46 147.35 59.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.72 174.43 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.568 2.179 . . . . 0.0 112.301 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -111.91 32.77 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.66 -179.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.658 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -149.18 -40.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 410' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -89.6 154.47 19.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.79 170.43 13.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.43 ' CB ' HG21 ' A' ' 448' ' ' VAL . . . -98.2 138.75 35.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 110.991 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.889 ' HB2' HD13 ' A' ' 390' ' ' LEU . 58.7 t80 -94.44 130.19 40.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.49 HG21 ' O ' ' A' ' 429' ' ' LYS . 12.1 mt -80.23 114.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.79 HD13 HG22 ' B' ' 4' ' ' ILE . 9.4 mt -82.13 -72.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.609 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.145 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.921 HG22 ' CD1' ' A' ' 385' ' ' ILE . 3.3 t -111.8 140.43 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.571 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 19.6 mm -79.69 144.99 61.6 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.37 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.48 ' HD2' HG22 ' A' ' 418' ' ' ILE . 23.3 Cg_exo -65.83 -3.91 9.02 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.881 2.387 . . . . 0.0 114.521 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 421' ' ' THR . 22.5 m-20 -138.35 71.03 1.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.965 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.645 HG21 ' HA3' ' A' ' 384' ' ' GLY . 1.1 p -159.55 165.61 17.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.141 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.413 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 31.9 Cg_exo -60.8 -23.78 77.42 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.622 2.215 . . . . 0.0 111.62 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.488 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -57.78 -60.05 4.29 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.996 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -74.63 -26.74 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 422' ' ' PRO . . . -76.16 -26.16 55.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.363 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -79.29 -70.36 1.33 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.417 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 166.64 34.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.449 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.4 OUTLIER -104.47 -173.11 2.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.778 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 429' ' ' LYS . . . . . 0.49 ' O ' HG21 ' A' ' 414' ' ' ILE . 0.4 OUTLIER 177.46 169.09 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 0.8 OUTLIER -87.58 52.48 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -158.89 28.37 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.625 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB2' HD12 ' A' ' 414' ' ' ILE . 5.3 m-20 -142.36 -177.2 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.403 HG11 HD22 ' A' ' 390' ' ' LEU . 24.0 t -145.16 107.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.42 138.48 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.674 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.869 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -133.57 -43.07 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.52 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.869 ' N ' HD12 ' A' ' 435' ' ' ILE . 41.5 p -114.72 155.5 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.952 HG21 HG11 ' A' ' 451' ' ' VAL . 1.5 tt -157.61 118.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.483 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 1.3 p-10 45.52 33.85 1.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.494 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.8 28.74 34.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.724 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.483 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 51.5 mt-30 -124.01 143.4 50.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.864 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 9.3 t -92.09 110.69 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.717 HG11 HG22 ' A' ' 448' ' ' VAL . 25.7 t -93.89 159.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.547 HG22 ' OD2' ' A' ' 447' ' ' ASP . 22.4 m -130.36 -45.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.502 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.454 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -141.05 176.42 8.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.225 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.412 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.52 -40.45 78.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -56.42 -25.6 50.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.879 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.848 ' O ' HG23 ' A' ' 451' ' ' VAL . 4.9 m-20 -87.05 -30.74 20.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.717 HG22 HG11 ' A' ' 442' ' ' VAL . 23.5 t -70.58 -43.32 77.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.504 ' HA ' HD12 ' A' ' 452' ' ' ILE . 33.0 t -50.97 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.335 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -49.88 -41.61 45.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.36 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.952 HG11 HG21 ' A' ' 437' ' ' ILE . 39.6 t -58.88 -45.5 91.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.076 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 449' ' ' SER . 22.3 mt -58.86 -40.49 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.65 0.4 57.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.158 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -46.74 5.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -111.18 165.28 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.4 t -103.64 -32.17 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 p -106.37 102.45 11.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.741 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.782 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.6 mt -93.5 129.46 39.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.947 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' ASN . . . . . 0.54 ' ND2' HG23 ' A' ' 472' ' ' THR . 2.4 m-80 -123.91 88.09 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.5 mtt -92.2 129.68 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 470' ' ' MET . 27.1 t -107.47 126.29 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.904 HG22 HD13 ' A' ' 471' ' ' ILE . 1.5 m -121.22 159.37 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.175 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 119.95 40.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 1.5 mtp180 -120.62 133.18 55.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.486 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.18 -103.83 1.23 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.219 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.22 27.72 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.619 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.33 157.12 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.254 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.88 142.91 28.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.449 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.683 ' O ' HG13 ' A' ' 461' ' ' VAL . 3.4 mt -129.24 141.09 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.478 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -97.47 119.81 36.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.513 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.904 HD13 HG22 ' A' ' 462' ' ' VAL . 4.4 mp -122.16 137.02 57.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.54 HG23 ' ND2' ' A' ' 459' ' ' ASN . 58.6 m -117.24 127.37 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 422' ' ' PRO . 21.8 t -123.66 122.24 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.096 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 28.5 mm -103.02 109.86 62.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.01 151.42 82.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.078 . . . . 0.0 112.299 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -102.74 158.44 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -96.46 132.01 42.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 382' ' ' TYR . 0.9 OUTLIER -153.24 141.31 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.13 113.63 26.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.803 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo . . . . . 0 C--O 1.248 1.012 0 C-N-CA 122.381 2.054 . . . . 0.0 112.349 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.741 0.305 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p 51.81 26.35 3.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.169 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.14 106.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.79 HG22 HD13 ' A' ' 415' ' ' ILE . 3.3 pt -76.19 149.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.531 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -121.14 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.627 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -70.33 70.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.073 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.2 t -135.59 -48.95 0.7 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.804 0.335 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.67 -50.99 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 7.1 ttt -63.68 118.33 8.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -146.73 169.42 19.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 475' ' ' PRO . 0.1 OUTLIER -58.56 162.18 4.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.73 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.451 ' CB ' HG22 ' A' ' 478' ' ' ILE . 33.1 t80 -134.17 125.91 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.307 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.639 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.8 pt -117.67 -26.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 75.67 64.57 2.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.648 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.984 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.31 123.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.527 ' N ' HD13 ' A' ' 385' ' ' ILE . 0.1 OUTLIER -90.04 126.97 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.476 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -128.85 152.59 48.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 179.589 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.443 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.5 OUTLIER -130.63 -179.4 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 111.481 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 7.5 p -98.46 94.7 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.169 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.916 HD13 ' HB2' ' A' ' 413' ' ' TYR . 9.0 tp -47.63 121.55 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.571 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.11 165.81 13.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.797 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -27.27 63.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -66.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.166 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -40.24 74.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.217 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.293 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -83.91 -30.68 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.037 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.98 -31.19 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.023 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.26 -47.32 44.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -65.45 -37.84 88.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.047 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.83 -42.86 94.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -87.7 -17.51 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.434 ' HB3' ' CD1' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -150.08 87.04 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.715 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -25.72 67.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -23.62 11.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.284 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 402' ' ' HIS . 3.7 m-85 -53.18 163.69 0.87 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.484 ' HB2' HG22 ' A' ' 408' ' ' VAL . 18.6 Cg_endo -59.09 178.22 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.306 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -105.63 35.84 2.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 408' ' ' VAL . 20.1 m -120.34 92.87 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.49 -33.8 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.56 163.23 21.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 126.21 175.97 14.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.375 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 388' ' ' MET . . . -102.8 157.37 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.916 ' HB2' HD13 ' A' ' 390' ' ' LEU . 69.4 t80 -104.82 128.72 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.984 HG23 HD11 ' A' ' 385' ' ' ILE . 24.6 mt -80.7 109.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.552 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.581 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.7 mp -71.86 -70.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -151.43 166.82 29.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.299 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.555 HG22 HG12 ' A' ' 385' ' ' ILE . 35.0 t -132.84 155.39 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.043 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -90.28 132.56 35.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.406 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.22 57.72 3.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.542 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 169.41 47.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.061 0.457 . . . . 0.0 110.383 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.409 HG21 ' HB ' ' A' ' 418' ' ' ILE . 4.2 p -149.86 164.46 20.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.974 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.64 -26.85 67.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.269 1.979 . . . . 0.0 111.101 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 428' ' ' LEU . . . -54.91 -54.39 43.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.116 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.73 -29.99 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.67 -29.42 65.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.12 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.44 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -74.0 -30.2 61.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.481 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.88 23.67 2.97 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.767 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.843 HD11 HG21 ' A' ' 473' ' ' VAL . 1.2 mt -95.67 -175.59 3.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.772 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.65 152.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -61.74 -175.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.702 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 24.6 m120 61.23 22.35 12.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.951 ' HB2' HD12 ' A' ' 414' ' ' ILE . 28.5 m-20 -122.66 -176.5 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 412' ' ' ALA . 34.9 t -143.69 127.54 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.623 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.65 152.76 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.441 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 408' ' ' VAL . 1.2 pp -141.2 -55.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.469 ' N ' HD12 ' A' ' 435' ' ' ILE . 16.7 p -120.42 157.32 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.313 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.887 HG21 HG11 ' A' ' 451' ' ' VAL . 1.8 tt -151.04 119.94 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.344 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.487 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 0.9 OUTLIER 43.4 44.08 4.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.693 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.62 49.24 8.16 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.793 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.487 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 3.8 mt-30 -144.88 158.97 43.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.702 0.287 . . . . 0.0 110.672 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 6.0 p -106.49 112.19 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.048 HG11 HG22 ' A' ' 448' ' ' VAL . 4.2 t -100.08 147.58 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 6.3 m -130.82 -42.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.4 p -127.93 168.11 15.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.01 0.434 . . . . 0.0 111.284 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.476 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.34 -41.14 79.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -57.24 -28.92 63.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.726 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.8 ' O ' HG23 ' A' ' 451' ' ' VAL . 7.4 m-20 -77.77 -36.47 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 1.048 HG22 HG11 ' A' ' 442' ' ' VAL . 28.4 t -69.55 -41.86 80.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.806 ' HA ' HD12 ' A' ' 452' ' ' ILE . 1.7 t -54.72 -63.17 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.601 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -46.96 -29.18 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.458 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.887 HG11 HG21 ' A' ' 437' ' ' ILE . 30.4 t -68.61 -48.58 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' A' ' 449' ' ' SER . 3.6 mt -58.62 -33.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -91.13 -21.55 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.251 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -88.67 -59.91 2.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.02 127.14 35.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -39.06 75.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -104.67 116.26 31.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.839 ' HB3' HD11 ' A' ' 437' ' ' ILE . 9.0 mt -102.34 133.99 46.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.274 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -135.13 93.9 3.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.638 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.589 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -97.67 156.81 16.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.562 HG22 ' HG3' ' A' ' 470' ' ' MET . 21.0 t -124.4 124.6 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.975 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.508 HG11 ' OD2' ' A' ' 432' ' ' ASP . 5.6 t -108.58 147.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -105.44 140.11 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.174 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.563 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.6 mtp180 -144.52 133.84 23.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 57.88 -100.24 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.494 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -140.07 28.38 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 111.06 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.25 152.62 46.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.165 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -96.29 139.26 32.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.541 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 464' ' ' ARG . 2.4 mt -126.7 123.28 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.562 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -90.64 127.19 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 470' ' ' MET . 11.7 mm -124.46 135.16 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.976 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 44.9 m -116.51 121.13 40.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.843 HG21 HD11 ' A' ' 428' ' ' LEU . 34.9 t -127.34 119.92 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.87 111.96 64.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.639 ' HB3' HG23 ' A' ' 383' ' ' ILE . 41.3 Cg_endo -67.08 173.95 7.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.07 . . . . 0.0 112.349 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -160.41 174.31 14.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.46 131.69 36.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.787 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' ILE . . . . . 0.451 HG22 ' CB ' ' A' ' 382' ' ' TYR . 14.0 tt -131.05 153.38 39.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -123.3 127.79 25.49 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.411 2.074 . . . . 0.0 112.288 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.803 0.335 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m 60.05 37.6 21.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -59.46 90.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.581 HG22 ' CD1' ' A' ' 415' ' ' ILE . 27.5 pt -75.69 129.2 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -108.95 99.35 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.079 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -74.46 66.39 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 452' ' ' ILE . 16.7 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.2 p -176.07 165.5 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -75.73 120.37 21.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.0 -59.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -137.93 137.05 37.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -96.31 -177.97 4.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.688 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -160.41 119.84 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.7 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.1 pt -108.2 -3.68 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.332 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.675 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 60.56 50.82 63.42 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.649 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.673 HG13 HG22 ' A' ' 417' ' ' VAL . 11.7 tt -154.1 140.23 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.025 0.44 . . . . 0.0 111.07 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.797 ' HB3' HD12 ' A' ' 415' ' ' ILE . 2.9 mtt-85 -90.76 132.08 36.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.738 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.586 ' HE3' ' HB1' ' A' ' 445' ' ' ALA . 0.1 OUTLIER -136.96 133.5 35.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.639 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 10.2 ptm -121.34 176.33 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.3 p -106.12 130.39 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 413' ' ' TYR . 2.3 tp -74.65 96.86 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 4.4 t -87.45 177.52 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 82.7 p -63.93 -16.67 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -80.77 -42.29 22.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.787 0.327 . . . . 0.0 111.25 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -43.03 9.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.92 79.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.338 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -29.99 61.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.009 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -30.92 71.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 84.1 mt -69.89 -33.35 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -74.46 -24.42 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.0 -37.73 33.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.071 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -82.69 -66.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.46 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -76.07 -52.42 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.08 -52.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.686 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.51 38.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 1.6 m-85 -91.01 167.72 15.39 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.671 0.272 . . . . 0.0 110.51 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.02 -21.48 21.63 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.533 2.155 . . . . 0.0 112.472 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.7 t0 73.3 46.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 408' ' ' VAL . 18.9 m -113.2 97.54 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.023 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -56.72 -29.08 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.536 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 14.8 m -93.13 159.86 15.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.031 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 127.53 150.01 7.29 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.451 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.14 135.81 35.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.638 ' HB2' HD13 ' A' ' 390' ' ' LEU . 86.5 t80 -90.07 132.47 35.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.789 HD12 ' CB ' ' A' ' 432' ' ' ASP . 10.3 mt -86.18 116.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 386' ' ' ARG . 3.3 mt -89.22 -144.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.253 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.672 ' H ' HG22 ' A' ' 415' ' ' ILE . 9.2 pt-20 -79.67 155.27 28.11 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.088 -0.382 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.673 HG22 HG13 ' A' ' 385' ' ' ILE . 21.2 t -127.15 151.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.045 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.59 HG22 ' HD2' ' A' ' 419' ' ' PRO . 8.4 mm -87.4 145.63 38.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.621 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.59 ' HD2' HG22 ' A' ' 418' ' ' ILE . 16.5 Cg_exo -68.7 -3.48 11.31 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.988 2.459 . . . . 0.0 114.113 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.87 62.87 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.712 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.675 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.7 OUTLIER -154.45 158.02 32.27 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.009 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.412 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 34.3 Cg_exo -59.03 -20.25 52.65 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.554 2.17 . . . . 0.0 111.701 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.444 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -62.4 -60.12 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.77 -28.89 66.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.54 -27.63 45.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.27 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.02 65.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.353 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.1 23.85 2.87 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.774 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.751 HD23 HG21 ' A' ' 471' ' ' ILE . 1.2 mt -93.43 -170.0 2.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.314 . . . . 0.0 110.693 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.48 153.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -65.88 171.34 4.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 64.51 27.33 13.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.027 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.789 ' CB ' HD12 ' A' ' 414' ' ' ILE . 3.8 m-20 -118.88 -175.76 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.71 122.88 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.571 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 435' ' ' ILE . 2.8 mt -86.13 160.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.507 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.471 ' N ' HG22 ' A' ' 434' ' ' ILE . 1.4 pp -146.37 -49.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 435' ' ' ILE . 94.4 p -118.02 161.84 19.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.014 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.858 HG21 HG11 ' A' ' 451' ' ' VAL . 3.6 tt -155.62 119.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.505 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 1.2 p-10 49.11 33.09 4.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.624 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.29 28.02 28.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.819 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.505 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 9.3 mt-30 -121.23 164.16 17.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 110.647 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 69.3 p -106.56 114.15 28.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.147 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.93 HG11 HG22 ' A' ' 448' ' ' VAL . 11.7 t -101.54 141.72 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.17 -25.8 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.494 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.16 175.7 13.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.273 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.586 ' HB1' ' HE3' ' A' ' 387' ' ' MET . . . -56.51 -41.13 76.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.405 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 1.3 p-10 -55.44 -28.66 55.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.765 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.818 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.8 OUTLIER -82.18 -32.95 29.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.733 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.93 HG22 HG11 ' A' ' 442' ' ' VAL . 21.8 t -76.0 -41.92 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.211 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.67 ' HA ' HD12 ' A' ' 452' ' ' ILE . 15.0 t -52.61 -57.44 10.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.344 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -53.97 -42.22 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.858 HG11 HG21 ' A' ' 437' ' ' ILE . 47.0 t -59.63 -47.59 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 449' ' ' SER . 8.4 mt -57.9 -30.96 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.946 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -7.11 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.545 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -99.71 -48.66 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.701 0.286 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -102.04 166.52 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.2 -36.69 6.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 98.53 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.771 ' HB3' HD11 ' A' ' 437' ' ' ILE . 8.4 mt -89.78 119.95 30.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.051 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.16 91.21 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.99 142.85 29.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 469' ' ' ILE . 23.7 t -103.37 128.95 56.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.21 156.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 140.59 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.081 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.703 ' HB3' HD11 ' A' ' 469' ' ' ILE . 3.7 ttt-85 -143.53 124.52 14.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 64.42 -98.51 0.28 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.226 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -140.05 27.28 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 0.0 110.766 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -145.23 162.78 36.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.7 139.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 464' ' ' ARG . 2.1 mt -127.68 158.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.36 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.464 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -106.0 126.2 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.541 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.751 HG21 HD23 ' A' ' 428' ' ' LEU . 23.7 mm -115.37 137.12 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.27 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 m -116.17 140.6 49.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.689 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.761 ' C ' HD12 ' A' ' 474' ' ' ILE . 20.1 t -150.03 135.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.761 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -117.88 109.73 40.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.585 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.7 ' HB3' HG23 ' A' ' 383' ' ' ILE . 30.2 Cg_endo -63.81 152.41 80.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.438 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -89.16 -179.53 5.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.85 138.09 44.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 14.0 tt -155.37 152.39 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.989 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -140.93 133.7 14.41 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.766 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.418 2.078 . . . . 0.0 112.319 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.775 0.322 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.6 m -73.22 65.09 0.81 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.869 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -79.82 -9.9 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.3 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.603 HG22 ' CD1' ' A' ' 415' ' ' ILE . 9.7 pt 41.08 91.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.862 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.405 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 10.7 m95 -79.95 91.09 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.887 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -69.38 71.75 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.402 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.4 t . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.243 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.78 90.26 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 56.7 m170 60.53 37.62 19.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.96 103.71 7.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -176.89 136.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.59 161.59 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.679 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -140.02 126.2 19.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.362 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.766 HG13 HG22 ' A' ' 385' ' ' ILE . 5.7 pt -119.27 -2.67 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.403 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.597 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 54.91 62.45 6.25 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.814 ' CD1' HG22 ' A' ' 417' ' ' VAL . 7.2 tp -153.75 129.86 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -90.7 132.42 35.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.436 ' CA ' HD12 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -141.06 138.83 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.856 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.456 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 6.2 ptm -120.93 165.79 14.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.298 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 82.8 p -93.44 109.25 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.513 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.5 tp -53.22 121.37 7.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.304 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.1 t -90.16 166.91 13.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -30.83 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 21.0 m -70.45 -29.52 66.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -91.12 -39.91 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.058 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.471 ' HB1' HG12 ' A' ' 409' ' ' ILE . . . -59.7 -50.4 73.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.246 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -32.93 74.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.66 -45.15 54.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.082 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.27 -31.45 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.069 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -67.37 -47.13 71.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.013 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -27.42 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.155 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -91.74 -62.41 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.401 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -64.66 -59.81 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.072 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 10.7 mtt85 79.65 -7.84 1.65 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.502 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.28 14.85 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.704 0.287 . . . . 0.0 111.162 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 406' ' ' PRO . 30.2 m-85 -105.53 128.8 25.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 405' ' ' PHE . 32.3 Cg_exo -58.07 -174.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.113 . . . . 0.0 112.346 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.53 23.47 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 406' ' ' PRO . 26.4 m -83.35 -23.31 8.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.059 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.8 HG23 ' O ' ' A' ' 409' ' ' ILE . 0.0 OUTLIER 37.0 75.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.468 0.652 . . . . 0.0 111.94 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 7.2 p -169.46 131.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.22 173.78 19.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.432 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.34 140.88 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 0.0 111.08 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.638 ' HB2' HD13 ' A' ' 390' ' ' LEU . 43.2 t80 -98.13 133.5 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 432' ' ' ASP . 15.3 mt -82.6 116.2 26.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.436 HD12 ' CA ' ' A' ' 387' ' ' MET . 3.1 mt -77.96 -60.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.619 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 385' ' ' ILE . 0.4 OUTLIER -159.75 139.49 11.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.293 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.814 HG22 ' CD1' ' A' ' 385' ' ' ILE . 13.6 t -105.45 136.95 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.118 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.517 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 33.8 mm -82.84 138.46 43.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.238 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 418' ' ' ILE . 42.7 Cg_endo -68.0 4.2 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 114.243 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -132.44 56.46 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.517 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.597 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.6 OUTLIER -155.63 164.91 19.66 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.458 ' HB2' HG13 ' A' ' 473' ' ' VAL . 32.1 Cg_exo -60.84 -20.94 68.74 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.651 2.234 . . . . 0.0 111.828 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.464 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -61.94 -59.15 5.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.21 -34.85 77.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.732 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -23.22 55.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -74.72 -34.35 53.66 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.414 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 25.4 2.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.85 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.833 HD23 HG21 ' A' ' 471' ' ' ILE . 0.8 OUTLIER -93.39 -163.66 1.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 0.0 110.652 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.4 169.1 6.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.816 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.67 36.17 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.013 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.82 27.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.551 ' HB2' HD12 ' A' ' 414' ' ' ILE . 10.3 m-20 -128.94 175.71 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.004 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.65 116.9 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 434' ' ' ILE . 3.8 mp -67.2 155.52 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 436' ' ' SER . 2.3 pp -148.78 -45.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.57 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.811 ' N ' HD12 ' A' ' 435' ' ' ILE . 15.6 p -124.07 154.78 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.973 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 458' ' ' LEU . 3.5 tt -153.59 112.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.055 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.468 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 0.5 OUTLIER 43.03 51.17 5.43 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.676 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 71.05 43.72 56.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.708 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.468 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 40.6 mt-30 -146.35 126.53 13.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.79 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 65.5 m -81.48 118.22 22.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.925 HG11 ' CG2' ' A' ' 448' ' ' VAL . 7.1 t -98.94 144.7 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.905 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 9.1 m -118.52 -36.82 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.653 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.0 p -144.68 179.59 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.86 94.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.072 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.413 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 23.8 p30 -54.82 -25.88 31.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.52 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.5 m-20 -81.52 -52.06 7.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.986 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.925 ' CG2' HG11 ' A' ' 442' ' ' VAL . 46.8 t -55.77 -35.82 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.288 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 452' ' ' ILE . 10.8 t -58.74 -61.68 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.374 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.4 -28.76 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.493 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 437' ' ' ILE . 59.5 t -73.32 -47.49 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.009 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 383' ' ' ILE . 15.4 mt -58.17 -28.54 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 -6.79 26.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.442 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -100.07 -47.22 5.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -105.06 144.59 31.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -29.03 21.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.761 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -109.73 97.38 6.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.535 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.8 mt -89.71 120.13 30.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.84 85.81 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.665 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.56 128.13 36.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.79 HG22 ' HG3' ' A' ' 470' ' ' MET . 18.8 t -99.56 126.66 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 463' ' ' ARG . 23.9 t -115.24 154.08 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' ARG . . . . . 0.405 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -110.48 119.86 40.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.432 ' HB2' HD11 ' A' ' 469' ' ' ILE . 18.6 mtp180 -119.53 140.83 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 58.51 -97.34 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.34 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -140.25 24.96 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -142.56 158.02 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.174 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.23 137.68 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.585 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 464' ' ' ARG . 2.0 mt -126.91 141.86 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.79 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -92.31 139.55 30.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.772 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.833 HG21 HD23 ' A' ' 428' ' ' LEU . 12.6 mm -128.82 134.11 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.175 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.0 m -107.57 132.67 53.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 474' ' ' ILE . 23.3 t -144.31 124.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.223 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.5 mp -115.72 110.05 44.86 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.731 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.723 ' HB3' HG23 ' A' ' 383' ' ' ILE . 20.4 Cg_endo -60.86 -178.13 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.207 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -136.77 -178.5 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -110.35 125.8 53.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.829 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 17.0 tt -118.06 133.05 66.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.46 115.45 7.57 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.448 2.098 . . . . 0.0 112.293 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.815 0.34 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.456 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 0.8 OUTLIER -67.72 -69.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 51.16 51.29 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.85 130.47 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.228 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.413 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.4 m0 -111.64 101.22 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.936 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -75.75 68.63 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.134 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.3 m -135.28 116.91 14.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.777 0.323 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -110.23 116.37 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -146.75 130.62 17.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -143.89 165.6 27.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.52 146.41 27.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.856 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.433 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 17.3 t80 -159.99 129.58 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.757 HG13 HG22 ' A' ' 385' ' ' ILE . 23.3 pt -116.11 -3.87 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.42 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.574 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 56.62 60.31 9.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.87 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.757 HG22 HG13 ' A' ' 383' ' ' ILE . 11.2 tt -165.08 144.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.976 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.459 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -100.36 157.99 16.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.523 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -154.05 137.53 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.561 ' HG2' HD11 ' A' ' 415' ' ' ILE . 1.3 ptp -115.5 173.79 6.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.115 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 89.2 p -99.34 99.78 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.285 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.853 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.1 tp -47.56 109.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 9.0 t -90.16 150.83 21.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 m -46.19 -36.54 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.593 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -47.15 84.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.35 -31.91 24.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.141 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -60.65 -36.23 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -88.89 -29.29 19.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -68.49 -25.51 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.178 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.01 -32.08 39.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.172 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -85.77 -29.72 23.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -37.59 48.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.994 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -53.77 6.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 104.24 11.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -83.12 60.79 5.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.737 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -142.75 13.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.144 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.78 150.72 48.96 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.78 ' HB2' HG22 ' A' ' 408' ' ' VAL . 50.0 Cg_exo -53.39 166.76 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.634 2.222 . . . . 0.0 112.293 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.56 3.72 43.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.78 HG22 ' HB2' ' A' ' 406' ' ' PRO . 15.6 m -70.93 112.8 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 111.067 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pp -92.26 -29.57 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.155 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 142.16 41.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.2 177.2 14.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.0 151.87 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.853 ' HB2' HD13 ' A' ' 390' ' ' LEU . 31.1 t80 -93.49 136.08 34.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 432' ' ' ASP . 40.3 mt -81.09 119.92 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.106 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.616 HD13 ' HD1' ' A' ' 413' ' ' TYR . 1.5 mm -89.27 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.359 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 415' ' ' ILE . 1.9 pt-20 -79.57 142.81 35.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 385' ' ' ILE . 21.2 t -111.27 151.25 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.172 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 421' ' ' THR . 18.5 mm -84.14 136.77 40.5 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 61.7 Cg_endo -73.09 58.98 3.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.43 2.086 . . . . 0.0 112.662 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.25 40.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.872 0.367 . . . . 0.0 111.028 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.574 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.1 OUTLIER -138.92 172.24 6.87 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 77.9 Cg_endo -78.38 -9.43 16.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.487 2.125 . . . . 0.0 112.194 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.824 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -72.57 -58.9 3.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.031 0.444 . . . . 0.0 110.824 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -33.3 74.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -85.56 -27.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -64.37 -70.14 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.36 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.2 28.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.054 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.824 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.3 OUTLIER -105.71 -175.94 2.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.753 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.97 155.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 63.64 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.95 36.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.807 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.866 ' HB2' HD12 ' A' ' 414' ' ' ILE . 4.9 m-20 -146.24 -176.05 5.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.8 t -143.81 125.65 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.305 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.73 145.87 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.705 HD12 ' N ' ' A' ' 436' ' ' SER . 2.4 pp -137.87 -43.48 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.657 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.705 ' N ' HD12 ' A' ' 435' ' ' ILE . 60.3 p -122.49 152.36 40.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.915 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.641 HD12 HG11 ' A' ' 451' ' ' VAL . 0.0 OUTLIER -148.0 119.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.538 ' N ' HD13 ' A' ' 437' ' ' ILE . 13.1 p30 48.04 28.08 1.38 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.05 25.77 28.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.459 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -116.73 166.17 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.8 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.6 117.49 34.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.565 HG11 HG22 ' A' ' 448' ' ' VAL . 92.9 t -105.23 147.18 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.95 -44.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.332 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.2 p -132.88 168.31 18.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 111.121 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.523 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.0 -37.98 72.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.071 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -58.5 -29.95 66.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.0 m-20 -76.91 -40.72 46.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.781 HG12 HD11 ' A' ' 452' ' ' ILE . 37.5 t -69.86 -35.71 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.096 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.445 ' HA ' HG11 ' B' ' 7' ' ' VAL . 27.2 t -57.59 -63.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -48.46 -32.49 7.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.892 HG13 ' OE2' ' A' ' 455' ' ' GLU . 55.1 t -70.84 -48.5 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.226 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.781 HD11 HG12 ' A' ' 448' ' ' VAL . 8.0 mt -61.65 -30.04 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.259 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -92.02 -19.02 22.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -98.67 -64.3 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' GLU . . . . . 0.892 ' OE2' HG13 ' A' ' 451' ' ' VAL . 1.8 mp0 -78.41 138.76 38.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 474' ' ' ILE . 17.6 m -89.43 -34.21 16.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' THR . . . . . 0.623 ' HA ' HD12 ' A' ' 474' ' ' ILE . 31.5 p -99.13 108.0 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.484 ' HB3' HD11 ' A' ' 437' ' ' ILE . 2.5 mt -108.7 120.14 41.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 111.418 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -123.74 93.46 3.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.415 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.442 ' HE2' ' HB3' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -99.46 152.35 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.365 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 469' ' ' ILE . 24.3 t -114.91 127.57 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.738 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.853 HG23 HD13 ' A' ' 471' ' ' ILE . 17.7 t -114.0 138.25 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.22 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -106.31 134.07 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.973 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.594 ' HE ' HD13 ' A' ' 469' ' ' ILE . 0.2 OUTLIER -139.31 132.74 30.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.69 0.86 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.305 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -140.13 28.98 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -140.22 155.64 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.019 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.38 138.95 33.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.627 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.594 HD13 ' HE ' ' A' ' 464' ' ' ARG . 3.2 mt -126.73 139.25 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.602 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.3 OUTLIER -103.56 133.8 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.853 HD13 HG23 ' A' ' 462' ' ' VAL . 3.2 mp -135.27 148.87 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 13.8 m -134.65 125.4 27.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.081 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 422' ' ' PRO . 21.1 t -127.85 119.83 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 457' ' ' THR . 27.7 mm -105.24 109.47 63.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.314 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.449 ' HG3' HG23 ' A' ' 452' ' ' ILE . 54.3 Cg_exo -52.0 143.62 39.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.282 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -100.47 -177.95 3.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.42 142.95 34.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 18.5 tt -146.24 142.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -98.67 117.53 64.39 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.442 2.095 . . . . 0.0 112.246 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.815 0.341 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.495 ' HA ' ' HE2' ' A' ' 388' ' ' MET . 97.6 p -102.33 47.17 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.04 74.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.502 HD13 ' N ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER -52.64 151.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.465 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -112.08 101.95 10.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -73.28 65.03 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 449' ' ' SER . 17.8 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.121 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.78 38.89 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.866 0.365 . . . . 0.0 110.921 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -109.47 95.47 5.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.92 146.74 23.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -83.9 160.29 21.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -58.21 156.44 9.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.768 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.607 ' CB ' HG22 ' A' ' 478' ' ' ILE . 3.7 t80 -139.55 120.49 14.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.5 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.774 HG13 HG22 ' A' ' 385' ' ' ILE . 12.2 pt -124.57 -2.96 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.716 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 49.32 68.08 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 1.067 HD13 HG22 ' A' ' 417' ' ' VAL . 4.5 tp -153.52 118.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.822 0.344 . . . . 0.0 110.534 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.404 ' HD2' ' CG ' ' A' ' 416' ' ' GLU . 9.5 mtt85 -91.29 132.04 36.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.482 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -138.59 143.69 39.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.427 ' HE1' ' HA ' ' B' ' 2' ' ' SER . 6.0 ptm -128.06 159.47 34.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.165 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.3 p -77.82 101.32 6.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.7 tp -55.38 100.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 11.6 t -87.53 156.25 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.6 t -51.59 -25.77 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -75.68 -29.13 58.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.253 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -99.84 -39.12 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.558 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -58.17 -40.06 80.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.211 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -83.05 -32.08 27.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.981 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.25 -34.55 75.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.85 -39.54 76.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -59.2 -22.52 61.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.75 -23.26 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -67.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.172 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -80.26 -49.08 12.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 5.0 ttm105 83.52 -39.53 0.08 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.958 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -68.23 -9.73 49.3 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -56.77 152.89 24.52 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.474 ' HG2' HG22 ' A' ' 408' ' ' VAL . 25.6 Cg_endo -61.98 -172.14 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.78 2.32 . . . . 0.0 112.525 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.05 33.55 3.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 406' ' ' PRO . 3.7 m -101.56 164.79 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.116 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.697 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -138.77 -39.53 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.459 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 410' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -79.25 167.58 20.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 111.33 170.56 19.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.511 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.2 140.45 29.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 0.0 111.091 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.835 ' HB2' HD13 ' A' ' 390' ' ' LEU . 45.7 t80 -95.57 126.3 40.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.005 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 432' ' ' ASP . 18.6 mt -80.0 110.04 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.805 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.9 mp -75.24 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.404 ' CG ' ' HD2' ' A' ' 386' ' ' ARG . 11.8 pt-20 -157.84 156.12 30.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 111.221 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 1.067 HG22 HD13 ' A' ' 385' ' ' ILE . 14.0 t -128.4 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.531 ' HB ' HG23 ' A' ' 421' ' ' THR . 7.3 mm -88.95 136.62 30.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 39.7 Cg_endo -67.38 -5.87 15.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.639 2.226 . . . . 0.0 113.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -112.48 46.83 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.114 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.716 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -149.62 170.31 7.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 422' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 64.1 Cg_endo -75.5 -11.42 20.6 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.215 1.943 . . . . 0.0 111.867 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.511 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -67.07 -59.27 3.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.091 0.472 . . . . 0.0 110.936 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -29.76 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.715 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.25 38.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.318 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -78.29 -22.18 68.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.74 16.08 5.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.731 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.511 HD12 ' CA ' ' A' ' 423' ' ' ALA . 0.8 OUTLIER -95.49 -171.6 2.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 110.636 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -177.32 146.5 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -176.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 33.2 m120 56.1 24.91 8.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.051 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.923 ' HB2' HD12 ' A' ' 414' ' ' ILE . 6.2 m-20 -120.48 -175.75 3.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.805 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.53 123.76 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.463 HD11 HG12 ' A' ' 414' ' ' ILE . 1.4 mp -83.79 146.59 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.588 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -135.24 -43.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.554 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.828 ' N ' HD12 ' A' ' 435' ' ' ILE . 24.9 p -119.99 147.77 44.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.361 . . . . 0.0 111.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.2 tt -144.87 114.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.061 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.5 HD22 ' HG3' ' A' ' 440' ' ' GLN . 1.4 p-10 44.49 43.92 6.69 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.601 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 79.39 27.4 55.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.758 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.5 ' HG3' HD22 ' A' ' 438' ' ' ASN . 6.6 mm100 -131.46 126.32 34.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.916 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.19 125.54 29.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.928 HG11 ' CG2' ' A' ' 448' ' ' VAL . 3.0 t -108.94 150.75 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.19 -28.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.661 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 20.2 p -148.58 170.33 18.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.482 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -59.98 -42.24 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.079 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.431 ' ND2' ' OD1' ' A' ' 447' ' ' ASP . 0.5 OUTLIER -53.67 -26.99 25.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.862 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.2 m-20 -83.32 -37.99 22.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.668 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.928 ' CG2' HG11 ' A' ' 442' ' ' VAL . 41.4 t -68.23 -33.28 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 26.8 t -60.13 -60.29 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.281 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.82 -29.52 41.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.478 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 447' ' ' ASP . 42.0 t -69.2 -51.56 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 111.114 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 448' ' ' VAL . 5.9 mt -57.94 -29.23 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.023 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.323 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -99.16 -58.02 2.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -82.43 132.17 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 59.5 m -74.22 -37.02 63.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' THR . . . . . 0.457 ' C ' HD23 ' A' ' 458' ' ' LEU . 6.4 t -107.83 127.08 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.558 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.709 ' HB3' HD11 ' A' ' 437' ' ' ILE . 8.6 mt -119.73 119.74 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.328 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' ASN . . . . . 0.467 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.4 m-80 -119.15 99.67 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.426 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.99 144.41 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.9 t -102.82 139.25 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.452 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 463' ' ' ARG . 3.3 t -139.29 160.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.199 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 462' ' ' VAL . 1.3 tmm_? -97.47 119.69 36.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.625 ' HB2' HD12 ' A' ' 469' ' ' ILE . 7.7 ttt180 -109.34 119.77 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.383 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.49 -92.01 0.26 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.094 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -140.38 25.92 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.829 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.01 154.44 43.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.79 130.16 45.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.631 ' O ' HG13 ' A' ' 461' ' ' VAL . 1.8 mt -129.02 151.49 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.311 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.527 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -93.6 119.86 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.444 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.68 137.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.372 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.467 HG23 ' OD1' ' A' ' 459' ' ' ASN . 50.2 m -111.13 126.28 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.545 HG22 ' HA3' ' A' ' 426' ' ' GLY . 20.7 t -139.13 141.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 21.5 mm -124.21 117.47 26.85 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.62 162.45 34.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.466 2.11 . . . . 0.0 112.279 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.56 -179.74 6.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -109.04 125.86 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' ILE . . . . . 0.607 HG22 ' CB ' ' A' ' 382' ' ' TYR . 19.7 tt -134.65 123.66 42.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.9 116.23 62.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.824 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.462 2.108 . . . . 0.0 112.341 179.89 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.81 0.338 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.427 ' HA ' ' HE1' ' A' ' 388' ' ' MET . 19.5 m -89.85 54.27 2.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -65.2 79.99 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.805 HG22 ' CD1' ' A' ' 415' ' ' ILE . 2.2 pt -85.29 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.36 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.19 95.16 5.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.89 66.26 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.785 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.524 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.8 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 27.6 m -78.19 146.97 34.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 60.04 76.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 4.0 ptp -78.3 -172.14 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 55.2 tttt 64.22 90.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.971 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 475' ' ' PRO . 27.7 mttm -77.15 -176.64 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.698 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -128.41 125.05 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.377 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 385' ' ' ILE . 30.5 pt -136.84 -1.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.874 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 48.14 70.67 0.7 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.993 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.984 HD13 HG22 ' A' ' 417' ' ' VAL . 6.8 tp -165.22 121.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.612 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 1.5 mtt85 -90.78 139.2 30.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.722 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.507 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -140.13 146.39 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.441 ' C ' ' HB2' ' A' ' 445' ' ' ALA . 1.4 ptp -120.62 -179.64 4.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.4 p -103.39 105.74 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 413' ' ' TYR . 4.6 tp -57.0 99.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.054 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.5 t -80.74 162.65 24.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 53.4 p -57.91 -20.54 37.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 20.6 m -77.6 -33.41 53.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.096 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -49.49 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.164 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.467 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -52.01 -34.11 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.615 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.38 -26.79 23.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.164 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -39.11 73.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 10.7 mt -58.01 -32.2 67.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -80.92 -26.25 36.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.13 -26.07 20.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.13 -42.22 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' HIS . . . . . 0.432 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -93.62 -53.65 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 4.6 mtt180 84.55 -23.13 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.599 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 -23.8 32.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -58.39 147.4 68.37 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.58 ' HB2' HG22 ' A' ' 408' ' ' VAL . 41.8 Cg_endo -67.62 166.98 22.19 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.571 2.181 . . . . 0.0 112.233 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.16 -23.31 64.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.176 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 406' ' ' PRO . 15.5 m -54.97 91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.885 0.374 . . . . 0.0 111.309 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.9 -30.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -69.35 151.33 46.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 125.01 -177.51 16.86 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.758 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.682 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -110.68 170.55 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.808 ' HB2' HD13 ' A' ' 390' ' ' LEU . 24.1 t80 -116.8 137.79 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.883 HD12 ' HB2' ' A' ' 432' ' ' ASP . 21.9 mt -86.04 117.29 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.612 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 12.4 mm -75.24 -68.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.125 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.714 ' O ' HD12 ' A' ' 385' ' ' ILE . 9.5 pt-20 -159.92 150.23 18.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.732 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.984 HG22 HD13 ' A' ' 385' ' ' ILE . 20.4 t -113.72 151.4 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.604 ' HB ' HG23 ' A' ' 421' ' ' THR . 17.9 mm -86.7 143.51 35.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 37.1 Cg_exo -61.9 -7.92 10.57 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.8 2.333 . . . . 0.0 113.594 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -135.08 71.51 1.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.701 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.696 HG21 ' HA3' ' A' ' 384' ' ' GLY . 24.5 p -149.7 156.3 38.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.351 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.63 -21.16 70.19 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.143 1.895 . . . . 0.0 110.351 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.899 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -66.2 -60.05 3.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.496 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.95 -32.82 74.54 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.055 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.14 -25.68 59.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -75.12 -66.44 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.191 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 162.08 29.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.158 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.899 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.6 OUTLIER -99.24 -175.72 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.73 139.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.719 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.38 179.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.41 19.99 11.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.883 ' HB2' HD12 ' A' ' 414' ' ' ILE . 8.2 m-20 -120.28 -176.03 3.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.671 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 412' ' ' ALA . 26.1 t -147.97 117.26 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 111.524 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.466 HG23 ' HB3' ' A' ' 460' ' ' MET . 1.6 mp -76.57 152.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.189 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.685 HD12 ' N ' ' A' ' 436' ' ' SER . 1.7 pp -139.35 -51.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.764 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.685 ' N ' HD12 ' A' ' 435' ' ' ILE . 84.2 p -113.02 144.27 42.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 111.091 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.724 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.1 tt -140.7 113.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 438' ' ' ASN . 2.2 p-10 43.9 45.67 6.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.533 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 73.72 52.46 8.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.703 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.9 157.96 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.654 0.264 . . . . 0.0 110.814 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.7 m -103.21 114.47 28.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.245 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.961 HG11 HG22 ' A' ' 448' ' ' VAL . 21.6 t -99.34 141.69 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.018 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.98 -37.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.503 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.14 172.43 12.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 111.264 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.507 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.37 -41.79 76.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.086 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -55.35 -29.52 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.712 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 451' ' ' VAL . 3.0 m-20 -80.01 -33.94 38.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.961 HG22 HG11 ' A' ' 442' ' ' VAL . 26.0 t -72.99 -38.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.632 ' HA ' HD12 ' A' ' 452' ' ' ILE . 12.1 t -55.63 -63.13 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.515 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -48.83 -28.41 3.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.375 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 447' ' ' ASP . 38.7 t -72.86 -49.6 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 449' ' ' SER . 5.2 mt -57.86 -26.44 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -100.13 -11.52 20.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.421 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -99.79 -47.72 4.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.719 0.295 . . . . 0.0 111.012 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -98.72 150.32 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 -33.85 11.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.661 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 457' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 457' ' ' THR . 5.2 t -106.15 96.21 6.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.576 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.724 ' HB3' HD11 ' A' ' 437' ' ' ILE . 12.3 mt -90.24 122.03 32.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -113.9 90.51 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.585 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.501 ' CG ' HD12 ' A' ' 437' ' ' ILE . 5.2 mtm -99.83 131.73 45.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.27 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.4 t -99.79 119.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.817 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.731 HG23 HD13 ' A' ' 471' ' ' ILE . 6.7 t -103.82 160.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' ARG . . . . . 0.452 ' N ' HG12 ' A' ' 462' ' ' VAL . 5.5 tmm_? -116.03 131.01 57.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.834 ' HB2' HD11 ' A' ' 469' ' ' ILE . 9.9 mtp180 -136.34 119.94 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.75 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.42 -109.92 3.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.494 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.59 27.14 6.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.659 0.266 . . . . 0.0 111.061 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.97 157.83 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -98.3 150.14 21.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.834 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mp -129.37 136.63 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.885 0.374 . . . . 0.0 111.331 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.5 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.1 OUTLIER -100.25 122.07 42.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.293 179.575 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.731 HD13 HG23 ' A' ' 462' ' ' VAL . 3.3 mp -125.4 126.73 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.926 0.394 . . . . 0.0 111.706 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.8 m -114.03 119.61 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.066 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.709 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.5 t -132.32 141.38 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 0.0 111.704 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.709 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -114.95 114.17 43.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 383' ' ' ILE . 15.1 Cg_endo -57.27 135.54 70.88 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.362 2.042 . . . . 0.0 112.362 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.32 151.85 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -99.84 133.46 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 478' ' ' ILE . 1.9 tt -134.13 115.61 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.111 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.42 125.85 62.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.39 2.06 . . . . 0.0 112.254 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.795 0.331 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m 59.83 44.38 13.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -72.97 113.65 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.47 145.57 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -113.54 99.83 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 386' ' ' ARG . 2.4 t90 -76.17 72.12 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.11 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.3 p -124.58 158.71 32.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.821 0.343 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.77 38.78 17.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -118.59 120.97 39.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -132.96 -66.83 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.786 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -67.16 137.97 56.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.534 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -131.87 119.95 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.31 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.633 HD12 ' CG2' ' A' ' 385' ' ' ILE . 24.8 pt -122.53 -12.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.611 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.727 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 54.85 69.66 1.19 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.057 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.633 ' CG2' HD12 ' A' ' 383' ' ' ILE . 11.3 tt -165.27 152.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.026 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.496 ' HG3' ' HB ' ' A' ' 415' ' ' ILE . 1.8 ptm180 -122.07 132.05 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.5 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.508 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -128.52 131.69 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.006 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.486 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 10.0 ptm -109.64 158.44 18.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.037 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.7 p -87.57 109.12 19.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 398' ' ' LEU . 5.4 tp -56.07 114.64 2.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.3 t -86.46 159.09 19.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.4 t -56.05 -25.7 46.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.233 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.32 -39.14 54.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.093 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.502 ' H ' HG23 ' A' ' 391' ' ' THR . 25.3 mmtt -87.44 -27.25 22.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -56.06 -42.14 76.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.288 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -85.98 -30.21 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.82 -32.42 73.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 390' ' ' LEU . 6.2 mt -66.07 -55.55 15.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.2 -30.92 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -51.41 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -34.0 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.801 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -119.71 104.69 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -82.07 59.23 4.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -159.8 26.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.14 151.96 38.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.607 ' HG2' HG22 ' A' ' 408' ' ' VAL . 37.2 Cg_endo -65.92 -176.16 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.14 20.25 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.607 HG22 ' HG2' ' A' ' 406' ' ' PRO . 13.2 m -89.62 160.5 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.927 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.33 -33.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.801 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.3 m -93.9 159.37 15.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.7 165.49 11.4 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -92.79 138.25 31.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.857 ' HB2' HD13 ' A' ' 390' ' ' LEU . 43.5 t80 -92.62 128.2 38.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.053 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.912 HD12 ' HB2' ' A' ' 432' ' ' ASP . 13.9 mt -79.71 116.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.52 ' CD1' HG22 ' B' ' 4' ' ' ILE . 4.8 mt -83.76 -68.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.639 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 430' ' ' GLU . 10.5 pt-20 -159.58 144.71 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.994 0.426 . . . . 0.0 111.305 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.614 HG22 HD12 ' A' ' 385' ' ' ILE . 8.5 t -116.66 137.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.846 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.52 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 4.9 mm -79.66 138.86 54.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.675 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 27.0 Cg_exo -62.75 -10.39 19.67 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.909 2.406 . . . . 0.0 113.771 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.33 55.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.001 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.727 HG21 ' HA3' ' A' ' 384' ' ' GLY . 1.1 p -153.96 157.95 32.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.07 -25.17 79.06 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.432 2.088 . . . . 0.0 111.251 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.551 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -58.72 -58.45 8.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.008 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.81 -30.24 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.667 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.74 -26.55 57.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -73.25 -30.15 63.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.204 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.82 23.16 3.12 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.819 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 471' ' ' ILE . 0.9 OUTLIER -91.73 -176.65 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.748 0.309 . . . . 0.0 110.768 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.17 159.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 416' ' ' GLU . 0.0 OUTLIER -71.65 -176.98 1.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 59.41 27.57 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.912 ' HB2' HD12 ' A' ' 414' ' ' ILE . 7.1 m-20 -125.23 -177.93 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.703 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -146.27 124.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.379 . . . . 0.0 111.495 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 435' ' ' ILE . 3.4 mt -89.34 154.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.715 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.739 HD12 ' N ' ' A' ' 436' ' ' SER . 2.0 pp -141.69 -48.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.745 0.307 . . . . 0.0 111.717 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.739 ' N ' HD12 ' A' ' 435' ' ' ILE . 77.1 p -113.8 152.93 29.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.653 HG21 HG11 ' A' ' 451' ' ' VAL . 7.6 tt -150.83 112.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.65 HD22 ' HG3' ' A' ' 440' ' ' GLN . 0.8 OUTLIER 44.98 41.51 5.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.679 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 80.55 23.92 59.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.851 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.65 ' HG3' HD22 ' A' ' 438' ' ' ASN . 6.8 mm100 -125.05 120.68 32.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.699 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 11.5 p -72.69 123.35 23.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.258 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.955 HG11 HG22 ' A' ' 448' ' ' VAL . 10.2 t -107.67 143.14 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.833 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.68 4.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.1 p -170.2 164.72 9.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.891 0.377 . . . . 0.0 111.222 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.508 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -58.07 -45.18 87.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.06 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.425 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 23.7 p30 -57.34 -29.15 63.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.78 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.824 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.6 m-20 -75.12 -35.56 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.955 HG22 HG11 ' A' ' 442' ' ' VAL . 33.5 t -73.02 -39.46 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.376 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 452' ' ' ILE . 23.0 t -57.02 -63.94 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.458 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -47.1 -32.2 4.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.423 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 447' ' ' ASP . 45.6 t -68.85 -45.54 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.975 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 449' ' ' SER . 22.1 mt -59.65 -29.66 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -6.09 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.356 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.06 -46.96 5.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.28 155.35 20.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 8.5 t -97.8 -35.85 10.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.3 95.93 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.6 ' HB3' HD11 ' A' ' 437' ' ' ILE . 4.8 mt -94.0 119.29 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.25 93.28 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.462 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.53 160.29 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.671 HG22 ' HG3' ' A' ' 470' ' ' MET . 20.3 t -119.56 127.6 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.801 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.3 141.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -96.73 119.88 36.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.37 126.78 48.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.25 -99.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.373 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.92 29.32 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 110.837 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -141.74 147.99 38.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.089 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -90.11 136.26 33.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.38 136.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.34 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -97.14 119.9 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.534 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 428' ' ' LEU . 18.1 mm -115.36 145.1 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.189 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 31.0 m -135.04 132.8 38.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.652 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.8 t -141.08 138.33 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.248 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.652 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -112.66 109.99 52.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.432 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.0 Cg_endo -59.4 119.1 6.13 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.332 2.022 . . . . 0.0 112.14 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -79.92 169.0 18.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -97.01 147.61 23.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 1.7 tt -154.02 140.41 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -118.73 123.04 29.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.768 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.488 2.125 . . . . 0.0 112.268 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.869 0.366 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.486 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 0.7 OUTLIER -60.05 -69.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.728 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 54.05 52.17 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.3 pp -75.45 155.34 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.42 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.425 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 20.8 m95 -127.34 79.65 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.706 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -67.51 75.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.56 ' O ' HG12 ' B' ' 7' ' ' VAL . 22.0 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.064 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.01 79.15 1.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.901 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.28 149.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.53 36.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.08 98.59 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.082 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -127.52 169.11 14.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.649 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' TYR . . . . . 0.471 ' HB2' HG21 ' A' ' 478' ' ' ILE . 51.6 t80 -147.01 128.41 14.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.344 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 385' ' ' ILE . 7.1 pt -118.31 -10.62 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.731 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 60.83 71.06 0.85 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.828 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.966 HD13 HG22 ' A' ' 417' ' ' VAL . 7.3 tp -164.41 123.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.811 0.338 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -89.71 129.61 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' B' ' 5' ' ' TRP . 0.0 OUTLIER -132.88 146.56 51.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.851 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.416 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.0 ptm -127.82 160.84 30.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.7 p -80.05 101.67 8.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.63 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.922 HD13 ' HB2' ' A' ' 413' ' ' TYR . 8.2 tp -54.65 108.8 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.6 t -88.82 157.78 18.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.858 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.56 -25.55 60.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.59 -27.93 61.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.113 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -99.61 -40.1 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.36 67.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -89.97 -34.76 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.54 -37.07 74.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.81 -32.48 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -68.22 -41.67 80.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -56.34 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -33.73 76.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -130.96 105.98 8.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 55.94 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.051 0.453 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.45 -20.18 4.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.77 129.09 88.76 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.028 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.525 ' HG2' HG22 ' A' ' 408' ' ' VAL . 33.1 Cg_endo -64.14 -167.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.271 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.88 64.8 4.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 406' ' ' PRO . 14.1 m -137.79 81.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 410' ' ' SER . 2.7 pp -59.38 -31.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' SER . . . . . 0.48 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.8 OUTLIER -93.41 144.73 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 137.82 178.23 15.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.494 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -100.77 158.18 16.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 111.019 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.922 ' HB2' HD13 ' A' ' 390' ' ' LEU . 13.0 t80 -114.82 127.75 55.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.896 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.861 ' CG2' HD11 ' A' ' 385' ' ' ILE . 4.6 mt -80.71 118.82 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.75 HD13 HG22 ' B' ' 4' ' ' ILE . 5.1 mt -83.65 -55.36 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.568 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 385' ' ' ILE . 4.3 pt-20 -160.68 162.89 32.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.349 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.966 HG22 HD13 ' A' ' 385' ' ' ILE . 25.5 t -119.7 155.63 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.672 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' A' ' 419' ' ' PRO . 1.7 mp -95.27 139.41 22.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 420' ' ' ASP . 21.3 Cg_endo -60.73 102.93 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.455 2.103 . . . . 0.0 112.205 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 419' ' ' PRO . 13.2 m-20 94.0 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.144 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.731 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -150.65 158.09 35.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.175 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.19 -22.45 74.19 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.124 1.883 . . . . 0.0 110.726 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.466 ' CA ' ' HG ' ' A' ' 428' ' ' LEU . . . -64.74 -60.07 3.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.912 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' GLU . . . . . 0.74 ' HB2' HG11 ' A' ' 417' ' ' VAL . 1.9 tm-20 -72.82 -39.86 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.974 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.28 70.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.276 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -78.61 -70.15 1.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 174.48 39.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.453 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.492 HD21 HG21 ' A' ' 473' ' ' VAL . 0.1 OUTLIER -87.61 175.45 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.921 0.391 . . . . 0.0 111.166 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -165.01 143.54 6.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.492 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 3.6 pt-20 -87.05 47.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 111.291 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -169.53 33.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.582 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -131.89 -179.52 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 412' ' ' ALA . 30.6 t -134.65 121.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.419 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.9 mt -76.04 150.93 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.6 HD12 ' HB3' ' A' ' 436' ' ' SER . 1.5 pp -141.38 -50.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.6 ' HB3' HD12 ' A' ' 435' ' ' ILE . 17.4 p -112.04 159.21 18.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 111.213 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.595 HD11 ' HB3' ' A' ' 458' ' ' LEU . 2.5 tt -164.14 114.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.078 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.4 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.0 p30 46.11 34.22 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.666 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.45 32.86 24.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.69 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.572 ' HB2' HG23 ' A' ' 437' ' ' ILE . 0.2 OUTLIER -128.09 134.3 49.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 110.64 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.29 104.6 14.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.282 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.874 HG11 HG22 ' A' ' 448' ' ' VAL . 32.9 t -88.06 136.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.64 -3.66 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.7 OUTLIER -169.95 168.76 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.238 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.48 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.01 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -54.79 -27.53 42.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.9 m-20 -79.81 -33.68 40.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.795 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.874 HG22 HG11 ' A' ' 442' ' ' VAL . 25.0 t -72.06 -40.35 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.264 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 4.5 t -56.07 -59.13 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.453 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.75 -25.6 11.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.568 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.857 HG13 ' OE2' ' A' ' 455' ' ' GLU . 47.1 t -76.01 -49.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.502 HD11 HG12 ' A' ' 448' ' ' VAL . 8.0 mt -59.43 -26.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -19.32 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.252 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -96.39 -60.88 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.81 0.338 . . . . 0.0 110.744 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' GLU . . . . . 0.857 ' OE2' HG13 ' A' ' 451' ' ' VAL . 2.0 mp0 -83.75 124.57 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 67.9 m -71.83 -37.26 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 9.0 p -101.65 123.58 45.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.76 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.595 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.5 mt -107.73 119.93 40.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -118.66 84.5 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.634 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.3 mtt -91.48 161.29 15.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 469' ' ' ILE . 19.4 t -132.41 126.12 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.785 HG23 HD13 ' A' ' 471' ' ' ILE . 10.0 t -125.24 150.19 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -106.42 126.68 52.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.514 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.4 mtp-105 -125.34 133.27 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.736 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.92 -104.94 1.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.236 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.49 25.93 3.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.834 0.35 . . . . 0.0 110.692 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -146.52 149.65 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.045 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.46 142.84 27.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.587 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.6 mt -128.63 155.39 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.349 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 3.9 mmt -109.54 119.9 40.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.479 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ILE . . . . . 0.785 HD13 HG23 ' A' ' 462' ' ' VAL . 3.7 mp -108.96 120.61 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 19.3 m -102.28 121.5 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.552 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.492 HG21 HD21 ' A' ' 428' ' ' LEU . 23.2 t -127.85 144.31 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.486 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 28.3 mm -127.77 109.9 20.47 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.855 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.56 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.1 Cg_endo -59.72 149.65 81.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.394 2.063 . . . . 0.0 112.288 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.45 176.84 5.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -103.55 139.44 38.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' ILE . . . . . 0.471 HG21 ' HB2' ' A' ' 382' ' ' TYR . 10.0 tt -149.14 143.54 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -122.03 117.95 29.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.25 1.104 0 C-N-CA 122.388 2.058 . . . . 0.0 112.339 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.837 0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m 60.65 45.33 10.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -66.76 88.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.75 HG22 HD13 ' A' ' 415' ' ' ILE . 24.3 pt -74.35 141.24 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.41 ' HB3' ' HE2' ' A' ' 387' ' ' MET . 9.2 m95 -119.58 94.09 4.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.38 77.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.418 HG12 ' OXT' ' B' ' 7' ' ' VAL . 11.7 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.156 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 24.2 p -171.31 106.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 59.48 29.44 19.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 64.0 mmm -130.75 68.82 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -140.78 177.29 8.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.762 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 475' ' ' PRO . 24.6 mttm -59.64 -178.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.788 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -160.04 128.42 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.175 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.591 HG23 ' HB3' ' A' ' 475' ' ' PRO . 12.7 pt -118.48 -5.74 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.271 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLY . . . . . 0.445 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 55.78 66.15 3.05 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.654 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ILE . . . . . 0.896 HG12 HG22 ' A' ' 417' ' ' VAL . 0.0 OUTLIER -153.45 124.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.815 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 386' ' ' ARG . . . . . 0.617 ' N ' HD13 ' A' ' 385' ' ' ILE . 25.3 mtt180 -90.2 123.88 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.069 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' MET . . . . . 0.475 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -131.21 145.03 51.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 388' ' ' MET . . . . . 0.541 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.7 OUTLIER -122.23 179.09 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.6 p -104.75 104.83 14.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.665 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 413' ' ' TYR . 6.2 tp -51.97 114.81 1.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.269 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.3 t -90.23 170.16 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 56.2 m -67.84 -14.5 63.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.527 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.3 t -87.94 -35.96 17.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 0.0 111.204 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.464 ' H ' HG23 ' A' ' 391' ' ' THR . 0.6 OUTLIER -84.86 -30.92 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.95 98.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -76.53 -33.31 58.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -29.18 70.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.49 -49.34 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.041 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -58.59 -30.37 67.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.092 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.36 -37.57 80.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.95 -65.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.56 -58.4 8.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 75.8 -54.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.362 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -44.72 -29.7 0.81 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.01 138.91 71.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.78 -159.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.485 2.123 . . . . 0.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -101.57 27.31 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.2 m -71.74 140.3 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.98 -30.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 16.8 m -101.62 -178.2 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 112.61 167.21 17.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.598 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 388' ' ' MET . . . -108.6 151.6 25.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' TYR . . . . . 0.776 ' HB2' HD13 ' A' ' 390' ' ' LEU . 52.8 t80 -101.46 128.72 47.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ILE . . . . . 0.937 HD12 ' HB2' ' A' ' 432' ' ' ASP . 16.1 mt -79.94 114.62 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.826 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' ILE . . . . . 0.833 ' CD1' HG22 ' B' ' 4' ' ' ILE . 4.1 mt -78.76 -66.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.27 158.57 41.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 111.585 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' VAL . . . . . 0.896 HG22 HG12 ' A' ' 385' ' ' ILE . 41.3 t -130.63 153.3 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.824 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' ILE . . . . . 0.829 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.1 mp -97.22 129.8 31.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.523 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.98 -12.91 16.69 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.009 2.473 . . . . 0.0 113.857 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' ASP . . . . . 0.829 ' H ' HG22 ' A' ' 418' ' ' ILE . 4.0 m-20 -111.24 53.48 0.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' THR . . . . . 0.445 HG21 ' HA3' ' A' ' 384' ' ' GLY . 18.1 p -153.89 153.82 29.2 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.095 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.58 -24.46 45.02 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.099 1.866 . . . . 0.0 110.906 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 428' ' ' LEU . . . -58.81 -60.25 4.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.37 -30.96 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.726 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.0 -15.46 58.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -84.07 -31.85 24.89 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.349 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 125.59 16.97 2.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.153 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 3.9 mt -85.69 -171.21 3.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.133 0.467 . . . . 0.0 110.74 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.86 153.87 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.43 -178.91 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 28.59 16.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.937 ' HB2' HD12 ' A' ' 414' ' ' ILE . 54.3 m-20 -132.63 170.02 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.751 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.26 127.06 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.324 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 414' ' ' ILE . 2.1 mp -84.89 147.85 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.569 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 436' ' ' SER . 2.2 pp -137.99 -43.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.728 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' SER . . . . . 0.821 ' N ' HD12 ' A' ' 435' ' ' ILE . 23.6 p -124.94 151.94 44.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.091 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 437' ' ' ILE . . . . . 0.729 HD12 ' CG ' ' A' ' 460' ' ' MET . 1.5 tt -148.81 115.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.982 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' ASN . . . . . 0.495 ' ND2' ' HG3' ' A' ' 440' ' ' GLN . 1.3 p-10 47.64 36.36 5.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.641 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.03 30.18 32.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.747 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' GLN . . . . . 0.495 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 6.1 mt-30 -122.78 145.69 48.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.778 0.323 . . . . 0.0 110.736 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.2 t -86.76 107.88 18.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.605 HG11 HG22 ' A' ' 448' ' ' VAL . 62.0 t -93.16 152.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 444' ' ' SER . 10.7 m -139.76 -46.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 443' ' ' VAL . 2.3 p -132.64 166.48 22.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.999 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' ALA . . . . . 0.475 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.21 -38.05 70.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.293 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' ASN . . . . . 0.4 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 1.2 p-10 -58.53 -29.67 66.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -77.63 -41.26 39.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 448' ' ' VAL . . . . . 0.686 HG12 HD11 ' A' ' 452' ' ' ILE . 32.9 t -63.16 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 449' ' ' SER . . . . . 0.704 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.6 t -54.89 -66.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.547 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 447' ' ' ASP . 40.7 t -75.62 -46.12 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.289 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 452' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.4 mt -58.76 -32.9 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 -4.15 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.628 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -100.38 -49.7 4.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.67 150.25 22.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 -35.88 14.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.807 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.21 96.83 6.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.6 mt -91.35 121.16 32.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' ASN . . . . . 0.523 ' CG ' HG23 ' A' ' 472' ' ' THR . 5.9 m-80 -111.78 90.21 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' MET . . . . . 0.729 ' CG ' HD12 ' A' ' 437' ' ' ILE . 3.2 mtm -95.71 130.35 42.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.105 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 461' ' ' VAL . . . . . 0.599 HG22 ' HG3' ' A' ' 470' ' ' MET . 22.1 t -99.22 122.82 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.956 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 432' ' ' ASP . 3.9 t -111.64 148.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.953 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.27 131.35 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' ARG . . . . . 0.613 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.9 mtp180 -138.74 125.53 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 69.52 -101.4 0.83 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.464 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -140.12 25.39 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.655 0.264 . . . . 0.0 111.116 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -140.08 151.77 45.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.821 0.344 . . . . 0.0 111.2 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.08 139.24 31.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mt -125.62 129.18 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 111.362 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 470' ' ' MET . . . . . 0.599 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -93.8 120.11 33.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.51 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 8.6 mm -117.8 142.9 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.31 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.523 HG23 ' CG ' ' A' ' 459' ' ' ASN . 1.3 m -123.45 136.03 54.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 473' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 474' ' ' ILE . 5.7 t -143.82 137.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.249 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 474' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -113.66 109.8 50.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' PRO . . . . . 0.591 ' HB3' HG23 ' A' ' 383' ' ' ILE . 28.8 Cg_endo -63.07 134.14 44.55 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.059 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.89 -177.4 5.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -124.38 122.34 37.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 15.8 tt -106.08 145.49 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -149.56 111.58 3.42 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo . . . . . 0 C--O 1.25 1.086 0 C-N-CA 122.446 2.097 . . . . 0.0 112.371 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 64.5 p -96.78 40.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.97 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.8 mtm-85 -58.09 89.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ILE . . . . . 0.833 HG22 ' CD1' ' A' ' 415' ' ' ILE . 5.0 pt -83.36 115.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' TRP . . . . . 0.4 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.5 m0 -99.76 101.29 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 8.8 t90 -82.59 63.32 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.787 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.463 ' O ' HG12 ' B' ' 7' ' ' VAL . 25.5 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.059 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.528 ' HB2' HG22 ' A' ' 452' ' ' ILE . 6.9 mmtt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.711 0.291 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -141.76 123.14 14.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.257 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.571 HD12 ' CG2' ' A' ' 385' ' ' ILE . 5.4 pt -113.29 -13.72 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.347 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.52 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 72.14 57.53 5.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.772 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.891 HD11 HG23 ' A' ' 414' ' ' ILE . 12.4 tt -160.18 151.74 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.14 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 17.7 mtt180 -106.02 127.6 53.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.476 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -134.71 145.29 48.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.9 ptm -127.27 160.55 30.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 83.9 p -85.4 110.02 18.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.5 tp -58.06 89.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.018 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 394' ' ' LYS . 5.7 t -75.72 166.47 23.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.77 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.1 t -49.53 -36.11 22.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.425 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -63.73 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.175 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.416 ' H ' HG23 ' A' ' 391' ' ' THR . 0.0 OUTLIER -57.28 -49.6 75.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.9 -39.69 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.313 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.04 -29.19 39.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.6 -34.81 79.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.19 -43.15 78.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.05 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -59.63 -34.35 72.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.64 -37.87 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -82.51 -70.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 96.46 8.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.04 60.43 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.8 14.23 1.92 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.23 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.31 150.96 40.08 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.685 ' HB2' HG22 ' A' ' 408' ' ' VAL . 53.6 Cg_exo -52.09 179.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.87 28.42 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' A' ' 406' ' ' PRO . 14.9 m -101.38 173.84 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.731 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -138.63 16.7 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.373 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.2 p -116.2 139.89 49.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.882 0.372 . . . . 0.0 110.801 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.12 167.06 11.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.35 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -101.56 142.9 32.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.128 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.756 ' HB2' HD13 ' A' ' 390' ' ' LEU . 45.0 t80 -104.14 130.38 51.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.891 HG23 HD11 ' A' ' 385' ' ' ILE . 17.4 mt -80.08 128.76 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.54 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.806 HD13 HG22 ' B' ' 4' ' ' ILE . 62.7 mt -96.24 -68.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.563 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 153.12 40.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 0.0 111.044 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.16 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.8 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.5 mp -79.84 134.69 56.57 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.308 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.97 -11.21 2.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.249 2.632 . . . . 0.0 114.678 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . 0.8 ' H ' HG22 ' A' ' 418' ' ' ILE . 14.7 m-20 -130.95 76.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.52 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.2 OUTLIER -160.15 163.58 21.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.603 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.64 -25.17 78.13 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.408 2.072 . . . . 0.0 111.6 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -59.14 -54.67 44.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.169 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.08 -31.08 65.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.5 -30.51 59.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.265 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.98 -38.15 84.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.35 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.77 29.42 1.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.82 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.87 HD23 HG21 ' A' ' 471' ' ' ILE . 0.4 OUTLIER -96.97 -164.28 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.686 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.25 163.71 22.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.854 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 41.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 0.0 110.977 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -151.88 28.54 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.59 ' HB2' HD12 ' A' ' 414' ' ' ILE . 1.0 OUTLIER -126.57 -177.04 3.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 29.8 t -136.68 123.21 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.315 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 435' ' ' ILE . 1.7 mp -77.04 157.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 436' ' ' SER . 2.0 pp -148.79 -46.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.411 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 435' ' ' ILE . 54.2 p -124.34 160.95 26.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.979 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.996 HG21 HG11 ' A' ' 451' ' ' VAL . 2.8 tt -156.58 119.57 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.249 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.445 ' ND2' HG12 ' A' ' 437' ' ' ILE . 19.6 p30 43.54 46.94 6.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.718 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 74.27 47.18 18.2 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.713 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -142.95 161.49 37.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.679 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 61.9 m -111.62 110.5 20.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.961 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.937 HG11 HG22 ' A' ' 448' ' ' VAL . 5.3 t -95.04 152.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 444' ' ' SER . 27.9 m -130.12 -42.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.453 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 443' ' ' VAL . 2.2 p -134.3 172.35 13.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 0.0 111.242 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.476 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.38 -42.97 78.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.416 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 25.1 p30 -55.31 -29.14 57.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.843 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.83 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.8 m-20 -78.52 -35.68 45.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.937 HG22 HG11 ' A' ' 442' ' ' VAL . 32.4 t -69.75 -41.51 79.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.266 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.666 ' HA ' HD12 ' A' ' 452' ' ' ILE . 20.2 t -54.78 -62.62 1.54 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.529 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -48.28 -35.97 13.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.409 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.996 HG11 HG21 ' A' ' 437' ' ' ILE . 40.3 t -65.81 -46.05 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.068 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.5 mt -61.92 -31.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.135 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.03 -14.3 24.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.455 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -94.37 -44.99 7.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.317 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.13 128.52 53.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 53.9 m -70.2 -37.71 75.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.7 p -104.25 121.38 43.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.582 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.772 ' HB3' HD11 ' A' ' 437' ' ' ILE . 9.2 mt -107.38 129.27 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.6 m-80 -127.92 83.07 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.642 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.499 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.1 OUTLIER -89.68 136.62 32.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.495 HG22 ' HG3' ' A' ' 470' ' ' MET . 21.8 t -99.07 126.51 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.164 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.412 HG11 ' OD2' ' A' ' 432' ' ' ASP . 11.6 t -121.15 129.3 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -89.73 120.96 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -124.3 128.52 49.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.03 -100.98 0.89 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.347 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -139.93 23.85 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -141.91 148.35 38.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.147 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -91.73 136.46 33.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.1 mt -126.01 146.59 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.216 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.495 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -101.89 119.92 39.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.87 HG21 HD23 ' A' ' 428' ' ' LEU . 12.1 mm -107.17 133.6 51.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.4 HG23 ' OD1' ' A' ' 459' ' ' ASN . 0.2 OUTLIER -114.54 126.55 55.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.936 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 428' ' ' LEU . 20.6 t -135.98 130.35 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.03 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 33.8 mm -105.24 109.92 63.8 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.457 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.9 Cg_endo -58.06 175.49 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -123.92 155.81 37.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.985 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.821 0.343 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 60.4 71.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.806 HG22 HD13 ' A' ' 415' ' ' ILE . 9.2 pt -84.82 134.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.416 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 12.5 m95 -117.91 91.11 3.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 3.8 t90 -70.71 72.47 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.44 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.2 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.679 0.276 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.449 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 52.1 t80 -152.97 131.76 12.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.668 HG13 HG22 ' A' ' 385' ' ' ILE . 22.4 pt -116.85 -14.95 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.62 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 67.01 61.95 4.83 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.882 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.941 HD11 HG23 ' A' ' 414' ' ' ILE . 10.3 tt -165.37 137.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 111.266 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.509 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -96.59 145.9 25.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.782 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.504 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -141.46 139.5 33.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.742 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.446 ' CG ' HD11 ' A' ' 415' ' ' ILE . 6.2 ptm -116.83 162.88 17.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.9 p -85.37 115.85 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 398' ' ' LEU . 6.6 tp -69.13 84.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.8 t -71.12 173.7 7.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.9 m -62.56 -19.1 63.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.305 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -46.43 12.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.464 ' H ' HG23 ' A' ' 391' ' ' THR . 0.0 OUTLIER -82.91 -32.65 27.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -65.58 -51.02 62.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.386 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.19 -29.47 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -38.09 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.06 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 390' ' ' LEU . 6.1 mt -62.45 -52.58 62.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -29.93 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -60.0 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -65.68 -42.4 91.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.058 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -119.89 113.94 21.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -82.92 -27.44 30.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -25.64 59.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 402' ' ' HIS . 4.8 m-85 -55.46 161.27 3.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.582 ' HB2' HG22 ' A' ' 408' ' ' VAL . 45.6 Cg_endo -68.53 173.2 10.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.59 2.193 . . . . 0.0 112.21 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -98.31 30.98 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 406' ' ' PRO . 13.2 m -114.66 126.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.66 -30.16 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.51 173.78 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 104.65 173.94 24.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.443 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.28 140.14 43.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.15 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.849 ' HB2' HD13 ' A' ' 390' ' ' LEU . 23.3 t80 -90.54 128.06 36.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.668 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.941 HG23 HD11 ' A' ' 385' ' ' ILE . 8.0 mt -79.88 127.94 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 9.6 mm -85.4 -69.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -160.14 153.79 22.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.723 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.491 HG22 HD12 ' A' ' 385' ' ' ILE . 12.5 t -118.09 139.05 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.466 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 22.7 mm -79.75 146.57 64.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.507 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 418' ' ' ILE . 15.8 Cg_exo -69.52 6.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.822 2.348 . . . . 0.0 113.877 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.06 62.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.146 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.547 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.1 OUTLIER -155.42 171.81 6.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.772 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.46 ' HB2' HG13 ' A' ' 473' ' ' VAL . 82.3 Cg_endo -79.19 -18.12 11.36 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.535 2.157 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.616 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -60.43 -58.87 6.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.049 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.423 ' N ' HG11 ' A' ' 417' ' ' VAL . 3.4 tp10 -68.37 -27.76 66.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.63 38.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.383 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -76.24 -39.19 32.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.435 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 133.24 16.97 1.16 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.154 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 471' ' ' ILE . 3.0 mt -85.99 -170.65 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.074 0.437 . . . . 0.0 110.68 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.82 141.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 16.0 pm0 -62.22 178.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 62.88 23.5 14.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.805 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.733 ' HB2' HD12 ' A' ' 414' ' ' ILE . 17.1 m-20 -125.42 -177.11 3.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.554 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -139.47 123.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 111.536 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.3 154.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -141.86 -49.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.683 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.71 ' N ' HD12 ' A' ' 435' ' ' ILE . 52.3 p -114.14 155.43 26.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.207 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.1 tt -157.77 111.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.028 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.418 ' ND2' HG12 ' A' ' 437' ' ' ILE . 13.5 p30 45.43 41.65 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.578 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 78.7 35.1 32.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.769 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.55 ' HB2' HG23 ' A' ' 437' ' ' ILE . 17.4 mm-40 -134.62 125.57 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.766 0.317 . . . . 0.0 110.924 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 68.8 p -80.93 110.77 16.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.906 HG11 ' CG2' ' A' ' 448' ' ' VAL . 10.8 t -92.2 143.1 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.11 -32.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.48 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.99 177.59 9.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.239 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.504 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -61.14 -42.45 98.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.037 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.433 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 24.5 p30 -53.87 -26.25 23.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.874 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -79.91 -50.69 10.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.688 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.906 ' CG2' HG11 ' A' ' 442' ' ' VAL . 41.3 t -56.75 -37.25 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.291 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 24.8 t -57.1 -65.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.399 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -51.67 -32.16 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.37 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 447' ' ' ASP . 41.5 t -66.64 -49.91 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.67 HD11 HG12 ' A' ' 448' ' ' VAL . 9.1 mt -58.25 -29.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -97.14 -14.28 21.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.422 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -97.64 -54.64 3.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 451' ' ' VAL . 17.2 mm-40 -86.48 126.3 34.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.927 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 73.5 m -69.03 -36.84 78.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . 0.579 ' C ' HD23 ' A' ' 458' ' ' LEU . 1.5 p -108.44 136.27 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.679 ' HB3' HD11 ' A' ' 437' ' ' ILE . 4.0 mt -120.14 140.74 50.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.052 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . 0.717 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.1 m-80 -141.9 91.78 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.586 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.449 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -96.74 159.34 14.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 23.7 t -129.93 122.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.875 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.745 ' O ' HD12 ' A' ' 469' ' ' ILE . 5.6 t -112.91 147.45 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.206 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -114.61 139.36 49.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.804 ' HG2' HD11 ' A' ' 469' ' ' ILE . 21.1 ptt180 -132.23 126.51 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.793 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 59.93 -96.51 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -136.88 29.0 2.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 0.0 110.961 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.54 143.79 39.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.95 141.77 28.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.675 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.804 HD11 ' HG2' ' A' ' 464' ' ' ARG . 0.8 OUTLIER -127.03 125.31 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.159 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.522 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.0 OUTLIER -95.93 125.27 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.769 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 428' ' ' LEU . 3.5 mp -125.5 132.55 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.401 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.717 HG23 ' OD1' ' A' ' 459' ' ' ASN . 1.2 m -116.71 119.82 36.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.435 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 428' ' ' LEU . 21.2 t -124.92 140.71 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 111.399 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.569 HD12 HG22 ' A' ' 457' ' ' THR . 27.3 mm -124.09 111.99 28.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.717 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.449 ' HB3' HG23 ' A' ' 383' ' ' ILE . 23.9 Cg_endo -62.05 144.23 95.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.315 2.01 . . . . 0.0 112.353 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.7 171.62 7.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.968 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.788 0.328 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -65.5 99.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.455 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.8 pt -69.5 157.03 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.433 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 13.3 m95 -118.78 91.89 3.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.426 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 5.4 t90 -72.98 79.64 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.18 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.856 0.36 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -154.37 159.16 41.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.843 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.849 HG22 ' HG2' ' A' ' 422' ' ' PRO . 0.7 OUTLIER -135.38 -59.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.37 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 115.5 49.32 0.48 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.359 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.886 HD13 HG22 ' A' ' 417' ' ' VAL . 5.5 tp -138.93 132.58 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.031 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -89.8 129.82 36.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.561 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.457 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -138.36 157.57 45.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.106 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 412' ' ' ALA . 1.5 ptm -134.32 -179.59 5.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 4.2 p -94.67 15.82 17.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.369 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.778 HD13 ' HB2' ' A' ' 413' ' ' TYR . 12.5 tp 47.26 95.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.874 0.369 . . . . 0.0 111.481 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.673 HG23 ' H ' ' A' ' 394' ' ' LYS . 2.6 t -71.67 156.26 39.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.23 -30.57 70.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.1 m -66.62 -56.67 9.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.673 ' H ' HG23 ' A' ' 391' ' ' THR . 0.1 OUTLIER -71.43 -29.84 65.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.619 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -57.59 -60.01 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.45 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -61.9 -36.38 81.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 395' ' ' ALA . 4.7 mt -61.1 -43.5 98.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -66.12 -30.54 71.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -59.89 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -68.53 -60.62 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.8 85.23 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 65.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.124 0.488 . . . . 0.0 110.854 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -167.54 28.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -89.63 167.34 17.71 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.773 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.64 -24.4 12.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.527 2.151 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.6 t0 68.36 51.79 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.51 90.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.025 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.545 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -46.54 -30.97 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.474 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.4 m -116.61 130.49 56.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 163.57 178.33 37.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 434' ' ' ILE . . . -98.08 123.41 42.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.778 ' HB2' HD13 ' A' ' 390' ' ' LEU . 62.5 t80 -97.83 129.99 44.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.767 HG23 HD11 ' A' ' 385' ' ' ILE . 21.5 mt -80.69 109.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.605 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.768 HD13 HG22 ' B' ' 4' ' ' ILE . 2.8 mp -72.89 -58.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.294 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.735 ' O ' HD12 ' A' ' 385' ' ' ILE . 17.1 pt-20 -160.1 147.78 16.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.814 0.34 . . . . 0.0 111.208 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.886 HG22 HD13 ' A' ' 385' ' ' ILE . 24.8 t -108.85 133.28 54.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.939 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.508 ' O ' HG22 ' A' ' 421' ' ' THR . 0.3 OUTLIER -80.4 156.7 73.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.93 44.08 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.793 2.329 . . . . 0.0 112.58 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -173.31 35.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.562 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 418' ' ' ILE . 4.0 t -129.46 154.39 80.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.023 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.849 ' HG2' HG22 ' A' ' 383' ' ' ILE . 36.1 Cg_exo -61.19 -24.39 79.0 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.761 2.308 . . . . 0.0 112.325 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.848 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -53.72 -38.56 64.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.66 -29.66 59.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.39 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.953 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.724 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -67.89 -69.57 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.29 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 151.69 39.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.81 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.874 HD23 HG21 ' A' ' 471' ' ' ILE . 1.1 mt -98.48 -165.12 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -178.97 170.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.04 28.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.22 12.97 3.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.494 ' HB2' HD12 ' A' ' 414' ' ' ILE . 15.9 m-20 -119.12 173.37 6.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.631 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 412' ' ' ALA . 28.4 t -138.25 117.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.365 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 412' ' ' ALA . 3.6 mp -66.2 142.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.668 HD12 ' HB3' ' A' ' 436' ' ' SER . 2.1 pp -136.43 -46.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.567 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.668 ' HB3' HD12 ' A' ' 435' ' ' ILE . 24.2 p -121.7 156.51 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.926 HG21 HG11 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -151.54 124.45 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.002 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 13.9 p30 44.71 30.89 0.57 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.576 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.22 27.26 23.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -118.13 170.19 9.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.746 0.307 . . . . 0.0 110.713 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 16.4 m -118.35 111.09 18.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.97 HG11 HG22 ' A' ' 448' ' ' VAL . 10.8 t -97.67 161.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.478 ' N ' HG12 ' A' ' 442' ' ' VAL . 8.6 m -139.45 -48.31 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.475 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.7 OUTLIER -126.05 167.82 14.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.414 . . . . 0.0 111.282 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.457 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.75 -41.38 81.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -55.84 -26.34 46.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.817 ' O ' HG23 ' A' ' 451' ' ' VAL . 6.3 m-20 -86.88 -29.74 21.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.97 HG22 HG11 ' A' ' 442' ' ' VAL . 13.4 t -72.13 -44.67 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.314 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.526 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.7 t -50.84 -64.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.624 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -46.61 -36.5 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.474 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.926 HG11 HG21 ' A' ' 437' ' ' ILE . 41.1 t -63.33 -50.09 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.207 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.2 mt -58.75 -37.2 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -90.34 -4.88 56.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.399 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -100.07 -51.35 3.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.63 142.36 28.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 5.3 t -81.28 -38.25 27.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.674 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . 0.526 HG22 HD12 ' A' ' 474' ' ' ILE . 1.0 OUTLIER -106.61 117.76 34.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.601 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.765 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.0 mt -101.97 126.75 48.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -132.22 92.78 3.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.634 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.489 ' HG3' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -96.74 151.69 19.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.35 121.95 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.017 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 463' ' ' ARG . 9.0 t -107.43 161.42 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . 0.47 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -124.83 138.7 54.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.0 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.759 ' HB2' HD11 ' A' ' 469' ' ' ILE . 0.3 OUTLIER -147.65 121.27 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.743 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.79 -113.68 5.84 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.26 29.37 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.52 150.2 43.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.243 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -94.25 147.15 23.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.759 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.0 OUTLIER -127.88 132.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.256 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.31 119.88 39.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.654 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.874 HG21 HD23 ' A' ' 428' ' ' LEU . 11.5 mm -112.54 132.67 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 25.1 m -122.62 119.86 32.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.724 HG22 ' HA3' ' A' ' 426' ' ' GLY . 24.5 t -130.1 133.74 63.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.526 HD12 HG22 ' A' ' 457' ' ' THR . 26.3 mm -118.11 109.14 41.23 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.608 ' HB3' HG23 ' A' ' 383' ' ' ILE . 39.5 Cg_endo -66.84 -172.71 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.462 2.108 . . . . 0.0 112.226 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -143.1 173.5 11.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.857 0.361 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 113.6 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.768 HG22 HD13 ' A' ' 415' ' ' ILE . 2.6 pt -81.26 118.13 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -94.71 92.65 7.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -68.24 85.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.123 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.6 mttp . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.801 0.334 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -131.0 126.98 37.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 385' ' ' ILE . 11.0 pt -116.72 -4.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.425 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.478 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 50.07 67.27 1.91 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.857 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.958 HD13 HG22 ' A' ' 417' ' ' VAL . 4.8 tp -151.73 126.22 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 110.841 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.426 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 27.7 mtt85 -89.9 125.96 35.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.85 142.53 47.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.457 ' HB3' HD11 ' A' ' 415' ' ' ILE . 8.6 ptm -125.54 156.98 38.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 49.2 p -84.21 114.53 21.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' ' 395' ' ' ALA . 6.8 tp -63.93 81.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.4 t -62.12 158.69 16.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 m -57.42 -23.24 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -54.7 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.092 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.746 ' H ' HG23 ' A' ' 391' ' ' THR . 0.5 OUTLIER -63.71 -45.16 91.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.169 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.594 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -59.18 -39.85 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.185 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -77.63 -29.87 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.79 -47.57 62.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.14 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.5 -44.06 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -65.86 -31.7 72.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.74 -43.31 94.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 ttm-85 -93.09 -20.34 20.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.311 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -135.57 78.79 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -69.14 -22.8 63.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.79 -26.64 10.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -65.06 160.39 56.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.835 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.27 -167.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.565 2.177 . . . . 0.0 112.243 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -116.7 31.33 6.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.015 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.7 m -91.9 132.27 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.611 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -110.5 -18.26 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.31 154.23 18.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 116.56 159.35 11.65 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.616 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -90.11 147.77 23.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.117 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.547 ' HB2' HD13 ' A' ' 390' ' ' LEU . 74.6 t80 -102.42 131.25 49.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 432' ' ' ASP . 21.2 mt -80.01 122.92 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.889 ' CD1' HG22 ' B' ' 4' ' ' ILE . 17.9 mt -91.84 -61.24 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.831 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.769 ' O ' HD12 ' A' ' 385' ' ' ILE . 8.0 pt-20 -157.88 149.29 21.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.403 . . . . 0.0 111.415 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.958 HG22 HD13 ' A' ' 385' ' ' ILE . 20.4 t -117.4 140.37 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -86.79 135.37 35.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.729 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 7.9 Cg_exo -72.57 56.18 2.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.779 2.319 . . . . 0.0 112.496 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 178.25 40.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.162 0.506 . . . . 0.0 110.498 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.4 OUTLIER -142.78 173.83 4.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -75.77 -13.87 19.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.132 1.888 . . . . 0.0 111.856 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.499 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -66.15 -56.9 9.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.65 -31.78 70.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.456 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.94 -30.62 58.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.843 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -66.86 -34.06 86.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.255 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.95 26.83 2.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.843 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 471' ' ' ILE . 0.3 OUTLIER -96.47 -177.81 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -159.64 161.5 35.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.762 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -85.59 56.17 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.17 31.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.034 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 414' ' ' ILE . 14.9 m-20 -135.22 -174.34 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.815 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 412' ' ' ALA . 38.6 t -142.21 123.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.312 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.7 mt -75.7 147.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -138.69 -46.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.351 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.763 ' N ' HD12 ' A' ' 435' ' ' ILE . 90.9 p -116.93 156.32 27.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.726 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.932 HG21 HG11 ' A' ' 451' ' ' VAL . 4.5 tt -155.9 114.51 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.198 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.427 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.7 p30 44.33 33.42 0.85 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.454 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.68 36.16 9.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.773 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.47 114.42 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 m -70.19 114.4 8.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.93 HG11 HG22 ' A' ' 448' ' ' VAL . 2.7 t -97.65 162.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 444' ' ' SER . 16.1 m -133.76 -45.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.433 ' N ' HG23 ' A' ' 443' ' ' VAL . 1.9 p -130.95 173.73 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.16 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.84 94.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.045 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.428 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 1.3 p-10 -53.99 -26.64 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.863 ' O ' HG23 ' A' ' 451' ' ' VAL . 12.5 m-20 -86.85 -41.4 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.93 HG22 HG11 ' A' ' 442' ' ' VAL . 46.9 t -63.19 -30.63 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.131 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.494 ' HA ' HD12 ' A' ' 452' ' ' ILE . 4.9 t -63.59 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -51.27 -36.38 41.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.504 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.932 HG11 HG21 ' A' ' 437' ' ' ILE . 40.9 t -60.72 -47.73 91.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 448' ' ' VAL . 5.5 mt -62.09 -37.5 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.15 -8.05 55.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.224 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -98.92 -46.82 5.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.819 0.343 . . . . 0.0 110.843 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.26 140.33 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 35.3 t -84.88 -34.31 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.739 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . 0.474 HG22 HD12 ' A' ' 474' ' ' ILE . 2.1 p -109.17 100.21 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.758 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 452' ' ' ILE . 8.3 mt -94.53 136.31 34.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.7 m-80 -133.82 89.02 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.633 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.458 ' HE1' ' HB ' ' A' ' 473' ' ' VAL . 0.1 OUTLIER -92.48 173.78 7.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 470' ' ' MET . 13.2 t -134.68 145.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.883 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 432' ' ' ASP . 7.3 t -140.58 153.47 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.001 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -101.76 119.84 39.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.98 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.496 ' HB2' HD12 ' A' ' 469' ' ' ILE . 9.3 mtp180 -127.81 139.64 52.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.7 -101.72 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.169 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -140.19 20.56 2.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.778 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -145.8 168.47 20.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.92 136.08 42.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.649 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.8 mt -127.53 143.98 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.593 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -90.7 119.89 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.714 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 428' ' ' LEU . 21.8 mm -103.21 130.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.455 HG23 ' OD1' ' A' ' 459' ' ' ASN . 0.2 OUTLIER -102.77 129.12 49.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.013 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.458 ' HB ' ' HE1' ' A' ' 460' ' ' MET . 18.4 t -140.36 119.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.474 HD12 HG22 ' A' ' 457' ' ' THR . 21.2 mm -108.19 109.85 61.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.165 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.459 ' HG3' HG23 ' A' ' 452' ' ' ILE . 58.2 Cg_exo -51.43 131.27 35.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.43 2.087 . . . . 0.0 112.33 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.0 170.56 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.841 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.816 0.341 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -60.16 117.05 4.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.889 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.4 pt -84.26 123.08 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.6 m95 -108.57 95.37 5.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.426 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 6.8 t90 -76.85 62.56 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.808 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.064 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.739 0.305 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -152.02 124.42 8.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.024 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 385' ' ' ILE . 24.5 pt -113.36 -4.2 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.463 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.551 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 53.6 65.82 3.17 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.734 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.807 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.13 124.82 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.947 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 1.9 mtp180 -92.3 125.15 36.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.505 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -127.07 137.28 53.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.416 ' HB3' HD11 ' A' ' 415' ' ' ILE . 3.7 ptm -115.85 173.26 6.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.012 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.5 p -97.69 105.55 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.632 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.867 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.2 tp -54.37 98.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.7 t -87.01 165.09 16.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.839 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.8 m -58.92 -29.7 67.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.067 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 71.2 m -78.55 -19.05 53.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -51.26 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 111.072 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -57.35 -45.84 83.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.313 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -66.72 -29.71 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.82 -41.06 62.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.993 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 395' ' ' ALA . 7.1 mt -59.97 -38.45 82.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -34.2 68.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.98 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -77.28 -29.27 53.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -53.25 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -116.31 115.74 26.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.003 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.79 55.62 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.841 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -146.97 19.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.103 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.83 158.28 35.35 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 -172.74 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.588 2.192 . . . . 0.0 112.211 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -109.29 32.03 5.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 11.7 m -102.3 129.6 53.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pt -102.57 -32.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.5 m -87.78 149.9 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.773 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 132.17 -157.8 22.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -132.96 127.62 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.867 ' HB2' HD13 ' A' ' 390' ' ' LEU . 41.4 t80 -90.33 128.03 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.807 HG23 HD11 ' A' ' 385' ' ' ILE . 15.3 mt -80.57 109.97 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.515 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -71.3 -58.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 430' ' ' GLU . 6.4 pt-20 -158.31 152.14 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.401 . . . . 0.0 111.245 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.53 HG22 ' CG1' ' A' ' 385' ' ' ILE . 22.2 t -127.95 136.35 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.954 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.596 HG22 ' HD2' ' A' ' 419' ' ' PRO . 8.4 mm -79.86 146.23 63.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.596 ' HD2' HG22 ' A' ' 418' ' ' ILE . 11.9 Cg_exo -71.15 0.52 6.54 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.744 2.296 . . . . 0.0 113.319 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -127.35 61.75 1.38 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.8 OUTLIER -152.7 168.99 10.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.564 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.561 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 59.7 Cg_endo -74.31 -18.06 20.89 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.265 1.977 . . . . 0.0 111.48 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -61.8 -59.22 5.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.554 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.49 -27.08 64.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.563 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.44 -30.45 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.18 1.26 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 167.97 31.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.903 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.661 HD11 HG21 ' A' ' 473' ' ' VAL . 0.3 OUTLIER -108.12 -168.15 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.805 0.336 . . . . 0.0 110.82 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.55 169.62 2.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.774 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 416' ' ' GLU . 0.4 OUTLIER -89.92 49.93 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -160.46 29.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.472 ' HB2' HD12 ' A' ' 414' ' ' ILE . 29.8 m-20 -134.15 -177.34 4.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.58 117.89 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.19 149.58 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 436' ' ' SER . 2.3 pp -141.95 -47.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.78 ' N ' HD12 ' A' ' 435' ' ' ILE . 96.3 p -123.64 144.94 49.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.97 HG21 HG11 ' A' ' 451' ' ' VAL . 3.9 tt -143.52 119.62 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 18.9 p30 44.85 30.49 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.734 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.07 20.37 42.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.201 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -112.31 157.67 20.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.78 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.17 118.3 31.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.628 HG11 HG22 ' A' ' 448' ' ' VAL . 57.9 t -109.51 127.45 66.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.29 6.49 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.95 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.9 OUTLIER -170.41 161.52 8.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.881 0.372 . . . . 0.0 111.152 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.505 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -58.2 -45.19 88.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.048 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.42 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 36.4 p-10 -56.58 -28.42 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.819 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.5 OUTLIER -77.69 -33.8 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.628 HG22 HG11 ' A' ' 442' ' ' VAL . 18.0 t -74.45 -37.39 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.195 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.542 ' HA ' HD12 ' A' ' 452' ' ' ILE . 7.6 t -55.27 -57.55 11.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -54.94 -41.04 70.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.339 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.97 HG11 HG21 ' A' ' 437' ' ' ILE . 39.5 t -58.56 -47.34 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.148 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 449' ' ' SER . 8.4 mt -58.8 -36.05 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.68 -0.84 54.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.322 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -100.22 -47.8 4.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 110.916 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.2 152.81 31.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.75 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.9 t -94.27 -35.61 12.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.695 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 94.3 6.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.714 ' HB3' HD11 ' A' ' 437' ' ' ILE . 14.9 mt -89.86 123.24 33.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -111.13 83.16 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.434 ' HE3' ' HB2' ' A' ' 458' ' ' LEU . 2.6 mtt -90.29 133.35 35.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 469' ' ' ILE . 28.7 t -108.28 124.71 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.902 HG23 HD13 ' A' ' 471' ' ' ILE . 3.0 t -111.27 163.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.6 OUTLIER -124.76 143.91 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.047 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.765 ' HB2' HD11 ' A' ' 469' ' ' ILE . 16.0 mtp180 -144.73 130.36 19.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.82 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.22 -99.54 0.21 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.436 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.26 30.89 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.754 0.312 . . . . 0.0 110.944 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.12 144.94 24.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.765 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mp -128.76 129.65 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 111.317 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.69 125.21 47.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.492 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.902 HD13 HG23 ' A' ' 462' ' ' VAL . 3.8 mp -132.66 143.61 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.44 . . . . 0.0 111.618 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.18 135.92 53.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.768 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.5 t -135.94 135.1 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.566 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.768 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.5 mp -119.83 109.26 37.97 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.586 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.12 155.96 5.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.425 2.084 . . . . 0.0 112.292 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.18 170.62 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.97 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.917 0.389 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.0 mtt-85 -61.62 89.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.515 HG22 ' CD1' ' A' ' 415' ' ' ILE . 2.3 pp -80.78 133.43 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.42 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.4 m0 -112.04 88.13 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.42 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 7.3 t90 -71.17 68.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.422 HG23 ' HE3' ' A' ' 387' ' ' MET . 21.1 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.198 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.8 mptt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.727 0.298 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 384' ' ' GLY . 13.0 t80 -155.83 121.1 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.241 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.0 pt -111.35 -13.02 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.237 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.559 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 70.42 52.77 15.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.729 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.797 HD11 HG23 ' A' ' 414' ' ' ILE . 10.9 tt -165.31 137.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.419 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -89.96 158.18 17.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.463 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.426 ' HE3' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -153.22 133.63 13.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.448 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.8 OUTLIER -110.69 173.8 6.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.019 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.3 p -100.16 112.6 24.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.832 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 398' ' ' LEU . 4.3 tp -63.52 88.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.127 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 2.3 t -85.57 167.37 15.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.32 -39.68 6.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.728 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -68.97 -58.36 4.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 111.229 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -52.5 64.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.323 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.25 -33.89 21.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.474 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -90.1 -29.51 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.043 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -65.32 -44.0 89.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 390' ' ' LEU . 3.4 mt -58.69 -39.23 80.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.046 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -67.08 -30.2 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -68.83 -59.38 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -66.03 -38.54 88.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.798 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.03 98.23 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -81.91 59.72 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.036 0.446 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.39 23.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.939 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -93.87 146.37 31.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.4 ' HB2' HG22 ' A' ' 408' ' ' VAL . 51.0 Cg_exo -53.17 179.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.269 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.42 38.23 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.814 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 408' ' ' VAL . 34.9 m -109.44 117.39 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.51 -29.72 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 435' ' ' ILE . 0.2 OUTLIER -87.11 148.85 25.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.003 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 122.21 170.43 13.71 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.685 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -108.46 152.71 24.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.026 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.707 ' HB2' HD13 ' A' ' 390' ' ' LEU . 27.2 t80 -92.19 133.79 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 432' ' ' ASP . 38.2 mt -79.98 121.78 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.037 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 416' ' ' GLU . 2.0 mm -88.76 -152.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.623 ' H ' HG22 ' A' ' 415' ' ' ILE . 17.0 pt-20 -79.35 145.15 33.58 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 0.0 111.074 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.473 HG11 ' N ' ' A' ' 424' ' ' GLU . 14.2 t -110.9 159.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.467 ' N ' HG12 ' A' ' 417' ' ' VAL . 20.6 mm -96.86 136.0 21.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.8 59.03 4.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.519 2.146 . . . . 0.0 112.579 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 174.93 44.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.586 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.559 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.2 OUTLIER -150.95 173.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -76.18 -16.28 17.77 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.309 2.006 . . . . 0.0 112.089 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -60.63 -60.05 4.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.473 ' N ' HG11 ' A' ' 417' ' ' VAL . 6.0 tp10 -74.06 -23.25 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 422' ' ' PRO . . . -82.04 -26.12 34.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.13 -70.06 1.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 171.55 30.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.997 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.539 HD21 HG21 ' A' ' 473' ' ' VAL . 0.2 OUTLIER -107.74 176.03 5.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.829 0.315 . . . . 0.0 110.643 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.99 157.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.28 77.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.95 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.846 ' HB2' HD12 ' A' ' 414' ' ' ILE . 22.9 m-20 -72.24 179.32 3.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.978 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 412' ' ' ALA . 22.7 t -139.8 131.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.556 HG23 ' HB3' ' A' ' 460' ' ' MET . 3.2 mt -86.06 145.34 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.735 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -140.57 -48.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.735 ' N ' HD12 ' A' ' 435' ' ' ILE . 19.1 p -110.01 158.79 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.2 tt -158.48 116.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.281 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.402 ' ND2' HG12 ' A' ' 437' ' ' ILE . 19.5 p30 42.52 50.54 4.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.649 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 70.61 44.96 56.03 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.798 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -137.97 152.94 49.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 55.6 m -103.79 107.32 18.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.941 HG11 ' CG2' ' A' ' 448' ' ' VAL . 13.3 t -100.29 143.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.07 -4.21 5.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.93 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.8 p -169.97 168.27 8.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.249 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.426 ' HB1' ' HE3' ' A' ' 387' ' ' MET . . . -58.15 -43.84 87.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.417 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 18.3 p30 -53.31 -27.0 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.803 ' O ' HG23 ' A' ' 451' ' ' VAL . 13.0 m-20 -84.86 -33.77 22.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.758 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.941 ' CG2' HG11 ' A' ' 442' ' ' VAL . 45.8 t -72.95 -37.36 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.205 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.406 ' HA ' HD12 ' A' ' 452' ' ' ILE . 11.1 t -55.26 -59.14 5.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.71 -24.64 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.28 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 447' ' ' ASP . 37.7 t -76.5 -50.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.165 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.499 HD11 HG12 ' A' ' 448' ' ' VAL . 7.8 mt -56.58 -27.58 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.21 -11.93 22.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.403 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.04 -51.04 3.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -95.03 134.91 37.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.55 -34.97 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.2 p -103.34 115.22 30.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.703 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.1 mt -106.93 133.54 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.227 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 90.15 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.518 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.556 ' HB3' HG23 ' A' ' 434' ' ' ILE . 0.0 OUTLIER -97.28 149.05 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.308 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 469' ' ' ILE . 25.6 t -120.38 125.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.837 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.783 HG22 HD13 ' A' ' 471' ' ' ILE . 16.1 m -117.25 -179.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.353 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -119.46 125.99 50.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.82 ' HB3' HD11 ' A' ' 469' ' ' ILE . 1.2 ttt85 -118.55 120.24 36.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.61 -94.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.277 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -140.05 27.12 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -144.56 168.46 20.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.92 140.09 42.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 464' ' ' ARG . 1.9 mt -128.13 147.38 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 111.232 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.577 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -94.97 125.36 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.713 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.783 HD13 HG22 ' A' ' 462' ' ' VAL . 4.8 mp -121.0 127.91 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.259 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 55.3 m -106.93 122.95 47.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.539 HG21 HD21 ' A' ' 428' ' ' LEU . 27.1 t -127.63 137.21 58.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.044 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -122.65 109.63 32.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.738 ' HB3' HG23 ' A' ' 383' ' ' ILE . 47.9 Cg_endo -68.55 159.46 53.42 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.419 2.079 . . . . 0.0 112.35 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.54 -176.1 2.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.942 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.412 ' HB3' HG23 ' B' ' 4' ' ' ILE . 26.4 m . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.793 0.33 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 56.32 39.24 30.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' B' ' 2' ' ' SER . 2.0 pp -75.27 148.14 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.417 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 9.7 m0 -109.7 111.15 22.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -80.7 75.87 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.563 ' O ' HG12 ' B' ' 7' ' ' VAL . 10.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.149 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.84 0.352 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -145.67 131.46 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.82 HG13 HG22 ' A' ' 385' ' ' ILE . 3.6 pt -127.71 12.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.725 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 42.95 63.14 2.08 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.375 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 1.006 HD13 HG22 ' A' ' 417' ' ' VAL . 7.2 tp -148.74 124.33 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.163 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 386' ' ' ARG . 11.6 mtt180 -89.64 121.27 31.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.79 ' CE ' HG23 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -128.86 147.46 50.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.056 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.44 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 5.5 ptm -127.51 173.9 9.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.934 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 31.9 p -89.16 99.98 12.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.925 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.2 tp -58.53 88.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.624 HG23 ' H ' ' A' ' 394' ' ' LYS . 7.7 t -75.79 169.53 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.809 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.7 p -54.65 -37.65 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.1 t -69.62 -56.14 8.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.624 ' H ' HG23 ' A' ' 391' ' ' THR . 0.1 OUTLIER -62.45 -39.11 92.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.66 80.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.141 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -27.74 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -45.74 83.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.04 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 17.8 mt -67.14 -30.93 71.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -30.8 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -50.76 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.92 -68.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 87.55 7.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -78.71 61.64 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -151.19 21.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.945 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 398' ' ' LEU . 23.2 m-85 -91.57 159.33 38.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.99 174.83 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.659 2.239 . . . . 0.0 112.188 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.33 45.73 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.36 148.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 410' ' ' SER . 2.7 pp -125.37 -40.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.298 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . 0.623 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -75.44 133.0 41.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.887 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 146.06 -177.59 24.33 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.407 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.587 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -106.68 141.53 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.925 ' HB2' HD13 ' A' ' 390' ' ' LEU . 64.2 t80 -94.71 137.84 33.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.835 HG23 HD11 ' A' ' 385' ' ' ILE . 23.0 mt -87.04 116.41 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.681 ' CD1' HG22 ' B' ' 4' ' ' ILE . 37.0 mt -84.84 -62.93 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.464 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.855 ' O ' HD12 ' A' ' 385' ' ' ILE . 10.9 pt-20 -154.57 153.57 31.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.158 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 1.006 HG22 HD13 ' A' ' 385' ' ' ILE . 21.7 t -121.36 141.83 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.456 ' HB ' HG22 ' A' ' 421' ' ' THR . 16.2 mm -81.52 142.55 50.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.83 -0.91 8.52 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.816 2.344 . . . . 0.0 113.686 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -130.55 59.58 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.25 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.472 ' OG1' ' HD2' ' A' ' 422' ' ' PRO . 0.7 OUTLIER -160.54 157.8 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.472 ' HD2' ' OG1' ' A' ' 421' ' ' THR . 31.9 Cg_exo -60.14 -20.68 62.67 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -58.0 -38.09 75.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.012 0.434 . . . . 0.0 110.985 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -84.72 -30.95 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.695 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.15 -31.5 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.561 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -66.75 -35.5 89.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.271 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.77 27.48 2.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.861 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.501 HD23 HG21 ' A' ' 471' ' ' ILE . 1.3 mt -92.63 -174.28 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.817 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.577 ' O ' HG21 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -179.91 169.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.907 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.88 54.65 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.84 26.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.206 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.522 ' HB2' HD12 ' A' ' 414' ' ' ILE . 1.6 m-20 -138.96 -174.53 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.837 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 412' ' ' ALA . 21.8 t -143.36 119.41 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.369 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.55 116.92 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.732 HD12 ' HB3' ' A' ' 436' ' ' SER . 2.6 pp -105.05 -42.18 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.692 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.732 ' HB3' HD12 ' A' ' 435' ' ' ILE . 51.6 p -126.53 159.52 33.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.962 0.411 . . . . 0.0 111.062 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.747 ' CG2' HG11 ' A' ' 451' ' ' VAL . 3.4 tt -156.54 113.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 24.0 p30 44.23 44.61 6.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.75 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.15 37.93 36.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.072 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.475 ' HB2' HG23 ' A' ' 437' ' ' ILE . 7.4 mm-40 -131.99 128.3 38.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t -76.34 110.19 10.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 443' ' ' VAL . 58.0 t -90.61 156.07 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.462 ' N ' HG12 ' A' ' 442' ' ' VAL . 12.2 m -145.95 -47.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.451 ' N ' HG23 ' A' ' 443' ' ' VAL . 1.6 p -137.5 171.63 14.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.014 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.36 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.303 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.409 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 25.7 p30 -54.42 -26.1 28.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.34 -57.3 3.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.805 HG12 HD11 ' A' ' 452' ' ' ILE . 38.9 t -47.57 -40.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.569 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 452' ' ' ILE . 6.9 t -55.55 -63.71 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.49 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -50.31 -26.87 5.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.545 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.747 HG11 ' CG2' ' A' ' 437' ' ' ILE . 60.5 t -77.56 -46.95 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.805 HD11 HG12 ' A' ' 448' ' ' VAL . 7.3 mt -57.8 -27.53 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.165 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -100.31 -8.76 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.552 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.07 -49.46 4.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.18 132.4 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -35.72 55.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.806 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 2.6 t -104.34 116.07 31.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.634 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.5 mt -102.69 129.98 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.016 0.436 . . . . 0.0 111.315 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . 0.617 ' OD1' HG23 ' A' ' 472' ' ' THR . 20.5 m-80 -131.84 96.82 4.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.55 147.15 26.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.5 t -121.54 132.93 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.776 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.4 m -132.77 167.91 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 111.338 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 119.78 34.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.016 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 23.1 mtp180 -116.14 136.36 53.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.526 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.7 -101.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.218 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.37 28.6 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.799 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -143.59 147.66 34.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.148 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.06 140.04 30.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.562 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.4 mt -131.12 142.61 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.459 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.46 119.72 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.501 HG21 HD23 ' A' ' 428' ' ' LEU . 11.2 mm -105.47 136.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.654 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.617 HG23 ' OD1' ' A' ' 459' ' ' ASN . 21.3 m -124.18 119.56 29.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.369 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.561 HG22 ' HA3' ' A' ' 426' ' ' GLY . 22.4 t -129.32 141.12 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.336 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 27.9 mm -119.21 109.98 38.32 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.651 ' HB3' HG23 ' A' ' 383' ' ' ILE . 17.9 Cg_endo -59.57 164.77 10.7 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.487 2.125 . . . . 0.0 112.404 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -113.89 -176.83 2.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.44 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 3.6 p . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.838 0.351 . . . . 0.0 111.318 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -64.81 88.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.781 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.681 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.7 pp -84.27 124.5 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.409 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m0 -109.92 120.4 42.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -82.56 58.37 4.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.79 HG23 ' CE ' ' A' ' 387' ' ' MET . 1.8 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.037 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.838 0.351 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.43 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 19.2 t80 -144.49 122.3 11.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.667 HG13 HG22 ' A' ' 385' ' ' ILE . 10.1 pt -106.17 -5.55 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.48 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.523 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 56.89 64.39 4.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.512 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.967 HD13 HG22 ' A' ' 417' ' ' VAL . 3.8 tp -161.36 134.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.011 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.519 ' H ' HD12 ' A' ' 385' ' ' ILE . 20.4 mtt180 -91.34 133.0 35.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.669 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.418 ' HA ' HD12 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -140.78 150.33 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.406 ' CE ' ' CB ' ' B' ' 2' ' ' SER . 1.8 ptm -128.26 -177.59 4.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.793 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.8 p -99.48 9.74 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.53 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.8 tp 52.42 97.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.3 t -83.65 163.58 20.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -31.92 68.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -30.32 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -96.73 -42.27 8.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -64.91 -52.11 58.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.24 66.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.6 -39.03 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 395' ' ' ALA . 9.8 mt -64.17 -45.66 87.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.97 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -59.29 -29.97 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.34 -28.73 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -93.23 -29.69 15.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -100.67 -53.66 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.011 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 74.48 -59.26 0.56 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -47.13 -28.32 1.74 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.372 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -55.94 161.79 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -175.34 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.606 2.204 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.94 -11.98 19.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.351 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.6 m -52.39 167.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.734 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -136.73 12.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.467 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.4 m -130.37 130.61 44.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.813 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 171.52 169.04 33.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.379 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 434' ' ' ILE . . . -100.28 122.81 43.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 111.161 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.762 ' HB2' HD13 ' A' ' 390' ' ' LEU . 54.5 t80 -103.87 128.97 51.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.781 HG23 HD11 ' A' ' 385' ' ' ILE . 4.3 mt -79.81 114.98 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.589 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.526 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -78.48 -70.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.628 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.665 ' O ' HD12 ' A' ' 385' ' ' ILE . 4.8 pt-20 -144.17 143.12 30.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.967 HG22 HD13 ' A' ' 385' ' ' ILE . 21.3 t -111.37 146.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.05 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -98.35 128.96 31.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.78 61.53 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.698 2.266 . . . . 0.0 112.38 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.44 40.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.598 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.523 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -145.65 158.92 49.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.801 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.92 -23.2 33.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.327 2.018 . . . . 0.0 111.808 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.439 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -58.36 -60.06 4.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.207 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.78 -31.51 64.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.745 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.69 68.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.58 -30.98 70.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.383 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 24.91 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.777 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.584 HD23 HG21 ' A' ' 471' ' ' ILE . 0.1 OUTLIER -102.33 -177.66 3.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.776 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.74 179.66 7.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.767 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.76 31.63 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -143.24 26.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.593 ' C ' HD12 ' A' ' 414' ' ' ILE . 62.3 m-20 -119.44 -177.75 3.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.588 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 412' ' ' ALA . 38.8 t -142.07 129.58 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 0.0 111.403 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 412' ' ' ALA . 2.1 mp -86.09 152.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.669 HD12 ' N ' ' A' ' 436' ' ' SER . 1.9 pp -140.63 -50.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.654 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.669 ' N ' HD12 ' A' ' 435' ' ' ILE . 69.9 p -128.67 158.44 38.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.842 HD13 HG11 ' A' ' 451' ' ' VAL . 10.8 tt -150.3 118.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.337 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 19.8 p30 44.78 35.35 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.931 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.34 38.94 8.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.985 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -129.44 145.19 51.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.547 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.59 104.4 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.462 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.563 HG11 HG22 ' A' ' 448' ' ' VAL . 59.5 t -86.6 147.45 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.459 HG22 ' OD2' ' A' ' 447' ' ' ASP . 17.0 m -133.72 -45.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.37 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.444 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -133.67 169.86 16.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.422 . . . . 0.0 111.149 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.4 71.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.019 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.41 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 16.6 p30 -59.5 -30.59 68.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.831 ' O ' HG23 ' A' ' 451' ' ' VAL . 3.7 m-20 -75.62 -43.5 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.787 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.563 HG22 HG11 ' A' ' 442' ' ' VAL . 45.9 t -63.23 -37.04 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.814 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.5 t -59.42 -65.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.467 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -48.25 -27.6 2.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.842 HG11 HD13 ' A' ' 437' ' ' ILE . 47.4 t -71.32 -43.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.814 HD12 ' HA ' ' A' ' 449' ' ' SER . 4.8 mt -61.98 -32.36 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.91 -17.26 25.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.328 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -93.47 -47.51 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.13 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.76 142.25 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 474' ' ' ILE . 0.4 OUTLIER -92.59 -32.18 14.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.677 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.3 t -109.03 99.95 9.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.707 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.5 mt -90.22 133.71 34.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -134.24 91.77 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.628 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.433 ' HE1' ' HB3' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -108.48 152.39 24.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 469' ' ' ILE . 27.2 t -100.05 141.69 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.628 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 432' ' ' ASP . 4.2 t -142.28 160.53 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.175 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . 0.432 ' N ' HG12 ' A' ' 462' ' ' VAL . 6.8 tmm_? -98.92 133.15 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.867 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.458 ' HB3' HD11 ' A' ' 469' ' ' ILE . 7.8 ttp180 -130.55 132.61 45.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.04 -95.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.157 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.06 21.36 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.701 0.286 . . . . 0.0 110.851 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -143.58 164.7 29.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.02 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.43 137.22 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.4 mt -131.8 160.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.535 ' SD ' HG22 ' A' ' 461' ' ' VAL . 0.9 OUTLIER -99.68 119.69 38.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.16 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.584 HG21 HD23 ' A' ' 428' ' ' LEU . 13.1 mm -107.89 152.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 458' ' ' LEU . 91.8 m -139.02 119.79 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.797 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 428' ' ' LEU . 21.3 t -122.74 151.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 456' ' ' SER . 21.2 mm -121.35 109.9 34.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.437 ' HB3' HG23 ' A' ' 383' ' ' ILE . 26.2 Cg_endo -62.17 152.23 77.29 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.358 2.039 . . . . 0.0 112.237 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.54 168.68 10.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.406 ' CB ' ' CE ' ' A' ' 388' ' ' MET . 1.1 p . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.822 0.344 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -59.68 108.45 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.526 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.6 pt -79.22 127.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.22 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.41 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m95 -107.29 91.08 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 1.5 t90 -73.57 68.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.516 HG12 ' OXT' ' B' ' 7' ' ' VAL . 20.5 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.198 -0.905 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 452' ' ' ILE . 6.5 mmtt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.653 0.264 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -155.85 120.47 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.254 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.588 HG13 HG22 ' A' ' 385' ' ' ILE . 12.0 pt -111.16 -22.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 80.64 66.92 1.59 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.801 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.629 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.29 129.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.389 . . . . 0.0 110.813 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -89.95 120.42 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.483 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -126.36 143.65 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.812 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.47 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.8 ptm -123.52 164.53 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 40.1 p -85.87 99.43 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.886 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.6 tp -55.76 108.59 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.52 170.33 10.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.766 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.8 m -58.17 -21.76 48.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.421 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.3 t -77.61 -47.28 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.98 -32.14 25.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.168 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.31 -36.35 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.205 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -90.01 -32.47 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.29 -33.49 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.25 -49.88 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -58.29 -43.1 87.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.47 -25.98 67.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -93.06 -62.13 1.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 1.0 OUTLIER -85.05 -59.46 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 79.72 -49.2 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.03 -27.04 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.717 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 29.6 m-85 -43.01 163.16 0.16 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.428 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.98 -20.83 14.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.625 2.217 . . . . 0.0 112.761 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 75.71 40.56 0.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 110.781 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.519 HG11 HG21 ' A' ' 435' ' ' ILE . 2.8 m -101.35 98.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pp -55.63 -29.27 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.38 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.84 141.48 39.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 145.47 176.97 19.87 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -104.28 155.62 18.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.886 ' HB2' HD13 ' A' ' 390' ' ' LEU . 46.5 t80 -107.66 138.46 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.954 HD12 ' HB2' ' A' ' 432' ' ' ASP . 27.6 mt -89.74 109.96 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.765 ' CD1' HG22 ' B' ' 4' ' ' ILE . 5.3 mt -74.51 -66.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.214 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.85 167.85 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.887 0.375 . . . . 0.0 111.139 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.498 HG22 HG12 ' A' ' 385' ' ' ILE . 21.2 t -134.84 147.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.3 mp -79.72 134.5 57.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.308 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 50.5 Cg_exo -55.33 -12.47 5.73 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.031 2.487 . . . . 0.0 114.686 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . 0.799 ' H ' HG22 ' A' ' 418' ' ' ILE . 41.0 m-20 -132.97 72.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.925 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 4.9 p -159.08 160.87 28.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.984 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.95 -20.17 51.58 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.329 2.02 . . . . 0.0 111.41 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.492 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -61.19 -60.15 4.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -76.33 -30.57 57.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.24 -7.4 59.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.558 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 471' ' ' ILE . . . -90.15 -31.74 10.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.418 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 129.79 17.79 1.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.022 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 423' ' ' ALA . 0.9 OUTLIER -96.9 -175.87 3.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.75 146.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.97 -177.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.64 24.94 12.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.954 ' HB2' HD12 ' A' ' 414' ' ' ILE . 8.9 m-20 -126.71 177.01 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 412' ' ' ALA . 33.1 t -136.89 126.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.472 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 435' ' ' ILE . 3.8 mt -81.11 154.58 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.577 HD12 ' N ' ' A' ' 436' ' ' SER . 1.9 pp -143.19 -47.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.577 ' N ' HD12 ' A' ' 435' ' ' ILE . 94.6 p -120.94 154.99 35.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.344 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.572 HD11 ' HB3' ' A' ' 458' ' ' LEU . 2.7 tt -153.88 116.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 16.9 p30 45.43 32.03 0.99 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.545 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.37 8.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.693 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -133.53 138.1 45.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.29 107.9 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 448' ' ' VAL . 63.2 t -90.75 146.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 444' ' ' SER . 26.2 m -129.32 -43.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.335 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.441 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -138.62 172.32 13.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.913 0.387 . . . . 0.0 111.17 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.483 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.33 -38.76 74.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.404 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 6.1 p30 -59.19 -29.74 67.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -76.65 -38.35 54.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 442' ' ' VAL . 38.9 t -70.12 -37.99 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.785 ' HA ' HD12 ' A' ' 452' ' ' ILE . 9.5 t -56.67 -62.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.322 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -50.43 -29.18 9.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.885 HG13 ' OE2' ' A' ' 455' ' ' GLU . 59.9 t -70.78 -42.96 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.277 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 449' ' ' SER . 4.6 mt -63.23 -33.85 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.33 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 -13.06 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.622 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -99.94 -54.03 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.767 0.318 . . . . 0.0 110.774 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . 0.885 ' OE2' HG13 ' A' ' 451' ' ' VAL . 1.8 mp0 -89.46 132.82 34.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -36.23 42.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.677 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . 0.446 ' C ' HD23 ' A' ' 458' ' ' LEU . 2.5 t -105.47 125.51 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.684 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.572 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.7 mt -119.65 149.4 42.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -147.3 97.65 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.451 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 1.1 mtm -102.77 144.74 30.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 469' ' ' ILE . 19.7 t -111.58 127.26 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.686 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.912 HG23 HD13 ' A' ' 471' ' ' ILE . 2.3 t -121.28 158.66 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.26 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -104.0 119.67 39.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.994 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.572 ' HB2' HD12 ' A' ' 469' ' ' ILE . 0.2 OUTLIER -119.51 127.32 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.434 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.22 -99.13 0.85 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.177 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.22 24.82 2.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.767 0.318 . . . . 0.0 110.677 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.57 162.63 36.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.97 141.01 34.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.627 ' O ' HG13 ' A' ' 461' ' ' VAL . 4.0 mt -130.74 143.24 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.369 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.585 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -94.76 124.42 38.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.645 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.912 HD13 HG23 ' A' ' 462' ' ' VAL . 4.4 mp -113.79 140.28 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 111.343 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 70.8 m -116.9 119.87 36.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.76 131.68 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.53 110.76 57.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 148.88 87.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.101 . . . . 0.0 112.336 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.88 -178.77 3.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.406 ' HA ' ' CE ' ' A' ' 388' ' ' MET . 11.4 p . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.825 0.345 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -61.3 93.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.765 HG22 ' CD1' ' A' ' 415' ' ' ILE . 46.4 pt -83.59 137.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.302 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.404 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 12.9 m95 -116.81 89.61 3.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.45 82.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.144 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mttp . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.817 0.342 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -118.44 126.29 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 385' ' ' ILE . 9.7 pt -122.44 -1.1 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.333 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 46.92 62.94 3.47 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.082 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 1.076 HD13 HG22 ' A' ' 417' ' ' VAL . 6.8 tp -149.16 122.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -89.73 128.18 36.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.403 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -132.93 140.59 47.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.511 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.42 ' CE ' ' HA ' ' B' ' 2' ' ' SER . 7.7 ptm -119.31 158.84 25.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.028 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 21.3 p -83.11 106.27 14.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.3 tp -56.92 102.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.075 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.9 t -89.94 174.54 7.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 27.8 t -66.96 -33.02 74.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 60.6 p -68.88 -28.59 66.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -95.83 -48.6 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.988 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.92 -59.93 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.26 68.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.37 -38.28 89.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.29 -36.61 74.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.996 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -77.75 -31.69 52.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -28.99 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -54.98 3.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -73.46 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 57.5 mtm180 82.73 -25.62 0.15 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.752 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -20.51 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.752 0.311 . . . . 0.0 110.957 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.45 153.95 74.57 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.973 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.7 -179.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.637 2.224 . . . . 0.0 112.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -111.74 30.77 6.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.13 150.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.523 ' C ' HD12 ' A' ' 409' ' ' ILE . 2.7 pp -125.33 17.12 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.455 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -140.29 142.85 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.16 156.49 7.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -91.45 152.08 20.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.756 ' HB2' HD13 ' A' ' 390' ' ' LEU . 59.8 t80 -107.37 131.66 54.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.907 HD12 ' HB2' ' A' ' 432' ' ' ASP . 18.3 mt -83.97 111.08 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.853 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -75.35 -66.42 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.848 ' O ' HD12 ' A' ' 385' ' ' ILE . 3.5 pt-20 -155.61 167.14 31.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 0.0 111.175 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 1.076 HG22 HD13 ' A' ' 385' ' ' ILE . 12.5 t -127.53 156.95 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -96.32 133.43 24.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.54 60.02 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.766 2.311 . . . . 0.0 112.82 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 168.88 44.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.972 0.415 . . . . 0.0 110.757 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 384' ' ' GLY . 7.7 p -141.84 162.19 47.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 34.8 Cg_endo -66.72 -14.13 42.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.012 1.808 . . . . 0.0 111.17 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -68.73 -59.94 2.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.645 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.86 -32.71 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -82.4 -21.14 35.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.296 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -72.42 -29.93 65.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.304 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 121.1 17.65 4.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.026 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 471' ' ' ILE . 2.5 mt -88.2 -167.08 1.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.91 0.355 . . . . 0.0 110.732 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.9 146.34 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -179.36 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 60.09 22.52 11.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.907 ' HB2' HD12 ' A' ' 414' ' ' ILE . 9.5 m-20 -119.3 -175.87 3.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.412 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.48 117.28 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.543 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.444 HD11 HG12 ' A' ' 414' ' ' ILE . 4.0 mt -78.42 123.05 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.461 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -110.07 -48.63 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.882 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 435' ' ' ILE . 3.8 t -119.24 160.97 21.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 111.294 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.799 HG21 HG11 ' A' ' 451' ' ' VAL . 1.0 OUTLIER -154.28 119.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.024 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.404 ' ND2' HG12 ' A' ' 437' ' ' ILE . 16.1 p30 44.43 42.41 5.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.511 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 77.5 41.92 19.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.635 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -135.69 162.6 32.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 108.55 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.942 HG11 ' CG2' ' A' ' 448' ' ' VAL . 2.5 t -94.59 148.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.247 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.58 -35.96 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.333 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.6 p -147.5 176.03 10.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.212 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.403 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -59.06 -41.12 87.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.176 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.409 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 17.6 p30 -53.91 -24.22 15.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.268 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.9 OUTLIER -86.33 -50.01 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.942 ' CG2' HG11 ' A' ' 442' ' ' VAL . 43.9 t -54.93 -40.7 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.488 ' HA ' HG11 ' B' ' 7' ' ' VAL . 42.2 t -53.13 -68.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.469 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -51.69 -35.06 41.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.641 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 447' ' ' ASP . 43.7 t -64.09 -49.33 81.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.294 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.854 HD11 HG12 ' A' ' 448' ' ' VAL . 8.4 mt -57.68 -40.53 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.223 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.01 -5.21 59.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.325 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -100.18 -47.66 4.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . 0.438 ' O ' HD21 ' A' ' 458' ' ' LEU . 1.9 mm-40 -100.13 133.57 44.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.047 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -34.42 48.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . 0.406 ' HA ' HD12 ' A' ' 474' ' ' ILE . 1.5 t -105.08 103.21 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.765 HD11 HG23 ' A' ' 452' ' ' ILE . 12.4 mt -96.08 153.36 17.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -154.43 96.76 1.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.645 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.519 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -104.26 135.51 45.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.263 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 25.8 t -102.09 120.41 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 463' ' ' ARG . 5.0 t -105.54 160.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . 0.44 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -120.92 124.41 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.589 ' HB2' HD11 ' A' ' 469' ' ' ILE . 30.5 mtp85 -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.702 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.53 -98.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.346 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -140.28 24.84 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 111.033 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -139.77 157.36 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.91 139.62 35.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.646 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.8 mt -128.21 128.01 68.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.08 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.66 125.13 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.769 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.736 HG21 HD23 ' A' ' 428' ' ' LEU . 28.9 mm -120.04 136.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.9 m -109.61 135.05 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.703 ' O ' HD13 ' A' ' 474' ' ' ILE . 11.5 t -138.91 146.22 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.065 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 473' ' ' VAL . 30.0 mm -134.03 110.34 11.89 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 474' ' ' ILE . 19.2 Cg_endo -58.57 132.91 51.05 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.398 2.065 . . . . 0.0 112.309 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -94.83 -174.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.42 ' HA ' ' CE ' ' A' ' 388' ' ' MET . 37.4 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.686 0.279 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 52.54 65.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.444 . . . . 0.0 110.656 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.853 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.4 pt -82.05 96.25 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.335 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.409 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.0 m0 -65.64 104.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.826 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -76.76 67.01 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 449' ' ' SER . 21.9 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.21 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.6 mptt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -118.08 119.55 35.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.363 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.595 HD12 ' CG2' ' A' ' 385' ' ' ILE . 16.4 pt -130.58 -8.97 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.478 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.645 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 50.67 68.1 1.61 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.747 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.921 ' CD1' HG22 ' A' ' 417' ' ' VAL . 8.1 tp -157.0 135.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -101.03 129.43 46.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.412 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -135.45 146.19 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.49 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.0 ptm -128.26 157.44 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.071 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.7 p -79.48 101.32 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.889 HD13 ' HB2' ' A' ' 413' ' ' TYR . 9.4 tp -51.79 97.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.4 t -84.8 158.54 20.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.785 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.3 m -57.51 -22.05 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.12 -28.28 54.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.308 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -100.33 -37.4 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.131 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.51 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -62.87 -50.95 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.367 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -28.33 67.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -34.25 73.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.065 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.576 HD22 ' CE2' ' A' ' 405' ' ' PHE . 62.8 mt -60.17 -41.83 93.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.027 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -75.11 -30.81 60.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.77 -33.15 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.7 -33.34 20.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -145.59 120.63 10.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.97 -27.73 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -55.79 -27.2 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.115 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.576 ' CE2' HD22 ' A' ' 398' ' ' LEU . 8.4 m-85 -57.46 147.35 59.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.72 174.43 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.568 2.179 . . . . 0.0 112.301 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -111.91 32.77 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.66 -179.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.658 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -149.18 -40.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -89.6 154.47 19.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.79 170.43 13.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.43 ' CB ' HG21 ' A' ' 448' ' ' VAL . . . -98.2 138.75 35.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 110.991 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.889 ' HB2' HD13 ' A' ' 390' ' ' LEU . 58.7 t80 -94.44 130.19 40.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.49 HG21 ' O ' ' A' ' 429' ' ' LYS . 12.1 mt -80.23 114.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.79 HD13 HG22 ' B' ' 4' ' ' ILE . 9.4 mt -82.13 -72.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.609 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.145 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.921 HG22 ' CD1' ' A' ' 385' ' ' ILE . 3.3 t -111.8 140.43 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.571 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 19.6 mm -79.69 144.99 61.6 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.37 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.48 ' HD2' HG22 ' A' ' 418' ' ' ILE . 23.3 Cg_exo -65.83 -3.91 9.02 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.881 2.387 . . . . 0.0 114.521 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 421' ' ' THR . 22.5 m-20 -138.35 71.03 1.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.965 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.645 HG21 ' HA3' ' A' ' 384' ' ' GLY . 1.1 p -159.55 165.61 17.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.141 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.413 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 31.9 Cg_exo -60.8 -23.78 77.42 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.622 2.215 . . . . 0.0 111.62 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.488 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -57.78 -60.05 4.29 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.996 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -74.63 -26.74 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 422' ' ' PRO . . . -76.16 -26.16 55.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.363 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -79.29 -70.36 1.33 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.417 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 166.64 34.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.449 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.4 OUTLIER -104.47 -173.11 2.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.778 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . 0.49 ' O ' HG21 ' A' ' 414' ' ' ILE . 0.4 OUTLIER 177.46 169.09 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 0.8 OUTLIER -87.58 52.48 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -158.89 28.37 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.625 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB2' HD12 ' A' ' 414' ' ' ILE . 5.3 m-20 -142.36 -177.2 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.403 HG11 HD22 ' A' ' 390' ' ' LEU . 24.0 t -145.16 107.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.42 138.48 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.674 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.869 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -133.57 -43.07 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.52 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.869 ' N ' HD12 ' A' ' 435' ' ' ILE . 41.5 p -114.72 155.5 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.952 HG21 HG11 ' A' ' 451' ' ' VAL . 1.5 tt -157.61 118.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 455' ' ' GLU . 13.5 p30 45.52 33.85 1.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.494 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.8 28.74 34.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.724 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -124.01 143.4 50.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.864 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 9.3 t -92.09 110.69 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.717 HG11 HG22 ' A' ' 448' ' ' VAL . 25.7 t -93.89 159.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.547 HG22 ' OD2' ' A' ' 447' ' ' ASP . 22.4 m -130.36 -45.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.502 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.454 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -141.05 176.42 8.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.225 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.412 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.52 -40.45 78.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -56.42 -25.6 50.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.879 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.848 ' O ' HG23 ' A' ' 451' ' ' VAL . 4.9 m-20 -87.05 -30.74 20.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.717 HG22 HG11 ' A' ' 442' ' ' VAL . 23.5 t -70.58 -43.32 77.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.504 ' HA ' HD12 ' A' ' 452' ' ' ILE . 33.0 t -50.97 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.335 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -49.88 -41.61 45.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.36 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.952 HG11 HG21 ' A' ' 437' ' ' ILE . 39.6 t -58.88 -45.5 91.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.076 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 449' ' ' SER . 22.3 mt -58.86 -40.49 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.65 0.4 57.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.158 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -46.74 5.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . 0.401 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 4.1 mm-40 -111.18 165.28 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.4 t -103.64 -32.17 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 p -106.37 102.45 11.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.741 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.782 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.6 mt -93.5 129.46 39.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.947 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . 0.54 ' ND2' HG23 ' A' ' 472' ' ' THR . 2.4 m-80 -123.91 88.09 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.5 mtt -92.2 129.68 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 470' ' ' MET . 27.1 t -107.47 126.29 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.904 HG22 HD13 ' A' ' 471' ' ' ILE . 1.5 m -121.22 159.37 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.175 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 119.95 40.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 1.5 mtp180 -120.62 133.18 55.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.486 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.18 -103.83 1.23 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.219 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -138.22 27.72 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.619 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.33 157.12 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.254 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.88 142.91 28.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.449 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.683 ' O ' HG13 ' A' ' 461' ' ' VAL . 3.4 mt -129.24 141.09 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.478 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -97.47 119.81 36.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.513 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.904 HD13 HG22 ' A' ' 462' ' ' VAL . 4.4 mp -122.16 137.02 57.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.54 HG23 ' ND2' ' A' ' 459' ' ' ASN . 58.6 m -117.24 127.37 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 422' ' ' PRO . 21.8 t -123.66 122.24 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.096 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 28.5 mm -103.02 109.86 62.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.01 151.42 82.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.078 . . . . 0.0 112.299 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -102.74 158.44 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.833 179.96 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.736 0.303 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.14 106.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.79 HG22 HD13 ' A' ' 415' ' ' ILE . 3.3 pt -76.19 149.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.531 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -121.14 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.627 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -70.33 70.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.073 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 475' ' ' PRO . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.658 0.266 . . . . 0.0 110.73 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -134.17 125.91 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.307 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.639 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.8 pt -117.67 -26.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 75.67 64.57 2.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.648 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.984 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.31 123.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.527 ' N ' HD13 ' A' ' 385' ' ' ILE . 0.1 OUTLIER -90.04 126.97 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.476 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -128.85 152.59 48.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 179.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.443 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.5 OUTLIER -130.63 -179.4 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 111.481 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 7.5 p -98.46 94.7 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.169 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.916 HD13 ' HB2' ' A' ' 413' ' ' TYR . 9.0 tp -47.63 121.55 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.571 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.11 165.81 13.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.797 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -27.27 63.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -66.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.166 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -40.24 74.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.217 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.293 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -83.91 -30.68 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.037 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.98 -31.19 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.023 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.26 -47.32 44.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -65.45 -37.84 88.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.047 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.83 -42.86 94.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -87.7 -17.51 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.434 ' HB3' ' CD1' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -150.08 87.04 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.715 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -25.72 67.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -23.62 11.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.284 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 402' ' ' HIS . 3.7 m-85 -53.18 163.69 0.87 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.484 ' HB2' HG22 ' A' ' 408' ' ' VAL . 18.6 Cg_endo -59.09 178.22 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.306 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -105.63 35.84 2.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 408' ' ' VAL . 20.1 m -120.34 92.87 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.49 -33.8 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.56 163.23 21.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 126.21 175.97 14.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.375 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 388' ' ' MET . . . -102.8 157.37 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.916 ' HB2' HD13 ' A' ' 390' ' ' LEU . 69.4 t80 -104.82 128.72 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.984 HG23 HD11 ' A' ' 385' ' ' ILE . 24.6 mt -80.7 109.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.552 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.581 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.7 mp -71.86 -70.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -151.43 166.82 29.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.299 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.555 HG22 HG12 ' A' ' 385' ' ' ILE . 35.0 t -132.84 155.39 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.043 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -90.28 132.56 35.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.406 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.22 57.72 3.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.542 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 169.41 47.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.061 0.457 . . . . 0.0 110.383 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.409 HG21 ' HB ' ' A' ' 418' ' ' ILE . 4.2 p -149.86 164.46 20.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.974 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.64 -26.85 67.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.269 1.979 . . . . 0.0 111.101 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 428' ' ' LEU . . . -54.91 -54.39 43.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.116 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.73 -29.99 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.67 -29.42 65.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.12 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.44 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -74.0 -30.2 61.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.481 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.88 23.67 2.97 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.767 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.843 HD11 HG21 ' A' ' 473' ' ' VAL . 1.2 mt -95.67 -175.59 3.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.772 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.65 152.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -61.74 -175.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.702 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 24.6 m120 61.23 22.35 12.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.951 ' HB2' HD12 ' A' ' 414' ' ' ILE . 28.5 m-20 -122.66 -176.5 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 412' ' ' ALA . 34.9 t -143.69 127.54 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.623 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.65 152.76 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.441 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 408' ' ' VAL . 1.2 pp -141.2 -55.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.469 ' N ' HD12 ' A' ' 435' ' ' ILE . 16.7 p -120.42 157.32 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.313 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.887 HG21 HG11 ' A' ' 451' ' ' VAL . 1.8 tt -151.04 119.94 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.344 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.427 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.3 p30 43.4 44.08 4.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.693 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.62 49.24 8.16 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.793 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -144.88 158.97 43.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.702 0.287 . . . . 0.0 110.672 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 6.0 p -106.49 112.19 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 1.048 HG11 HG22 ' A' ' 448' ' ' VAL . 4.2 t -100.08 147.58 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 6.3 m -130.82 -42.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.4 p -127.93 168.11 15.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.01 0.434 . . . . 0.0 111.284 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.476 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.34 -41.14 79.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -57.24 -28.92 63.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.726 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.8 ' O ' HG23 ' A' ' 451' ' ' VAL . 7.4 m-20 -77.77 -36.47 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 1.048 HG22 HG11 ' A' ' 442' ' ' VAL . 28.4 t -69.55 -41.86 80.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.806 ' HA ' HD12 ' A' ' 452' ' ' ILE . 1.7 t -54.72 -63.17 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.601 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -46.96 -29.18 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.458 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.887 HG11 HG21 ' A' ' 437' ' ' ILE . 30.4 t -68.61 -48.58 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' A' ' 449' ' ' SER . 3.6 mt -58.62 -33.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -91.13 -21.55 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.251 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -88.67 -59.91 2.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.02 127.14 35.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -39.06 75.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -104.67 116.26 31.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.839 ' HB3' HD11 ' A' ' 437' ' ' ILE . 9.0 mt -102.34 133.99 46.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.274 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -135.13 93.9 3.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.638 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.589 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -97.67 156.81 16.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.562 HG22 ' HG3' ' A' ' 470' ' ' MET . 21.0 t -124.4 124.6 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.975 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.508 HG11 ' OD2' ' A' ' 432' ' ' ASP . 5.6 t -108.58 147.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -105.44 140.11 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.174 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.563 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.6 mtp180 -144.52 133.84 23.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 57.88 -100.24 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.494 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -140.07 28.38 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 111.06 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.25 152.62 46.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.165 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -96.29 139.26 32.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.541 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 464' ' ' ARG . 2.4 mt -126.7 123.28 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.562 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -90.64 127.19 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 470' ' ' MET . 11.7 mm -124.46 135.16 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.976 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 44.9 m -116.51 121.13 40.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.843 HG21 HD11 ' A' ' 428' ' ' LEU . 34.9 t -127.34 119.92 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.87 111.96 64.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.639 ' HB3' HG23 ' A' ' 383' ' ' ILE . 41.3 Cg_endo -67.08 173.95 7.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.07 . . . . 0.0 112.349 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -160.41 174.31 14.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.787 179.861 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.794 0.33 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -59.46 90.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.581 HG22 ' CD1' ' A' ' 415' ' ' ILE . 27.5 pt -75.69 129.2 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -108.95 99.35 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.079 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -74.46 66.39 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 452' ' ' ILE . 16.7 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.76 0.314 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -160.41 119.84 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.7 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.1 pt -108.2 -3.68 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.332 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.675 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 60.56 50.82 63.42 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.649 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.673 HG13 HG22 ' A' ' 417' ' ' VAL . 11.7 tt -154.1 140.23 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.025 0.44 . . . . 0.0 111.07 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.797 ' HB3' HD12 ' A' ' 415' ' ' ILE . 2.9 mtt-85 -90.76 132.08 36.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.738 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.586 ' HE3' ' HB1' ' A' ' 445' ' ' ALA . 0.1 OUTLIER -136.96 133.5 35.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.639 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 10.2 ptm -121.34 176.33 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.3 p -106.12 130.39 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 413' ' ' TYR . 2.3 tp -74.65 96.86 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 4.4 t -87.45 177.52 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 82.7 p -63.93 -16.67 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -80.77 -42.29 22.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.787 0.327 . . . . 0.0 111.25 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -43.03 9.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.92 79.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.338 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -29.99 61.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.009 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -30.92 71.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 84.1 mt -69.89 -33.35 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -74.46 -24.42 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.0 -37.73 33.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.071 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -82.69 -66.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.46 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -76.07 -52.42 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.08 -52.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.686 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.51 38.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 1.6 m-85 -91.01 167.72 15.39 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.671 0.272 . . . . 0.0 110.51 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.02 -21.48 21.63 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.533 2.155 . . . . 0.0 112.472 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.7 t0 73.3 46.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 408' ' ' VAL . 18.9 m -113.2 97.54 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.023 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -56.72 -29.08 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.536 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 14.8 m -93.13 159.86 15.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.031 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 127.53 150.01 7.29 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.451 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.14 135.81 35.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.638 ' HB2' HD13 ' A' ' 390' ' ' LEU . 86.5 t80 -90.07 132.47 35.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.789 HD12 ' CB ' ' A' ' 432' ' ' ASP . 10.3 mt -86.18 116.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 386' ' ' ARG . 3.3 mt -89.22 -144.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.253 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.672 ' H ' HG22 ' A' ' 415' ' ' ILE . 9.2 pt-20 -79.67 155.27 28.11 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.088 -0.382 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.673 HG22 HG13 ' A' ' 385' ' ' ILE . 21.2 t -127.15 151.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.045 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.59 HG22 ' HD2' ' A' ' 419' ' ' PRO . 8.4 mm -87.4 145.63 38.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.621 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.59 ' HD2' HG22 ' A' ' 418' ' ' ILE . 16.5 Cg_exo -68.7 -3.48 11.31 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.988 2.459 . . . . 0.0 114.113 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.87 62.87 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.712 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.675 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.7 OUTLIER -154.45 158.02 32.27 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.009 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.412 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 34.3 Cg_exo -59.03 -20.25 52.65 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.554 2.17 . . . . 0.0 111.701 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.444 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -62.4 -60.12 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.77 -28.89 66.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.54 -27.63 45.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.27 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.02 65.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.353 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.1 23.85 2.87 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.774 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.751 HD23 HG21 ' A' ' 471' ' ' ILE . 1.2 mt -93.43 -170.0 2.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.314 . . . . 0.0 110.693 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.48 153.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -65.88 171.34 4.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 64.51 27.33 13.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.027 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.789 ' CB ' HD12 ' A' ' 414' ' ' ILE . 3.8 m-20 -118.88 -175.76 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.71 122.88 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.571 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 435' ' ' ILE . 2.8 mt -86.13 160.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.507 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.471 ' N ' HG22 ' A' ' 434' ' ' ILE . 1.4 pp -146.37 -49.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 435' ' ' ILE . 94.4 p -118.02 161.84 19.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.014 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.858 HG21 HG11 ' A' ' 451' ' ' VAL . 3.6 tt -155.62 119.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.5 p30 49.11 33.09 4.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.624 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.29 28.02 28.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.819 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -121.23 164.16 17.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 110.647 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 69.3 p -106.56 114.15 28.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.147 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.93 HG11 HG22 ' A' ' 448' ' ' VAL . 11.7 t -101.54 141.72 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.17 -25.8 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.494 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.16 175.7 13.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.273 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.586 ' HB1' ' HE3' ' A' ' 387' ' ' MET . . . -56.51 -41.13 76.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.405 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 8.6 p30 -55.44 -28.66 55.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.765 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.818 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.8 OUTLIER -82.18 -32.95 29.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.733 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.93 HG22 HG11 ' A' ' 442' ' ' VAL . 21.8 t -76.0 -41.92 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.211 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.67 ' HA ' HD12 ' A' ' 452' ' ' ILE . 15.0 t -52.61 -57.44 10.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.344 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -53.97 -42.22 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.858 HG11 HG21 ' A' ' 437' ' ' ILE . 47.0 t -59.63 -47.59 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 449' ' ' SER . 8.4 mt -57.9 -30.96 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.946 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -7.11 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.545 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -99.71 -48.66 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.701 0.286 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -102.04 166.52 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.2 -36.69 6.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 98.53 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.771 ' HB3' HD11 ' A' ' 437' ' ' ILE . 8.4 mt -89.78 119.95 30.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.051 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.16 91.21 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.99 142.85 29.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 469' ' ' ILE . 23.7 t -103.37 128.95 56.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.21 156.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 140.59 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.081 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.703 ' HB3' HD11 ' A' ' 469' ' ' ILE . 3.7 ttt-85 -143.53 124.52 14.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 64.42 -98.51 0.28 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.226 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -140.05 27.28 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 0.0 110.766 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -145.23 162.78 36.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.7 139.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 464' ' ' ARG . 2.1 mt -127.68 158.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.36 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.464 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -106.0 126.2 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.541 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.751 HG21 HD23 ' A' ' 428' ' ' LEU . 23.7 mm -115.37 137.12 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.27 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 m -116.17 140.6 49.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.689 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.761 ' C ' HD12 ' A' ' 474' ' ' ILE . 20.1 t -150.03 135.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.761 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -117.88 109.73 40.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.585 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.7 ' HB3' HG23 ' A' ' 383' ' ' ILE . 30.2 Cg_endo -63.81 152.41 80.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.438 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -89.16 -179.53 5.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.912 0.387 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -79.82 -9.9 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.3 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.603 HG22 ' CD1' ' A' ' 415' ' ' ILE . 9.7 pt 41.08 91.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.862 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.405 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 10.7 m95 -79.95 91.09 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.887 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -69.38 71.75 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.402 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.4 t . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.243 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.65 0.262 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -140.02 126.2 19.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.362 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.766 HG13 HG22 ' A' ' 385' ' ' ILE . 5.7 pt -119.27 -2.67 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.403 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.597 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 54.91 62.45 6.25 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.814 ' CD1' HG22 ' A' ' 417' ' ' VAL . 7.2 tp -153.75 129.86 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -90.7 132.42 35.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.436 ' CA ' HD12 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -141.06 138.83 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.856 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.456 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 6.2 ptm -120.93 165.79 14.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.298 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 82.8 p -93.44 109.25 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.513 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.5 tp -53.22 121.37 7.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.304 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.1 t -90.16 166.91 13.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -30.83 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 21.0 m -70.45 -29.52 66.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -91.12 -39.91 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.058 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.471 ' HB1' HG12 ' A' ' 409' ' ' ILE . . . -59.7 -50.4 73.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.246 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -32.93 74.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.66 -45.15 54.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.082 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.27 -31.45 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.069 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -67.37 -47.13 71.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.013 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -27.42 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.155 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -91.74 -62.41 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.401 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -64.66 -59.81 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.072 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 10.7 mtt85 79.65 -7.84 1.65 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.502 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.28 14.85 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.704 0.287 . . . . 0.0 111.162 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 406' ' ' PRO . 30.2 m-85 -105.53 128.8 25.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 405' ' ' PHE . 32.3 Cg_exo -58.07 -174.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.113 . . . . 0.0 112.346 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.53 23.47 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 406' ' ' PRO . 26.4 m -83.35 -23.31 8.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.059 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.8 HG23 ' O ' ' A' ' 409' ' ' ILE . 0.0 OUTLIER 37.0 75.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.468 0.652 . . . . 0.0 111.94 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 7.2 p -169.46 131.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.22 173.78 19.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.432 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.34 140.88 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 0.0 111.08 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.638 ' HB2' HD13 ' A' ' 390' ' ' LEU . 43.2 t80 -98.13 133.5 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 432' ' ' ASP . 15.3 mt -82.6 116.2 26.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.436 HD12 ' CA ' ' A' ' 387' ' ' MET . 3.1 mt -77.96 -60.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.619 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 385' ' ' ILE . 0.4 OUTLIER -159.75 139.49 11.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.293 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.814 HG22 ' CD1' ' A' ' 385' ' ' ILE . 13.6 t -105.45 136.95 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.118 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.517 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 33.8 mm -82.84 138.46 43.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.238 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 418' ' ' ILE . 42.7 Cg_endo -68.0 4.2 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 114.243 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -132.44 56.46 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.517 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.597 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.6 OUTLIER -155.63 164.91 19.66 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.458 ' HB2' HG13 ' A' ' 473' ' ' VAL . 32.1 Cg_exo -60.84 -20.94 68.74 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.651 2.234 . . . . 0.0 111.828 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.464 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -61.94 -59.15 5.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.21 -34.85 77.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.732 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -23.22 55.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -74.72 -34.35 53.66 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.414 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 25.4 2.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.85 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.833 HD23 HG21 ' A' ' 471' ' ' ILE . 0.8 OUTLIER -93.39 -163.66 1.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 0.0 110.652 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.4 169.1 6.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.816 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.67 36.17 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.013 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.82 27.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.551 ' HB2' HD12 ' A' ' 414' ' ' ILE . 10.3 m-20 -128.94 175.71 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.004 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.65 116.9 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 434' ' ' ILE . 3.8 mp -67.2 155.52 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 436' ' ' SER . 2.3 pp -148.78 -45.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.57 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.811 ' N ' HD12 ' A' ' 435' ' ' ILE . 15.6 p -124.07 154.78 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.973 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 458' ' ' LEU . 3.5 tt -153.59 112.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.055 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.428 ' ND2' HG12 ' A' ' 437' ' ' ILE . 22.9 p30 43.03 51.17 5.43 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.676 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 71.05 43.72 56.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.708 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -146.35 126.53 13.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 65.5 m -81.48 118.22 22.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.925 HG11 ' CG2' ' A' ' 448' ' ' VAL . 7.1 t -98.94 144.7 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.905 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 9.1 m -118.52 -36.82 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.653 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.0 p -144.68 179.59 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.86 94.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.072 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.413 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 23.8 p30 -54.82 -25.88 31.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.52 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.5 m-20 -81.52 -52.06 7.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.986 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.925 ' CG2' HG11 ' A' ' 442' ' ' VAL . 46.8 t -55.77 -35.82 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.288 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 452' ' ' ILE . 10.8 t -58.74 -61.68 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.374 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.4 -28.76 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.493 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 437' ' ' ILE . 59.5 t -73.32 -47.49 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.009 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 383' ' ' ILE . 15.4 mt -58.17 -28.54 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 -6.79 26.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.442 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -100.07 -47.22 5.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -105.06 144.59 31.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -29.03 21.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.761 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -109.73 97.38 6.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.535 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.8 mt -89.71 120.13 30.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.84 85.81 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.665 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.56 128.13 36.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.79 HG22 ' HG3' ' A' ' 470' ' ' MET . 18.8 t -99.56 126.66 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 463' ' ' ARG . 23.9 t -115.24 154.08 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . 0.405 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -110.48 119.86 40.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.432 ' HB2' HD11 ' A' ' 469' ' ' ILE . 18.6 mtp180 -119.53 140.83 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 58.51 -97.34 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.34 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -140.25 24.96 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -142.56 158.02 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.174 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.23 137.68 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.585 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 464' ' ' ARG . 2.0 mt -126.91 141.86 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.79 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -92.31 139.55 30.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.772 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.833 HG21 HD23 ' A' ' 428' ' ' LEU . 12.6 mm -128.82 134.11 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.175 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.0 m -107.57 132.67 53.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 474' ' ' ILE . 23.3 t -144.31 124.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.223 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.5 mp -115.72 110.05 44.86 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.731 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.723 ' HB3' HG23 ' A' ' 383' ' ' ILE . 20.4 Cg_endo -60.86 -178.13 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.207 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -136.77 -178.5 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.829 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.456 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.763 0.316 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 51.16 51.29 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.85 130.47 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.228 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.413 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.4 m0 -111.64 101.22 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.936 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -75.75 68.63 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.134 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . 0.433 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 17.3 t80 -159.99 129.58 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.757 HG13 HG22 ' A' ' 385' ' ' ILE . 23.3 pt -116.11 -3.87 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.42 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.574 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 56.62 60.31 9.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.87 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.757 HG22 HG13 ' A' ' 383' ' ' ILE . 11.2 tt -165.08 144.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.976 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.459 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -100.36 157.99 16.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.523 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -154.05 137.53 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.561 ' HG2' HD11 ' A' ' 415' ' ' ILE . 1.3 ptp -115.5 173.79 6.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.115 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 89.2 p -99.34 99.78 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.285 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.853 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.1 tp -47.56 109.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 9.0 t -90.16 150.83 21.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 m -46.19 -36.54 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.593 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -47.15 84.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.35 -31.91 24.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.141 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -60.65 -36.23 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -88.89 -29.29 19.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -68.49 -25.51 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.178 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.01 -32.08 39.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.172 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -85.77 -29.72 23.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -37.59 48.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.994 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -53.77 6.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 104.24 11.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -83.12 60.79 5.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.737 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -142.75 13.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.144 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.78 150.72 48.96 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.78 ' HB2' HG22 ' A' ' 408' ' ' VAL . 50.0 Cg_exo -53.39 166.76 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.634 2.222 . . . . 0.0 112.293 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.56 3.72 43.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.78 HG22 ' HB2' ' A' ' 406' ' ' PRO . 15.6 m -70.93 112.8 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 111.067 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pp -92.26 -29.57 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.155 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 142.16 41.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.2 177.2 14.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.0 151.87 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.853 ' HB2' HD13 ' A' ' 390' ' ' LEU . 31.1 t80 -93.49 136.08 34.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 432' ' ' ASP . 40.3 mt -81.09 119.92 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.106 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.616 HD13 ' HD1' ' A' ' 413' ' ' TYR . 1.5 mm -89.27 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.359 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 415' ' ' ILE . 1.9 pt-20 -79.57 142.81 35.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 385' ' ' ILE . 21.2 t -111.27 151.25 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.172 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 421' ' ' THR . 18.5 mm -84.14 136.77 40.5 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 61.7 Cg_endo -73.09 58.98 3.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.43 2.086 . . . . 0.0 112.662 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.25 40.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.872 0.367 . . . . 0.0 111.028 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.574 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.1 OUTLIER -138.92 172.24 6.87 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 77.9 Cg_endo -78.38 -9.43 16.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.487 2.125 . . . . 0.0 112.194 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.824 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -72.57 -58.9 3.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.031 0.444 . . . . 0.0 110.824 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -33.3 74.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -85.56 -27.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -64.37 -70.14 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.36 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.2 28.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.054 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.824 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.3 OUTLIER -105.71 -175.94 2.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.753 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.97 155.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 63.64 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.95 36.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.807 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.866 ' HB2' HD12 ' A' ' 414' ' ' ILE . 4.9 m-20 -146.24 -176.05 5.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.8 t -143.81 125.65 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.305 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.73 145.87 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.705 HD12 ' N ' ' A' ' 436' ' ' SER . 2.4 pp -137.87 -43.48 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.657 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.705 ' N ' HD12 ' A' ' 435' ' ' ILE . 60.3 p -122.49 152.36 40.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.915 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.641 HD12 HG11 ' A' ' 451' ' ' VAL . 0.0 OUTLIER -148.0 119.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.538 ' N ' HD13 ' A' ' 437' ' ' ILE . 13.1 p30 48.04 28.08 1.38 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.05 25.77 28.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.459 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -116.73 166.17 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.8 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.6 117.49 34.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.565 HG11 HG22 ' A' ' 448' ' ' VAL . 92.9 t -105.23 147.18 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.95 -44.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.332 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.2 p -132.88 168.31 18.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 111.121 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.523 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.0 -37.98 72.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.071 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -58.5 -29.95 66.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.0 m-20 -76.91 -40.72 46.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.781 HG12 HD11 ' A' ' 452' ' ' ILE . 37.5 t -69.86 -35.71 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.096 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.445 ' HA ' HG11 ' B' ' 7' ' ' VAL . 27.2 t -57.59 -63.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -48.46 -32.49 7.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.892 HG13 ' OE2' ' A' ' 455' ' ' GLU . 55.1 t -70.84 -48.5 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.226 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.781 HD11 HG12 ' A' ' 448' ' ' VAL . 8.0 mt -61.65 -30.04 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.259 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -92.02 -19.02 22.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -98.67 -64.3 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . 0.892 ' OE2' HG13 ' A' ' 451' ' ' VAL . 1.8 mp0 -78.41 138.76 38.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 474' ' ' ILE . 17.6 m -89.43 -34.21 16.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . 0.623 ' HA ' HD12 ' A' ' 474' ' ' ILE . 31.5 p -99.13 108.0 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.484 ' HB3' HD11 ' A' ' 437' ' ' ILE . 2.5 mt -108.7 120.14 41.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 111.418 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -123.74 93.46 3.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.415 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.442 ' HE2' ' HB3' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -99.46 152.35 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.365 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 469' ' ' ILE . 24.3 t -114.91 127.57 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.738 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.853 HG23 HD13 ' A' ' 471' ' ' ILE . 17.7 t -114.0 138.25 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.22 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -106.31 134.07 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.973 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.594 ' HE ' HD13 ' A' ' 469' ' ' ILE . 0.2 OUTLIER -139.31 132.74 30.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.69 0.86 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.305 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -140.13 28.98 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -140.22 155.64 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.019 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.38 138.95 33.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.627 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.594 HD13 ' HE ' ' A' ' 464' ' ' ARG . 3.2 mt -126.73 139.25 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.602 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.3 OUTLIER -103.56 133.8 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.853 HD13 HG23 ' A' ' 462' ' ' VAL . 3.2 mp -135.27 148.87 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 13.8 m -134.65 125.4 27.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.081 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 422' ' ' PRO . 21.1 t -127.85 119.83 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 457' ' ' THR . 27.7 mm -105.24 109.47 63.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.314 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.449 ' HG3' HG23 ' A' ' 452' ' ' ILE . 54.3 Cg_exo -52.0 143.62 39.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.282 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -100.47 -177.95 3.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.495 ' HA ' ' HE2' ' A' ' 388' ' ' MET . 97.6 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.925 0.393 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.04 74.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.502 HD13 ' N ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER -52.64 151.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.465 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -112.08 101.95 10.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -73.28 65.03 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 449' ' ' SER . 17.8 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.121 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.7 mttp . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.691 0.281 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -139.55 120.49 14.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.5 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.774 HG13 HG22 ' A' ' 385' ' ' ILE . 12.2 pt -124.57 -2.96 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.716 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 49.32 68.08 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 1.067 HD13 HG22 ' A' ' 417' ' ' VAL . 4.5 tp -153.52 118.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.822 0.344 . . . . 0.0 110.534 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.404 ' HD2' ' CG ' ' A' ' 416' ' ' GLU . 9.5 mtt85 -91.29 132.04 36.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.482 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -138.59 143.69 39.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.427 ' HE1' ' HA ' ' B' ' 2' ' ' SER . 6.0 ptm -128.06 159.47 34.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.165 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.3 p -77.82 101.32 6.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.7 tp -55.38 100.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 11.6 t -87.53 156.25 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.6 t -51.59 -25.77 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -75.68 -29.13 58.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.253 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -99.84 -39.12 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.558 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -58.17 -40.06 80.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.211 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -83.05 -32.08 27.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.981 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.25 -34.55 75.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.85 -39.54 76.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -59.2 -22.52 61.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.75 -23.26 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -67.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.172 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -80.26 -49.08 12.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 5.0 ttm105 83.52 -39.53 0.08 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.958 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -68.23 -9.73 49.3 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -56.77 152.89 24.52 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.474 ' HG2' HG22 ' A' ' 408' ' ' VAL . 25.6 Cg_endo -61.98 -172.14 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.78 2.32 . . . . 0.0 112.525 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.05 33.55 3.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 406' ' ' PRO . 3.7 m -101.56 164.79 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.116 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.697 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -138.77 -39.53 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.459 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -79.25 167.58 20.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 111.33 170.56 19.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.511 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.2 140.45 29.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 0.0 111.091 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.835 ' HB2' HD13 ' A' ' 390' ' ' LEU . 45.7 t80 -95.57 126.3 40.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.005 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 432' ' ' ASP . 18.6 mt -80.0 110.04 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.805 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.9 mp -75.24 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.404 ' CG ' ' HD2' ' A' ' 386' ' ' ARG . 11.8 pt-20 -157.84 156.12 30.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 111.221 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 1.067 HG22 HD13 ' A' ' 385' ' ' ILE . 14.0 t -128.4 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.531 ' HB ' HG23 ' A' ' 421' ' ' THR . 7.3 mm -88.95 136.62 30.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 39.7 Cg_endo -67.38 -5.87 15.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.639 2.226 . . . . 0.0 113.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -112.48 46.83 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.114 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.716 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -149.62 170.31 7.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 64.1 Cg_endo -75.5 -11.42 20.6 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.215 1.943 . . . . 0.0 111.867 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.511 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -67.07 -59.27 3.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.091 0.472 . . . . 0.0 110.936 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -29.76 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.715 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.25 38.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.318 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -78.29 -22.18 68.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.74 16.08 5.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.731 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.511 HD12 ' CA ' ' A' ' 423' ' ' ALA . 0.8 OUTLIER -95.49 -171.6 2.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 110.636 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -177.32 146.5 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -176.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 33.2 m120 56.1 24.91 8.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.051 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.923 ' HB2' HD12 ' A' ' 414' ' ' ILE . 6.2 m-20 -120.48 -175.75 3.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.805 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.53 123.76 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.463 HD11 HG12 ' A' ' 414' ' ' ILE . 1.4 mp -83.79 146.59 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.588 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -135.24 -43.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.554 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.828 ' N ' HD12 ' A' ' 435' ' ' ILE . 24.9 p -119.99 147.77 44.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.361 . . . . 0.0 111.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.2 tt -144.87 114.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.061 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.408 ' ND2' HG12 ' A' ' 437' ' ' ILE . 14.1 p30 44.49 43.92 6.69 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.601 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 79.39 27.4 55.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.758 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.414 ' HB2' HG23 ' A' ' 437' ' ' ILE . 6.6 mm100 -131.46 126.32 34.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.916 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.19 125.54 29.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.928 HG11 ' CG2' ' A' ' 448' ' ' VAL . 3.0 t -108.94 150.75 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.19 -28.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.661 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 20.2 p -148.58 170.33 18.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.482 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -59.98 -42.24 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.079 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -53.67 -26.99 25.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.862 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.2 m-20 -83.32 -37.99 22.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.668 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.928 ' CG2' HG11 ' A' ' 442' ' ' VAL . 41.4 t -68.23 -33.28 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 26.8 t -60.13 -60.29 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.281 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.82 -29.52 41.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.478 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 447' ' ' ASP . 42.0 t -69.2 -51.56 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 111.114 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 448' ' ' VAL . 5.9 mt -57.94 -29.23 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.023 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.323 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -99.16 -58.02 2.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -82.43 132.17 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 59.5 m -74.22 -37.02 63.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . 0.457 ' C ' HD23 ' A' ' 458' ' ' LEU . 6.4 t -107.83 127.08 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.558 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.709 ' HB3' HD11 ' A' ' 437' ' ' ILE . 8.6 mt -119.73 119.74 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.328 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . 0.467 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.4 m-80 -119.15 99.67 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.426 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.99 144.41 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.9 t -102.82 139.25 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.452 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 463' ' ' ARG . 3.3 t -139.29 160.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.199 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 462' ' ' VAL . 1.3 tmm_? -97.47 119.69 36.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.625 ' HB2' HD12 ' A' ' 469' ' ' ILE . 7.7 ttt180 -109.34 119.77 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.383 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.49 -92.01 0.26 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.094 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -140.38 25.92 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.829 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.01 154.44 43.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.79 130.16 45.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.631 ' O ' HG13 ' A' ' 461' ' ' VAL . 1.8 mt -129.02 151.49 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.311 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.527 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -93.6 119.86 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.444 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.68 137.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.372 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.467 HG23 ' OD1' ' A' ' 459' ' ' ASN . 50.2 m -111.13 126.28 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.545 HG22 ' HA3' ' A' ' 426' ' ' GLY . 20.7 t -139.13 141.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 21.5 mm -124.21 117.47 26.85 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.62 162.45 34.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.466 2.11 . . . . 0.0 112.279 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.56 -179.74 6.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.427 ' HA ' ' HE1' ' A' ' 388' ' ' MET . 19.5 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.916 0.389 . . . . 0.0 111.018 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -65.2 79.99 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.805 HG22 ' CD1' ' A' ' 415' ' ' ILE . 2.2 pt -85.29 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.36 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.19 95.16 5.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.89 66.26 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.785 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.524 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.8 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 475' ' ' PRO . 27.7 mttm . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.769 0.319 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -128.41 125.05 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.377 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 385' ' ' ILE . 30.5 pt -136.84 -1.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.874 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 48.14 70.67 0.7 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.993 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.984 HD13 HG22 ' A' ' 417' ' ' VAL . 6.8 tp -165.22 121.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.612 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 1.5 mtt85 -90.78 139.2 30.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.722 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.507 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -140.13 146.39 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.441 ' C ' ' HB2' ' A' ' 445' ' ' ALA . 1.4 ptp -120.62 -179.64 4.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.4 p -103.39 105.74 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 413' ' ' TYR . 4.6 tp -57.0 99.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.054 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.5 t -80.74 162.65 24.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 53.4 p -57.91 -20.54 37.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 20.6 m -77.6 -33.41 53.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.096 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -49.49 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.164 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.467 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -52.01 -34.11 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.615 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.38 -26.79 23.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.164 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -39.11 73.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 10.7 mt -58.01 -32.2 67.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -80.92 -26.25 36.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.13 -26.07 20.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.13 -42.22 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . 0.432 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -93.62 -53.65 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 4.6 mtt180 84.55 -23.13 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.599 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 -23.8 32.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -58.39 147.4 68.37 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.58 ' HB2' HG22 ' A' ' 408' ' ' VAL . 41.8 Cg_endo -67.62 166.98 22.19 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.571 2.181 . . . . 0.0 112.233 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.16 -23.31 64.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.176 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 406' ' ' PRO . 15.5 m -54.97 91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.885 0.374 . . . . 0.0 111.309 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.9 -30.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -69.35 151.33 46.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 125.01 -177.51 16.86 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.758 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.682 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -110.68 170.55 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.808 ' HB2' HD13 ' A' ' 390' ' ' LEU . 24.1 t80 -116.8 137.79 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.883 HD12 ' HB2' ' A' ' 432' ' ' ASP . 21.9 mt -86.04 117.29 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.612 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 12.4 mm -75.24 -68.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.125 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.714 ' O ' HD12 ' A' ' 385' ' ' ILE . 9.5 pt-20 -159.92 150.23 18.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.732 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.984 HG22 HD13 ' A' ' 385' ' ' ILE . 20.4 t -113.72 151.4 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.604 ' HB ' HG23 ' A' ' 421' ' ' THR . 17.9 mm -86.7 143.51 35.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 37.1 Cg_exo -61.9 -7.92 10.57 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.8 2.333 . . . . 0.0 113.594 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -135.08 71.51 1.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.701 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.696 HG21 ' HA3' ' A' ' 384' ' ' GLY . 24.5 p -149.7 156.3 38.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.351 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.63 -21.16 70.19 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.143 1.895 . . . . 0.0 110.351 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.899 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -66.2 -60.05 3.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.496 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.95 -32.82 74.54 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.055 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.14 -25.68 59.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -75.12 -66.44 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.191 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 162.08 29.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.158 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.899 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.6 OUTLIER -99.24 -175.72 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.73 139.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.719 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.38 179.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.41 19.99 11.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.883 ' HB2' HD12 ' A' ' 414' ' ' ILE . 8.2 m-20 -120.28 -176.03 3.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.671 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 412' ' ' ALA . 26.1 t -147.97 117.26 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 111.524 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.466 HG23 ' HB3' ' A' ' 460' ' ' MET . 1.6 mp -76.57 152.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.189 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.685 HD12 ' N ' ' A' ' 436' ' ' SER . 1.7 pp -139.35 -51.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.764 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.685 ' N ' HD12 ' A' ' 435' ' ' ILE . 84.2 p -113.02 144.27 42.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 111.091 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.724 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.1 tt -140.7 113.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.413 ' ND2' HG12 ' A' ' 437' ' ' ILE . 11.7 p30 43.9 45.67 6.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.533 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 73.72 52.46 8.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.703 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.9 157.96 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.654 0.264 . . . . 0.0 110.814 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.7 m -103.21 114.47 28.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.245 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.961 HG11 HG22 ' A' ' 448' ' ' VAL . 21.6 t -99.34 141.69 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.018 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.98 -37.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.503 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.14 172.43 12.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 111.264 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.507 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.37 -41.79 76.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.086 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -55.35 -29.52 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.712 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 451' ' ' VAL . 3.0 m-20 -80.01 -33.94 38.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.961 HG22 HG11 ' A' ' 442' ' ' VAL . 26.0 t -72.99 -38.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.632 ' HA ' HD12 ' A' ' 452' ' ' ILE . 12.1 t -55.63 -63.13 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.515 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -48.83 -28.41 3.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.375 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 447' ' ' ASP . 38.7 t -72.86 -49.6 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 449' ' ' SER . 5.2 mt -57.86 -26.44 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -100.13 -11.52 20.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.421 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -99.79 -47.72 4.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.719 0.295 . . . . 0.0 111.012 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -98.72 150.32 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 -33.85 11.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.661 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 457' ' ' THR . 5.2 t -106.15 96.21 6.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.576 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.724 ' HB3' HD11 ' A' ' 437' ' ' ILE . 12.3 mt -90.24 122.03 32.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -113.9 90.51 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.585 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.501 ' CG ' HD12 ' A' ' 437' ' ' ILE . 5.2 mtm -99.83 131.73 45.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.27 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.4 t -99.79 119.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.817 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.731 HG23 HD13 ' A' ' 471' ' ' ILE . 6.7 t -103.82 160.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . 0.452 ' N ' HG12 ' A' ' 462' ' ' VAL . 5.5 tmm_? -116.03 131.01 57.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.834 ' HB2' HD11 ' A' ' 469' ' ' ILE . 9.9 mtp180 -136.34 119.94 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.75 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.42 -109.92 3.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.494 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -126.59 27.14 6.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.659 0.266 . . . . 0.0 111.061 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.97 157.83 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -98.3 150.14 21.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.834 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mp -129.37 136.63 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.885 0.374 . . . . 0.0 111.331 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.5 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.1 OUTLIER -100.25 122.07 42.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.293 179.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.731 HD13 HG23 ' A' ' 462' ' ' VAL . 3.3 mp -125.4 126.73 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.926 0.394 . . . . 0.0 111.706 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.8 m -114.03 119.61 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.066 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.709 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.5 t -132.32 141.38 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 0.0 111.704 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.709 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -114.95 114.17 43.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 383' ' ' ILE . 15.1 Cg_endo -57.27 135.54 70.88 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.362 2.042 . . . . 0.0 112.362 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.32 151.85 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.791 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.826 0.346 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -72.97 113.65 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.47 145.57 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -113.54 99.83 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 386' ' ' ARG . 2.4 t90 -76.17 72.12 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.11 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 3.8 mptt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.671 0.272 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -131.87 119.95 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.31 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.633 HD12 ' CG2' ' A' ' 385' ' ' ILE . 24.8 pt -122.53 -12.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.611 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.727 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 54.85 69.66 1.19 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.057 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.633 ' CG2' HD12 ' A' ' 383' ' ' ILE . 11.3 tt -165.27 152.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.026 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.496 ' HG3' ' HB ' ' A' ' 415' ' ' ILE . 1.8 ptm180 -122.07 132.05 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.5 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.508 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -128.52 131.69 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.006 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.486 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 10.0 ptm -109.64 158.44 18.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.037 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.7 p -87.57 109.12 19.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 398' ' ' LEU . 5.4 tp -56.07 114.64 2.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.3 t -86.46 159.09 19.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.4 t -56.05 -25.7 46.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.233 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.32 -39.14 54.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.093 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.502 ' H ' HG23 ' A' ' 391' ' ' THR . 25.3 mmtt -87.44 -27.25 22.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -56.06 -42.14 76.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.288 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -85.98 -30.21 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.82 -32.42 73.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 390' ' ' LEU . 6.2 mt -66.07 -55.55 15.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.2 -30.92 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -51.41 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -34.0 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.801 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -119.71 104.69 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -82.07 59.23 4.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -159.8 26.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.14 151.96 38.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.607 ' HG2' HG22 ' A' ' 408' ' ' VAL . 37.2 Cg_endo -65.92 -176.16 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.14 20.25 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.607 HG22 ' HG2' ' A' ' 406' ' ' PRO . 13.2 m -89.62 160.5 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.927 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.33 -33.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.801 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.3 m -93.9 159.37 15.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.7 165.49 11.4 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -92.79 138.25 31.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.857 ' HB2' HD13 ' A' ' 390' ' ' LEU . 43.5 t80 -92.62 128.2 38.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.053 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.912 HD12 ' HB2' ' A' ' 432' ' ' ASP . 13.9 mt -79.71 116.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.52 ' CD1' HG22 ' B' ' 4' ' ' ILE . 4.8 mt -83.76 -68.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.639 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 430' ' ' GLU . 10.5 pt-20 -159.58 144.71 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.994 0.426 . . . . 0.0 111.305 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.614 HG22 HD12 ' A' ' 385' ' ' ILE . 8.5 t -116.66 137.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.846 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.52 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 4.9 mm -79.66 138.86 54.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.675 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 27.0 Cg_exo -62.75 -10.39 19.67 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.909 2.406 . . . . 0.0 113.771 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.33 55.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.001 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.727 HG21 ' HA3' ' A' ' 384' ' ' GLY . 1.1 p -153.96 157.95 32.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.07 -25.17 79.06 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.432 2.088 . . . . 0.0 111.251 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.551 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -58.72 -58.45 8.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.008 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.81 -30.24 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.667 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.74 -26.55 57.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -73.25 -30.15 63.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.204 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.82 23.16 3.12 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.819 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 471' ' ' ILE . 0.9 OUTLIER -91.73 -176.65 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.748 0.309 . . . . 0.0 110.768 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.17 159.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 416' ' ' GLU . 0.0 OUTLIER -71.65 -176.98 1.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 59.41 27.57 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.912 ' HB2' HD12 ' A' ' 414' ' ' ILE . 7.1 m-20 -125.23 -177.93 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.703 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -146.27 124.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.379 . . . . 0.0 111.495 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 435' ' ' ILE . 3.4 mt -89.34 154.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.715 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.739 HD12 ' N ' ' A' ' 436' ' ' SER . 2.0 pp -141.69 -48.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.745 0.307 . . . . 0.0 111.717 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.739 ' N ' HD12 ' A' ' 435' ' ' ILE . 77.1 p -113.8 152.93 29.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.653 HG21 HG11 ' A' ' 451' ' ' VAL . 7.6 tt -150.83 112.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.42 ' ND2' HG12 ' A' ' 437' ' ' ILE . 18.0 p30 44.98 41.51 5.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.679 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 80.55 23.92 59.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.851 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.459 ' HB2' HG23 ' A' ' 437' ' ' ILE . 6.8 mm100 -125.05 120.68 32.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.699 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 11.5 p -72.69 123.35 23.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.258 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.955 HG11 HG22 ' A' ' 448' ' ' VAL . 10.2 t -107.67 143.14 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.833 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.68 4.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.1 p -170.2 164.72 9.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.891 0.377 . . . . 0.0 111.222 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.508 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -58.07 -45.18 87.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.06 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.425 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 23.7 p30 -57.34 -29.15 63.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.78 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.824 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.6 m-20 -75.12 -35.56 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.955 HG22 HG11 ' A' ' 442' ' ' VAL . 33.5 t -73.02 -39.46 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.376 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 452' ' ' ILE . 23.0 t -57.02 -63.94 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.458 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -47.1 -32.2 4.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.423 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 447' ' ' ASP . 45.6 t -68.85 -45.54 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.975 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 449' ' ' SER . 22.1 mt -59.65 -29.66 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -6.09 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.356 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.06 -46.96 5.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.28 155.35 20.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 8.5 t -97.8 -35.85 10.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.3 95.93 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.6 ' HB3' HD11 ' A' ' 437' ' ' ILE . 4.8 mt -94.0 119.29 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.25 93.28 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.462 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.53 160.29 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.671 HG22 ' HG3' ' A' ' 470' ' ' MET . 20.3 t -119.56 127.6 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.801 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.3 141.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -96.73 119.88 36.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.37 126.78 48.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.25 -99.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.373 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.92 29.32 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 110.837 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -141.74 147.99 38.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.089 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -90.11 136.26 33.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.38 136.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.34 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -97.14 119.9 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.534 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 428' ' ' LEU . 18.1 mm -115.36 145.1 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.189 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 31.0 m -135.04 132.8 38.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.652 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.8 t -141.08 138.33 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.248 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.652 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -112.66 109.99 52.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.432 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.0 Cg_endo -59.4 119.1 6.13 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.332 2.022 . . . . 0.0 112.14 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -79.92 169.0 18.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.907 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.486 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.724 0.297 . . . . 0.0 110.728 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 54.05 52.17 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.3 pp -75.45 155.34 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.42 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.425 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 20.8 m95 -127.34 79.65 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.706 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -67.51 75.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.56 ' O ' HG12 ' B' ' 7' ' ' VAL . 22.0 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.064 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 31.6 mttt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.668 0.27 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -147.01 128.41 14.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.344 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 385' ' ' ILE . 7.1 pt -118.31 -10.62 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.731 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 60.83 71.06 0.85 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.828 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.966 HD13 HG22 ' A' ' 417' ' ' VAL . 7.3 tp -164.41 123.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.811 0.338 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -89.71 129.61 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' B' ' 5' ' ' TRP . 0.0 OUTLIER -132.88 146.56 51.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.851 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.416 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.0 ptm -127.82 160.84 30.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.7 p -80.05 101.67 8.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.63 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.922 HD13 ' HB2' ' A' ' 413' ' ' TYR . 8.2 tp -54.65 108.8 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.6 t -88.82 157.78 18.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.858 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.56 -25.55 60.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.59 -27.93 61.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.113 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -99.61 -40.1 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.36 67.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -89.97 -34.76 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.54 -37.07 74.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.81 -32.48 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -68.22 -41.67 80.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -56.34 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -33.73 76.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -130.96 105.98 8.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 55.94 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.051 0.453 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.45 -20.18 4.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.77 129.09 88.76 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.028 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.525 ' HG2' HG22 ' A' ' 408' ' ' VAL . 33.1 Cg_endo -64.14 -167.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.271 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.88 64.8 4.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 406' ' ' PRO . 14.1 m -137.79 81.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 410' ' ' SER . 2.7 pp -59.38 -31.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . 0.48 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.8 OUTLIER -93.41 144.73 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 137.82 178.23 15.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.494 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -100.77 158.18 16.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 111.019 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.922 ' HB2' HD13 ' A' ' 390' ' ' LEU . 13.0 t80 -114.82 127.75 55.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.896 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.861 ' CG2' HD11 ' A' ' 385' ' ' ILE . 4.6 mt -80.71 118.82 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.75 HD13 HG22 ' B' ' 4' ' ' ILE . 5.1 mt -83.65 -55.36 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.568 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 385' ' ' ILE . 4.3 pt-20 -160.68 162.89 32.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.349 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.966 HG22 HD13 ' A' ' 385' ' ' ILE . 25.5 t -119.7 155.63 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.672 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' A' ' 419' ' ' PRO . 1.7 mp -95.27 139.41 22.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 420' ' ' ASP . 21.3 Cg_endo -60.73 102.93 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.455 2.103 . . . . 0.0 112.205 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 419' ' ' PRO . 13.2 m-20 94.0 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.144 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.731 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -150.65 158.09 35.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.175 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.19 -22.45 74.19 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.124 1.883 . . . . 0.0 110.726 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.466 ' CA ' ' HG ' ' A' ' 428' ' ' LEU . . . -64.74 -60.07 3.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.912 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . 0.74 ' HB2' HG11 ' A' ' 417' ' ' VAL . 1.9 tm-20 -72.82 -39.86 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.974 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.28 70.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.276 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -78.61 -70.15 1.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 174.48 39.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.453 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.492 HD21 HG21 ' A' ' 473' ' ' VAL . 0.1 OUTLIER -87.61 175.45 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.921 0.391 . . . . 0.0 111.166 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -165.01 143.54 6.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.492 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 3.6 pt-20 -87.05 47.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 111.291 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -169.53 33.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.582 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -131.89 -179.52 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 412' ' ' ALA . 30.6 t -134.65 121.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.419 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.9 mt -76.04 150.93 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.6 HD12 ' HB3' ' A' ' 436' ' ' SER . 1.5 pp -141.38 -50.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.6 ' HB3' HD12 ' A' ' 435' ' ' ILE . 17.4 p -112.04 159.21 18.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 111.213 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.595 HD11 ' HB3' ' A' ' 458' ' ' LEU . 2.5 tt -164.14 114.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.078 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . 0.4 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.0 p30 46.11 34.22 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.666 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.45 32.86 24.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.69 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . 0.572 ' HB2' HG23 ' A' ' 437' ' ' ILE . 0.2 OUTLIER -128.09 134.3 49.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 110.64 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.29 104.6 14.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.282 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.874 HG11 HG22 ' A' ' 448' ' ' VAL . 32.9 t -88.06 136.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.64 -3.66 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.7 OUTLIER -169.95 168.76 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.238 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.48 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.01 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -54.79 -27.53 42.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.9 m-20 -79.81 -33.68 40.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.795 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.874 HG22 HG11 ' A' ' 442' ' ' VAL . 25.0 t -72.06 -40.35 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.264 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 4.5 t -56.07 -59.13 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.453 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.75 -25.6 11.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.568 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.857 HG13 ' OE2' ' A' ' 455' ' ' GLU . 47.1 t -76.01 -49.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.502 HD11 HG12 ' A' ' 448' ' ' VAL . 8.0 mt -59.43 -26.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -19.32 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.252 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -96.39 -60.88 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.81 0.338 . . . . 0.0 110.744 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . 0.857 ' OE2' HG13 ' A' ' 451' ' ' VAL . 2.0 mp0 -83.75 124.57 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 67.9 m -71.83 -37.26 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 9.0 p -101.65 123.58 45.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.76 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.595 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.5 mt -107.73 119.93 40.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -118.66 84.5 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.634 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.3 mtt -91.48 161.29 15.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 469' ' ' ILE . 19.4 t -132.41 126.12 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.785 HG23 HD13 ' A' ' 471' ' ' ILE . 10.0 t -125.24 150.19 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -106.42 126.68 52.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.514 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.4 mtp-105 -125.34 133.27 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.736 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.92 -104.94 1.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.236 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.49 25.93 3.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.834 0.35 . . . . 0.0 110.692 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -146.52 149.65 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.045 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.46 142.84 27.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.587 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.6 mt -128.63 155.39 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.349 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 3.9 mmt -109.54 119.9 40.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.479 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . 0.785 HD13 HG23 ' A' ' 462' ' ' VAL . 3.7 mp -108.96 120.61 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 19.3 m -102.28 121.5 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.552 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.492 HG21 HD21 ' A' ' 428' ' ' LEU . 23.2 t -127.85 144.31 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.486 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 28.3 mm -127.77 109.9 20.47 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.855 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.56 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.1 Cg_endo -59.72 149.65 81.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.394 2.063 . . . . 0.0 112.288 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.45 176.84 5.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.889 0.376 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -66.76 88.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.75 HG22 HD13 ' A' ' 415' ' ' ILE . 24.3 pt -74.35 141.24 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.41 ' HB3' ' HE2' ' A' ' 387' ' ' MET . 9.2 m95 -119.58 94.09 4.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.38 77.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.418 HG12 ' OXT' ' B' ' 7' ' ' VAL . 11.7 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.156 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 475' ' ' PRO . 24.6 mttm . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.736 0.303 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -160.04 128.42 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.175 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.591 HG23 ' HB3' ' A' ' 475' ' ' PRO . 12.7 pt -118.48 -5.74 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.271 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . 0.445 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 55.78 66.15 3.05 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.654 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' ILE . . . . . 0.896 HG12 HG22 ' A' ' 417' ' ' VAL . 0.0 OUTLIER -153.45 124.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.815 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' ARG . . . . . 0.617 ' N ' HD13 ' A' ' 385' ' ' ILE . 25.3 mtt180 -90.2 123.88 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.069 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' MET . . . . . 0.475 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -131.21 145.03 51.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' MET . . . . . 0.541 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.7 OUTLIER -122.23 179.09 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.6 p -104.75 104.83 14.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.665 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 413' ' ' TYR . 6.2 tp -51.97 114.81 1.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.269 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.3 t -90.23 170.16 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 56.2 m -67.84 -14.5 63.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.527 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.3 t -87.94 -35.96 17.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 0.0 111.204 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.464 ' H ' HG23 ' A' ' 391' ' ' THR . 0.6 OUTLIER -84.86 -30.92 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.95 98.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -76.53 -33.31 58.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -29.18 70.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.49 -49.34 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.041 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -58.59 -30.37 67.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.092 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.36 -37.57 80.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.95 -65.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.56 -58.4 8.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 75.8 -54.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.362 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -44.72 -29.7 0.81 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.01 138.91 71.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.78 -159.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.485 2.123 . . . . 0.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -101.57 27.31 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.2 m -71.74 140.3 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.98 -30.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 16.8 m -101.62 -178.2 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 112.61 167.21 17.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.598 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 388' ' ' MET . . . -108.6 151.6 25.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' TYR . . . . . 0.776 ' HB2' HD13 ' A' ' 390' ' ' LEU . 52.8 t80 -101.46 128.72 47.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ILE . . . . . 0.937 HD12 ' HB2' ' A' ' 432' ' ' ASP . 16.1 mt -79.94 114.62 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.826 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' ILE . . . . . 0.833 ' CD1' HG22 ' B' ' 4' ' ' ILE . 4.1 mt -78.76 -66.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.27 158.57 41.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 111.585 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' VAL . . . . . 0.896 HG22 HG12 ' A' ' 385' ' ' ILE . 41.3 t -130.63 153.3 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.824 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' ILE . . . . . 0.829 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.1 mp -97.22 129.8 31.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.523 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.98 -12.91 16.69 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.009 2.473 . . . . 0.0 113.857 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' ASP . . . . . 0.829 ' H ' HG22 ' A' ' 418' ' ' ILE . 4.0 m-20 -111.24 53.48 0.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' THR . . . . . 0.445 HG21 ' HA3' ' A' ' 384' ' ' GLY . 18.1 p -153.89 153.82 29.2 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.095 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.58 -24.46 45.02 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.099 1.866 . . . . 0.0 110.906 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 428' ' ' LEU . . . -58.81 -60.25 4.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.37 -30.96 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.726 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.0 -15.46 58.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -84.07 -31.85 24.89 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.349 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 125.59 16.97 2.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.153 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 3.9 mt -85.69 -171.21 3.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.133 0.467 . . . . 0.0 110.74 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.86 153.87 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.43 -178.91 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 28.59 16.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.937 ' HB2' HD12 ' A' ' 414' ' ' ILE . 54.3 m-20 -132.63 170.02 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.751 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.26 127.06 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.324 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 414' ' ' ILE . 2.1 mp -84.89 147.85 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.569 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 436' ' ' SER . 2.2 pp -137.99 -43.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.728 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' SER . . . . . 0.821 ' N ' HD12 ' A' ' 435' ' ' ILE . 23.6 p -124.94 151.94 44.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.091 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' ILE . . . . . 0.729 HD12 ' CG ' ' A' ' 460' ' ' MET . 1.5 tt -148.81 115.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.982 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.7 p30 47.64 36.36 5.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.641 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.03 30.18 32.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.747 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -122.78 145.69 48.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.778 0.323 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.2 t -86.76 107.88 18.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.605 HG11 HG22 ' A' ' 448' ' ' VAL . 62.0 t -93.16 152.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 444' ' ' SER . 10.7 m -139.76 -46.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 443' ' ' VAL . 2.3 p -132.64 166.48 22.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.999 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' ALA . . . . . 0.475 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.21 -38.05 70.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.293 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' ASN . . . . . 0.4 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 5.4 p30 -58.53 -29.67 66.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -77.63 -41.26 39.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' VAL . . . . . 0.686 HG12 HD11 ' A' ' 452' ' ' ILE . 32.9 t -63.16 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' SER . . . . . 0.704 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.6 t -54.89 -66.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.547 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 447' ' ' ASP . 40.7 t -75.62 -46.12 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.289 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.4 mt -58.76 -32.9 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 -4.15 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.628 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -100.38 -49.7 4.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.67 150.25 22.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 -35.88 14.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.807 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.21 96.83 6.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.6 mt -91.35 121.16 32.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' ASN . . . . . 0.523 ' CG ' HG23 ' A' ' 472' ' ' THR . 5.9 m-80 -111.78 90.21 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' MET . . . . . 0.729 ' CG ' HD12 ' A' ' 437' ' ' ILE . 3.2 mtm -95.71 130.35 42.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.105 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' VAL . . . . . 0.599 HG22 ' HG3' ' A' ' 470' ' ' MET . 22.1 t -99.22 122.82 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.956 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 432' ' ' ASP . 3.9 t -111.64 148.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.953 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.27 131.35 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' ARG . . . . . 0.613 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.9 mtp180 -138.74 125.53 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 69.52 -101.4 0.83 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.464 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -140.12 25.39 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.655 0.264 . . . . 0.0 111.116 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -140.08 151.77 45.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.821 0.344 . . . . 0.0 111.2 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.08 139.24 31.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mt -125.62 129.18 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 111.362 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' MET . . . . . 0.599 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -93.8 120.11 33.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.51 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 8.6 mm -117.8 142.9 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.31 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.523 HG23 ' CG ' ' A' ' 459' ' ' ASN . 1.3 m -123.45 136.03 54.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 474' ' ' ILE . 5.7 t -143.82 137.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.249 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -113.66 109.8 50.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' PRO . . . . . 0.591 ' HB3' HG23 ' A' ' 383' ' ' ILE . 28.8 Cg_endo -63.07 134.14 44.55 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.059 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.89 -177.4 5.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.91 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 64.5 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.773 0.32 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.8 mtm-85 -58.09 89.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ILE . . . . . 0.833 HG22 ' CD1' ' A' ' 415' ' ' ILE . 5.0 pt -83.36 115.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' TRP . . . . . 0.4 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.5 m0 -99.76 101.29 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 8.8 t90 -82.59 63.32 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.787 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.463 ' O ' HG12 ' B' ' 7' ' ' VAL . 25.5 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.059 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.6 m -152.14 -66.36 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.832 0.349 . . . . 0.0 110.87 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -129.61 101.09 5.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 1.2 mtp -156.09 164.46 38.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 1.9 tptm 61.35 93.15 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.953 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.528 ' HB2' HG22 ' A' ' 452' ' ' ILE . 6.9 mmtt -71.64 -176.63 1.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.749 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.422 ' HB2' HG22 ' A' ' 478' ' ' ILE . 11.3 t80 -141.76 123.14 14.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.257 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.571 HD12 ' CG2' ' A' ' 385' ' ' ILE . 5.4 pt -113.29 -13.72 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.347 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.52 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 72.14 57.53 5.65 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.772 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.891 HD11 HG23 ' A' ' 414' ' ' ILE . 12.4 tt -160.18 151.74 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 111.14 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 17.7 mtt180 -106.02 127.6 53.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.476 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -134.71 145.29 48.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 7.9 ptm -127.27 160.55 30.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 83.9 p -85.4 110.02 18.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.814 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.5 tp -58.06 89.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.018 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 394' ' ' LYS . 5.7 t -75.72 166.47 23.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.77 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.1 t -49.53 -36.11 22.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.425 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -63.73 1.02 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.175 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.416 ' H ' HG23 ' A' ' 391' ' ' THR . 0.0 OUTLIER -57.28 -49.6 75.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.219 -179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.9 -39.69 55.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.313 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.04 -29.19 39.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.006 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.6 -34.81 79.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.063 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.19 -43.15 78.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.05 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -59.63 -34.35 72.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.64 -37.87 67.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.835 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -82.51 -70.09 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.82 96.46 8.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.04 60.43 3.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.8 14.23 1.92 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.23 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -106.31 150.96 40.08 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.808 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.685 ' HB2' HG22 ' A' ' 408' ' ' VAL . 53.6 Cg_exo -52.09 179.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.57 2.18 . . . . 0.0 112.31 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -98.87 28.42 4.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' A' ' 406' ' ' PRO . 14.9 m -101.38 173.84 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.991 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.731 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -138.63 16.7 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.373 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.2 p -116.2 139.89 49.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.882 0.372 . . . . 0.0 110.801 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.12 167.06 11.13 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.35 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -101.56 142.9 32.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.913 0.387 . . . . 0.0 111.128 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.756 ' HB2' HD13 ' A' ' 390' ' ' LEU . 45.0 t80 -104.14 130.38 51.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.891 HG23 HD11 ' A' ' 385' ' ' ILE . 17.4 mt -80.08 128.76 38.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.54 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.806 HD13 HG22 ' B' ' 4' ' ' ILE . 62.7 mt -96.24 -68.68 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.563 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.12 153.12 40.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 0.0 111.044 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . . . . . . . . . 19.5 t -125.16 136.01 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.175 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.8 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.5 mp -79.84 134.69 56.57 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.308 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.97 -11.21 2.36 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.249 2.632 . . . . 0.0 114.678 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . 0.8 ' H ' HG22 ' A' ' 418' ' ' ILE . 14.7 m-20 -130.95 76.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.52 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.2 OUTLIER -160.15 163.58 21.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.603 179.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.64 -25.17 78.13 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.408 2.072 . . . . 0.0 111.6 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . . . . . . . . . . . -59.14 -54.67 44.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.169 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.08 -31.08 65.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.984 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.5 -30.51 59.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.265 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -68.98 -38.15 84.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.35 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.77 29.42 1.54 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.82 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.87 HD23 HG21 ' A' ' 471' ' ' ILE . 0.4 OUTLIER -96.97 -164.28 1.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.686 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.25 163.71 22.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.854 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.48 41.45 1.09 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.908 0.385 . . . . 0.0 110.977 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -151.88 28.54 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.59 ' HB2' HD12 ' A' ' 414' ' ' ILE . 1.0 OUTLIER -126.57 -177.04 3.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 29.8 t -136.68 123.21 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.315 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 435' ' ' ILE . 1.7 mp -77.04 157.9 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.765 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 436' ' ' SER . 2.0 pp -148.79 -46.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.411 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 435' ' ' ILE . 54.2 p -124.34 160.95 26.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.979 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.996 HG21 HG11 ' A' ' 451' ' ' VAL . 2.8 tt -156.58 119.57 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.249 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.445 ' ND2' HG12 ' A' ' 437' ' ' ILE . 19.6 p30 43.54 46.94 6.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.718 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 74.27 47.18 18.2 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.713 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -142.95 161.49 37.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.679 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 61.9 m -111.62 110.5 20.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.961 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.937 HG11 HG22 ' A' ' 448' ' ' VAL . 5.3 t -95.04 152.39 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 444' ' ' SER . 27.9 m -130.12 -42.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.453 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 443' ' ' VAL . 2.2 p -134.3 172.35 13.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.396 . . . . 0.0 111.242 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.476 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.38 -42.97 78.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.416 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 25.1 p30 -55.31 -29.14 57.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.843 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.83 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.8 m-20 -78.52 -35.68 45.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.771 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.937 HG22 HG11 ' A' ' 442' ' ' VAL . 32.4 t -69.75 -41.51 79.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.266 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.666 ' HA ' HD12 ' A' ' 452' ' ' ILE . 20.2 t -54.78 -62.62 1.54 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.529 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -48.28 -35.97 13.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.409 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.996 HG11 HG21 ' A' ' 437' ' ' ILE . 40.3 t -65.81 -46.05 89.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.068 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.5 mt -61.92 -31.65 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.135 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 7.6 ptpt -95.03 -14.3 24.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.455 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -94.37 -44.99 7.66 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.317 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -106.13 128.52 53.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.1 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 53.9 m -70.2 -37.71 75.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.72 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.7 p -104.25 121.38 43.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.582 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.772 ' HB3' HD11 ' A' ' 437' ' ' ILE . 9.2 mt -107.38 129.27 54.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.6 m-80 -127.92 83.07 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.642 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.499 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.1 OUTLIER -89.68 136.62 32.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.008 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.495 HG22 ' HG3' ' A' ' 470' ' ' MET . 21.8 t -99.07 126.51 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.164 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.412 HG11 ' OD2' ' A' ' 432' ' ' ASP . 11.6 t -121.15 129.3 75.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.786 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -89.73 120.96 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.215 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -124.3 128.52 49.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.592 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.03 -100.98 0.89 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.347 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -139.93 23.85 2.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 110.863 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -141.91 148.35 38.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.147 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -91.73 136.46 33.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.601 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.1 mt -126.01 146.59 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.216 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.495 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -101.89 119.92 39.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.605 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.87 HG21 HD23 ' A' ' 428' ' ' LEU . 12.1 mm -107.17 133.6 51.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.134 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.4 HG23 ' OD1' ' A' ' 459' ' ' ASN . 0.2 OUTLIER -114.54 126.55 55.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.936 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 428' ' ' LEU . 20.6 t -135.98 130.35 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.03 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 33.8 mm -105.24 109.92 63.8 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.457 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.9 Cg_endo -58.06 175.49 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.51 2.14 . . . . 0.0 112.407 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -123.92 155.81 37.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.899 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -94.21 135.2 35.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . 0.422 HG22 ' HB2' ' A' ' 382' ' ' TYR . 0.8 OUTLIER -160.06 137.31 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.995 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -139.68 115.18 8.09 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.25 1.087 0 C-N-CA 122.387 2.058 . . . . 0.0 112.315 179.935 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.861 0.362 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.64 -74.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.2 mtp85 60.4 71.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.806 HG22 HD13 ' A' ' 415' ' ' ILE . 9.2 pt -84.82 134.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.11 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.416 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 12.5 m95 -117.91 91.11 3.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.441 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 3.8 t90 -70.71 72.47 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.44 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.2 t . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.118 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 47.3 m -90.11 122.64 33.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.96 92.35 0.13 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.993 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 8.6 mtt -84.46 155.85 22.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.28 140.49 48.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -123.63 143.13 50.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.449 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 52.1 t80 -152.97 131.76 12.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.012 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.668 HG13 HG22 ' A' ' 385' ' ' ILE . 22.4 pt -116.85 -14.95 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.62 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.547 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 67.01 61.95 4.83 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.882 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.941 HD11 HG23 ' A' ' 414' ' ' ILE . 10.3 tt -165.37 137.97 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 111.266 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.509 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -96.59 145.9 25.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.782 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.504 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -141.46 139.5 33.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.742 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.446 ' CG ' HD11 ' A' ' 415' ' ' ILE . 6.2 ptm -116.83 162.88 17.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.131 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.9 p -85.37 115.85 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 398' ' ' LEU . 6.6 tp -69.13 84.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.99 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.8 t -71.12 173.7 7.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.821 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 19.9 m -62.56 -19.1 63.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.305 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.06 -46.43 12.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.191 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.464 ' H ' HG23 ' A' ' 391' ' ' THR . 0.0 OUTLIER -82.91 -32.65 27.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.147 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -65.58 -51.02 62.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.386 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.19 -29.47 66.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.18 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -38.09 88.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.06 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.891 HD11 HD11 ' A' ' 390' ' ' LEU . 6.1 mt -62.45 -52.58 62.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.059 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -29.93 68.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.27 -60.0 2.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.991 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 24.2 ttt85 -65.68 -42.4 91.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.058 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.433 ' HB3' ' CD2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -119.89 113.94 21.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -82.92 -27.44 30.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.952 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.14 -25.64 59.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.152 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 402' ' ' HIS . 4.8 m-85 -55.46 161.27 3.07 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.582 ' HB2' HG22 ' A' ' 408' ' ' VAL . 45.6 Cg_endo -68.53 173.2 10.19 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.59 2.193 . . . . 0.0 112.21 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -98.31 30.98 2.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 406' ' ' PRO . 13.2 m -114.66 126.79 72.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.1 pp -89.66 -30.16 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.51 173.78 8.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.839 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 104.65 173.94 24.8 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.443 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.28 140.14 43.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.348 . . . . 0.0 111.15 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.849 ' HB2' HD13 ' A' ' 390' ' ' LEU . 23.3 t80 -90.54 128.06 36.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.668 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.941 HG23 HD11 ' A' ' 385' ' ' ILE . 8.0 mt -79.88 127.94 38.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.917 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 9.6 mm -85.4 -69.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -160.14 153.79 22.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.723 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.491 HG22 HD12 ' A' ' 385' ' ' ILE . 12.5 t -118.09 139.05 46.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.466 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 22.7 mm -79.75 146.57 64.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.507 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 418' ' ' ILE . 15.8 Cg_exo -69.52 6.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.822 2.348 . . . . 0.0 113.877 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.06 62.31 1.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.367 . . . . 0.0 111.146 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.547 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.1 OUTLIER -155.42 171.81 6.77 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.772 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.46 ' HB2' HG13 ' A' ' 473' ' ' VAL . 82.3 Cg_endo -79.19 -18.12 11.36 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.535 2.157 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.616 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -60.43 -58.87 6.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.049 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.423 ' N ' HG11 ' A' ' 417' ' ' VAL . 3.4 tp10 -68.37 -27.76 66.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.859 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.63 38.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.383 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -76.24 -39.19 32.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.435 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 133.24 16.97 1.16 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.154 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 471' ' ' ILE . 3.0 mt -85.99 -170.65 3.2 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 117.074 0.437 . . . . 0.0 110.68 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.82 141.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.891 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 16.0 pm0 -62.22 178.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 62.88 23.5 14.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.805 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.733 ' HB2' HD12 ' A' ' 414' ' ' ILE . 17.1 m-20 -125.42 -177.11 3.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.554 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -139.47 123.95 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.856 0.36 . . . . 0.0 111.536 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 7.5 mt -82.3 154.22 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.541 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -141.86 -49.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.683 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.71 ' N ' HD12 ' A' ' 435' ' ' ILE . 52.3 p -114.14 155.43 26.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.823 0.344 . . . . 0.0 111.207 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.1 tt -157.77 111.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.028 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.418 ' ND2' HG12 ' A' ' 437' ' ' ILE . 13.5 p30 45.43 41.65 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.578 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 78.7 35.1 32.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.769 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.55 ' HB2' HG23 ' A' ' 437' ' ' ILE . 17.4 mm-40 -134.62 125.57 27.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.766 0.317 . . . . 0.0 110.924 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 68.8 p -80.93 110.77 16.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.906 HG11 ' CG2' ' A' ' 448' ' ' VAL . 10.8 t -92.2 143.1 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.036 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.11 -32.73 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.48 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.99 177.59 9.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.976 0.417 . . . . 0.0 111.239 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.504 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -61.14 -42.45 98.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.037 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.433 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 24.5 p30 -53.87 -26.25 23.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.874 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -79.91 -50.69 10.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.688 179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.906 ' CG2' HG11 ' A' ' 442' ' ' VAL . 41.3 t -56.75 -37.25 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.291 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 24.8 t -57.1 -65.5 0.61 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.399 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -51.67 -32.16 28.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.37 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.874 HG23 ' O ' ' A' ' 447' ' ' ASP . 41.5 t -66.64 -49.91 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.67 HD11 HG12 ' A' ' 448' ' ' VAL . 9.1 mt -58.25 -29.6 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.063 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -97.14 -14.28 21.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.422 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -97.64 -54.64 3.06 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.863 0.363 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . 0.441 ' HG3' HG13 ' A' ' 451' ' ' VAL . 17.2 mm-40 -86.48 126.3 34.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.927 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 73.5 m -69.03 -36.84 78.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . 0.579 ' C ' HD23 ' A' ' 458' ' ' LEU . 1.5 p -108.44 136.27 48.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.725 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.679 ' HB3' HD11 ' A' ' 437' ' ' ILE . 4.0 mt -120.14 140.74 50.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.052 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . 0.717 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.1 m-80 -141.9 91.78 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.586 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.449 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -96.74 159.34 14.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.227 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 23.7 t -129.93 122.4 54.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.875 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.745 ' O ' HD12 ' A' ' 469' ' ' ILE . 5.6 t -112.91 147.45 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.206 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -114.61 139.36 49.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.961 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.804 ' HG2' HD11 ' A' ' 469' ' ' ILE . 21.1 ptt180 -132.23 126.51 33.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.793 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 59.93 -96.51 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.527 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -136.88 29.0 2.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 0.0 110.961 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.54 143.79 39.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.061 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -89.95 141.77 28.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.675 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.804 HD11 ' HG2' ' A' ' 464' ' ' ARG . 0.8 OUTLIER -127.03 125.31 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.159 -179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.522 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.0 OUTLIER -95.93 125.27 40.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.769 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 428' ' ' LEU . 3.5 mp -125.5 132.55 70.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.401 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.717 HG23 ' OD1' ' A' ' 459' ' ' ASN . 1.2 m -116.71 119.82 36.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.435 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 428' ' ' LEU . 21.2 t -124.92 140.71 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.953 0.406 . . . . 0.0 111.399 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.569 HD12 HG22 ' A' ' 457' ' ' THR . 27.3 mm -124.09 111.99 28.55 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.717 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.449 ' HB3' HG23 ' A' ' 383' ' ' ILE . 23.9 Cg_endo -62.05 144.23 95.89 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.315 2.01 . . . . 0.0 112.353 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.7 171.62 7.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.968 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.14 135.65 33.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.919 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.94 134.76 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.4 109.93 50.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.893 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.515 2.144 . . . . 0.0 112.274 179.952 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.818 0.342 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.58 30.62 15.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.826 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -65.5 99.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.846 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.455 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.8 pt -69.5 157.03 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.213 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.433 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 13.3 m95 -118.78 91.89 3.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.892 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.426 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 5.4 t90 -72.98 79.64 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.18 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.464 -0.255 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.51 122.03 24.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 0.0 110.901 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -108.35 121.12 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 5.3 ttm -128.83 178.52 6.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.85 167.17 16.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.94 146.41 23.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -154.37 159.16 41.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.843 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.849 HG22 ' HG2' ' A' ' 422' ' ' PRO . 0.7 OUTLIER -135.38 -59.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.37 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 115.5 49.32 0.48 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.359 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.886 HD13 HG22 ' A' ' 417' ' ' VAL . 5.5 tp -138.93 132.58 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.031 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -89.8 129.82 36.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.561 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.457 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -138.36 157.57 45.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.106 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.425 ' O ' ' HA ' ' A' ' 412' ' ' ALA . 1.5 ptm -134.32 -179.59 5.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 4.2 p -94.67 15.82 17.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.369 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.778 HD13 ' HB2' ' A' ' 413' ' ' TYR . 12.5 tp 47.26 95.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.874 0.369 . . . . 0.0 111.481 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.673 HG23 ' H ' ' A' ' 394' ' ' LYS . 2.6 t -71.67 156.26 39.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.87 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.23 -30.57 70.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 5.1 m -66.62 -56.67 9.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.982 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.673 ' H ' HG23 ' A' ' 391' ' ' THR . 0.1 OUTLIER -71.43 -29.84 65.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.962 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.619 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -57.59 -60.01 4.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.298 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -64.45 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.998 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -61.9 -36.38 81.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 395' ' ' ALA . 4.7 mt -61.1 -43.5 98.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -66.12 -30.54 71.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.004 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -59.89 4.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -68.53 -60.62 2.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.8 85.23 2.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 65.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.124 0.488 . . . . 0.0 110.854 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -167.54 28.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.949 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -89.63 167.34 17.71 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.773 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.64 -24.4 12.79 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.527 2.151 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.6 t0 68.36 51.79 0.66 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.945 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.51 90.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.025 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.545 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -46.54 -30.97 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.474 -179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.4 m -116.61 130.49 56.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 163.57 178.33 37.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.347 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' A' ' 434' ' ' ILE . . . -98.08 123.41 42.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.778 ' HB2' HD13 ' A' ' 390' ' ' LEU . 62.5 t80 -97.83 129.99 44.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.278 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.767 HG23 HD11 ' A' ' 385' ' ' ILE . 21.5 mt -80.69 109.74 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.605 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.768 HD13 HG22 ' B' ' 4' ' ' ILE . 2.8 mp -72.89 -58.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.294 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.735 ' O ' HD12 ' A' ' 385' ' ' ILE . 17.1 pt-20 -160.1 147.78 16.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.814 0.34 . . . . 0.0 111.208 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.886 HG22 HD13 ' A' ' 385' ' ' ILE . 24.8 t -108.85 133.28 54.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.939 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.508 ' O ' HG22 ' A' ' 421' ' ' THR . 0.3 OUTLIER -80.4 156.7 73.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -83.93 44.08 1.5 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.793 2.329 . . . . 0.0 112.58 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -173.31 35.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.562 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 418' ' ' ILE . 4.0 t -129.46 154.39 80.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.023 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.849 ' HG2' HG22 ' A' ' 383' ' ' ILE . 36.1 Cg_exo -61.19 -24.39 79.0 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.761 2.308 . . . . 0.0 112.325 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.848 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -53.72 -38.56 64.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.167 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.66 -29.66 59.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.86 -36.39 59.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.953 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.724 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -67.89 -69.57 1.34 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.29 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 151.69 39.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.81 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.874 HD23 HG21 ' A' ' 471' ' ' ILE . 1.1 mt -98.48 -165.12 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.872 0.367 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -178.97 170.46 1.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.488 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.04 28.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.152 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.22 12.97 3.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.012 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.494 ' HB2' HD12 ' A' ' 414' ' ' ILE . 15.9 m-20 -119.12 173.37 6.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.631 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 412' ' ' ALA . 28.4 t -138.25 117.78 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.365 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 412' ' ' ALA . 3.6 mp -66.2 142.5 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.448 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.668 HD12 ' HB3' ' A' ' 436' ' ' SER . 2.1 pp -136.43 -46.18 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.567 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.668 ' HB3' HD12 ' A' ' 435' ' ' ILE . 24.2 p -121.7 156.51 32.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.926 HG21 HG11 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -151.54 124.45 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.002 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 13.9 p30 44.71 30.89 0.57 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.576 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.22 27.26 23.61 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -118.13 170.19 9.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.746 0.307 . . . . 0.0 110.713 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 16.4 m -118.35 111.09 18.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.147 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.97 HG11 HG22 ' A' ' 448' ' ' VAL . 10.8 t -97.67 161.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.478 ' N ' HG12 ' A' ' 442' ' ' VAL . 8.6 m -139.45 -48.31 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.475 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.7 OUTLIER -126.05 167.82 14.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.968 0.414 . . . . 0.0 111.282 -179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.457 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.75 -41.38 81.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.117 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -55.84 -26.34 46.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.803 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.817 ' O ' HG23 ' A' ' 451' ' ' VAL . 6.3 m-20 -86.88 -29.74 21.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.97 HG22 HG11 ' A' ' 442' ' ' VAL . 13.4 t -72.13 -44.67 64.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.314 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.526 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.7 t -50.84 -64.64 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.624 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -46.61 -36.5 7.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.474 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.926 HG11 HG21 ' A' ' 437' ' ' ILE . 41.1 t -63.33 -50.09 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.207 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.2 mt -58.75 -37.2 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -90.34 -4.88 56.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.399 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -100.07 -51.35 3.71 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.928 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -96.63 142.36 28.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.049 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 5.3 t -81.28 -38.25 27.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.674 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . 0.526 HG22 HD12 ' A' ' 474' ' ' ILE . 1.0 OUTLIER -106.61 117.76 34.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.601 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.765 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.0 mt -101.97 126.75 48.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -132.22 92.78 3.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.634 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.489 ' HG3' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -96.74 151.69 19.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.206 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 43.0 t -118.35 121.95 68.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.017 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 463' ' ' ARG . 9.0 t -107.43 161.42 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . 0.47 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -124.83 138.7 54.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.0 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.759 ' HB2' HD11 ' A' ' 469' ' ' ILE . 0.3 OUTLIER -147.65 121.27 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.743 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.79 -113.68 5.84 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.493 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -125.26 29.37 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -140.52 150.2 43.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.243 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -94.25 147.15 23.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.533 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.759 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.0 OUTLIER -127.88 132.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.256 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.31 119.88 39.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.654 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.874 HG21 HD23 ' A' ' 428' ' ' LEU . 11.5 mm -112.54 132.67 60.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 25.1 m -122.62 119.86 32.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.977 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.724 HG22 ' HA3' ' A' ' 426' ' ' GLY . 24.5 t -130.1 133.74 63.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.526 HD12 HG22 ' A' ' 457' ' ' THR . 26.3 mm -118.11 109.14 41.23 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.004 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.608 ' HB3' HG23 ' A' ' 383' ' ' ILE . 39.5 Cg_endo -66.84 -172.71 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.462 2.108 . . . . 0.0 112.226 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -143.1 173.5 11.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -102.83 130.34 49.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 16.5 tt -148.37 155.62 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.019 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.65 121.17 28.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--O 1.249 1.069 0 C-N-CA 122.413 2.076 . . . . 0.0 112.292 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.754 0.311 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.0 m 64.26 36.33 9.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.99 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 113.6 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.768 HG22 HD13 ' A' ' 415' ' ' ILE . 2.6 pt -81.26 118.13 28.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -94.71 92.65 7.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -68.24 85.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.123 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.44 125.53 54.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.21 -69.01 0.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.882 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.39 97.05 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.812 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -138.65 146.92 42.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 2.6 mttp -110.93 155.2 23.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.713 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.444 ' HB3' HG22 ' A' ' 478' ' ' ILE . 76.1 t80 -131.0 126.98 37.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 385' ' ' ILE . 11.0 pt -116.72 -4.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.425 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.478 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 50.07 67.27 1.91 Allowed Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.857 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.958 HD13 HG22 ' A' ' 417' ' ' VAL . 4.8 tp -151.73 126.22 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 0.0 110.841 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.426 ' HG3' ' CD1' ' B' ' 6' ' ' TRP . 27.7 mtt85 -89.9 125.96 35.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.85 142.53 47.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.728 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.457 ' HB3' HD11 ' A' ' 415' ' ' ILE . 8.6 ptm -125.54 156.98 38.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.086 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 49.2 p -84.21 114.53 21.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' ' 395' ' ' ALA . 6.8 tp -63.93 81.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.746 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.4 t -62.12 158.69 16.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 26.5 m -57.42 -23.24 48.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.02 -54.7 5.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.092 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.746 ' H ' HG23 ' A' ' 391' ' ' THR . 0.5 OUTLIER -63.71 -45.16 91.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.169 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.594 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -59.18 -39.85 83.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.185 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -77.63 -29.87 51.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -69.79 -47.57 62.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.14 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 58.3 mt -58.5 -44.06 89.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -65.86 -31.7 72.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.004 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.74 -43.31 94.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.976 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 10.8 ttm-85 -93.09 -20.34 20.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.311 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -135.57 78.79 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.867 0.365 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -69.14 -22.8 63.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.112 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.79 -26.64 10.13 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -65.06 160.39 56.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.835 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.27 -167.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.565 2.177 . . . . 0.0 112.243 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -116.7 31.33 6.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.015 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 9.7 m -91.9 132.27 36.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.067 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.611 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -110.5 -18.26 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -100.31 154.23 18.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 116.56 159.35 11.65 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.445 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.616 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -90.11 147.77 23.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.937 0.399 . . . . 0.0 111.117 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.547 ' HB2' HD13 ' A' ' 390' ' ' LEU . 74.6 t80 -102.42 131.25 49.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 432' ' ' ASP . 21.2 mt -80.01 122.92 36.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.597 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.889 ' CD1' HG22 ' B' ' 4' ' ' ILE . 17.9 mt -91.84 -61.24 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.831 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.769 ' O ' HD12 ' A' ' 385' ' ' ILE . 8.0 pt-20 -157.88 149.29 21.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.945 0.403 . . . . 0.0 111.415 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.958 HG22 HD13 ' A' ' 385' ' ' ILE . 20.4 t -117.4 140.37 40.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.819 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -86.79 135.37 35.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.729 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 7.9 Cg_exo -72.57 56.18 2.76 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.779 2.319 . . . . 0.0 112.496 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 178.25 40.87 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.162 0.506 . . . . 0.0 110.498 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.4 OUTLIER -142.78 173.83 4.23 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.356 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -75.77 -13.87 19.71 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.132 1.888 . . . . 0.0 111.856 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.499 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -66.15 -56.9 9.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.759 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -69.65 -31.78 70.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.456 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.94 -30.62 58.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.843 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -66.86 -34.06 86.01 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.255 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.95 26.83 2.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.843 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 471' ' ' ILE . 0.3 OUTLIER -96.47 -177.81 4.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.89 0.376 . . . . 0.0 110.77 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -159.64 161.5 35.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.762 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -85.59 56.17 3.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -165.17 31.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.034 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.518 ' HB2' HD12 ' A' ' 414' ' ' ILE . 14.9 m-20 -135.22 -174.34 3.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.815 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 412' ' ' ALA . 38.6 t -142.21 123.83 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.312 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.7 mt -75.7 147.71 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.716 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -138.69 -46.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.351 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.763 ' N ' HD12 ' A' ' 435' ' ' ILE . 90.9 p -116.93 156.32 27.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.726 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.932 HG21 HG11 ' A' ' 451' ' ' VAL . 4.5 tt -155.9 114.51 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.198 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.427 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.7 p30 44.33 33.42 0.85 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.454 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.68 36.16 9.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.773 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.47 114.42 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 34.1 m -70.19 114.4 8.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.031 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.93 HG11 HG22 ' A' ' 448' ' ' VAL . 2.7 t -97.65 162.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 444' ' ' SER . 16.1 m -133.76 -45.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.37 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.433 ' N ' HG23 ' A' ' 443' ' ' VAL . 1.9 p -130.95 173.73 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.94 0.4 . . . . 0.0 111.16 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.84 94.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.045 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.428 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 1.3 p-10 -53.99 -26.64 26.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.863 ' O ' HG23 ' A' ' 451' ' ' VAL . 12.5 m-20 -86.85 -41.4 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.864 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.93 HG22 HG11 ' A' ' 442' ' ' VAL . 46.9 t -63.19 -30.63 50.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.131 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.494 ' HA ' HD12 ' A' ' 452' ' ' ILE . 4.9 t -63.59 -63.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -51.27 -36.38 41.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.504 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.932 HG11 HG21 ' A' ' 437' ' ' ILE . 40.9 t -60.72 -47.73 91.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.33 . . . . 0.0 111.111 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 448' ' ' VAL . 5.5 mt -62.09 -37.5 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.08 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.15 -8.05 55.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.224 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 50.9 ttt85 -98.92 -46.82 5.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.819 0.343 . . . . 0.0 110.843 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -102.26 140.33 36.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 35.3 t -84.88 -34.31 22.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.739 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . 0.474 HG22 HD12 ' A' ' 474' ' ' ILE . 2.1 p -109.17 100.21 9.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.758 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.547 HD11 HG23 ' A' ' 452' ' ' ILE . 8.3 mt -94.53 136.31 34.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.154 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . 0.455 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.7 m-80 -133.82 89.02 2.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.633 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.458 ' HE1' ' HB ' ' A' ' 473' ' ' VAL . 0.1 OUTLIER -92.48 173.78 7.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 470' ' ' MET . 13.2 t -134.68 145.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.883 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 432' ' ' ASP . 7.3 t -140.58 153.47 21.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.951 0.405 . . . . 0.0 111.001 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -101.76 119.84 39.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.98 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.496 ' HB2' HD12 ' A' ' 469' ' ' ILE . 9.3 mtp180 -127.81 139.64 52.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.607 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.7 -101.72 0.96 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.169 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -140.19 20.56 2.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.862 0.363 . . . . 0.0 110.778 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -145.8 168.47 20.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -101.92 136.08 42.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.649 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.8 mt -127.53 143.98 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.593 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -90.7 119.89 31.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.714 179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 428' ' ' LEU . 21.8 mm -103.21 130.03 54.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.196 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.455 HG23 ' OD1' ' A' ' 459' ' ' ASN . 0.2 OUTLIER -102.77 129.12 49.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.013 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.458 ' HB ' ' HE1' ' A' ' 460' ' ' MET . 18.4 t -140.36 119.72 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.474 HD12 HG22 ' A' ' 457' ' ' THR . 21.2 mm -108.19 109.85 61.87 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.165 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.459 ' HG3' HG23 ' A' ' 452' ' ' ILE . 58.2 Cg_exo -51.43 131.27 35.97 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.43 2.087 . . . . 0.0 112.33 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.0 170.56 9.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.97 129.83 54.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.841 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . 0.444 HG22 ' HB3' ' A' ' 382' ' ' TYR . 19.6 tt -140.97 152.76 20.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -147.51 119.13 4.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.843 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.462 2.108 . . . . 0.0 112.307 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.808 0.337 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.5 m 55.55 26.46 9.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.076 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -60.16 117.05 4.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.889 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.4 pt -84.26 123.08 38.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.08 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.428 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.6 m95 -108.57 95.37 5.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.426 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 6.8 t90 -76.85 62.56 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.808 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.064 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.484 -0.247 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 46.8 t -129.11 -43.87 1.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 66.42 -76.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.63 112.41 24.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.845 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.02 147.86 48.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.897 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.13 152.01 22.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -152.02 124.42 8.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.024 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.788 HG13 HG22 ' A' ' 385' ' ' ILE . 24.5 pt -113.36 -4.2 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.463 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.551 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 53.6 65.82 3.17 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.734 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.807 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.13 124.82 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.947 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.427 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 1.9 mtp180 -92.3 125.15 36.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.505 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -127.07 137.28 53.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.971 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.416 ' HB3' HD11 ' A' ' 415' ' ' ILE . 3.7 ptm -115.85 173.26 6.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.012 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 34.5 p -97.69 105.55 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.632 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.867 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.2 tp -54.37 98.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.7 t -87.01 165.09 16.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.839 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.8 m -58.92 -29.7 67.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.067 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 71.2 m -78.55 -19.05 53.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.184 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.05 -51.26 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 0.0 111.072 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -57.35 -45.84 83.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.313 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -66.72 -29.71 69.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.82 -41.06 62.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.993 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 395' ' ' ALA . 7.1 mt -59.97 -38.45 82.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -34.2 68.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.98 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -77.28 -29.27 53.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.054 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.18 -53.25 4.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -116.31 115.74 26.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.003 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.79 55.62 3.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.841 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -146.97 19.75 1.26 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.103 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -109.83 158.28 35.35 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.92 -172.74 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.588 2.192 . . . . 0.0 112.211 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -109.29 32.03 5.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.825 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 11.7 m -102.3 129.6 53.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pt -102.57 -32.99 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.111 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.5 m -87.78 149.9 23.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.773 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 132.17 -157.8 22.64 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.448 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -132.96 127.62 34.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 111.121 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.867 ' HB2' HD13 ' A' ' 390' ' ' LEU . 41.4 t80 -90.33 128.03 36.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.983 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.807 HG23 HD11 ' A' ' 385' ' ' ILE . 15.3 mt -80.57 109.97 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.764 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.515 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -71.3 -58.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 430' ' ' GLU . 6.4 pt-20 -158.31 152.14 23.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.941 0.401 . . . . 0.0 111.245 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.53 HG22 ' CG1' ' A' ' 385' ' ' ILE . 22.2 t -127.95 136.35 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.954 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.596 HG22 ' HD2' ' A' ' 419' ' ' PRO . 8.4 mm -79.86 146.23 63.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.596 ' HD2' HG22 ' A' ' 418' ' ' ILE . 11.9 Cg_exo -71.15 0.52 6.54 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.744 2.296 . . . . 0.0 113.319 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -127.35 61.75 1.38 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.251 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 422' ' ' PRO . 0.8 OUTLIER -152.7 168.99 10.32 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.564 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.561 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 59.7 Cg_endo -74.31 -18.06 20.89 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.265 1.977 . . . . 0.0 111.48 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -61.8 -59.22 5.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.554 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -69.49 -27.08 64.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.563 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -77.44 -30.45 53.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.18 1.26 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.287 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 167.97 31.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.903 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.661 HD11 HG21 ' A' ' 473' ' ' VAL . 0.3 OUTLIER -108.12 -168.15 1.33 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.805 0.336 . . . . 0.0 110.82 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -177.55 169.62 2.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.774 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 416' ' ' GLU . 0.4 OUTLIER -89.92 49.93 1.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.05 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -160.46 29.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.472 ' HB2' HD12 ' A' ' 414' ' ' ILE . 29.8 m-20 -134.15 -177.34 4.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.866 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 42.0 t -139.58 117.89 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.19 149.58 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.762 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.78 HD12 ' N ' ' A' ' 436' ' ' SER . 2.3 pp -141.95 -47.56 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.483 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.78 ' N ' HD12 ' A' ' 435' ' ' ILE . 96.3 p -123.64 144.94 49.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.97 HG21 HG11 ' A' ' 451' ' ' VAL . 3.9 tt -143.52 119.62 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.23 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 18.9 p30 44.85 30.49 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.734 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.07 20.37 42.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.65 -0.785 . . . . 0.0 113.201 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -112.31 157.67 20.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.78 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.17 118.3 31.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.628 HG11 HG22 ' A' ' 448' ' ' VAL . 57.9 t -109.51 127.45 66.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.874 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.29 6.49 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.95 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.9 OUTLIER -170.41 161.52 8.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.881 0.372 . . . . 0.0 111.152 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.505 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -58.2 -45.19 88.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.048 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.42 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 36.4 p-10 -56.58 -28.42 60.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.739 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.819 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.5 OUTLIER -77.69 -33.8 53.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.628 HG22 HG11 ' A' ' 442' ' ' VAL . 18.0 t -74.45 -37.39 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.195 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.542 ' HA ' HD12 ' A' ' 452' ' ' ILE . 7.6 t -55.27 -57.55 11.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.328 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -54.94 -41.04 70.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.339 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.97 HG11 HG21 ' A' ' 437' ' ' ILE . 39.5 t -58.56 -47.34 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.148 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 449' ' ' SER . 8.4 mt -58.8 -36.05 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.945 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.68 -0.84 54.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.322 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -100.22 -47.8 4.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.897 0.379 . . . . 0.0 110.916 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.2 152.81 31.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.75 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.9 t -94.27 -35.61 12.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.695 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.97 94.3 6.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.45 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.714 ' HB3' HD11 ' A' ' 437' ' ' ILE . 14.9 mt -89.86 123.24 33.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.154 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -111.13 83.16 1.72 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.632 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.434 ' HE3' ' HB2' ' A' ' 458' ' ' LEU . 2.6 mtt -90.29 133.35 35.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 469' ' ' ILE . 28.7 t -108.28 124.71 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.904 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.902 HG23 HD13 ' A' ' 471' ' ' ILE . 3.0 t -111.27 163.24 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.6 OUTLIER -124.76 143.91 50.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.047 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.765 ' HB2' HD11 ' A' ' 469' ' ' ILE . 16.0 mtp180 -144.73 130.36 19.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.82 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.22 -99.54 0.21 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.436 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.26 30.89 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.754 0.312 . . . . 0.0 110.944 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -138.82 153.52 48.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -93.12 144.94 24.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.625 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.765 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mp -128.76 129.65 68.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 111.317 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.69 125.21 47.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.492 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.902 HD13 HG23 ' A' ' 462' ' ' VAL . 3.8 mp -132.66 143.61 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.44 . . . . 0.0 111.618 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.18 135.92 53.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.768 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.5 t -135.94 135.1 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.884 0.373 . . . . 0.0 111.566 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.768 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.5 mp -119.83 109.26 37.97 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.586 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -51.12 155.96 5.69 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.425 2.084 . . . . 0.0 112.292 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -113.18 170.62 8.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.56 144.76 25.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.97 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 13.0 tt -143.5 130.46 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.046 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -115.19 111.97 44.42 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.859 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo . . . . . 0 C--O 1.249 1.037 0 C-N-CA 122.361 2.041 . . . . 0.0 112.341 179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.816 0.341 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -97.72 47.2 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.0 mtt-85 -61.62 89.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.515 HG22 ' CD1' ' A' ' 415' ' ' ILE . 2.3 pp -80.78 133.43 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.101 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.42 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.4 m0 -112.04 88.13 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.983 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.42 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 7.3 t90 -71.17 68.26 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.768 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.422 HG23 ' HE3' ' A' ' 387' ' ' MET . 21.1 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.198 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.3 m -131.64 31.81 4.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -101.89 28.6 5.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.47 119.67 23.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -151.53 122.51 7.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.999 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -84.68 172.82 11.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.597 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.429 ' CE1' ' HA2' ' A' ' 384' ' ' GLY . 13.0 t80 -155.83 121.1 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.241 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.0 pt -111.35 -13.02 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.237 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.559 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 70.42 52.77 15.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.729 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.797 HD11 HG23 ' A' ' 414' ' ' ILE . 10.9 tt -165.31 137.17 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.839 0.352 . . . . 0.0 111.044 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.419 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -89.96 158.18 17.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.463 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.426 ' HE3' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -153.22 133.63 13.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.448 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.8 OUTLIER -110.69 173.8 6.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.019 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.3 p -100.16 112.6 24.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.832 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 398' ' ' LEU . 4.3 tp -63.52 88.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.127 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 2.3 t -85.57 167.37 15.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.32 -39.68 6.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.728 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -68.97 -58.36 4.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.824 0.345 . . . . 0.0 111.229 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.24 -52.5 64.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.323 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -50.25 -33.89 21.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.474 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -90.1 -29.51 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.043 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -65.32 -44.0 89.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 390' ' ' LEU . 3.4 mt -58.69 -39.23 80.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.046 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -67.08 -30.2 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.019 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -68.83 -59.38 3.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -66.03 -38.54 88.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.798 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -125.03 98.23 5.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -81.91 59.72 4.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.036 0.446 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.39 23.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.939 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -93.87 146.37 31.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.4 ' HB2' HG22 ' A' ' 408' ' ' VAL . 51.0 Cg_exo -53.17 179.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.532 2.155 . . . . 0.0 112.269 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.42 38.23 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.814 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 408' ' ' VAL . 34.9 m -109.44 117.39 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.1 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.51 -29.72 5.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.146 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 435' ' ' ILE . 0.2 OUTLIER -87.11 148.85 25.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.003 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 122.21 170.43 13.71 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.863 -0.685 . . . . 0.0 112.431 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -108.46 152.71 24.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 0.0 111.026 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.707 ' HB2' HD13 ' A' ' 390' ' ' LEU . 27.2 t80 -92.19 133.79 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.846 HD12 ' HB2' ' A' ' 432' ' ' ASP . 38.2 mt -79.98 121.78 33.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.037 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.623 HG22 ' H ' ' A' ' 416' ' ' GLU . 2.0 mm -88.76 -152.28 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.211 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.623 ' H ' HG22 ' A' ' 415' ' ' ILE . 17.0 pt-20 -79.35 145.15 33.58 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.931 0.396 . . . . 0.0 111.074 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.473 HG11 ' N ' ' A' ' 424' ' ' GLU . 14.2 t -110.9 159.49 10.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.028 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.467 ' N ' HG12 ' A' ' 417' ' ' VAL . 20.6 mm -96.86 136.0 21.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.8 59.03 4.15 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.519 2.146 . . . . 0.0 112.579 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 174.93 44.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.586 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.559 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.2 OUTLIER -150.95 173.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 -179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 66.7 Cg_endo -76.18 -16.28 17.77 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.309 2.006 . . . . 0.0 112.089 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -60.63 -60.05 4.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.473 ' N ' HG11 ' A' ' 417' ' ' VAL . 6.0 tp10 -74.06 -23.25 59.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 422' ' ' PRO . . . -82.04 -26.12 34.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.363 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -76.13 -70.06 1.32 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.451 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 171.55 30.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.997 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.539 HD21 HG21 ' A' ' 473' ' ' VAL . 0.2 OUTLIER -107.74 176.03 5.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.829 0.315 . . . . 0.0 110.643 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.99 157.94 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.991 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.28 77.23 0.73 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.032 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 178.95 -41.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.022 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.846 ' HB2' HD12 ' A' ' 414' ' ' ILE . 22.9 m-20 -72.24 179.32 3.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.978 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 412' ' ' ALA . 22.7 t -139.8 131.11 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.556 HG23 ' HB3' ' A' ' 460' ' ' MET . 3.2 mt -86.06 145.34 7.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.735 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -140.57 -48.74 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.735 ' N ' HD12 ' A' ' 435' ' ' ILE . 19.1 p -110.01 158.79 17.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.81 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.2 tt -158.48 116.17 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.281 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.402 ' ND2' HG12 ' A' ' 437' ' ' ILE . 19.5 p30 42.52 50.54 4.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.649 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 70.61 44.96 56.03 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.798 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -137.97 152.94 49.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 0.0 110.756 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 55.6 m -103.79 107.32 18.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.941 HG11 ' CG2' ' A' ' 448' ' ' VAL . 13.3 t -100.29 143.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.07 -4.21 5.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.93 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.8 p -169.97 168.27 8.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 111.249 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.426 ' HB1' ' HE3' ' A' ' 387' ' ' MET . . . -58.15 -43.84 87.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.199 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.417 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 18.3 p30 -53.31 -27.0 20.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.962 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.803 ' O ' HG23 ' A' ' 451' ' ' VAL . 13.0 m-20 -84.86 -33.77 22.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.758 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.941 ' CG2' HG11 ' A' ' 442' ' ' VAL . 45.8 t -72.95 -37.36 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.205 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.406 ' HA ' HD12 ' A' ' 452' ' ' ILE . 11.1 t -55.26 -59.14 5.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -53.71 -24.64 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.28 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 447' ' ' ASP . 37.7 t -76.5 -50.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.165 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.499 HD11 HG12 ' A' ' 448' ' ' VAL . 7.8 mt -56.58 -27.58 25.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.21 -11.93 22.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.403 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -100.04 -51.04 3.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.818 0.342 . . . . 0.0 110.969 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -95.03 134.91 37.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.973 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.55 -34.97 40.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.738 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 6.2 p -103.34 115.22 30.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.703 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.1 mt -106.93 133.54 51.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.227 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -136.68 90.15 2.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.518 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.556 ' HB3' HG23 ' A' ' 434' ' ' ILE . 0.0 OUTLIER -97.28 149.05 22.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.308 -179.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 469' ' ' ILE . 25.6 t -120.38 125.1 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.837 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.783 HG22 HD13 ' A' ' 471' ' ' ILE . 16.1 m -117.25 -179.69 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.353 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -119.46 125.99 50.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.82 ' HB3' HD11 ' A' ' 469' ' ' ILE . 1.2 ttt85 -118.55 120.24 36.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.554 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 71.61 -94.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.277 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -140.05 27.12 2.19 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -144.56 168.46 20.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.92 140.09 42.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.527 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.82 HD11 ' HB3' ' A' ' 464' ' ' ARG . 1.9 mt -128.13 147.38 32.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 0.0 111.232 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.577 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -94.97 125.36 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.713 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.783 HD13 HG22 ' A' ' 462' ' ' VAL . 4.8 mp -121.0 127.91 76.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.259 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 55.3 m -106.93 122.95 47.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.539 HG21 HD21 ' A' ' 428' ' ' LEU . 27.1 t -127.63 137.21 58.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.044 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -122.65 109.63 32.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.149 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.738 ' HB3' HG23 ' A' ' 383' ' ' ILE . 47.9 Cg_endo -68.55 159.46 53.42 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.419 2.079 . . . . 0.0 112.35 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -108.54 -176.1 2.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -116.73 131.93 56.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 18.7 tt -148.64 150.08 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -101.95 121.07 52.03 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.351 2.034 . . . . 0.0 112.29 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.848 0.356 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.412 ' HB3' HG23 ' B' ' 4' ' ' ILE . 26.4 m -72.37 -54.16 10.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.746 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 56.32 39.24 30.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' B' ' 2' ' ' SER . 2.0 pp -75.27 148.14 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.196 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.417 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 9.7 m0 -109.7 111.15 22.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -80.7 75.87 7.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.853 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.563 ' O ' HG12 ' B' ' 7' ' ' VAL . 10.5 t . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.149 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 14.9 t -152.09 172.67 15.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.739 0.304 . . . . 0.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -125.99 41.46 3.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.005 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -147.7 68.62 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.938 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -143.71 102.36 3.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.788 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.81 146.51 28.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.928 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.5 ' HB2' HG21 ' A' ' 478' ' ' ILE . 73.2 t80 -145.67 131.46 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.82 HG13 HG22 ' A' ' 385' ' ' ILE . 3.6 pt -127.71 12.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.725 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 42.95 63.14 2.08 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.375 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 1.006 HD13 HG22 ' A' ' 417' ' ' VAL . 7.2 tp -148.74 124.33 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.923 0.392 . . . . 0.0 111.163 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 386' ' ' ARG . 11.6 mtt180 -89.64 121.27 31.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.563 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.79 ' CE ' HG23 ' B' ' 7' ' ' VAL . 0.0 OUTLIER -128.86 147.46 50.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.056 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.44 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 5.5 ptm -127.51 173.9 9.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.934 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 31.9 p -89.16 99.98 12.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.83 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.925 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.2 tp -58.53 88.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.624 HG23 ' H ' ' A' ' 394' ' ' LYS . 7.7 t -75.79 169.53 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.809 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.7 p -54.65 -37.65 65.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.128 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.1 t -69.62 -56.14 8.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.624 ' H ' HG23 ' A' ' 391' ' ' THR . 0.1 OUTLIER -62.45 -39.11 92.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.66 80.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.141 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.78 -27.74 61.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.954 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.07 -45.74 83.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.04 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.429 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 17.8 mt -67.14 -30.93 71.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.957 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.66 -30.8 46.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -50.76 72.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.92 -68.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 87.55 7.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.805 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -78.71 61.64 3.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -151.19 21.14 0.75 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.945 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 398' ' ' LEU . 23.2 m-85 -91.57 159.33 38.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.774 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.99 174.83 0.56 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.659 2.239 . . . . 0.0 112.188 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -94.33 45.73 1.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.36 148.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 410' ' ' SER . 2.7 pp -125.37 -40.71 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.298 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . 0.623 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -75.44 133.0 41.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.887 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 146.06 -177.59 24.33 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.407 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.587 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -106.68 141.53 37.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 111.116 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.925 ' HB2' HD13 ' A' ' 390' ' ' LEU . 64.2 t80 -94.71 137.84 33.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.835 HG23 HD11 ' A' ' 385' ' ' ILE . 23.0 mt -87.04 116.41 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.681 ' CD1' HG22 ' B' ' 4' ' ' ILE . 37.0 mt -84.84 -62.93 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.464 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.855 ' O ' HD12 ' A' ' 385' ' ' ILE . 10.9 pt-20 -154.57 153.57 31.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 111.158 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 1.006 HG22 HD13 ' A' ' 385' ' ' ILE . 21.7 t -121.36 141.83 40.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.998 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.456 ' HB ' HG22 ' A' ' 421' ' ' THR . 16.2 mm -81.52 142.55 50.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.773 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.83 -0.91 8.52 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.816 2.344 . . . . 0.0 113.686 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -130.55 59.58 1.65 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.25 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.472 ' OG1' ' HD2' ' A' ' 422' ' ' PRO . 0.7 OUTLIER -160.54 157.8 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.98 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.472 ' HD2' ' OG1' ' A' ' 421' ' ' THR . 31.9 Cg_exo -60.14 -20.68 62.67 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.616 2.211 . . . . 0.0 112.461 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -58.0 -38.09 75.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.012 0.434 . . . . 0.0 110.985 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -84.72 -30.95 24.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.695 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.15 -31.5 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.033 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.561 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -66.75 -35.5 89.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.271 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.77 27.48 2.1 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.861 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.501 HD23 HG21 ' A' ' 471' ' ' ILE . 1.3 mt -92.63 -174.28 3.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.82 0.343 . . . . 0.0 110.817 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.577 ' O ' HG21 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -179.91 169.99 1.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.907 179.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.88 54.65 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.97 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.84 26.54 0.22 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.206 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.522 ' HB2' HD12 ' A' ' 414' ' ' ILE . 1.6 m-20 -138.96 -174.53 3.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.837 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 412' ' ' ALA . 21.8 t -143.36 119.41 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.369 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.6 mt -72.55 116.92 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.716 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.732 HD12 ' HB3' ' A' ' 436' ' ' SER . 2.6 pp -105.05 -42.18 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.692 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.732 ' HB3' HD12 ' A' ' 435' ' ' ILE . 51.6 p -126.53 159.52 33.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.962 0.411 . . . . 0.0 111.062 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.747 ' CG2' HG11 ' A' ' 451' ' ' VAL . 3.4 tt -156.54 113.51 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.001 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 24.0 p30 44.23 44.61 6.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.75 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.15 37.93 36.11 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.072 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.475 ' HB2' HG23 ' A' ' 437' ' ' ILE . 7.4 mm-40 -131.99 128.3 38.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t -76.34 110.19 10.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.944 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 443' ' ' VAL . 58.0 t -90.61 156.07 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.462 ' N ' HG12 ' A' ' 442' ' ' VAL . 12.2 m -145.95 -47.05 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.451 ' N ' HG23 ' A' ' 443' ' ' VAL . 1.6 p -137.5 171.63 14.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.014 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.36 79.31 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.303 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.409 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 25.7 p30 -54.42 -26.1 28.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -82.34 -57.3 3.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.938 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.805 HG12 HD11 ' A' ' 452' ' ' ILE . 38.9 t -47.57 -40.56 7.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.569 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.613 ' HA ' HD12 ' A' ' 452' ' ' ILE . 6.9 t -55.55 -63.71 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.49 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -50.31 -26.87 5.28 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.545 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.747 HG11 ' CG2' ' A' ' 437' ' ' ILE . 60.5 t -77.56 -46.95 26.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.128 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.805 HD11 HG12 ' A' ' 448' ' ' VAL . 7.3 mt -57.8 -27.53 30.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.165 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -100.31 -8.76 23.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.552 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.07 -49.46 4.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.78 0.324 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -97.18 132.4 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.064 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.23 -35.72 55.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.806 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 2.6 t -104.34 116.07 31.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.543 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.634 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.5 mt -102.69 129.98 49.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.016 0.436 . . . . 0.0 111.315 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . 0.617 ' OD1' HG23 ' A' ' 472' ' ' THR . 20.5 m-80 -131.84 96.82 4.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.517 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.55 147.15 26.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.233 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.5 t -121.54 132.93 69.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.776 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.4 m -132.77 167.91 25.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.861 0.363 . . . . 0.0 111.338 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.01 119.78 34.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.016 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 23.1 mtp180 -116.14 136.36 53.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.526 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.7 -101.15 0.43 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.218 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.37 28.6 2.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 0.0 110.799 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -143.59 147.66 34.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.148 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.06 140.04 30.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.639 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.562 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.4 mt -131.12 142.61 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.459 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -99.46 119.72 38.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.213 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.501 HG21 HD23 ' A' ' 428' ' ' LEU . 11.2 mm -105.47 136.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.654 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.617 HG23 ' OD1' ' A' ' 459' ' ' ASN . 21.3 m -124.18 119.56 29.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.369 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.561 HG22 ' HA3' ' A' ' 426' ' ' GLY . 22.4 t -129.32 141.12 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.336 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 27.9 mm -119.21 109.98 38.32 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.651 ' HB3' HG23 ' A' ' 383' ' ' ILE . 17.9 Cg_endo -59.57 164.77 10.7 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.487 2.125 . . . . 0.0 112.404 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -113.89 -176.83 2.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -101.88 121.09 41.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.84 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . 0.5 HG21 ' HB2' ' A' ' 382' ' ' TYR . 19.8 tt -116.24 144.91 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.02 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -126.66 109.55 22.82 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo . . . . . 0 C--O 1.248 1.0 0 C-N-CA 122.429 2.086 . . . . 0.0 112.317 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.903 0.382 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.44 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 3.6 p 50.13 42.95 25.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.318 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -64.81 88.27 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.781 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.681 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.7 pp -84.27 124.5 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.265 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.409 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m0 -109.92 120.4 42.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -82.56 58.37 4.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.79 HG23 ' CE ' ' A' ' 387' ' ' MET . 1.8 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.037 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . 0.4 ' O ' ' CG ' ' A' ' 378' ' ' HIS . 0.3 OUTLIER 60.82 161.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.823 0.344 . . . . 0.0 110.889 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 377' ' ' SER . 39.0 m80 -159.45 -43.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -95.68 45.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.867 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -72.71 125.05 26.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.922 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 8.8 mmtm -67.17 134.77 52.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.43 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 19.2 t80 -144.49 122.3 11.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.667 HG13 HG22 ' A' ' 385' ' ' ILE . 10.1 pt -106.17 -5.55 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.48 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.523 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 56.89 64.39 4.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.512 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.967 HD13 HG22 ' A' ' 417' ' ' VAL . 3.8 tp -161.36 134.74 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.936 0.398 . . . . 0.0 111.011 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.519 ' H ' HD12 ' A' ' 385' ' ' ILE . 20.4 mtt180 -91.34 133.0 35.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.669 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.418 ' HA ' HD12 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -140.78 150.33 43.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.406 ' CE ' ' CB ' ' B' ' 2' ' ' SER . 1.8 ptm -128.26 -177.59 4.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.793 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 6.8 p -99.48 9.74 42.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.53 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.8 tp 52.42 97.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.838 0.352 . . . . 0.0 111.105 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.3 t -83.65 163.58 20.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -31.92 68.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.82 -30.32 71.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -96.73 -42.27 8.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.407 ' HA ' HD12 ' A' ' 398' ' ' LEU . . . -64.91 -52.11 58.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.14 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.85 -29.24 66.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.07 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.6 -39.03 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.986 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 395' ' ' ALA . 9.8 mt -64.17 -45.66 87.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.97 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -59.29 -29.97 67.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.025 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.34 -28.73 56.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.095 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -93.23 -29.69 15.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -100.67 -53.66 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.011 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 74.48 -59.26 0.56 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.198 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -47.13 -28.32 1.74 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.372 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -55.94 161.79 3.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.974 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -175.34 0.45 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.606 2.204 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.94 -11.98 19.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.351 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 29.6 m -52.39 167.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.842 0.353 . . . . 0.0 111.364 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.734 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -136.73 12.35 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.467 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 1.4 m -130.37 130.61 44.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.813 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 171.52 169.04 33.95 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.379 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 434' ' ' ILE . . . -100.28 122.81 43.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.804 0.335 . . . . 0.0 111.161 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.762 ' HB2' HD13 ' A' ' 390' ' ' LEU . 54.5 t80 -103.87 128.97 51.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.009 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.781 HG23 HD11 ' A' ' 385' ' ' ILE . 4.3 mt -79.81 114.98 21.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.589 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.526 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -78.48 -70.14 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.628 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.665 ' O ' HD12 ' A' ' 385' ' ' ILE . 4.8 pt-20 -144.17 143.12 30.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.883 0.373 . . . . 0.0 111.54 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.967 HG22 HD13 ' A' ' 385' ' ' ILE . 21.3 t -111.37 146.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.05 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -98.35 128.96 31.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.78 61.53 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.698 2.266 . . . . 0.0 112.38 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.44 40.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.598 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.523 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -145.65 158.92 49.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.801 -179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.92 -23.2 33.43 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.327 2.018 . . . . 0.0 111.808 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.439 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -58.36 -60.06 4.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.207 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -72.78 -31.51 64.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.745 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.93 -31.69 68.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -69.58 -30.98 70.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.383 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 24.91 2.67 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.777 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.584 HD23 HG21 ' A' ' 471' ' ' ILE . 0.1 OUTLIER -102.33 -177.66 3.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.791 0.329 . . . . 0.0 110.776 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.74 179.66 7.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.767 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.76 31.63 3.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.9 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -143.24 26.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.593 ' C ' HD12 ' A' ' 414' ' ' ILE . 62.3 m-20 -119.44 -177.75 3.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.588 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 412' ' ' ALA . 38.8 t -142.07 129.58 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.811 0.339 . . . . 0.0 111.403 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 412' ' ' ALA . 2.1 mp -86.09 152.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.605 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.669 HD12 ' N ' ' A' ' 436' ' ' SER . 1.9 pp -140.63 -50.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.654 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.669 ' N ' HD12 ' A' ' 435' ' ' ILE . 69.9 p -128.67 158.44 38.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.842 HD13 HG11 ' A' ' 451' ' ' VAL . 10.8 tt -150.3 118.44 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.337 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 19.8 p30 44.78 35.35 1.44 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.931 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.34 38.94 8.06 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.985 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -129.44 145.19 51.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 110.547 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.59 104.4 16.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.462 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.563 HG11 HG22 ' A' ' 448' ' ' VAL . 59.5 t -86.6 147.45 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.777 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.459 HG22 ' OD2' ' A' ' 447' ' ' ASP . 17.0 m -133.72 -45.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.37 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.444 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -133.67 169.86 16.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.985 0.422 . . . . 0.0 111.149 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.56 -36.4 71.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.019 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.41 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 16.6 p30 -59.5 -30.59 68.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.78 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.831 ' O ' HG23 ' A' ' 451' ' ' VAL . 3.7 m-20 -75.62 -43.5 47.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.787 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.563 HG22 HG11 ' A' ' 442' ' ' VAL . 45.9 t -63.23 -37.04 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.814 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.5 t -59.42 -65.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.467 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -48.25 -27.6 2.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.638 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.842 HG11 HD13 ' A' ' 437' ' ' ILE . 47.4 t -71.32 -43.57 73.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.914 0.388 . . . . 0.0 110.922 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.814 HD12 ' HA ' ' A' ' 449' ' ' SER . 4.8 mt -61.98 -32.36 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.91 -17.26 25.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.328 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -93.47 -47.51 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.13 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -99.76 142.25 31.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.048 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 474' ' ' ILE . 0.4 OUTLIER -92.59 -32.18 14.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.677 179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.3 t -109.03 99.95 9.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.571 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.707 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.5 mt -90.22 133.71 34.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -134.24 91.77 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.628 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.433 ' HE1' ' HB3' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -108.48 152.39 24.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 469' ' ' ILE . 27.2 t -100.05 141.69 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.628 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.472 HG13 ' HB3' ' A' ' 432' ' ' ASP . 4.2 t -142.28 160.53 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.175 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . 0.432 ' N ' HG12 ' A' ' 462' ' ' VAL . 6.8 tmm_? -98.92 133.15 43.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.867 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.458 ' HB3' HD11 ' A' ' 469' ' ' ILE . 7.8 ttp180 -130.55 132.61 45.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.602 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 63.04 -95.04 0.12 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.157 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -140.06 21.36 2.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.701 0.286 . . . . 0.0 110.851 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -143.58 164.7 29.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.02 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.43 137.22 40.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.684 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.4 mt -131.8 160.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.535 ' SD ' HG22 ' A' ' 461' ' ' VAL . 0.9 OUTLIER -99.68 119.69 38.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.16 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.584 HG21 HD23 ' A' ' 428' ' ' LEU . 13.1 mm -107.89 152.54 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.251 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 458' ' ' LEU . 91.8 m -139.02 119.79 14.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.797 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 428' ' ' LEU . 21.3 t -122.74 151.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.05 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 456' ' ' SER . 21.2 mm -121.35 109.9 34.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.437 ' HB3' HG23 ' A' ' 383' ' ' ILE . 26.2 Cg_endo -62.17 152.23 77.29 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.358 2.039 . . . . 0.0 112.237 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.54 168.68 10.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.857 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.75 141.69 29.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 18.4 tt -145.75 140.5 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -98.79 109.75 54.69 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.477 2.118 . . . . 0.0 112.41 179.945 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.907 0.384 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.406 ' CB ' ' CE ' ' A' ' 388' ' ' MET . 1.1 p -96.0 41.31 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.949 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -59.68 108.45 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.526 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.6 pt -79.22 127.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.22 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.41 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 10.9 m95 -107.29 91.08 3.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.881 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 1.5 t90 -73.57 68.97 1.22 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.887 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.516 HG12 ' OXT' ' B' ' 7' ' ' VAL . 20.5 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.198 -0.905 . . . . 0.0 111.123 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.83 26.11 6.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.762 0.315 . . . . 0.0 111.008 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 16.3 m80 54.08 86.31 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.064 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.46 -35.28 4.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.996 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -151.66 161.67 42.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.072 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 452' ' ' ILE . 6.5 mmtt -113.23 -175.76 2.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.737 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.693 ' HB2' HG21 ' A' ' 478' ' ' ILE . 80.6 t80 -155.85 120.47 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.254 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.588 HG13 HG22 ' A' ' 385' ' ' ILE . 12.0 pt -111.16 -22.67 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 80.64 66.92 1.59 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.801 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.629 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.29 129.08 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.916 0.389 . . . . 0.0 110.813 179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -89.95 120.42 31.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.121 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.483 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -126.36 143.65 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.812 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.47 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.8 ptm -123.52 164.53 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.145 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 40.1 p -85.87 99.43 11.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.723 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.886 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.6 tp -55.76 108.59 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.52 170.33 10.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.766 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 38.8 m -58.17 -21.76 48.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.421 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 13.3 t -77.61 -47.28 19.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.98 -32.14 25.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.168 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.31 -36.35 83.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.205 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -90.01 -32.47 16.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.29 -33.49 72.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.984 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.25 -49.88 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 6.5 mtmt -58.29 -43.1 87.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -61.47 -25.98 67.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -93.06 -62.13 1.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.091 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 1.0 OUTLIER -85.05 -59.46 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.137 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 79.72 -49.2 0.38 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.492 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.03 -27.04 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.717 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 29.6 m-85 -43.01 163.16 0.16 Allowed Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.428 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.98 -20.83 14.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.625 2.217 . . . . 0.0 112.761 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 75.71 40.56 0.29 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.945 0.402 . . . . 0.0 110.781 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.519 HG11 HG21 ' A' ' 435' ' ' ILE . 2.8 m -101.35 98.88 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.018 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.1 pp -55.63 -29.27 24.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.38 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.84 141.48 39.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.988 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 145.47 176.97 19.87 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -104.28 155.62 18.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.761 0.315 . . . . 0.0 111.026 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.886 ' HB2' HD13 ' A' ' 390' ' ' LEU . 46.5 t80 -107.66 138.46 43.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.954 HD12 ' HB2' ' A' ' 432' ' ' ASP . 27.6 mt -89.74 109.96 21.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.939 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.765 ' CD1' HG22 ' B' ' 4' ' ' ILE . 5.3 mt -74.51 -66.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.214 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.85 167.85 28.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.887 0.375 . . . . 0.0 111.139 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.498 HG22 HG12 ' A' ' 385' ' ' ILE . 21.2 t -134.84 147.84 29.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.799 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.3 mp -79.72 134.5 57.27 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.308 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 50.5 Cg_exo -55.33 -12.47 5.73 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.031 2.487 . . . . 0.0 114.686 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . 0.799 ' H ' HG22 ' A' ' 418' ' ' ILE . 41.0 m-20 -132.97 72.55 1.49 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.925 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 418' ' ' ILE . 4.9 p -159.08 160.87 28.8 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.984 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -58.95 -20.17 51.58 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.329 2.02 . . . . 0.0 111.41 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.492 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -61.19 -60.15 4.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.072 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -76.33 -30.57 57.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.893 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.24 -7.4 59.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.558 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 471' ' ' ILE . . . -90.15 -31.74 10.48 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.418 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 129.79 17.79 1.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.022 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 423' ' ' ALA . 0.9 OUTLIER -96.9 -175.87 3.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.75 146.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.97 -177.66 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 58.64 24.94 12.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.954 ' HB2' HD12 ' A' ' 414' ' ' ILE . 8.9 m-20 -126.71 177.01 6.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.654 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 412' ' ' ALA . 33.1 t -136.89 126.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.472 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 435' ' ' ILE . 3.8 mt -81.11 154.58 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.413 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.577 HD12 ' N ' ' A' ' 436' ' ' SER . 1.9 pp -143.19 -47.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.577 ' N ' HD12 ' A' ' 435' ' ' ILE . 94.6 p -120.94 154.99 35.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.979 0.419 . . . . 0.0 111.344 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.572 HD11 ' HB3' ' A' ' 458' ' ' LEU . 2.7 tt -153.88 116.53 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.944 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 16.9 p30 45.43 32.03 0.99 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.545 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 84.92 40.37 8.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.693 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -133.53 138.1 45.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -80.29 107.9 13.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.067 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 448' ' ' VAL . 63.2 t -90.75 146.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.793 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 444' ' ' SER . 26.2 m -129.32 -43.89 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.335 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.441 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -138.62 172.32 13.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.913 0.387 . . . . 0.0 111.17 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.483 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.33 -38.76 74.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.404 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 6.1 p30 -59.19 -29.74 67.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.766 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.797 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -76.65 -38.35 54.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 442' ' ' VAL . 38.9 t -70.12 -37.99 73.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.081 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.785 ' HA ' HD12 ' A' ' 452' ' ' ILE . 9.5 t -56.67 -62.15 1.93 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.322 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -50.43 -29.18 9.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.885 HG13 ' OE2' ' A' ' 455' ' ' GLU . 59.9 t -70.78 -42.96 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.277 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.785 HD12 ' HA ' ' A' ' 449' ' ' SER . 4.6 mt -63.23 -33.85 63.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.33 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 -13.06 26.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.622 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -99.94 -54.03 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.767 0.318 . . . . 0.0 110.774 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . 0.885 ' OE2' HG13 ' A' ' 451' ' ' VAL . 1.8 mp0 -89.46 132.82 34.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.81 -36.23 42.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.677 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . 0.446 ' C ' HD23 ' A' ' 458' ' ' LEU . 2.5 t -105.47 125.51 51.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.684 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.572 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.7 mt -119.65 149.4 42.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -147.3 97.65 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.451 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 1.1 mtm -102.77 144.74 30.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.258 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 469' ' ' ILE . 19.7 t -111.58 127.26 68.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.686 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.912 HG23 HD13 ' A' ' 471' ' ' ILE . 2.3 t -121.28 158.66 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.847 0.356 . . . . 0.0 111.26 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -104.0 119.67 39.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.994 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.572 ' HB2' HD12 ' A' ' 469' ' ' ILE . 0.2 OUTLIER -119.51 127.32 52.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.434 179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 72.22 -99.13 0.85 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.177 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -140.22 24.82 2.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.767 0.318 . . . . 0.0 110.677 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -144.57 162.63 36.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.97 141.01 34.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.583 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.627 ' O ' HG13 ' A' ' 461' ' ' VAL . 4.0 mt -130.74 143.24 41.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.369 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.585 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -94.76 124.42 38.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.645 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.912 HD13 HG23 ' A' ' 462' ' ' VAL . 4.4 mp -113.79 140.28 35.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 111.343 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 70.8 m -116.9 119.87 36.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.614 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.76 131.68 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.101 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.53 110.76 57.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.07 148.88 87.56 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.451 2.101 . . . . 0.0 112.336 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.88 -178.77 3.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -95.96 129.38 43.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . 0.693 HG21 ' HB2' ' A' ' 382' ' ' TYR . 19.6 tt -130.78 158.27 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.95 114.32 4.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.815 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 122.382 2.055 . . . . 0.0 112.311 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.406 ' HA ' ' CE ' ' A' ' 388' ' ' MET . 11.4 p 59.49 44.35 14.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.062 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -61.3 93.16 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.638 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.765 HG22 ' CD1' ' A' ' 415' ' ' ILE . 46.4 pt -83.59 137.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.302 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.404 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 12.9 m95 -116.81 89.61 3.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -70.45 82.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.785 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.144 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.128 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.71 110.27 10.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -95.38 120.17 35.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.786 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 53.5 mtt -140.93 124.56 16.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -69.85 -69.38 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.825 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -101.84 114.32 28.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.561 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -118.44 126.29 51.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 385' ' ' ILE . 9.7 pt -122.44 -1.1 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.333 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 46.92 62.94 3.47 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.082 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 1.076 HD13 HG22 ' A' ' 417' ' ' VAL . 6.8 tp -149.16 122.52 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.799 0.333 . . . . 0.0 110.758 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -89.73 128.18 36.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.403 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -132.93 140.59 47.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.511 179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.42 ' CE ' ' HA ' ' B' ' 2' ' ' SER . 7.7 ptm -119.31 158.84 25.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.028 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 21.3 p -83.11 106.27 14.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.3 tp -56.92 102.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.075 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.9 t -89.94 174.54 7.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 27.8 t -66.96 -33.02 74.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.941 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 60.6 p -68.88 -28.59 66.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.974 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 18.0 tptp -95.83 -48.6 5.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.988 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.92 -59.93 4.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -31.26 68.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.017 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -65.37 -38.28 89.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.29 -36.61 74.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.996 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -77.75 -31.69 52.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -28.99 62.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.993 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.83 -54.98 3.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.011 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.402 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -73.46 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 57.5 mtm180 82.73 -25.62 0.15 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.752 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.0 -20.51 38.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.752 0.311 . . . . 0.0 110.957 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -62.45 153.95 74.57 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.973 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.7 -179.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.637 2.224 . . . . 0.0 112.305 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -111.74 30.77 6.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.962 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 27.6 m -86.13 150.31 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.523 ' C ' HD12 ' A' ' 409' ' ' ILE . 2.7 pp -125.33 17.12 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.455 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -140.29 142.85 35.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 136.16 156.49 7.5 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.54 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -91.45 152.08 20.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.763 0.316 . . . . 0.0 111.035 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.756 ' HB2' HD13 ' A' ' 390' ' ' LEU . 59.8 t80 -107.37 131.66 54.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.907 HD12 ' HB2' ' A' ' 432' ' ' ASP . 18.3 mt -83.97 111.08 19.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.068 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.853 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.8 mp -75.35 -66.42 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.848 ' O ' HD12 ' A' ' 385' ' ' ILE . 3.5 pt-20 -155.61 167.14 31.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.861 0.363 . . . . 0.0 111.175 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 1.076 HG22 HD13 ' A' ' 385' ' ' ILE . 12.5 t -127.53 156.95 39.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.168 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.47 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -96.32 133.43 24.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.595 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.54 60.02 1.11 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.766 2.311 . . . . 0.0 112.82 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 168.88 44.59 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.972 0.415 . . . . 0.0 110.757 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 384' ' ' GLY . 7.7 p -141.84 162.19 47.57 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 34.8 Cg_endo -66.72 -14.13 42.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.012 1.808 . . . . 0.0 111.17 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.443 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -68.73 -59.94 2.75 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.645 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -67.86 -32.71 73.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.554 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -82.4 -21.14 35.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.296 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -72.42 -29.93 65.35 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.304 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 121.1 17.65 4.03 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.026 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 471' ' ' ILE . 2.5 mt -88.2 -167.08 1.76 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.91 0.355 . . . . 0.0 110.732 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.9 146.34 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -179.36 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 60.09 22.52 11.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.125 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.907 ' HB2' HD12 ' A' ' 414' ' ' ILE . 9.5 m-20 -119.3 -175.87 3.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.412 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.48 117.28 6.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.798 0.332 . . . . 0.0 111.543 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.444 HD11 HG12 ' A' ' 414' ' ' ILE . 4.0 mt -78.42 123.05 34.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.461 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.609 HD12 ' N ' ' A' ' 436' ' ' SER . 2.1 pp -110.07 -48.63 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.882 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.609 ' N ' HD12 ' A' ' 435' ' ' ILE . 3.8 t -119.24 160.97 21.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.441 . . . . 0.0 111.294 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.799 HG21 HG11 ' A' ' 451' ' ' VAL . 1.0 OUTLIER -154.28 119.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.024 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.404 ' ND2' HG12 ' A' ' 437' ' ' ILE . 16.1 p30 44.43 42.41 5.41 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.511 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 77.5 41.92 19.26 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.635 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.5 mm-40 -135.69 162.6 32.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 108.55 17.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.942 HG11 ' CG2' ' A' ' 448' ' ' VAL . 2.5 t -94.59 148.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.247 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.58 -35.96 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.333 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.6 p -147.5 176.03 10.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 111.212 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.403 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -59.06 -41.12 87.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.176 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.409 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 17.6 p30 -53.91 -24.22 15.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.268 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.909 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.9 OUTLIER -86.33 -50.01 7.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.942 ' CG2' HG11 ' A' ' 442' ' ' VAL . 43.9 t -54.93 -40.7 54.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.195 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.488 ' HA ' HG11 ' B' ' 7' ' ' VAL . 42.2 t -53.13 -68.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.469 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -51.69 -35.06 41.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.641 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.909 HG23 ' O ' ' A' ' 447' ' ' ASP . 43.7 t -64.09 -49.33 81.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.294 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.854 HD11 HG12 ' A' ' 448' ' ' VAL . 8.4 mt -57.68 -40.53 75.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.223 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.01 -5.21 59.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.325 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -100.18 -47.66 4.88 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.816 0.341 . . . . 0.0 111.055 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . 0.438 ' O ' HD21 ' A' ' 458' ' ' LEU . 1.9 mm-40 -100.13 133.57 44.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.047 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.39 -34.42 48.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . 0.406 ' HA ' HD12 ' A' ' 474' ' ' ILE . 1.5 t -105.08 103.21 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.765 HD11 HG23 ' A' ' 452' ' ' ILE . 12.4 mt -96.08 153.36 17.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -154.43 96.76 1.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.645 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.519 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -104.26 135.51 45.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.263 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . . . . . . . . . 25.8 t -102.09 120.41 51.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 463' ' ' ARG . 5.0 t -105.54 160.22 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . 0.44 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -120.92 124.41 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.932 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.589 ' HB2' HD11 ' A' ' 469' ' ' ILE . 30.5 mtp85 -125.24 131.14 53.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.702 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 66.53 -98.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.346 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -140.28 24.84 2.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.718 0.294 . . . . 0.0 111.033 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -139.77 157.36 45.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.903 0.382 . . . . 0.0 111.167 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.91 139.62 35.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.646 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.8 mt -128.21 128.01 68.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.08 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.66 125.13 35.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.769 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.736 HG21 HD23 ' A' ' 428' ' ' LEU . 28.9 mm -120.04 136.76 56.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.359 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 10.9 m -109.61 135.05 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.819 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.703 ' O ' HD13 ' A' ' 474' ' ' ILE . 11.5 t -138.91 146.22 26.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.065 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 473' ' ' VAL . 30.0 mm -134.03 110.34 11.89 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 474' ' ' ILE . 19.2 Cg_endo -58.57 132.91 51.05 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.398 2.065 . . . . 0.0 112.309 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -94.83 -174.88 3.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.54 152.96 34.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 2.5 tt -150.45 133.59 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -143.65 123.63 7.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.248 1.007 0 C-N-CA 122.375 2.05 . . . . 0.0 112.335 179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.687 0.279 . . . . 0.0 111.444 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.42 ' HA ' ' CE ' ' A' ' 388' ' ' MET . 37.4 m 61.9 -81.08 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.943 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 52.54 65.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.033 0.444 . . . . 0.0 110.656 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.853 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.4 pt -82.05 96.25 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.335 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.409 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.0 m0 -65.64 104.2 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.826 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -76.76 67.01 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 449' ' ' SER . 21.9 t . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.21 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 4.8 t -109.1 -50.79 2.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.838 0.352 . . . . 0.0 110.816 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -92.93 53.95 2.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -121.06 106.38 11.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.137 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.5 -50.63 2.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.533 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -106.75 146.37 30.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.482 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.403 ' HB2' ' CG2' ' A' ' 478' ' ' ILE . 30.1 t80 -118.08 119.55 35.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.94 0.4 . . . . 0.0 111.363 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.595 HD12 ' CG2' ' A' ' 385' ' ' ILE . 16.4 pt -130.58 -8.97 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.478 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.645 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 50.67 68.1 1.61 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.747 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.921 ' CD1' HG22 ' A' ' 417' ' ' VAL . 8.1 tp -157.0 135.58 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.812 0.339 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 21.9 mtt180 -101.03 129.43 46.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.412 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -135.45 146.19 47.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.49 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.0 ptm -128.26 157.44 40.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.071 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 78.7 p -79.48 101.32 8.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.646 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.889 HD13 ' HB2' ' A' ' 413' ' ' TYR . 9.4 tp -51.79 97.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.151 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 15.4 t -84.8 158.54 20.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.785 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.3 m -57.51 -22.05 41.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.12 -28.28 54.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.308 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -100.33 -37.4 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.131 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.51 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -62.87 -50.95 68.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.367 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -28.33 67.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.66 -34.25 73.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.065 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.576 HD22 ' CE2' ' A' ' 405' ' ' PHE . 62.8 mt -60.17 -41.83 93.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.027 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 2.5 mtmp? -75.11 -30.81 60.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.77 -33.15 75.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.7 -33.34 20.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -145.59 120.63 10.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.795 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.97 -27.73 62.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.979 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -55.79 -27.2 49.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.115 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.576 ' CE2' HD22 ' A' ' 398' ' ' LEU . 8.4 m-85 -57.46 147.35 59.81 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.72 174.43 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.568 2.179 . . . . 0.0 112.301 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -111.91 32.77 5.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.85 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.66 -179.67 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.658 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -149.18 -40.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.3 OUTLIER -89.6 154.47 19.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 121.79 170.43 13.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.569 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.43 ' CB ' HG21 ' A' ' 448' ' ' VAL . . . -98.2 138.75 35.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 110.991 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.889 ' HB2' HD13 ' A' ' 390' ' ' LEU . 58.7 t80 -94.44 130.19 40.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.969 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.49 HG21 ' O ' ' A' ' 429' ' ' LYS . 12.1 mt -80.23 114.87 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.608 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.79 HD13 HG22 ' B' ' 4' ' ' ILE . 9.4 mt -82.13 -72.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.609 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.91 140.68 28.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.145 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.921 HG22 ' CD1' ' A' ' 385' ' ' ILE . 3.3 t -111.8 140.43 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.571 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 19.6 mm -79.69 144.99 61.6 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.37 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.48 ' HD2' HG22 ' A' ' 418' ' ' ILE . 23.3 Cg_exo -65.83 -3.91 9.02 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.881 2.387 . . . . 0.0 114.521 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 421' ' ' THR . 22.5 m-20 -138.35 71.03 1.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.965 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.645 HG21 ' HA3' ' A' ' 384' ' ' GLY . 1.1 p -159.55 165.61 17.75 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.141 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.413 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 31.9 Cg_exo -60.8 -23.78 77.42 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.622 2.215 . . . . 0.0 111.62 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.488 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -57.78 -60.05 4.29 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.996 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -74.63 -26.74 60.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 422' ' ' PRO . . . -76.16 -26.16 55.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.363 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -79.29 -70.36 1.33 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.417 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 166.64 34.11 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.449 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.4 OUTLIER -104.47 -173.11 2.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.875 0.369 . . . . 0.0 110.778 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . 0.49 ' O ' HG21 ' A' ' 414' ' ' ILE . 0.4 OUTLIER 177.46 169.09 0.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.704 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 0.8 OUTLIER -87.58 52.48 2.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -158.89 28.37 0.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.625 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB2' HD12 ' A' ' 414' ' ' ILE . 5.3 m-20 -142.36 -177.2 5.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.403 HG11 HD22 ' A' ' 390' ' ' LEU . 24.0 t -145.16 107.76 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.255 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 4.3 mt -58.42 138.48 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.674 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.869 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -133.57 -43.07 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.52 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.869 ' N ' HD12 ' A' ' 435' ' ' ILE . 41.5 p -114.72 155.5 26.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.886 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.952 HG21 HG11 ' A' ' 451' ' ' VAL . 1.5 tt -157.61 118.85 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 455' ' ' GLU . 13.5 p30 45.52 33.85 1.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.494 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.8 28.74 34.03 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.724 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -124.01 143.4 50.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.791 0.329 . . . . 0.0 110.864 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 9.3 t -92.09 110.69 22.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.061 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.717 HG11 HG22 ' A' ' 448' ' ' VAL . 25.7 t -93.89 159.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.903 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.547 HG22 ' OD2' ' A' ' 447' ' ' ASP . 22.4 m -130.36 -45.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.502 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.454 ' N ' HG23 ' A' ' 443' ' ' VAL . 0.7 OUTLIER -141.05 176.42 8.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.908 0.385 . . . . 0.0 111.225 -179.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.412 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.52 -40.45 78.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -56.42 -25.6 50.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.879 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.848 ' O ' HG23 ' A' ' 451' ' ' VAL . 4.9 m-20 -87.05 -30.74 20.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.827 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.717 HG22 HG11 ' A' ' 442' ' ' VAL . 23.5 t -70.58 -43.32 77.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.201 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.504 ' HA ' HD12 ' A' ' 452' ' ' ILE . 33.0 t -50.97 -62.33 1.68 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.335 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -49.88 -41.61 45.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.36 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.952 HG11 HG21 ' A' ' 437' ' ' ILE . 39.6 t -58.88 -45.5 91.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.076 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 449' ' ' SER . 22.3 mt -58.86 -40.49 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.65 0.4 57.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.158 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 -46.74 5.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.844 0.354 . . . . 0.0 110.692 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . 0.401 ' HG3' ' ND2' ' A' ' 438' ' ' ASN . 4.1 mm-40 -111.18 165.28 12.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.921 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 1.4 t -103.64 -32.17 9.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.847 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 p -106.37 102.45 11.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.741 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.782 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.6 mt -93.5 129.46 39.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.947 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . 0.54 ' ND2' HG23 ' A' ' 472' ' ' THR . 2.4 m-80 -123.91 88.09 2.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.705 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.5 mtt -92.2 129.68 38.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.205 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 470' ' ' MET . 27.1 t -107.47 126.29 63.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.785 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.904 HG22 HD13 ' A' ' 471' ' ' ILE . 1.5 m -121.22 159.37 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 0.0 111.175 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.41 119.95 40.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.107 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.408 ' HB2' ' CD1' ' A' ' 469' ' ' ILE . 1.5 mtp180 -120.62 133.18 55.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.486 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 70.18 -103.83 1.23 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.219 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -138.22 27.72 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 110.619 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.33 157.12 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.254 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -96.88 142.91 28.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.449 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.683 ' O ' HG13 ' A' ' 461' ' ' VAL . 3.4 mt -129.24 141.09 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.867 0.365 . . . . 0.0 111.478 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -97.47 119.81 36.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.513 179.627 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.904 HD13 HG22 ' A' ' 462' ' ' VAL . 4.4 mp -122.16 137.02 57.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.151 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.54 HG23 ' ND2' ' A' ' 459' ' ' ASN . 58.6 m -117.24 127.37 54.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 422' ' ' PRO . 21.8 t -123.66 122.24 64.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.096 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 28.5 mm -103.02 109.86 62.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.01 151.42 82.04 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.416 2.078 . . . . 0.0 112.299 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -102.74 158.44 16.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -96.46 132.01 42.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.833 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 382' ' ' TYR . 0.9 OUTLIER -153.24 141.31 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.13 113.63 26.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.803 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo . . . . . 0 C--O 1.248 1.012 0 C-N-CA 122.381 2.054 . . . . 0.0 112.349 -179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 120.741 0.305 . . . . 0.0 111.364 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 78.2 p 51.81 26.35 3.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.169 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.14 106.23 0.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.643 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.79 HG22 HD13 ' A' ' 415' ' ' ILE . 3.3 pt -76.19 149.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.531 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -121.14 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.627 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -70.33 70.25 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.831 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.073 -179.953 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.2 t -135.59 -48.95 0.7 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.804 0.335 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -96.67 -50.99 4.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 7.1 ttt -63.68 118.33 8.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -146.73 169.42 19.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 475' ' ' PRO . 0.1 OUTLIER -58.56 162.18 4.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.73 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.451 ' CB ' HG22 ' A' ' 478' ' ' ILE . 33.1 t80 -134.17 125.91 28.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.845 0.355 . . . . 0.0 111.307 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.639 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.8 pt -117.67 -26.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.274 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . 75.67 64.57 2.23 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.648 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.984 HD11 HG23 ' A' ' 414' ' ' ILE . 0.0 OUTLIER -165.31 123.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.722 0.296 . . . . 0.0 110.867 179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.527 ' N ' HD13 ' A' ' 385' ' ' ILE . 0.1 OUTLIER -90.04 126.97 35.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.476 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -128.85 152.59 48.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.626 179.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.443 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.5 OUTLIER -130.63 -179.4 5.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.118 0.485 . . . . 0.0 111.481 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 7.5 p -98.46 94.7 6.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.169 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.916 HD13 ' HB2' ' A' ' 413' ' ' TYR . 9.0 tp -47.63 121.55 4.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.571 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.11 165.81 13.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.797 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.26 -27.27 63.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.61 -66.68 0.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.166 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.61 -40.24 74.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.217 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.57 -39.89 85.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.293 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -83.91 -30.68 26.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.037 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -66.98 -31.19 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.023 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.26 -47.32 44.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.955 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 8.5 mtmm -65.45 -37.84 88.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.047 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -59.83 -42.86 94.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -87.7 -17.51 31.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.196 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.434 ' HB3' ' CD1' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -150.08 87.04 1.45 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.715 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.84 -25.72 67.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.051 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -23.62 11.59 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.284 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 402' ' ' HIS . 3.7 m-85 -53.18 163.69 0.87 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.069 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.484 ' HB2' HG22 ' A' ' 408' ' ' VAL . 18.6 Cg_endo -59.09 178.22 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.569 2.179 . . . . 0.0 112.306 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -105.63 35.84 2.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 408' ' ' VAL . 20.1 m -120.34 92.87 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.49 -33.8 58.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.228 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.56 163.23 21.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 126.21 175.97 14.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.375 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 388' ' ' MET . . . -102.8 157.37 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 111.093 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.916 ' HB2' HD13 ' A' ' 390' ' ' LEU . 69.4 t80 -104.82 128.72 53.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.115 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.984 HG23 HD11 ' A' ' 385' ' ' ILE . 24.6 mt -80.7 109.45 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.552 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.581 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.7 mp -71.86 -70.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.404 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -151.43 166.82 29.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 0.0 111.299 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.555 HG22 HG12 ' A' ' 385' ' ' ILE . 35.0 t -132.84 155.39 41.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.043 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 418' ' ' ILE . 1.3 mp -90.28 132.56 35.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.406 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.22 57.72 3.44 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.542 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 169.41 47.44 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.061 0.457 . . . . 0.0 110.383 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.409 HG21 ' HB ' ' A' ' 418' ' ' ILE . 4.2 p -149.86 164.46 20.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.974 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -56.64 -26.85 67.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.269 1.979 . . . . 0.0 111.101 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 428' ' ' LEU . . . -54.91 -54.39 43.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.116 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -83.73 -29.99 27.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -70.67 -29.42 65.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.12 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.44 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -74.0 -30.2 61.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.481 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.88 23.67 2.97 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.767 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.843 HD11 HG21 ' A' ' 473' ' ' VAL . 1.2 mt -95.67 -175.59 3.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.387 . . . . 0.0 110.772 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.65 152.87 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -61.74 -175.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.702 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 24.6 m120 61.23 22.35 12.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.996 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.951 ' HB2' HD12 ' A' ' 414' ' ' ILE . 28.5 m-20 -122.66 -176.5 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.495 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 412' ' ' ALA . 34.9 t -143.69 127.54 13.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.893 0.378 . . . . 0.0 111.623 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.65 152.76 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.441 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 408' ' ' VAL . 1.2 pp -141.2 -55.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.469 ' N ' HD12 ' A' ' 435' ' ' ILE . 16.7 p -120.42 157.32 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.901 0.381 . . . . 0.0 111.313 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.887 HG21 HG11 ' A' ' 451' ' ' VAL . 1.8 tt -151.04 119.94 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.344 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.427 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.3 p30 43.4 44.08 4.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.693 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 76.62 49.24 8.16 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.793 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -144.88 158.97 43.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.702 0.287 . . . . 0.0 110.672 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 6.0 p -106.49 112.19 25.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.009 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.048 HG11 HG22 ' A' ' 448' ' ' VAL . 4.2 t -100.08 147.58 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 6.3 m -130.82 -42.79 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.378 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.4 p -127.93 168.11 15.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.01 0.434 . . . . 0.0 111.284 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.476 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.34 -41.14 79.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.94 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -57.24 -28.92 63.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.726 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.8 ' O ' HG23 ' A' ' 451' ' ' VAL . 7.4 m-20 -77.77 -36.47 50.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.715 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 1.048 HG22 HG11 ' A' ' 442' ' ' VAL . 28.4 t -69.55 -41.86 80.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.237 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.806 ' HA ' HD12 ' A' ' 452' ' ' ILE . 1.7 t -54.72 -63.17 1.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.601 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -46.96 -29.18 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.458 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.887 HG11 HG21 ' A' ' 437' ' ' ILE . 30.4 t -68.61 -48.58 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.118 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.806 HD12 ' HA ' ' A' ' 449' ' ' SER . 3.6 mt -58.62 -33.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -91.13 -21.55 21.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.251 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -88.67 -59.91 2.1 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.811 0.339 . . . . 0.0 110.9 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -89.02 127.14 35.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.032 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.32 -39.06 75.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.727 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -104.67 116.26 31.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.606 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.839 ' HB3' HD11 ' A' ' 437' ' ' ILE . 9.0 mt -102.34 133.99 46.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.95 0.405 . . . . 0.0 111.274 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -135.13 93.9 3.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.638 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.589 ' CG ' HD12 ' A' ' 437' ' ' ILE . 0.0 OUTLIER -97.67 156.81 16.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.562 HG22 ' HG3' ' A' ' 470' ' ' MET . 21.0 t -124.4 124.6 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.975 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.508 HG11 ' OD2' ' A' ' 432' ' ' ASP . 5.6 t -108.58 147.13 13.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -105.44 140.11 39.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.174 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.563 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.6 mtp180 -144.52 133.84 23.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 57.88 -100.24 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.494 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -140.07 28.38 2.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 111.06 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -140.25 152.62 46.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.924 0.392 . . . . 0.0 111.165 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -96.29 139.26 32.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.541 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 464' ' ' ARG . 2.4 mt -126.7 123.28 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.562 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -90.64 127.19 36.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 470' ' ' MET . 11.7 mm -124.46 135.16 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.976 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 44.9 m -116.51 121.13 40.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.843 HG21 HD11 ' A' ' 428' ' ' LEU . 34.9 t -127.34 119.92 53.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.966 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.87 111.96 64.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.066 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.639 ' HB3' HG23 ' A' ' 383' ' ' ILE . 41.3 Cg_endo -67.08 173.95 7.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.406 2.07 . . . . 0.0 112.349 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -160.41 174.31 14.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -90.46 131.69 36.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.787 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . 0.451 HG22 ' CB ' ' A' ' 382' ' ' TYR . 14.0 tt -131.05 153.38 39.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -123.3 127.79 25.49 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--O 1.249 1.049 0 C-N-CA 122.411 2.074 . . . . 0.0 112.288 179.971 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.803 0.335 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m 60.05 37.6 21.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.963 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -59.46 90.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.82 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.581 HG22 ' CD1' ' A' ' 415' ' ' ILE . 27.5 pt -75.69 129.2 37.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.932 0.396 . . . . 0.0 111.063 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -108.95 99.35 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.079 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -74.46 66.39 1.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.781 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.528 HG11 HD13 ' A' ' 452' ' ' ILE . 16.7 t . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.092 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.2 p -176.07 165.5 2.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -75.73 120.37 21.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -173.0 -59.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -137.93 137.05 37.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -96.31 -177.97 4.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.688 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -160.41 119.84 2.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.191 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.7 HG23 ' HB3' ' A' ' 475' ' ' PRO . 5.1 pt -108.2 -3.68 10.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.332 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.675 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 60.56 50.82 63.42 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.649 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.673 HG13 HG22 ' A' ' 417' ' ' VAL . 11.7 tt -154.1 140.23 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.025 0.44 . . . . 0.0 111.07 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.797 ' HB3' HD12 ' A' ' 415' ' ' ILE . 2.9 mtt-85 -90.76 132.08 36.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.738 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.586 ' HE3' ' HB1' ' A' ' 445' ' ' ALA . 0.1 OUTLIER -136.96 133.5 35.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.639 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . . . . . . . . . 10.2 ptm -121.34 176.33 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.278 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 2.3 p -106.12 130.39 54.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 413' ' ' TYR . 2.3 tp -74.65 96.86 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 4.4 t -87.45 177.52 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.821 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 82.7 p -63.93 -16.67 62.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.437 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -80.77 -42.29 22.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.787 0.327 . . . . 0.0 111.25 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.96 -43.03 9.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.176 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.01 -41.92 79.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.338 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -29.99 61.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.009 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.47 -30.92 71.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.003 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.416 ' HB3' ' CE2' ' A' ' 405' ' ' PHE . 84.1 mt -69.89 -33.35 72.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -74.46 -24.42 59.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.139 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.0 -37.73 33.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.071 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -82.69 -66.41 0.89 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.46 ' HB2' ' CE2' ' A' ' 405' ' ' PHE . 0.2 OUTLIER -76.07 -52.42 10.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.08 -52.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.686 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.51 38.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 402' ' ' HIS . 1.6 m-85 -91.01 167.72 15.39 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.671 0.272 . . . . 0.0 110.51 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.02 -21.48 21.63 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.533 2.155 . . . . 0.0 112.472 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.7 t0 73.3 46.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.754 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 408' ' ' VAL . 18.9 m -113.2 97.54 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.023 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -56.72 -29.08 29.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.536 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 14.8 m -93.13 159.86 15.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.031 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 127.53 150.01 7.29 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.451 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.14 135.81 35.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.106 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.638 ' HB2' HD13 ' A' ' 390' ' ' LEU . 86.5 t80 -90.07 132.47 35.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.926 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.789 HD12 ' CB ' ' A' ' 432' ' ' ASP . 10.3 mt -86.18 116.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.201 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.797 HD12 ' HB3' ' A' ' 386' ' ' ARG . 3.3 mt -89.22 -144.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.253 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.672 ' H ' HG22 ' A' ' 415' ' ' ILE . 9.2 pt-20 -79.67 155.27 28.11 Favored 'General case' 0 C--N 1.335 -0.064 0 O-C-N 122.088 -0.382 . . . . 0.0 111.14 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.673 HG22 HG13 ' A' ' 385' ' ' ILE . 21.2 t -127.15 151.04 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.045 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.59 HG22 ' HD2' ' A' ' 419' ' ' PRO . 8.4 mm -87.4 145.63 38.0 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.621 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.59 ' HD2' HG22 ' A' ' 418' ' ' ILE . 16.5 Cg_exo -68.7 -3.48 11.31 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.988 2.459 . . . . 0.0 114.113 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -129.87 62.87 1.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.712 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.675 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.7 OUTLIER -154.45 158.02 32.27 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.009 179.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.412 ' HB2' ' CG1' ' A' ' 473' ' ' VAL . 34.3 Cg_exo -59.03 -20.25 52.65 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.554 2.17 . . . . 0.0 111.701 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.444 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -62.4 -60.12 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.77 -28.89 66.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.54 -27.63 45.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.27 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.02 65.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.353 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 120.1 23.85 2.87 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.774 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.751 HD23 HG21 ' A' ' 471' ' ' ILE . 1.2 mt -93.43 -170.0 2.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.758 0.314 . . . . 0.0 110.693 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.48 153.69 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -65.88 171.34 4.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 64.51 27.33 13.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.027 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.789 ' CB ' HD12 ' A' ' 414' ' ' ILE . 3.8 m-20 -118.88 -175.76 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.399 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.71 122.88 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 0.0 111.571 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 435' ' ' ILE . 2.8 mt -86.13 160.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.507 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.471 ' N ' HG22 ' A' ' 434' ' ' ILE . 1.4 pp -146.37 -49.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 435' ' ' ILE . 94.4 p -118.02 161.84 19.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.826 0.346 . . . . 0.0 111.014 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.858 HG21 HG11 ' A' ' 451' ' ' VAL . 3.6 tt -155.62 119.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.114 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 11.5 p30 49.11 33.09 4.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.624 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 86.29 28.02 28.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.819 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -121.23 164.16 17.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 110.647 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 69.3 p -106.56 114.15 28.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.147 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.93 HG11 HG22 ' A' ' 448' ' ' VAL . 11.7 t -101.54 141.72 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.054 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 2.7 m -118.17 -25.8 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.494 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.16 175.7 13.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.96 0.41 . . . . 0.0 111.273 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.586 ' HB1' ' HE3' ' A' ' 387' ' ' MET . . . -56.51 -41.13 76.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.405 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 8.6 p30 -55.44 -28.66 55.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.765 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.818 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.8 OUTLIER -82.18 -32.95 29.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.733 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.93 HG22 HG11 ' A' ' 442' ' ' VAL . 21.8 t -76.0 -41.92 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.211 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.67 ' HA ' HD12 ' A' ' 452' ' ' ILE . 15.0 t -52.61 -57.44 10.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.344 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -53.97 -42.22 68.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.858 HG11 HG21 ' A' ' 437' ' ' ILE . 47.0 t -59.63 -47.59 90.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.927 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 449' ' ' SER . 8.4 mt -57.9 -30.96 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.946 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -7.11 29.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.545 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -99.71 -48.66 4.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.701 0.286 . . . . 0.0 111.048 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -102.04 166.52 10.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.073 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.2 -36.69 6.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.72 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.13 98.53 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.658 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.771 ' HB3' HD11 ' A' ' 437' ' ' ILE . 8.4 mt -89.78 119.95 30.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.051 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -115.16 91.21 3.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.799 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.99 142.85 29.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.049 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 469' ' ' ILE . 23.7 t -103.37 128.95 56.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.21 156.71 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.013 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.68 140.59 31.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.081 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.703 ' HB3' HD11 ' A' ' 469' ' ' ILE . 3.7 ttt-85 -143.53 124.52 14.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 64.42 -98.51 0.28 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.226 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -140.05 27.28 2.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.869 0.366 . . . . 0.0 110.766 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -145.23 162.78 36.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.042 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -102.7 139.6 38.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.468 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 464' ' ' ARG . 2.1 mt -127.68 158.75 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.36 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.464 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -106.0 126.2 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.541 179.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.751 HG21 HD23 ' A' ' 428' ' ' LEU . 23.7 mm -115.37 137.12 49.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.27 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 7.4 m -116.17 140.6 49.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.689 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.761 ' C ' HD12 ' A' ' 474' ' ' ILE . 20.1 t -150.03 135.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.761 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -117.88 109.73 40.94 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.585 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.7 ' HB3' HG23 ' A' ' 383' ' ' ILE . 30.2 Cg_endo -63.81 152.41 80.78 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.402 2.068 . . . . 0.0 112.438 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -89.16 -179.53 5.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.85 138.09 44.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 14.0 tt -155.37 152.39 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.989 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -140.93 133.7 14.41 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.766 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.249 1.036 0 C-N-CA 122.418 2.078 . . . . 0.0 112.319 -179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.775 0.322 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.6 m -73.22 65.09 0.81 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.869 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -79.82 -9.9 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.3 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.603 HG22 ' CD1' ' A' ' 415' ' ' ILE . 9.7 pt 41.08 91.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.885 0.374 . . . . 0.0 111.862 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.405 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 10.7 m95 -79.95 91.09 5.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.887 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -69.38 71.75 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.801 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.402 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.4 t . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.243 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.78 90.26 0.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.905 0.383 . . . . 0.0 110.88 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 56.7 m170 60.53 37.62 19.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.96 103.71 7.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -176.89 136.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.59 161.59 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.679 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -140.02 126.2 19.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.362 . . . . 0.0 111.198 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.766 HG13 HG22 ' A' ' 385' ' ' ILE . 5.7 pt -119.27 -2.67 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.403 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.597 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 54.91 62.45 6.25 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.448 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.814 ' CD1' HG22 ' A' ' 417' ' ' VAL . 7.2 tp -153.75 129.86 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -90.7 132.42 35.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.436 ' CA ' HD12 ' A' ' 415' ' ' ILE . 0.0 OUTLIER -141.06 138.83 33.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.856 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.456 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 6.2 ptm -120.93 165.79 14.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.298 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 82.8 p -93.44 109.25 20.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.513 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 413' ' ' TYR . 5.5 tp -53.22 121.37 7.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.304 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.1 t -90.16 166.91 13.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.837 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 3.8 t -69.12 -30.83 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.049 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 21.0 m -70.45 -29.52 66.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.096 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -91.12 -39.91 11.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.058 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.471 ' HB1' HG12 ' A' ' 409' ' ' ILE . . . -59.7 -50.4 73.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.246 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -32.93 74.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.136 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -73.66 -45.15 54.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.082 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.27 -31.45 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.069 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -67.37 -47.13 71.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.013 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.71 -27.42 64.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.155 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -91.74 -62.41 1.43 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.052 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.401 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -64.66 -59.81 3.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.072 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 10.7 mtt85 79.65 -7.84 1.65 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.502 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.28 14.85 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.704 0.287 . . . . 0.0 111.162 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 406' ' ' PRO . 30.2 m-85 -105.53 128.8 25.81 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 405' ' ' PHE . 32.3 Cg_exo -58.07 -174.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.469 2.113 . . . . 0.0 112.346 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.53 23.47 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 406' ' ' PRO . 26.4 m -83.35 -23.31 8.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.059 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.8 HG23 ' O ' ' A' ' 409' ' ' ILE . 0.0 OUTLIER 37.0 75.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.468 0.652 . . . . 0.0 111.94 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 7.2 p -169.46 131.47 1.16 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.912 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 148.22 173.78 19.42 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.432 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -108.34 140.88 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.767 0.318 . . . . 0.0 111.08 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.638 ' HB2' HD13 ' A' ' 390' ' ' LEU . 43.2 t80 -98.13 133.5 42.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 432' ' ' ASP . 15.3 mt -82.6 116.2 26.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.537 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.436 HD12 ' CA ' ' A' ' 387' ' ' MET . 3.1 mt -77.96 -60.58 2.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.619 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 385' ' ' ILE . 0.4 OUTLIER -159.75 139.49 11.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.855 0.359 . . . . 0.0 111.293 -179.854 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.814 HG22 ' CD1' ' A' ' 385' ' ' ILE . 13.6 t -105.45 136.95 37.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.118 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.517 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 33.8 mm -82.84 138.46 43.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.238 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 418' ' ' ILE . 42.7 Cg_endo -68.0 4.2 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.65 2.233 . . . . 0.0 114.243 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -132.44 56.46 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.517 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.597 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.6 OUTLIER -155.63 164.91 19.66 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.458 ' HB2' HG13 ' A' ' 473' ' ' VAL . 32.1 Cg_exo -60.84 -20.94 68.74 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.651 2.234 . . . . 0.0 111.828 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.464 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -61.94 -59.15 5.54 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.036 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.21 -34.85 77.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.732 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -76.01 -23.22 55.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.266 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 422' ' ' PRO . . . -74.72 -34.35 53.66 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.414 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.91 25.4 2.55 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.85 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.833 HD23 HG21 ' A' ' 471' ' ' ILE . 0.8 OUTLIER -93.39 -163.66 1.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 0.0 110.652 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.4 169.1 6.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.816 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -95.67 36.17 1.3 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.013 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.82 27.83 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.841 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.551 ' HB2' HD12 ' A' ' 414' ' ' ILE . 10.3 m-20 -128.94 175.71 8.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.004 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 38.9 t -133.65 116.9 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.166 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 434' ' ' ILE . 3.8 mp -67.2 155.52 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.844 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.811 HD12 ' N ' ' A' ' 436' ' ' SER . 2.3 pp -148.78 -45.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.57 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.811 ' N ' HD12 ' A' ' 435' ' ' ILE . 15.6 p -124.07 154.78 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.973 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.788 HD11 ' HB3' ' A' ' 458' ' ' LEU . 3.5 tt -153.59 112.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.055 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.428 ' ND2' HG12 ' A' ' 437' ' ' ILE . 22.9 p30 43.03 51.17 5.43 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.676 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 71.05 43.72 56.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.708 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -146.35 126.53 13.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 65.5 m -81.48 118.22 22.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.925 HG11 ' CG2' ' A' ' 448' ' ' VAL . 7.1 t -98.94 144.7 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.905 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 9.1 m -118.52 -36.82 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.653 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 3.0 p -144.68 179.59 7.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.495 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.86 94.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.072 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.413 ' HA ' ' CH2' ' B' ' 5' ' ' TRP . 23.8 p30 -54.82 -25.88 31.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.065 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.52 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.5 m-20 -81.52 -52.06 7.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.986 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.925 ' CG2' HG11 ' A' ' 442' ' ' VAL . 46.8 t -55.77 -35.82 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.288 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.42 ' HA ' HD12 ' A' ' 452' ' ' ILE . 10.8 t -58.74 -61.68 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.374 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -51.4 -28.76 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.493 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.563 HG11 HG21 ' A' ' 437' ' ' ILE . 59.5 t -73.32 -47.49 46.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.775 0.321 . . . . 0.0 111.009 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 383' ' ' ILE . 15.4 mt -58.17 -28.54 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.64 -6.79 26.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.442 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -100.07 -47.22 5.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.928 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -105.06 144.59 31.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 -29.03 21.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.761 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 1.4 t -109.73 97.38 6.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.535 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 437' ' ' ILE . 6.8 mt -89.71 120.13 30.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.84 85.81 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.665 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -90.56 128.13 36.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.08 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.79 HG22 ' HG3' ' A' ' 470' ' ' MET . 18.8 t -99.56 126.66 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.805 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 463' ' ' ARG . 23.9 t -115.24 154.08 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . 0.405 ' N ' HG12 ' A' ' 462' ' ' VAL . 0.0 OUTLIER -110.48 119.86 40.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.432 ' HB2' HD11 ' A' ' 469' ' ' ILE . 18.6 mtp180 -119.53 140.83 49.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.768 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 58.51 -97.34 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.34 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -140.25 24.96 2.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.757 0.313 . . . . 0.0 110.839 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -142.56 158.02 44.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.174 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.23 137.68 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.585 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.432 HD11 ' HB2' ' A' ' 464' ' ' ARG . 2.0 mt -126.91 141.86 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.79 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.3 OUTLIER -92.31 139.55 30.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.772 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.833 HG21 HD23 ' A' ' 428' ' ' LEU . 12.6 mm -128.82 134.11 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.175 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 3.0 m -107.57 132.67 53.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 474' ' ' ILE . 23.3 t -144.31 124.18 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.223 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.5 mp -115.72 110.05 44.86 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.731 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.723 ' HB3' HG23 ' A' ' 383' ' ' ILE . 20.4 Cg_endo -60.86 -178.13 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.342 2.028 . . . . 0.0 112.207 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -136.77 -178.5 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -110.35 125.8 53.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.829 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 17.0 tt -118.06 133.05 66.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.46 115.45 7.57 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo . . . . . 0 C--O 1.249 1.027 0 C-N-CA 122.448 2.098 . . . . 0.0 112.293 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.815 0.34 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.456 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 0.8 OUTLIER -67.72 -69.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 51.16 51.29 17.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pt -72.85 130.47 35.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.228 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.413 ' CH2' ' HA ' ' A' ' 446' ' ' ASN . 10.4 m0 -111.64 101.22 9.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.936 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -75.75 68.63 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.806 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.134 -179.932 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.3 m -135.28 116.91 14.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.777 0.323 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -110.23 116.37 31.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -146.75 130.62 17.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -143.89 165.6 27.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.52 146.41 27.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.856 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.433 ' CZ ' ' HA2' ' A' ' 384' ' ' GLY . 17.3 t80 -159.99 129.58 5.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.969 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.757 HG13 HG22 ' A' ' 385' ' ' ILE . 23.3 pt -116.11 -3.87 10.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.42 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.574 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 56.62 60.31 9.21 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.87 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.757 HG22 HG13 ' A' ' 383' ' ' ILE . 11.2 tt -165.08 144.09 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.351 . . . . 0.0 110.976 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.459 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 0.0 OUTLIER -100.36 157.99 16.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.714 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.523 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -154.05 137.53 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.561 ' HG2' HD11 ' A' ' 415' ' ' ILE . 1.3 ptp -115.5 173.79 6.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.115 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 89.2 p -99.34 99.78 10.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.285 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.853 HD13 ' HB2' ' A' ' 413' ' ' TYR . 7.1 tp -47.56 109.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.568 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 9.0 t -90.16 150.83 21.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 18.1 m -46.19 -36.54 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.593 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -47.15 84.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.272 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.35 -31.91 24.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.141 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -60.65 -36.23 78.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.298 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -88.89 -29.29 19.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.11 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -68.49 -25.51 65.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.178 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.01 -32.08 39.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.172 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -85.77 -29.72 23.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -37.59 48.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.994 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -53.77 6.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.088 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.72 104.24 11.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 1.8 ttt85 -83.12 60.79 5.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.737 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -142.75 13.91 1.92 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.144 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.78 150.72 48.96 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.78 ' HB2' HG22 ' A' ' 408' ' ' VAL . 50.0 Cg_exo -53.39 166.76 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.634 2.222 . . . . 0.0 112.293 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.56 3.72 43.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.61 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.78 HG22 ' HB2' ' A' ' 406' ' ' PRO . 15.6 m -70.93 112.8 6.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.856 0.36 . . . . 0.0 111.067 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.4 pp -92.26 -29.57 4.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.155 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.2 142.16 41.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.2 177.2 14.76 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -109.0 151.87 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.818 0.342 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.853 ' HB2' HD13 ' A' ' 390' ' ' LEU . 31.1 t80 -93.49 136.08 34.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 432' ' ' ASP . 40.3 mt -81.09 119.92 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.106 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.616 HD13 ' HD1' ' A' ' 413' ' ' TYR . 1.5 mm -89.27 -151.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.359 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 415' ' ' ILE . 1.9 pt-20 -79.57 142.81 35.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.831 0.348 . . . . 0.0 110.991 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 385' ' ' ILE . 21.2 t -111.27 151.25 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.172 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 421' ' ' THR . 18.5 mm -84.14 136.77 40.5 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.405 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 61.7 Cg_endo -73.09 58.98 3.6 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.43 2.086 . . . . 0.0 112.662 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 176.25 40.54 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.872 0.367 . . . . 0.0 111.028 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.574 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.1 OUTLIER -138.92 172.24 6.87 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.874 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 77.9 Cg_endo -78.38 -9.43 16.25 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.487 2.125 . . . . 0.0 112.194 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.824 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -72.57 -58.9 3.01 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.031 0.444 . . . . 0.0 110.824 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -33.3 74.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -85.56 -27.72 25.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.265 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -64.37 -70.14 1.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.36 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 169.2 28.82 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.054 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.824 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.3 OUTLIER -105.71 -175.94 2.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.901 0.382 . . . . 0.0 110.753 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.97 155.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.679 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 63.64 1.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -176.95 36.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.807 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.866 ' HB2' HD12 ' A' ' 414' ' ' ILE . 4.9 m-20 -146.24 -176.05 5.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.743 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.8 t -143.81 125.65 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.305 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.73 145.87 8.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.812 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.705 HD12 ' N ' ' A' ' 436' ' ' SER . 2.4 pp -137.87 -43.48 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.657 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.705 ' N ' HD12 ' A' ' 435' ' ' ILE . 60.3 p -122.49 152.36 40.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.915 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.641 HD12 HG11 ' A' ' 451' ' ' VAL . 0.0 OUTLIER -148.0 119.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.538 ' N ' HD13 ' A' ' 437' ' ' ILE . 13.1 p30 48.04 28.08 1.38 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.05 25.77 28.19 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.459 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -116.73 166.17 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.8 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -99.6 117.49 34.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.565 HG11 HG22 ' A' ' 448' ' ' VAL . 92.9 t -105.23 147.18 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.781 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.95 -44.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.332 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.2 p -132.88 168.31 18.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.975 0.417 . . . . 0.0 111.121 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.523 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -57.0 -37.98 72.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.071 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -58.5 -29.95 66.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.0 m-20 -76.91 -40.72 46.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.71 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.781 HG12 HD11 ' A' ' 452' ' ' ILE . 37.5 t -69.86 -35.71 66.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.096 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.445 ' HA ' HG11 ' B' ' 7' ' ' VAL . 27.2 t -57.59 -63.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.4 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -48.46 -32.49 7.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.487 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.892 HG13 ' OE2' ' A' ' 455' ' ' GLU . 55.1 t -70.84 -48.5 56.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.226 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.781 HD11 HG12 ' A' ' 448' ' ' VAL . 8.0 mt -61.65 -30.04 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.259 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -92.02 -19.02 22.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.219 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -98.67 -64.3 1.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.0 110.927 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . 0.892 ' OE2' HG13 ' A' ' 451' ' ' VAL . 1.8 mp0 -78.41 138.76 38.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.016 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . 0.423 ' O ' HG23 ' A' ' 474' ' ' ILE . 17.6 m -89.43 -34.21 16.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.753 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . 0.623 ' HA ' HD12 ' A' ' 474' ' ' ILE . 31.5 p -99.13 108.0 20.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.414 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.484 ' HB3' HD11 ' A' ' 437' ' ' ILE . 2.5 mt -108.7 120.14 41.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 111.418 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -123.74 93.46 3.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.415 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.442 ' HE2' ' HB3' ' A' ' 458' ' ' LEU . 0.0 OUTLIER -99.46 152.35 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.365 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 469' ' ' ILE . 24.3 t -114.91 127.57 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.738 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.853 HG23 HD13 ' A' ' 471' ' ' ILE . 17.7 t -114.0 138.25 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.22 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 1.2 tpp85 -106.31 134.07 50.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.973 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.594 ' HE ' HD13 ' A' ' 469' ' ' ILE . 0.2 OUTLIER -139.31 132.74 30.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.769 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 67.73 -102.69 0.86 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.305 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -140.13 28.98 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.878 0.37 . . . . 0.0 110.878 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -140.22 155.64 46.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.019 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.38 138.95 33.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.627 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.594 HD13 ' HE ' ' A' ' 464' ' ' ARG . 3.2 mt -126.73 139.25 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.192 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.602 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.3 OUTLIER -103.56 133.8 47.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.969 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.853 HD13 HG23 ' A' ' 462' ' ' VAL . 3.2 mp -135.27 148.87 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.937 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 13.8 m -134.65 125.4 27.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.081 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 422' ' ' PRO . 21.1 t -127.85 119.83 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.838 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 457' ' ' THR . 27.7 mm -105.24 109.47 63.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.314 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.449 ' HG3' HG23 ' A' ' 452' ' ' ILE . 54.3 Cg_exo -52.0 143.62 39.82 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.412 2.075 . . . . 0.0 112.282 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -100.47 -177.95 3.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.42 142.95 34.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.951 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 18.5 tt -146.24 142.14 21.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -98.67 117.53 64.39 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.442 2.095 . . . . 0.0 112.246 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.815 0.341 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.495 ' HA ' ' HE2' ' A' ' 388' ' ' MET . 97.6 p -102.33 47.17 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -70.04 74.95 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.502 HD13 ' N ' ' B' ' 4' ' ' ILE . 0.2 OUTLIER -52.64 151.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.465 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -112.08 101.95 10.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -73.28 65.03 0.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.988 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 449' ' ' SER . 17.8 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.121 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.78 38.89 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.866 0.365 . . . . 0.0 110.921 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -109.47 95.47 5.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.92 146.74 23.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -83.9 160.29 21.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -58.21 156.44 9.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.768 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.607 ' CB ' HG22 ' A' ' 478' ' ' ILE . 3.7 t80 -139.55 120.49 14.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.829 0.347 . . . . 0.0 111.5 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.774 HG13 HG22 ' A' ' 385' ' ' ILE . 12.2 pt -124.57 -2.96 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.38 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.716 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 49.32 68.08 1.49 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.887 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 1.067 HD13 HG22 ' A' ' 417' ' ' VAL . 4.5 tp -153.52 118.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.822 0.344 . . . . 0.0 110.534 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.404 ' HD2' ' CG ' ' A' ' 416' ' ' GLU . 9.5 mtt85 -91.29 132.04 36.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.482 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -138.59 143.69 39.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.73 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.427 ' HE1' ' HA ' ' B' ' 2' ' ' SER . 6.0 ptm -128.06 159.47 34.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 111.165 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 53.3 p -77.82 101.32 6.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.529 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.835 HD13 ' HB2' ' A' ' 413' ' ' TYR . 10.7 tp -55.38 100.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.136 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 11.6 t -87.53 156.25 19.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.6 t -51.59 -25.77 7.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 m -75.68 -29.13 58.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.253 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -99.84 -39.12 8.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.817 0.341 . . . . 0.0 111.056 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.558 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -58.17 -40.06 80.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.211 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -83.05 -32.08 27.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.981 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.25 -34.55 75.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.93 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.85 -39.54 76.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.864 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -59.2 -22.52 61.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.75 -23.26 22.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.07 -67.12 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.172 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -80.26 -49.08 12.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.234 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 5.0 ttm105 83.52 -39.53 0.08 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.958 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -68.23 -9.73 49.3 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -56.77 152.89 24.52 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.787 0.327 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.474 ' HG2' HG22 ' A' ' 408' ' ' VAL . 25.6 Cg_endo -61.98 -172.14 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.78 2.32 . . . . 0.0 112.525 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.05 33.55 3.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.101 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 406' ' ' PRO . 3.7 m -101.56 164.79 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.116 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.697 ' H ' HD13 ' A' ' 409' ' ' ILE . 0.2 OUTLIER -138.77 -39.53 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.459 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . 0.425 ' N ' HG12 ' A' ' 409' ' ' ILE . 0.4 OUTLIER -79.25 167.58 20.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 111.33 170.56 19.03 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.511 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -94.2 140.45 29.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 0.0 111.091 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.835 ' HB2' HD13 ' A' ' 390' ' ' LEU . 45.7 t80 -95.57 126.3 40.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.005 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 432' ' ' ASP . 18.6 mt -80.0 110.04 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.805 ' CD1' HG22 ' B' ' 4' ' ' ILE . 2.9 mp -75.24 -62.31 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.201 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.404 ' CG ' ' HD2' ' A' ' 386' ' ' ARG . 11.8 pt-20 -157.84 156.12 30.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.848 0.356 . . . . 0.0 111.221 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 1.067 HG22 HD13 ' A' ' 385' ' ' ILE . 14.0 t -128.4 142.56 43.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.531 ' HB ' HG23 ' A' ' 421' ' ' THR . 7.3 mm -88.95 136.62 30.41 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 39.7 Cg_endo -67.38 -5.87 15.03 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.639 2.226 . . . . 0.0 113.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -112.48 46.83 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.114 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.716 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -149.62 170.31 7.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.665 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 421' ' ' THR . 64.1 Cg_endo -75.5 -11.42 20.6 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.215 1.943 . . . . 0.0 111.867 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.511 ' CA ' HD12 ' A' ' 428' ' ' LEU . . . -67.07 -59.27 3.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.091 0.472 . . . . 0.0 110.936 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.05 -29.76 64.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.715 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.25 38.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.318 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -78.29 -22.18 68.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.502 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.74 16.08 5.11 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.731 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.511 HD12 ' CA ' ' A' ' 423' ' ' ALA . 0.8 OUTLIER -95.49 -171.6 2.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.368 . . . . 0.0 110.636 179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -177.32 146.5 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.791 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -176.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 33.2 m120 56.1 24.91 8.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.051 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.923 ' HB2' HD12 ' A' ' 414' ' ' ILE . 6.2 m-20 -120.48 -175.75 3.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.805 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 22.1 t -142.53 123.76 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.463 HD11 HG12 ' A' ' 414' ' ' ILE . 1.4 mp -83.79 146.59 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.588 179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.828 HD12 ' N ' ' A' ' 436' ' ' SER . 2.5 pp -135.24 -43.54 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.554 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.828 ' N ' HD12 ' A' ' 435' ' ' ILE . 24.9 p -119.99 147.77 44.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.857 0.361 . . . . 0.0 111.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.2 tt -144.87 114.33 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.061 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.408 ' ND2' HG12 ' A' ' 437' ' ' ILE . 14.1 p30 44.49 43.92 6.69 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.601 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 79.39 27.4 55.16 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.758 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.414 ' HB2' HG23 ' A' ' 437' ' ' ILE . 6.6 mm100 -131.46 126.32 34.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.916 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.19 125.54 29.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.928 HG11 ' CG2' ' A' ' 448' ' ' VAL . 3.0 t -108.94 150.75 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.19 -28.19 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.661 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 20.2 p -148.58 170.33 18.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 111.241 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.482 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -59.98 -42.24 93.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.079 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -53.67 -26.99 25.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.953 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.862 ' O ' HG23 ' A' ' 451' ' ' VAL . 2.2 m-20 -83.32 -37.99 22.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.668 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.928 ' CG2' HG11 ' A' ' 442' ' ' VAL . 41.4 t -68.23 -33.28 59.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.289 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 26.8 t -60.13 -60.29 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.281 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -53.82 -29.52 41.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.478 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 447' ' ' ASP . 42.0 t -69.2 -51.56 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.782 0.325 . . . . 0.0 111.114 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 448' ' ' VAL . 5.9 mt -57.94 -29.23 35.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.023 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -92.95 -15.09 26.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.323 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -99.16 -58.02 2.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -82.43 132.17 35.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.008 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 59.5 m -74.22 -37.02 63.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.681 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . 0.457 ' C ' HD23 ' A' ' 458' ' ' LEU . 6.4 t -107.83 127.08 53.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.558 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.709 ' HB3' HD11 ' A' ' 437' ' ' ILE . 8.6 mt -119.73 119.74 34.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.328 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . 0.467 ' OD1' HG23 ' A' ' 472' ' ' THR . 3.4 m-80 -119.15 99.67 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.426 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.99 144.41 30.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.252 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.9 t -102.82 139.25 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.452 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 463' ' ' ARG . 3.3 t -139.29 160.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 111.199 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 462' ' ' VAL . 1.3 tmm_? -97.47 119.69 36.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.625 ' HB2' HD12 ' A' ' 469' ' ' ILE . 7.7 ttt180 -109.34 119.77 40.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.383 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.49 -92.01 0.26 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.094 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -140.38 25.92 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.764 0.316 . . . . 0.0 110.829 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -144.01 154.44 43.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.79 130.16 45.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.631 ' O ' HG13 ' A' ' 461' ' ' VAL . 1.8 mt -129.02 151.49 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.311 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.527 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -93.6 119.86 33.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.444 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 13.5 mm -103.68 137.09 33.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.372 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.467 HG23 ' OD1' ' A' ' 459' ' ' ASN . 50.2 m -111.13 126.28 54.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.803 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.545 HG22 ' HA3' ' A' ' 426' ' ' GLY . 20.7 t -139.13 141.18 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 21.5 mm -124.21 117.47 26.85 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.02 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.62 162.45 34.24 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.466 2.11 . . . . 0.0 112.279 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.56 -179.74 6.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -109.04 125.86 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . 0.607 HG22 ' CB ' ' A' ' 382' ' ' TYR . 19.7 tt -134.65 123.66 42.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.152 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.9 116.23 62.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.824 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--O 1.249 1.056 0 C-N-CA 122.462 2.108 . . . . 0.0 112.341 179.89 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.81 0.338 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.427 ' HA ' ' HE1' ' A' ' 388' ' ' MET . 19.5 m -89.85 54.27 2.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.018 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -65.2 79.99 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.573 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.805 HG22 ' CD1' ' A' ' 415' ' ' ILE . 2.2 pt -85.29 140.37 16.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.36 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -113.19 95.16 5.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -72.89 66.26 0.77 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.785 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.524 ' O ' HG12 ' B' ' 7' ' ' VAL . 21.8 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.111 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 112.581 -0.208 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 27.6 m -78.19 146.97 34.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 60.04 76.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.986 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 4.0 ptp -78.3 -172.14 2.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 55.2 tttt 64.22 90.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.971 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 475' ' ' PRO . 27.7 mttm -77.15 -176.64 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.698 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -128.41 125.05 37.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.377 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.736 HG13 HG22 ' A' ' 385' ' ' ILE . 30.5 pt -136.84 -1.72 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.874 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.696 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 48.14 70.67 0.7 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.993 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.984 HD13 HG22 ' A' ' 417' ' ' VAL . 6.8 tp -165.22 121.08 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 111.271 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.612 ' HB2' ' HB ' ' A' ' 415' ' ' ILE . 1.5 mtt85 -90.78 139.2 30.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.722 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.507 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -140.13 146.39 38.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.915 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.441 ' C ' ' HB2' ' A' ' 445' ' ' ALA . 1.4 ptp -120.62 -179.64 4.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.019 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 13.4 p -103.39 105.74 16.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.648 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 413' ' ' TYR . 4.6 tp -57.0 99.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.054 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.5 t -80.74 162.65 24.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.832 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 53.4 p -57.91 -20.54 37.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 20.6 m -77.6 -33.41 53.8 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.096 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.24 -49.49 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.164 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.467 ' HB2' ' HG ' ' A' ' 390' ' ' LEU . . . -52.01 -34.11 41.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.615 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.38 -26.79 23.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.164 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.64 -39.11 73.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 10.7 mt -58.01 -32.2 67.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.061 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -80.92 -26.25 36.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.052 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.13 -26.07 20.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.105 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.13 -42.22 13.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . 0.432 ' O ' ' CB ' ' A' ' 403' ' ' ARG . 0.0 OUTLIER -93.62 -53.65 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.011 -179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.432 ' CB ' ' O ' ' A' ' 402' ' ' HIS . 4.6 mtt180 84.55 -23.13 0.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.599 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.49 -23.8 32.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -58.39 147.4 68.37 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.58 ' HB2' HG22 ' A' ' 408' ' ' VAL . 41.8 Cg_endo -67.62 166.98 22.19 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.571 2.181 . . . . 0.0 112.233 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.16 -23.31 64.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.176 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 406' ' ' PRO . 15.5 m -54.97 91.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.885 0.374 . . . . 0.0 111.309 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -81.9 -30.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 2.8 p -69.35 151.33 46.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 125.01 -177.51 16.86 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.758 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.682 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -110.68 170.55 8.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.808 ' HB2' HD13 ' A' ' 390' ' ' LEU . 24.1 t80 -116.8 137.79 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.037 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.883 HD12 ' HB2' ' A' ' 432' ' ' ASP . 21.9 mt -86.04 117.29 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.612 ' HB ' ' HB2' ' A' ' 386' ' ' ARG . 12.4 mm -75.24 -68.39 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.125 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.714 ' O ' HD12 ' A' ' 385' ' ' ILE . 9.5 pt-20 -159.92 150.23 18.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.732 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.984 HG22 HD13 ' A' ' 385' ' ' ILE . 20.4 t -113.72 151.4 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.13 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.604 ' HB ' HG23 ' A' ' 421' ' ' THR . 17.9 mm -86.7 143.51 35.86 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.807 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.444 ' HD2' ' CG2' ' A' ' 418' ' ' ILE . 37.1 Cg_exo -61.9 -7.92 10.57 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.8 2.333 . . . . 0.0 113.594 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -135.08 71.51 1.44 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.701 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.696 HG21 ' HA3' ' A' ' 384' ' ' GLY . 24.5 p -149.7 156.3 38.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.351 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.63 -21.16 70.19 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.143 1.895 . . . . 0.0 110.351 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.899 ' HB1' HD12 ' A' ' 428' ' ' LEU . . . -66.2 -60.05 3.17 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.496 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.95 -32.82 74.54 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.055 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -74.14 -25.68 59.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.969 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -75.12 -66.44 1.91 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.191 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 162.08 29.8 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.64 -0.79 . . . . 0.0 113.158 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.899 HD12 ' HB1' ' A' ' 423' ' ' ALA . 0.6 OUTLIER -99.24 -175.72 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.945 0.403 . . . . 0.0 110.748 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.73 139.84 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.719 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.38 179.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.5 m120 62.41 19.99 11.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.994 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.883 ' HB2' HD12 ' A' ' 414' ' ' ILE . 8.2 m-20 -120.28 -176.03 3.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.671 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.682 HG13 ' O ' ' A' ' 412' ' ' ALA . 26.1 t -147.97 117.26 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 111.524 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.466 HG23 ' HB3' ' A' ' 460' ' ' MET . 1.6 mp -76.57 152.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.189 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.685 HD12 ' N ' ' A' ' 436' ' ' SER . 1.7 pp -139.35 -51.46 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.706 0.289 . . . . 0.0 111.764 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.685 ' N ' HD12 ' A' ' 435' ' ' ILE . 84.2 p -113.02 144.27 42.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.807 0.337 . . . . 0.0 111.091 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.724 HD11 ' HB3' ' A' ' 458' ' ' LEU . 1.1 tt -140.7 113.58 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.413 ' ND2' HG12 ' A' ' 437' ' ' ILE . 11.7 p30 43.9 45.67 6.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.533 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 73.72 52.46 8.23 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.703 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -148.9 157.96 43.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.654 0.264 . . . . 0.0 110.814 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 36.7 m -103.21 114.47 28.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.245 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.961 HG11 HG22 ' A' ' 448' ' ' VAL . 21.6 t -99.34 141.69 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.018 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.98 -37.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.503 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -144.14 172.43 12.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 111.264 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.507 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.37 -41.79 76.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.086 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -55.35 -29.52 58.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.712 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 451' ' ' VAL . 3.0 m-20 -80.01 -33.94 38.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.751 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.961 HG22 HG11 ' A' ' 442' ' ' VAL . 26.0 t -72.99 -38.77 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.143 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.632 ' HA ' HD12 ' A' ' 452' ' ' ILE . 12.1 t -55.63 -63.13 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.515 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -48.83 -28.41 3.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.375 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 447' ' ' ASP . 38.7 t -72.86 -49.6 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.168 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.632 HD12 ' HA ' ' A' ' 449' ' ' SER . 5.2 mt -57.86 -26.44 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 1.6 mtpp -100.13 -11.52 20.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.421 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 9.6 ttt85 -99.79 -47.72 4.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.719 0.295 . . . . 0.0 111.012 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -98.72 150.32 21.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.044 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 -33.85 11.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.661 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 457' ' ' THR . 5.2 t -106.15 96.21 6.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.576 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.724 ' HB3' HD11 ' A' ' 437' ' ' ILE . 12.3 mt -90.24 122.03 32.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -113.9 90.51 3.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.585 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.501 ' CG ' HD12 ' A' ' 437' ' ' ILE . 5.2 mtm -99.83 131.73 45.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.27 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 469' ' ' ILE . 21.4 t -99.79 119.91 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.817 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.731 HG23 HD13 ' A' ' 471' ' ' ILE . 6.7 t -103.82 160.0 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . 0.452 ' N ' HG12 ' A' ' 462' ' ' VAL . 5.5 tmm_? -116.03 131.01 57.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.834 ' HB2' HD11 ' A' ' 469' ' ' ILE . 9.9 mtp180 -136.34 119.94 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.75 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.42 -109.92 3.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.494 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -126.59 27.14 6.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.659 0.266 . . . . 0.0 111.061 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.97 157.83 44.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.876 0.37 . . . . 0.0 111.161 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -98.3 150.14 21.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.631 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.834 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mp -129.37 136.63 58.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.885 0.374 . . . . 0.0 111.331 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.5 ' C ' HD12 ' A' ' 471' ' ' ILE . 0.1 OUTLIER -100.25 122.07 42.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.293 179.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.731 HD13 HG23 ' A' ' 462' ' ' VAL . 3.3 mp -125.4 126.73 71.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.926 0.394 . . . . 0.0 111.706 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.8 m -114.03 119.61 37.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.066 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.709 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.5 t -132.32 141.38 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.006 0.431 . . . . 0.0 111.704 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.709 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -114.95 114.17 43.96 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.422 ' HA ' HG22 ' A' ' 383' ' ' ILE . 15.1 Cg_endo -57.27 135.54 70.88 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.362 2.042 . . . . 0.0 112.362 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -89.32 151.85 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -99.84 133.46 44.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.683 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 478' ' ' ILE . 1.9 tt -134.13 115.61 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.111 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.42 125.85 62.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.865 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--O 1.249 1.039 0 C-N-CA 122.39 2.06 . . . . 0.0 112.254 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.795 0.331 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m 59.83 44.38 13.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -72.97 113.65 10.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.836 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.47 145.57 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -113.54 99.83 8.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.42 ' CZ2' ' NH2' ' A' ' 386' ' ' ARG . 2.4 t90 -76.17 72.12 2.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.755 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.11 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.3 p -124.58 158.71 32.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.821 0.343 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.77 38.78 17.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -118.59 120.97 39.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.963 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -132.96 -66.83 0.65 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.786 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -67.16 137.97 56.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.534 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -131.87 119.95 21.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.31 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.633 HD12 ' CG2' ' A' ' 385' ' ' ILE . 24.8 pt -122.53 -12.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.611 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.727 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 54.85 69.66 1.19 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.057 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.633 ' CG2' HD12 ' A' ' 383' ' ' ILE . 11.3 tt -165.27 152.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 0.0 111.026 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.496 ' HG3' ' HB ' ' A' ' 415' ' ' ILE . 1.8 ptm180 -122.07 132.05 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.5 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.508 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -128.52 131.69 48.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.006 -179.58 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.486 ' HE3' ' HA ' ' B' ' 2' ' ' SER . 10.0 ptm -109.64 158.44 18.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.037 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 33.7 p -87.57 109.12 19.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.678 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 398' ' ' LEU . 5.4 tp -56.07 114.64 2.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.502 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.3 t -86.46 159.09 19.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.797 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 20.4 t -56.05 -25.7 46.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.233 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.32 -39.14 54.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.093 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.502 ' H ' HG23 ' A' ' 391' ' ' THR . 25.3 mmtt -87.44 -27.25 22.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -56.06 -42.14 76.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.288 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 16.3 ttmt -85.98 -30.21 22.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -63.82 -32.42 73.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 390' ' ' LEU . 6.2 mt -66.07 -55.55 15.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.2 -30.92 68.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -51.41 30.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.875 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -34.0 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.801 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -119.71 104.69 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -82.07 59.23 4.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -159.8 26.91 0.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.876 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.14 151.96 38.16 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.607 ' HG2' HG22 ' A' ' 408' ' ' VAL . 37.2 Cg_endo -65.92 -176.16 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.583 2.189 . . . . 0.0 112.328 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -96.14 20.25 10.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.607 HG22 ' HG2' ' A' ' 406' ' ' PRO . 13.2 m -89.62 160.5 2.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.814 0.34 . . . . 0.0 110.927 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.33 -33.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.801 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.3 m -93.9 159.37 15.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 0.0 110.89 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 131.7 165.49 11.4 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . . . . . . . . . . . -92.79 138.25 31.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.857 ' HB2' HD13 ' A' ' 390' ' ' LEU . 43.5 t80 -92.62 128.2 38.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.053 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.912 HD12 ' HB2' ' A' ' 432' ' ' ASP . 13.9 mt -79.71 116.91 24.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.27 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.52 ' CD1' HG22 ' B' ' 4' ' ' ILE . 4.8 mt -83.76 -68.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.639 -178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 430' ' ' GLU . 10.5 pt-20 -159.58 144.71 15.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.994 0.426 . . . . 0.0 111.305 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.614 HG22 HD12 ' A' ' 385' ' ' ILE . 8.5 t -116.66 137.42 50.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.846 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.52 ' HB ' ' CG2' ' A' ' 421' ' ' THR . 4.9 mm -79.66 138.86 54.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.675 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 418' ' ' ILE . 27.0 Cg_exo -62.75 -10.39 19.67 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.909 2.406 . . . . 0.0 113.771 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.33 55.8 0.73 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 111.001 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.727 HG21 ' HA3' ' A' ' 384' ' ' GLY . 1.1 p -153.96 157.95 32.5 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.309 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.07 -25.17 79.06 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.432 2.088 . . . . 0.0 111.251 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.551 ' HB3' ' CG1' ' A' ' 417' ' ' VAL . . . -58.72 -58.45 8.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.008 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.81 -30.24 68.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.667 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -75.74 -26.55 57.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.104 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -73.25 -30.15 63.21 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.204 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 119.82 23.16 3.12 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.819 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.83 HD23 HG21 ' A' ' 471' ' ' ILE . 0.9 OUTLIER -91.73 -176.65 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.748 0.309 . . . . 0.0 110.768 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.17 159.65 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.919 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 416' ' ' GLU . 0.0 OUTLIER -71.65 -176.98 1.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.048 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 59.41 27.57 16.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.912 ' HB2' HD12 ' A' ' 414' ' ' ILE . 7.1 m-20 -125.23 -177.93 4.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.703 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 23.0 t -146.27 124.01 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.897 0.379 . . . . 0.0 111.495 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 435' ' ' ILE . 3.4 mt -89.34 154.33 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.715 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.739 HD12 ' N ' ' A' ' 436' ' ' SER . 2.0 pp -141.69 -48.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.745 0.307 . . . . 0.0 111.717 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.739 ' N ' HD12 ' A' ' 435' ' ' ILE . 77.1 p -113.8 152.93 29.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.124 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.653 HG21 HG11 ' A' ' 451' ' ' VAL . 7.6 tt -150.83 112.76 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.42 ' ND2' HG12 ' A' ' 437' ' ' ILE . 18.0 p30 44.98 41.51 5.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.679 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 80.55 23.92 59.55 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.851 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.459 ' HB2' HG23 ' A' ' 437' ' ' ILE . 6.8 mm100 -125.05 120.68 32.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.699 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 11.5 p -72.69 123.35 23.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.258 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.955 HG11 HG22 ' A' ' 448' ' ' VAL . 10.2 t -107.67 143.14 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.833 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.68 4.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . . . . . . . . . 1.1 p -170.2 164.72 9.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.891 0.377 . . . . 0.0 111.222 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.508 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -58.07 -45.18 87.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.06 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.425 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 23.7 p30 -57.34 -29.15 63.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.78 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.824 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.6 m-20 -75.12 -35.56 61.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.955 HG22 HG11 ' A' ' 442' ' ' VAL . 33.5 t -73.02 -39.46 57.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.376 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 452' ' ' ILE . 23.0 t -57.02 -63.94 1.04 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.458 -179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -47.1 -32.2 4.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.423 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 447' ' ' ASP . 45.6 t -68.85 -45.54 80.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.975 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 449' ' ' SER . 22.1 mt -59.65 -29.66 43.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.54 -6.09 30.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.356 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.06 -46.96 5.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.28 155.35 20.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 8.5 t -97.8 -35.85 10.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.72 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.3 95.93 6.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.702 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.6 ' HB3' HD11 ' A' ' 437' ' ' ILE . 4.8 mt -94.0 119.29 32.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.048 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.25 93.28 4.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.462 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -98.53 160.29 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.671 HG22 ' HG3' ' A' ' 470' ' ' MET . 20.3 t -119.56 127.6 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.801 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 4.5 t -117.3 141.16 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.919 0.39 . . . . 0.0 111.352 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -96.73 119.88 36.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.876 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.37 126.78 48.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.832 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 61.25 -99.17 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.373 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -139.92 29.32 2.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.922 0.392 . . . . 0.0 110.837 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -141.74 147.99 38.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.089 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -90.11 136.26 33.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.744 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . . . . . . . . . 3.6 mt -127.38 136.0 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.969 0.414 . . . . 0.0 111.34 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -97.14 119.9 36.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.534 179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.83 HG21 HD23 ' A' ' 428' ' ' LEU . 18.1 mm -115.36 145.1 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.189 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 31.0 m -135.04 132.8 38.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.814 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.652 ' C ' HD12 ' A' ' 474' ' ' ILE . 21.8 t -141.08 138.33 33.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.248 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.652 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -112.66 109.99 52.76 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.432 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.0 Cg_endo -59.4 119.1 6.13 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.332 2.022 . . . . 0.0 112.14 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -79.92 169.0 18.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -97.01 147.61 23.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 1.7 tt -154.02 140.41 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.11 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -118.73 123.04 29.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.768 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.249 1.026 0 C-N-CA 122.488 2.125 . . . . 0.0 112.268 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.869 0.366 . . . . 0.0 111.157 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.486 ' HA ' ' HE3' ' A' ' 388' ' ' MET . 0.7 OUTLIER -60.05 -69.63 0.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.728 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 54.05 52.17 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.833 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 415' ' ' ILE . 1.3 pp -75.45 155.34 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.42 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.425 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 20.8 m95 -127.34 79.65 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.706 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -67.51 75.09 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.56 ' O ' HG12 ' B' ' 7' ' ' VAL . 22.0 t . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.064 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.01 79.15 1.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.901 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 62.28 149.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.53 36.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.08 98.59 10.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.082 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -127.52 169.11 14.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.649 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . 0.471 ' HB2' HG21 ' A' ' 478' ' ' ILE . 51.6 t80 -147.01 128.41 14.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.344 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 385' ' ' ILE . 7.1 pt -118.31 -10.62 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.464 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.731 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 60.83 71.06 0.85 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.828 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.966 HD13 HG22 ' A' ' 417' ' ' VAL . 7.3 tp -164.41 123.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.811 0.338 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -89.71 129.61 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' B' ' 5' ' ' TRP . 0.0 OUTLIER -132.88 146.56 51.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.851 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.416 ' HB3' HD11 ' A' ' 415' ' ' ILE . 7.0 ptm -127.82 160.84 30.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 3.7 p -80.05 101.67 8.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.63 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.922 HD13 ' HB2' ' A' ' 413' ' ' TYR . 8.2 tp -54.65 108.8 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.272 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 1.6 t -88.82 157.78 18.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.858 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.56 -25.55 60.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.59 -27.93 61.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.113 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt -99.61 -40.1 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -57.52 -33.36 67.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -89.97 -34.76 15.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.998 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.54 -37.07 74.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 79.8 mt -66.81 -32.48 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -68.22 -41.67 80.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -56.34 8.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.49 -33.73 76.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.847 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -130.96 105.98 8.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.809 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.39 55.94 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.051 0.453 . . . . 0.0 110.946 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -125.45 -20.18 4.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.337 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.77 129.09 88.76 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.028 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.525 ' HG2' HG22 ' A' ' 408' ' ' VAL . 33.1 Cg_endo -64.14 -167.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.486 2.124 . . . . 0.0 112.271 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -92.88 64.8 4.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.525 HG22 ' HG2' ' A' ' 406' ' ' PRO . 14.1 m -137.79 81.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 410' ' ' SER . 2.7 pp -59.38 -31.19 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . 0.48 ' N ' HD12 ' A' ' 409' ' ' ILE . 0.8 OUTLIER -93.41 144.73 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 -179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 137.82 178.23 15.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.625 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.494 ' O ' HG13 ' A' ' 433' ' ' VAL . . . -100.77 158.18 16.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.735 0.302 . . . . 0.0 111.019 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.922 ' HB2' HD13 ' A' ' 390' ' ' LEU . 13.0 t80 -114.82 127.75 55.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.896 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.861 ' CG2' HD11 ' A' ' 385' ' ' ILE . 4.6 mt -80.71 118.82 29.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.75 HD13 HG22 ' B' ' 4' ' ' ILE . 5.1 mt -83.65 -55.36 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.568 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . 0.82 ' O ' HD12 ' A' ' 385' ' ' ILE . 4.3 pt-20 -160.68 162.89 32.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.349 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.966 HG22 HD13 ' A' ' 385' ' ' ILE . 25.5 t -119.7 155.63 22.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.672 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' A' ' 419' ' ' PRO . 1.7 mp -95.27 139.41 22.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 420' ' ' ASP . 21.3 Cg_endo -60.73 102.93 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.455 2.103 . . . . 0.0 112.205 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 419' ' ' PRO . 13.2 m-20 94.0 77.36 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.144 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.731 HG21 ' HA3' ' A' ' 384' ' ' GLY . 0.8 OUTLIER -150.65 158.09 35.74 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.175 -179.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.19 -22.45 74.19 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.124 1.883 . . . . 0.0 110.726 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.466 ' CA ' ' HG ' ' A' ' 428' ' ' LEU . . . -64.74 -60.07 3.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.912 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . 0.74 ' HB2' HG11 ' A' ' 417' ' ' VAL . 1.9 tm-20 -72.82 -39.86 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.974 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.09 -33.28 70.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.276 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -78.61 -70.15 1.34 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.596 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 174.48 39.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.453 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.492 HD21 HG21 ' A' ' 473' ' ' VAL . 0.1 OUTLIER -87.61 175.45 7.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.921 0.391 . . . . 0.0 111.166 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -165.01 143.54 6.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.492 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 415' ' ' ILE . 3.6 pt-20 -87.05 47.48 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.362 . . . . 0.0 111.291 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -169.53 33.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.582 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -131.89 -179.52 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 412' ' ' ALA . 30.6 t -134.65 121.31 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.419 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 2.9 mt -76.04 150.93 6.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.531 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.6 HD12 ' HB3' ' A' ' 436' ' ' SER . 1.5 pp -141.38 -50.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.6 ' HB3' HD12 ' A' ' 435' ' ' ILE . 17.4 p -112.04 159.21 18.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.955 0.407 . . . . 0.0 111.213 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.595 HD11 ' HB3' ' A' ' 458' ' ' LEU . 2.5 tt -164.14 114.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.078 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . 0.4 ' ND2' HG12 ' A' ' 437' ' ' ILE . 17.0 p30 46.11 34.22 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.666 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.45 32.86 24.06 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.69 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . 0.572 ' HB2' HG23 ' A' ' 437' ' ' ILE . 0.2 OUTLIER -128.09 134.3 49.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 110.64 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.29 104.6 14.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.282 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.874 HG11 HG22 ' A' ' 448' ' ' VAL . 32.9 t -88.06 136.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.801 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.64 -3.66 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 448' ' ' VAL . 0.7 OUTLIER -169.95 168.76 8.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.936 0.398 . . . . 0.0 111.238 -179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . . . . . . . . . . . -57.97 -46.48 85.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.01 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -54.79 -27.53 42.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 451' ' ' VAL . 1.9 m-20 -79.81 -33.68 40.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.795 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.874 HG22 HG11 ' A' ' 442' ' ' VAL . 25.0 t -72.06 -40.35 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.264 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 4.5 t -56.07 -59.13 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.453 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -52.75 -25.6 11.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.568 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.857 HG13 ' OE2' ' A' ' 455' ' ' GLU . 47.1 t -76.01 -49.33 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.341 . . . . 0.0 111.123 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.502 HD11 HG12 ' A' ' 448' ' ' VAL . 8.0 mt -59.43 -26.45 34.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.161 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.36 -19.32 18.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.252 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -96.39 -60.88 1.52 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.81 0.338 . . . . 0.0 110.744 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . 0.857 ' OE2' HG13 ' A' ' 451' ' ' VAL . 2.0 mp0 -83.75 124.57 31.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 67.9 m -71.83 -37.26 70.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 9.0 p -101.65 123.58 45.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.76 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.595 ' HB3' HD11 ' A' ' 437' ' ' ILE . 7.5 mt -107.73 119.93 40.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.988 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -118.66 84.5 2.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.634 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . . . . . . . . . 2.3 mtt -91.48 161.29 15.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.037 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 469' ' ' ILE . 19.4 t -132.41 126.12 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.948 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.785 HG23 HD13 ' A' ' 471' ' ' ILE . 10.0 t -125.24 150.19 30.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.102 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -106.42 126.68 52.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.514 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.4 mtp-105 -125.34 133.27 52.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.736 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 68.92 -104.94 1.34 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.236 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.49 25.93 3.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.834 0.35 . . . . 0.0 110.692 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -146.52 149.65 34.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.045 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -91.46 142.84 27.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.59 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.587 ' O ' HG13 ' A' ' 461' ' ' VAL . 2.6 mt -128.63 155.39 40.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.381 . . . . 0.0 111.349 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . . . . . . . . . 3.9 mmt -109.54 119.9 40.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.479 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . 0.785 HD13 HG23 ' A' ' 462' ' ' VAL . 3.7 mp -108.96 120.61 60.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.371 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 19.3 m -102.28 121.5 42.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.552 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.492 HG21 HD21 ' A' ' 428' ' ' LEU . 23.2 t -127.85 144.31 38.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.486 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . . . . . . . . . 28.3 mm -127.77 109.9 20.47 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.855 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.56 ' HB3' HG23 ' A' ' 383' ' ' ILE . 18.1 Cg_endo -59.72 149.65 81.64 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.394 2.063 . . . . 0.0 112.288 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.45 176.84 5.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -103.55 139.44 38.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.86 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . 0.471 HG21 ' HB2' ' A' ' 382' ' ' TYR . 10.0 tt -149.14 143.54 18.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -122.03 117.95 29.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--O 1.25 1.104 0 C-N-CA 122.388 2.058 . . . . 0.0 112.339 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.837 0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m 60.65 45.33 10.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 -66.76 88.34 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.75 HG22 HD13 ' A' ' 415' ' ' ILE . 24.3 pt -74.35 141.24 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.41 ' HB3' ' HE2' ' A' ' 387' ' ' MET . 9.2 m95 -119.58 94.09 4.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.38 77.73 0.75 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.821 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.418 HG12 ' OXT' ' B' ' 7' ' ' VAL . 11.7 t . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.272 -0.871 . . . . 0.0 111.156 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 24.2 p -171.31 106.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 59.48 29.44 19.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.859 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' MET . . . . . . . . . . . . . 64.0 mmm -130.75 68.82 1.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -140.78 177.29 8.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.762 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 475' ' ' PRO . 24.6 mttm -59.64 -178.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.788 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -160.04 128.42 4.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.175 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.591 HG23 ' HB3' ' A' ' 475' ' ' PRO . 12.7 pt -118.48 -5.74 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.271 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . 0.445 ' HA3' HG21 ' A' ' 421' ' ' THR . . . 55.78 66.15 3.05 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.654 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ILE . . . . . 0.896 HG12 HG22 ' A' ' 417' ' ' VAL . 0.0 OUTLIER -153.45 124.81 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.875 0.369 . . . . 0.0 110.815 179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' ARG . . . . . 0.617 ' N ' HD13 ' A' ' 385' ' ' ILE . 25.3 mtt180 -90.2 123.88 34.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.069 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' MET . . . . . 0.475 ' SD ' ' HB1' ' A' ' 445' ' ' ALA . 0.0 OUTLIER -131.21 145.03 51.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' MET . . . . . 0.541 ' O ' ' HB1' ' A' ' 412' ' ' ALA . 0.7 OUTLIER -122.23 179.09 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' SER . . . . . . . . . . . . . 86.6 p -104.75 104.83 14.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.665 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' LEU . . . . . 0.776 HD13 ' HB2' ' A' ' 413' ' ' TYR . 6.2 tp -51.97 114.81 1.42 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.269 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 394' ' ' LYS . 1.3 t -90.23 170.16 10.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 56.2 m -67.84 -14.5 63.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.527 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.3 t -87.94 -35.96 17.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.77 0.319 . . . . 0.0 111.204 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.464 ' H ' HG23 ' A' ' 391' ' ' THR . 0.6 OUTLIER -84.86 -30.92 24.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.097 -179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.16 -43.95 98.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -76.53 -33.31 58.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.083 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -29.18 70.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.066 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 57.0 mt -74.49 -49.34 22.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.041 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' LYS . . . . . . . . . . . . . 7.9 mtmm -58.59 -30.37 67.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.092 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -68.36 -37.57 80.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.997 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.95 -65.31 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.911 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -60.56 -58.4 8.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . . . . . . . . . 8.0 mtt-85 75.8 -54.05 0.62 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.362 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -44.72 -29.7 0.81 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.629 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -56.01 138.91 71.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.78 -159.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.485 2.123 . . . . 0.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -101.57 27.31 6.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . . . . . . . . . 4.2 m -71.74 140.3 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.109 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' ILE . . . . . . . . . . . . . 1.2 pt -110.98 -30.4 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 16.8 m -101.62 -178.2 3.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.895 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 112.61 167.21 17.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.598 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' ALA . . . . . 0.541 ' HB1' ' O ' ' A' ' 388' ' ' MET . . . -108.6 151.6 25.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 0.0 111.14 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' TYR . . . . . 0.776 ' HB2' HD13 ' A' ' 390' ' ' LEU . 52.8 t80 -101.46 128.72 47.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ILE . . . . . 0.937 HD12 ' HB2' ' A' ' 432' ' ' ASP . 16.1 mt -79.94 114.62 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.826 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' ILE . . . . . 0.833 ' CD1' HG22 ' B' ' 4' ' ' ILE . 4.1 mt -78.76 -66.64 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.59 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.27 158.57 41.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.992 0.425 . . . . 0.0 111.585 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' VAL . . . . . 0.896 HG22 HG12 ' A' ' 385' ' ' ILE . 41.3 t -130.63 153.3 38.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.824 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' ILE . . . . . 0.829 HG22 ' H ' ' A' ' 420' ' ' ASP . 1.1 mp -97.22 129.8 31.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.523 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.98 -12.91 16.69 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.009 2.473 . . . . 0.0 113.857 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' ASP . . . . . 0.829 ' H ' HG22 ' A' ' 418' ' ' ILE . 4.0 m-20 -111.24 53.48 0.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.061 0.458 . . . . 0.0 110.375 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' THR . . . . . 0.445 HG21 ' HA3' ' A' ' 384' ' ' GLY . 18.1 p -153.89 153.82 29.2 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.095 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -55.58 -24.46 45.02 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.099 1.866 . . . . 0.0 110.906 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 428' ' ' LEU . . . -58.81 -60.25 4.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -72.37 -30.96 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.726 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -78.0 -15.46 58.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.379 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . 0.412 ' HA3' HG22 ' A' ' 473' ' ' VAL . . . -84.07 -31.85 24.89 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.349 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 125.59 16.97 2.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.153 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 423' ' ' ALA . 3.9 mt -85.69 -171.21 3.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.133 0.467 . . . . 0.0 110.74 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.86 153.87 0.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.43 -178.91 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 62.87 28.59 16.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.937 ' HB2' HD12 ' A' ' 414' ' ' ILE . 54.3 m-20 -132.63 170.02 15.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.751 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.26 127.06 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.324 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.586 HD11 HG12 ' A' ' 414' ' ' ILE . 2.1 mp -84.89 147.85 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.569 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.821 HD12 ' N ' ' A' ' 436' ' ' SER . 2.2 pp -137.99 -43.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.728 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' SER . . . . . 0.821 ' N ' HD12 ' A' ' 435' ' ' ILE . 23.6 p -124.94 151.94 44.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.091 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' ILE . . . . . 0.729 HD12 ' CG ' ' A' ' 460' ' ' MET . 1.5 tt -148.81 115.02 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.982 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' ASN . . . . . . . . . . . . . 12.7 p30 47.64 36.36 5.4 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.641 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLY . . . . . . . . . . . . . . . 83.03 30.18 32.18 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.747 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -122.78 145.69 48.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.778 0.323 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.2 t -86.76 107.88 18.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.605 HG11 HG22 ' A' ' 448' ' ' VAL . 62.0 t -93.16 152.45 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.805 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.428 HG23 ' N ' ' A' ' 444' ' ' SER . 10.7 m -139.76 -46.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.184 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' SER . . . . . 0.428 ' N ' HG23 ' A' ' 443' ' ' VAL . 2.3 p -132.64 166.48 22.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.999 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' ALA . . . . . 0.475 ' HB1' ' SD ' ' A' ' 387' ' ' MET . . . -56.21 -38.05 70.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.293 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' ASN . . . . . 0.4 ' HA ' ' CZ3' ' B' ' 5' ' ' TRP . 5.4 p30 -58.53 -29.67 66.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 451' ' ' VAL . 0.7 OUTLIER -77.63 -41.26 39.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.866 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' VAL . . . . . 0.686 HG12 HD11 ' A' ' 452' ' ' ILE . 32.9 t -63.16 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.269 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . 0.704 ' HA ' HD12 ' A' ' 452' ' ' ILE . 3.6 t -54.89 -66.05 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.547 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -48.48 -27.61 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 447' ' ' ASP . 40.7 t -75.62 -46.12 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.289 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' ILE . . . . . 0.704 HD12 ' HA ' ' A' ' 449' ' ' SER . 6.4 mt -58.76 -32.9 47.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.123 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.8 -4.15 44.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.628 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -100.38 -49.7 4.16 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -99.67 150.25 22.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 -35.88 14.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.807 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.21 96.83 6.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.729 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.727 ' HB3' HD11 ' A' ' 437' ' ' ILE . 10.6 mt -91.35 121.16 32.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.15 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' ASN . . . . . 0.523 ' CG ' HG23 ' A' ' 472' ' ' THR . 5.9 m-80 -111.78 90.21 3.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.808 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' MET . . . . . 0.729 ' CG ' HD12 ' A' ' 437' ' ' ILE . 3.2 mtm -95.71 130.35 42.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.105 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' VAL . . . . . 0.599 HG22 ' HG3' ' A' ' 470' ' ' MET . 22.1 t -99.22 122.82 51.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.956 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 432' ' ' ASP . 3.9 t -111.64 148.61 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.953 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.27 131.35 52.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.115 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' ARG . . . . . 0.613 ' HB2' HD11 ' A' ' 469' ' ' ILE . 17.9 mtp180 -138.74 125.53 20.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.668 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLY . . . . . . . . . . . . . . . 69.52 -101.4 0.83 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.464 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -140.12 25.39 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.655 0.264 . . . . 0.0 111.116 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -140.08 151.77 45.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.821 0.344 . . . . 0.0 111.2 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.08 139.24 31.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.485 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 464' ' ' ARG . 1.2 mt -125.62 129.18 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.836 0.351 . . . . 0.0 111.362 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' MET . . . . . 0.599 ' HG3' HG22 ' A' ' 461' ' ' VAL . 0.0 OUTLIER -93.8 120.11 33.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.51 179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ILE . . . . . . . . . . . . . 8.6 mm -117.8 142.9 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.31 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.523 HG23 ' CG ' ' A' ' 459' ' ' ASN . 1.3 m -123.45 136.03 54.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.633 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' VAL . . . . . 0.687 ' C ' HD12 ' A' ' 474' ' ' ILE . 5.7 t -143.82 137.78 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.249 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' ILE . . . . . 0.687 HD12 ' C ' ' A' ' 473' ' ' VAL . 1.4 mp -113.66 109.8 50.26 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' PRO . . . . . 0.591 ' HB3' HG23 ' A' ' 383' ' ' ILE . 28.8 Cg_endo -63.07 134.14 44.55 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.388 2.059 . . . . 0.0 112.256 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.89 -177.4 5.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.988 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -124.38 122.34 37.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.874 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' ILE . . . . . . . . . . . . . 15.8 tt -106.08 145.49 13.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -149.56 111.58 3.42 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo . . . . . 0 C--O 1.25 1.086 0 C-N-CA 122.446 2.097 . . . . 0.0 112.371 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 64.5 p -96.78 40.67 1.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.97 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 25.8 mtm-85 -58.09 89.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ILE . . . . . 0.833 HG22 ' CD1' ' A' ' 415' ' ' ILE . 5.0 pt -83.36 115.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' TRP . . . . . 0.4 ' CZ3' ' HA ' ' A' ' 446' ' ' ASN . 11.5 m0 -99.76 101.29 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.97 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 386' ' ' ARG . 8.8 t90 -82.59 63.32 6.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.787 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.463 ' O ' HG12 ' B' ' 7' ' ' VAL . 25.5 t . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.059 -179.949 . . . . . . . . 1 1 . 1 stop_ save_